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Genomic instability and more specifically aneuploidy, is a phenotype exhibited by
the majority of colorectal tumours and is associated with poor prognosis. It has been
hypothesised that mutations in genes involved in chromosome segregation and
mitotic checkpoints may contribute to aneuploid phenotypes in colon tumours. In
support of this hypothesis deletions and missense mutations in spindle checkpoint
genes BUB1 and BUBR1 have previously been reported in non-diploid colon cancers
with defective mitotic checkpoints, which also display chromosomal instability.
We identified a deleted BUBR1 transcript in 25% of a panel of aneuploid
colorectal tumours. The deletion, termed AE5, removes a protein domain that is
conserved between BUB1 and BUBR1 in humans and yeast and in which mutations
have previously been reported. We set out to determine the functional effects of this
deletion in a yeast model system and in vivo with human cell lines.
Constructs of the deleted forms of the genes were created in the S.cerevisiae
homologues, BUB1 and MAD3. The functional effects of expressing the deleted
Bublp and Mad3p proteins in strains null for the respective gene were studied with
respect to microtubule poison sensitivity, chromosome loss and spindle checkpoint
activity. Parallel control experiments used full-length gene constructs. We show that
cells expressing deleted proteins are more sensitive to microtubule poisons than those
expressing the full-length protein. Both the MAD3 and BUB1 AE5 mutants show a
chromosome loss phenotype indicative of a defect in chromosome segregation. We
observed a more severe phenotype in BUB1 AE5 deletion mutants, consistent with
the chromosome loss phenotype seen in a bubl null strain. This suggests that BUB1
may play a more significant role in mitosis than MAD3 in the yeast system. Using an
assay of individual cell growth in the presence of microtubule poisons, we show that
the MAD3 deletion mutant results in a defective mitotic checkpoint. An assay to
specifically investigate spindle checkpoint function in the BUB1 AE5 mutant,
revealed a similar abrogation of the spindle checkpoint. Next, we investigated the
ability of the mutant proteins to form spindle checkpoint complexes and found that
both Mad3p and Bublp AE5 proteins have reduced binding to Bub3p compared to
the full-length protein. The proportion of the Mad3p AE5 protein found in
IV
complexes with Cdc20p and Mad2p is also reduced. Furthermore, phosphorylation
of the Bublp AE5 mutant protein is markedly altered.
We initiated further experiments aiming to develop an in vivo system in diploid
human cell lines to investigate the effect of the BUBR1AE5 mutation on mitotic
checkpoint function and spindle protein complex formation.
The data presented in this thesis show that mutations of BUB1 and BUBRI
identified in colorectal cancers, involving protein domains with considerable amino
acid sequence similarities, substantially abrogate the spindle checkpoint and cause
chromosome segregation defects in S.cerevisiae. These findings have relevance to
understanding the nature of aneuploidy, chromosome mis-segregation and genomic
instability in colorectal tumour cells.
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When you walk through a storm
Hold your head up high,
And don't be afraid of the dark.
At the end of a storm,
There's a golden sky,
And the sweet silver song of a lark.
Walk on through the wind, Walk on through the rain,
Though your dreams be tossed and blown...
Walk on, walk on, with hope in your heart,
And you'll never walk alone...
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BER Base excision repair
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C. elegans Caenhorrhabditis elegans
CD Conserved domain
CDK Cyclin dependent kinase
CDKI Cyclin dependent kinase inhibitor
CIN Chromosomal instability
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COX Cycloxygenase
CRC Colorectal cancer









EGFP Enhanced green fluorescent protein
ES Embryonic stem
FACS Fluorescent activated cell sorting
FAP Familial adenomatous polyposis
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GFP Green fluorescent protein
GST Glutathione S-transferase
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HGU Human genetics unit
HNPCC Hereditary non-polyposis colorectal cancer
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HPV Human papilloma virus
HRP Horse raddish peroxidase
HTLV Human T-cell leukaemia virus
ICMB Institute of cellular and molecular biology
LPP Lambda protein phosphatase
MAD Mitotic arrest deficient
MCC Mitotic checkpoint complex
Vlll
MCS Multiple cloning site




MPF Mitosis promoting factor
MRC Medical research council
NaOH Sodium hydroxide
NER Nucleotide excision repair
NSAID Non-steroidal anti-inflammatory drugs
NSCLC Non small-cell lung cancer
OD Optical density
PAGE Polyacrylamide gel electrophoresis
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PEG Poly ethylene glycol
PhIP 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine
PTTG Pituitary tumour transforming gene
RNA Ribonucleic acid
RNAi RNA inhibition
RT-PCR Reverse transcriptase PCR
S. cerevisiae Saccharomyces cerevisiae, budding yeast
S.pombe Saccharomyces pombe, fission yeast
SDS Sodium dodecyl sulphate
SIN Septation initiation network
SNP Single nucleotide polymorphism
SV40 Simian virus 40
TAE Tris acetate EDTA
TEV Tobacco etch virus





YMM Yeast minimal media
YPD Yeast peptone dextrose
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Cancer is the second biggest killer of humans after heart disease. 1 in 3 people
will be diagnosed with cancer at some point in their lifetime and 1 in 4 will die from
cancer (CRUK: www.cancerresearchuk.org/aboutcancer/statistics/?version=:3').
Cancer occurs more frequently in older people with 65% of cases occurring in the
over 65s. Thus the incidence of cancer increases as advances in medical science
reduce early mortality and prolong life expectancy.
1.1.1 Colorectal Cancer
Colorectal cancer (CRC), including cancers of the colon and rectum, is a major
public health problem in developed countries. It is the third most commonly
diagnosed cancer and the second most common cause of cancer mortality (CRUK:
www.cancerresearchuk.org/aboutcancer/statistics/?version=3; ISD Scotland:
www.show.scot.nhs.uk/isd/index.htm). There are 0.5 million cases world wide each
year and 31,000 cases in the UK, with more than 20,000 deaths annually (Farrington,
2003). Despite improvements in research, surgery and clinical management, the
number of cases of CRC in Scotland has increased by 22.8% in males and 2.4% in
females between 1989-1999. The 5-year survival rate in Scotland is only 44.6%
(ISD Scotland; www.show.scot.nhs.uk/isd/index .htm).
1.1.2 Environmental and Genetic Factors in Colorectal Cancer
Colon cancer is predominantly a disease of the Western world and age-
standardised rates suggest that bowel cancer is fifteen times more common in
industrialised countries than in developing countries (Burkitt, 1971; Parkin et al.,
1999) indicating that there are environmental factors involved. Studies of migrants
from countries with low incidence to those with high incidence show they attain
cancer rates similar to their adoptive countries within a single generation (Haenszel,
1961; Stemmermann, 1970; McMichael and Giles, 1988). In most cases these
migrants have accepted the dietary habits of their adopted countries indicating that
differences in incidence rates may be explained at least in part by dietary factors.
Numerous studies have examined the effects of diet and lifestyle on colorectal cancer
1
and these are extensively reviewed elsewhere (Gertig and Hunter, 1998; Potter,
1999).
To summarise these publications they suggest an association between the
incidence of colorectal cancer and low dietary consumption of un-absorbable fibre
and refined carbohydrate due to an increased bowel transit time and increase in
faecal carcinogen concentrations (Burkitt, 1971; Willett, 1989; Trock et ah, 1990;
Levi et ah, 1999). A recent study of 520,000 individuals in 10 European countries
found an inverse relationship between dietary fibre intake and colorectal cancer and
estimated a doubling of dietary fibre in populations with low fibre intake could
reduce colorectal cancer risk by 40% (Bingham et ah, 2003). In addition, some
studies suggest a link between red meat consumption and colorectal carcinogenesis
explained in terms of its fat content, bile acid production and development of
carcinogens through cooking (Willett, 1989; Willett et al., 1990; Giovannucci et ah,
1994; Levi et ah, 1999). However these dietary studies are still speculative and
further studies have questioned these correlations (Giovannucci et ah, 1994;
Goldbohm et ah, 1994; Franceschi et ah, 1997). Other factors have also been
associated with an increased risk of colorectal cancer including alcohol consumption,
lack of physical activity and smoking (Longnecker et ah, 1990; Levi et ah, 1999; Le
Marchand et ah, 1997). Long-term aspirin and Non-steroidal anti inflammatory drug
(NSAID) intake has been shown to have a protective effect on colorectal cancer risk
mediated through inhibition of cycloxygenase (COX) enzymes and induction ofNF-
kB anti tumour activity (Muscat et ah, 1994; La Vecchia et ah, 1997; Williams et ah,
1999; Stark et ah, 2001). Despite evidence that environmental factors are important
in the development of CRC, the potential for manipulation of these factors for
prevention needs to be more clearly defined.
The multifactorial aetiology of CRC involves genetic susceptibility as well as
environmental factors. Recent advances in genetics and medicine have allowed
significant progress in understanding the molecular events involved in CRC
susceptibility and clinically impacting on the disease. Evidence suggests that 20-
25% of CRC has a familial component and common genetic changes involved in
sporadic CRC have also been elucidated (Fearon and Vogelstein, 1990). About 3%
of CRC is associated with early onset syndromes due to mutations in high penetrance
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genes (Bonelli et al., 1998; Dunlop et al., 2000; Farrington et al., 1998; Groden et al.,
1991; Parkin et ah, 1999).
Hereditary Non-polyposis colorectal cancer (HNPCC), is an early onset autosomal
dominant condition accounting for almost 3% of cancers of the colon and is
associated with germline mutations in Mismatch Repair (MMR) genes (Dunlop et al.,
2000; Mecklin et al., 1995; Lynch and de la Chapelle, 1999; Aaltonen et al., 1993;
Aaltonen et al., 1998). Affected family members inherit a mutant allele in one of the
MMR genes; MLH1, MSH2, MSH6 and more rarely MLH3 and PMS2 and one wild
type allele. During early tumour development the wild type allele is somatically
mutated, resulting in complete inactivation of the MMR system. This leads to a
characteristic mutator phenotype in which short repeated sequences, microsatellites,
which are more susceptible to mismatches, are altered in length and sequence
showing a microsatellite instability (MIN) phenotype. The mutator phenotype leads
to the rapid accumulation of somatic mutations which initiate and accelerate tumour
progression. HNPCC patients therefore develop CRC prematurely at an average age
of 45, more than 2 decades earlier than the general population (Peltomaki, 2001).
The relative cancer risk for HNPCC carriers approaches 100% with a favourable five
year survival rate of 65% compared to 44% for those with sporadic CRC (Dunlop et
al., 1997; Sankila et al., 1996). Other early onset cancer syndromes are also
associated with MMR and MIN defects including Turcots syndrome, characterised
by the occurrence of brain tumours, colorectal cancers and adenomas (Turcot et al.,
1959) and also Muir-Torre syndrome which manifests as the coincidence of
sebaceous skin tumours and internal malignancy (Muir et al., 1967; Torre, 1968).
Familial Adenomatous Polyposis (FAP) is another high risk early onset CRC
syndrome which results from germline mutations in the adenomatous polyposis coli
(APC) gene and is characterised by hundreds to thousands of benign polyps which
develop in the colon at an early age. The frequency and early onset of these polyps
invariably results in the progression of one or more to malignancy. FAP is a
relatively rare condition and germline APC mutation carriers account for less than
1% of CRC (Groden et al., 1991; Joslyn et ah, 1991; Kinzler et ah, 1991; Nishisho et
ah, 1991; Kinzler and Vogelstein, 1996; Bisgaard et ah, 1994; Farrington and
Dunlop, 2001).
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Recently germline mutations have been identified in MUTYH, a Base Excision
Repair (BER) gene in a multiple adenoma syndrome estimated to be responsible for
1-3% of CRC (A1 Tassan et al., 2002; Jones et al., 2002; Sieber et al., 2003; Halford
et al., 2003). Mutations in MUTYH are now thought to be involved in a polyposis
syndrome due to defects in oxidative damage which is prevelant in the gut. This may
promote unrepaired somatic lesions in genes such as APC producing the FAP-like
phenotype. Interestingly the pathogenic mutations identified are bi-allelic and
MUTYH mutations appear to act in a recessive manner to compromise BER and
increase cancer risk (Jones et al., 2002).
Other hereditary disorders associated with colon cancer include Puetz-Jeghers
syndrome, Cowden's disease and Juvenile polyposis (Liaw et al., 1997; Lynch et al.,
1997; Howe et al., 1998). These syndromes and their occurrence are summarised in
table 1.1.
Table 1.1 Hereditary Disorders Associated with Colon Cancer







Up to 3% Dunlop et al.,
2000
Muir Torre MLH1, MSH2 Very rare Muir, 1966;
Torre, 1997








STK1 Lynch et al., 1997
Cowden's disease PTEN >- <0.01% Liaw et al., 1997
Juvenile polyposis PTEN, SMAD4 -V Howe et al., 1998
Turcot syndrome APC, MMR Very rare Foulkes et al.,
1995
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In addition to these early onset disorders, which account for only about 3% of
CRC (Parkin et ah, 1999), there is evidence that other somatic gene mutations arise
during sporadic colorectal tumour development. The accumulation of these
mutations through sequence mutation or chromosomal abnormalities is important in
the initiation and progression of tumourigenesis from adenoma to carcinoma
(Vogelstein et al., 1988; Lengauer et ah, 1998; Fearon and Vogelstein, 1990; Kinzler
and Vogelstein, 1996; Boland, 2000). A series of genetic alterations lead to
progressive disregulation of the mechanisms controlling cell growth. It has been
proposed that the mutation of at least five genes is necessary for the formation of a
malignant tumour (Fearon and Vogelstein, 1990). The accumulation of the changes
appears to be more important than the order in which they occur but some mutations
are consistently associated with particular stages of the adenoma to carcinoma
pathway such as early mutation of APC (Kinzler and Vogelstein, 1996; Boland,
2000). Mutation of C-K-RAS and mutation or loss through chromosomal
rearrangements ofp53, DCC and APC are frequently observed in CRC (Vogelstein et
ah, 1988; Delattre et al., 1989; Fearon and Vogelstein, 1990). These changes are
accompanied by aneuploidy in most cases (Fearon and Vogelstein, 1990). This
tumourigenesis model is summarised in figure 1.1.
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Figure 1.1 Genetic changes associated with the adenoma to
carcinoma sequence of colorectal cancer.
Tumourigenesis proceeds through a series of genetic changes in oncogenes
such as K-ras and tumour supressor genes such as APC, DPC and p53.The
accumulation of sequential mutations causes the development of Aberrant
Crypt Foci (ACF), the precursors of adenomas and progression through stages
of adenoma development where tumours increase in size, dysplasia and
villous content. The overall accumulation of changes is of greater importance
than the order of changes. Both selection for growth advantage and genetic
instability drive this process. (Figure adapted from Fearon and Vogelstein,
1990 and Kinzler and Vogelstein, 1996).
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1.1.3 Selection and Mutation in Tumourigenesis
It is clear that the accumulation of genetic mutations is important in both familial
and sporadic colorectal cancer but there is much debate on the mechanisms by which
high frequencies of mutations accumulate in colorectal tumours. It is widely
accepted that the progression from adenoma to carcinoma results from successive
waves of clonal expansion and accumulation of genetic defects through cycles of cell
division (Nowell, 1976). However, the relative importance of selection for growth
advantage versus a mutator phenotype and genetic instability is still unclear. Loeb,
originally proposed that early mutation of genes involved in protecting the stability
of the genome, such as those involved in DNA repair or replication would invoke a
mutator phenotype necessary for tumour progression (Loeb, 2001). A population of
cells with a variety of mutations would result from the elevated mutation rate and
cells with mutations in genes involved in the control of cell division, invasion,
metastasis and apoptosis would preferentially survive selection pressures. This
model would explain the disparity between the mutation rate in normal cells and the
elevated frequency ofmutations seen in CRC (Loeb et ah, 1974; Peinado et ah, 1992;
Lengauer et ah, 1998; Loeb, 2001). The presence ofmutations in such mutator genes
in both familial and a subset of sporadic CRC supports this theory (Borresen et ah,
1995; Ma et ah, 2000).
Contradictory to the mutator hypothesis, Tomlinson and Bodmer argue that
selection for growth advantage is the initiating step in tumourigenesis and is
sufficient alone to explain tumour formation (Tomlinson and Bodmer, 1999;
Tomlinson et ah, 1996). They provide evidence that mutations in cancer genes such
as APC occur earlier in tumours than MMR defects and thus an increased mutation
rate does not drive tumour initiation (Homfray et ah, 1998). In this model mutations
which confer the strongest selection advantage to the tumour cell rather than those
which raise the intrinsic mutation rate are the most frequently seen in tumours. In
support of the selection model it has been noted that an increased mutation rate may
cause apoptosis (Cahill et ah, 1999; Tomlinson and Bodmer, 1999) and also that
mutations in Nucleotide Excision Repair (NER) and Base Excision Repair (BER),
which would also confer a mutator phenotype, are rarely seen in sporadic tumours
(Wu et ah, 2003; Halford et ah, 2003). This is disputed by further analysis ofAPC
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mutation status in tumours showing MIN and those which are stable. A higher
proportion of the MIN tumours harboured frameshift mutations in APC than the
stable tumours, indicating APC mutation is a secondary event promoted by earlier
mismatch repair defects (Huang et al., 1996).
It is likely that both a raised mutation rate through genetic instability and selection
for a growth advantage contribute to CRC development but the relative contribution
of these factors is unclear.
1.2 Genetic Instability in Colorectal Cancer
1.2.1 Microsateilite Instability Versus Chromosomal Instability
Genetic instability is a characteristic of almost all human tumours and is probably
important in their initiation and progression (Lengauer et al., 1998). There are 2
types of genetic instability; DNA sequence or Microsateilite Instability (MIN) and
Chromosomal Instability (CIN). The two types of instability rarely co-exist in
tumours although some recent studies suggest they are not necessarily independent
and there may be some overlap (Goel et al., 2003). MIN tumours are generally
diploid with rates of gross chromosomal change similar to normal cells whereas CIN
tumours are MMR proficient but are generally aneuploid with increased rates of
chromosomal change. This indicates that either MIN or CIN provides the genetic
instability to promote mutation and drive progression in each tumour (Orr-Weaver
and Weinberg, 1998; Lengauer et al., 1997; Lengauer et al., 1998). Thus instability,
be it microsatellite or chromosomal, increases as tumours grow and progress to
malignancy in an exponential manner (Lengauer et al., 1998). This can lead to
further genetic instability in the form of chromosome translocations and gene
amplifications as genes involved in recombination and DNA double strand break
repair such as p53, ATM and the BRCA genes become disrupted (Lengauer et al.,
1998). In addition genetic instability can disrupt genes involved in recognising DNA
damage and initiating apoptosis, such as p53, contributing further to the exponential
effect. In fact the inactivation of protective apoptosis is probably an essential step in
tumourigenesis. Genetic instability also has the effect of promoting heterogeneity
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between different tumours and between individual cells of a single tumour, which
presents a problem for cancer therapy (Lengauer et ah, 1998).
DNA sequence instability is produced by defects in DNA repair and replication
mechanisms such as NER, BER and MMR and results in changes in the nucleotide
sequence of individual genes (Lemos et ah, 2000; Dunlop et ah, 2000; Peltomaki et
ah, 2001). Sporadic colorectal tumours with DNA sequence instability are relatively
rare. About 13% of CRC have MMR defects and these show a characteristic
microsatellite instability phenotype as discussed previously (Peinado et ah, 1992;
Lengauer et ah, 1998).
Chromosomal Instability can be viewed cytogenetically as the loss, gain and
translocation of chromosomes and is seen in the majority of CRC (Lengauer et ah,
1998). CIN produces an imbalance in the number of chromosomes per cell, a
phenotype known as aneuploidy (Nowak et ah, 2002). The full significance of CIN
in tumour progression has been debated. It has been argued that CIN may be a result
of the abnormal growth and structure of a cancer cell rather than a cause. This is
contradicted by evidence that MIN/MIN cell fusions remain chromosomally stable,
arguing against non-specific factors (Lengauer et ah, 1997). Additionally some
precancerous colorectal lesions show aneuploidy suggesting it is an early event in
tumour initiation (Fischbach et ah, 1991). CIN is proposed as an alternative to
specific gene mutation in the initiation of carcinogenesis by producing mass
accumulation of gene mutations and accelerating loss of heterozygosity through
chromosomal abnormalities. This is supported by the difficulty in the identification
of cancer specific mutations, the lack of mutations seen in response to some
carcinogens and the aneuploid nature of almost all tumours (Li et ah, 2000). A two-
stage model has been proposed whereby carcinogens or spontaneous mutation induce
aneuploidy in normal cells through disruption of a mitotic, spindle or chromosome
related gene. The aberrant chromosome segregation disrupts the spindle machinery
and promotes karyotypic variation leading to an autocatalytic generation of
aneuploidy and eventually to neoplastic transformation (Li et ah, 2000).
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1.2.2 Causes of Aneuploidy
Although the cause ofMIN is well defined, the mechanisms which lead to CIN in
CRC are not clear. The frequency of CIN and aneuploidy in colorectal tumours,
particularly those with poor prognosis, provides good rationale for investigating its
genetic causes (Baba et al., 2002; Duesberg and Li, 2003; Karelia et al., 2001;
Risques et al., 2001). Unlike MIN, CIN is a dominant phenotype which cannot be
abolished by fusion with a chromosomally stable cell suggesting it may result from
gain of function type mutations (Lengauer et al., 1997). In cultured cells aneuploidy
often occurs simultaneously to p53 inactivation and G2/M phase cell cycle arrest
occurs in p53 deficient cells. However, inactivation of p53 does not affect
chromosomal stability in non-CIN cell lines and is therefore likely that p53
mutations exacerbate CIN but are not the underlying cause. This is supported by the
occurrence of aneuploidy and CIN early in tumourigenesis whereas p53 is
inactivated much later (Lengauer et al., 1998).
Studies in yeast indicate many different genetic defects can produce a CIN
phenotype including those involved in cell cycle checkpoints, chromosome
condensation, sister-chromatid cohesion, kinetochore structure and function and
microtubule formation (Murray, 1995; Nasmyth, 1996; Elledge, 1996; Paulovich et
al., 1997; Kolodner et al., 2002). Examples of genes which when mutated may
promote CIN in cancer are shown in Table 1.2 (adapted from Lengauer et al., 1998)
and some examples are discussed below.
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Table 1.2 Candidate Genes for the CIN Phenotype in Tumours
Protein Function Genes involved
Chromatin Structure
DNA methylation DNMT1, DNMT2, DNMT3A, DNMT3B
DNA acetylation HD1, HD2, HDAC3
Chromatin condensation DNA topoisomerases (Ila, Hp, TOP3),
helicases
Centrosome Aurora kinases, PLK1, NEP1,
NIMA-related kinases
Microtubules
Microtubule formation and dynein and kinesin superfamilies, dynactin,
motors tubulin
Microtubule associated MAP family, cytoplasmic linker proteins,
proteins EB1, STT4, G-proteins, CIN1, 2, 4
Kinetochore CENP-A, B, C, D, E, F, G, INCENPs, CAS,
CSE2
Chromatid cohesion
Cohesins SCC1, SCC2, SB1.8, SMC2, HCAP, SMC4,
MIS4, SA1
Regulators of cohesion RCC1, ASE1, PDS1, ESP1
Cell Cycle Checkpoints
Mitotic checkpoints MAD1, MAD2, MAD2B, BUB1, BUBR1,
BUB2, BUB3, MPSILI(TTK), p55CDC,
DMA1, CHER, ROD, ZW10
DNA damage checkpoint ATM, CHK1, CHK2, ATR, BRCA1, BRCA2,
HsRAD51, XRCC1, XRCC2, XRCC3, p53
Cell cycle regulators mitotic cyclins, MAP kinases, CDKs and
CDK inhibitors
Anaphase Promoting Complex
Complex proteins APC158, cullins (APC2, CUL1, CUL3, CUL4,
CUL5, CUL-2), CDC27/APC3, APC4, APC5,
CDC16/APC6, APC7, CDC359,
CDC23/APC8, APC11, CDC26
APC/C Regulators HCT1/CDH1, CDC20/p55CDC, CDC5L
Ubiquitination NEDD8, UBCH10
Genes shown in Bold indicate yeast genes without a known human homologue.
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Deregulation, duplication and altered distribution of centrosomes are often
reported in tumours and can lead to abnormal chromosome segregation (Kramer et
al., 2002). Abnormal numbers of centrosomes occur in breast, lung, prostate, colon,
bladder, pancreatic and brain tumours, and have been associated with CIN phenotype
in some of these (Kawamura et al., 2003; Salisbury et al., 1999; Pihan et al., 2001;
Brinkley, 2001; Zhou et al., 1998; Sato et al., 2001). Multipolar spindles are also
frequently observed in human tumours, probably as a result of these centrosome
abnormalities. There have been numerous studies reporting the over-expression of
centrosome-associated proteins in cancers. STK15, an aurora kinase involved in
spindle assembly and centrosome maturation, is over-expressed and amplified in
multiple human cancers (Zhou et al., 1998; Bischoff et al., 1998). Diploid
mammalian cell lines in which STK15 is over-expressed have abnormal numbers of
centrosomes, altered chromosome segregation and aneuploid phenotypes (Miyoshi et
al., 2001; Zhou et al., 1998). Over-expression ofpolo-like kinase PLK1, involved in
centrosome replication and dynamics, has also been reported in human tumours
including gliomas and colorectal tumours (Takahashi et al., 2003; Dietzmann et al.,
2001). BRCA1, associated with familial breast cancer, localises to and is
phosphorylated at the centrosome during cell division suggesting it may have
centrosome-associated functions (Salisbury et al., 1999). Inactivation ofp53 has also
been shown to lead to abnormal centrosome number in mouse embryonic fibroblasts
(Fukasawa et al., 1996) and p53~'~ mice show centrosome abnormalities and
aneuploidy suggesting p53 may also play a role in centrosome mediated aneuploidy
(Salisbury et al., 1999). However, centrosome abnormalities are also detected in
chromosomally unstable pre-invasive carcinomas of the cervix, prostate and breast
suggesting that centrosome defects, unlike p53 inactivation, may be an early step in
tumourigenesis and therefore although centrosome defects are probably an important
factor in aneuploidy, p53 is probably not the primary cause of these defects (Pihan et
al., 2003). INCENP, a kinetochore protein involved in chromosome condensation,
segregation and cytokinesis, is also over-expressed in a subset of colorectal cancer
cell lines (Adams et al., 2001).
Thus it appears that yeast are providing us with many clues into the candidate
genes involved in generating aneuploidy in cancer. However, progress is needed in
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the identification and characterisation of further genetic mechanisms involved in the
generation of aneuploid colorectal cancers.
1.3 The Cell Cycle in Cancer
The cell cycle is broadly divided into 2 phases; interphase and mitosis. During
Interphase, the longer of the two phases, cells grow in size and replicate their DNA.
Interphase can be divided into 3 sub-sections; Gapl (Gl), Synthesis (S) and Gap 2
(G2). Mitosis follows G2 and the cycle begins again. During the Gap phases cells
prepare themselves for the action phases of S phase and mitosis through intense
protein synthesis, for example. During S phase cells accurately replicate their DNA
and cohesion, which attaches sister chromatids during mitosis, is established. In
budding yeast the mitotic spindle is also assembled during S phase, but this occurs in
mitosis in most eukaryotes including mammals. In mitosis the newly replicated
sister chromatids attach to the spindle, are equally segregated and the cell physically
divides to produce 2 daughter cells genetically identical to both the mother cell and
each other.
1.3.1 Cyclins and Cyclin Dependent Kinases
The cell cycle is driven by altering levels and phosphorylation states of Cyclins
(eye), cyclin dependent kinases (CDK) and CDK inhibitors (CDKI). Different
cyclins interact with CDKs to activate them at each phase of the cell cycle. The
activated cyclin CDK complexes then phosphorylate key proteins to control cell
cycle progression. This process is best understood in yeast where a single CDK,
CDC28, interacts successively with a series of transiently expressed cyclins. In
mammalian cells this is complicated by the involvement of multiple CDKs and
cyclins. Most cells of the body are maintained in a quiescent state, GO and only re¬
enter the cell cycle upon induction by a mitogenic growth signal. Cells in GO retain
low levels of cyclin D through active proteolysis. The levels of cyclin D accumulate
in response to the release of growth factors and it interacts with CDK4 to stimulate
re-entry into the cell cycle. The CDK4-cycD complex co-operates with a CDK2-
cycE complex to phosphorylate the retinoblastoma protein (pRB). For this to
happen the CDK2-cycE complex must be released from its inhibitor p27, which is
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proteolytically degraded, a process initiated by activation of a ubiquitin ligase
complex SCFSkp2. Phosphorylation of pRB releases its inhibition of the E2F family
of transcription factors and allows them to transactivate genes essential for S phase
initiation and DNA replication (Molinari, 2000; Hartwell and Kastan, 1994).
The completion of DNA replication (and spindle formation in budding yeast)
marks the end of S phase and entry into the second preparatory phase, G2.
A CDC2-cycB complex, also known as mitosis promoting factor (MPF) initiates
mitosis. It is regulated by the availability of cyclin B, through synthesis and
localisation and also by phosphorylation status. MPF is maintained in an inactive
form in G2 by phosphorylation by the WEE1 kinase and only activates mitosis when
dephosphorylated by CDC25 phosphatases. The cyclin-CDK complexes exert
additional control on cell cycle progression through the phosphorylation and
activation of other proteins, including CDKIs, to ensure their own destruction and
progression to the next stage of the cycle. The cell cycle is summarised in figure 1.2.
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Figure 1.2 Cell cycle control
Progression through the cell cycle is controlled by a series of cyclins and
cyclin dependent kinases. GO is activated by an increase in levels of cyclin D
and formation of a CycD-CDK4 complex. This complex is also involved in
phosphorylation of pRb, releasing the transcription factor E2F to activate S
phase gene transcription. Release of CycE-CDK2 from its inhibitor p27 by
SCFskp2 is also required for E2F release. Mitosis is induced by CDC25
mediated dephosphorylation of Mitosis Promoting Factor (MPF), a complex
ofCyclin B and CDC2.
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Cell cycle genes are frequently mutated in various cancers. Cyclin B was found
to be over-expressed in 26% of a subset of colorectal cancers analysed and its over-
expression was found to initiate a CIN phenotype and alteration of the spindle
checkpoint in yeast (Sarafan-Vasseur et al., 2002). Cyclins A and D are also
frequently over-expressed in tumours (Yam et al., 2002; Molinari, 2000) and pRb is
often altered in tumours particularly retinoblastomas and sarcomas and is impaired
by tumour viruses such as Human Papilloma Virus (HPV) and Simian Virus 40
(SV40) (Molinari, 2000; Viallard et al., 2001). Cyclin E acts as a clinical indicator
of poor prognosis when elevated in breast cancer patients and human CDC4,
involved in the degradation of cyclin E is mutated in several tumour types (Clarke,
2002).
The cellular components involved in genome transmission and accurate cell
division; the spindle, the centrosomes and DNA are all carefully monitored during
their replication and segregation. Cell cycle regulation is exerted by the existence of
checkpoints through out the cell cycle, which halt progression to the next stage of the
cell cycle until certain criteria have been met. This ensures the stages of the cell
cycle occur without error, only once and in the correct order, thereby maintaining the
fidelity of cell division.
1.3.2 DNA Damage Checkpoints (G1/S and G2/M)
A DNA damage checkpoint operates at three stages of the cell cycle; Gl, S phase
and G2. It halts cell cycle progression or initiates apoptosis in response to DNA
damage through complex mechanisms involving p53, ATM, ATR and the BRCA1
and 2 proteins. DNA lesions are recognised by the ATM and ATR proteins and, in
response, p53 is upregulated, resulting in transcriptional activation of p53 dependent
genes. These in turn activate CHK1 and 2 resulting in the phosphorylation and
sequestration of CDC25 and sequestration of the CDC2-cycB complex in the
cytoplasm causing checkpoint arrest. CHK1 and 2 activation is also important for
BRCA1 phosphorylation, localisation and the DNA damage repair mechanisms.
Many of these genes have been implicated in familial and sporadic tumours and p53
in particular, is mutated in at least 50% of cancers (Molinari, 2000; O'Driscoll and
Jeggo, 2003; Hoeijmakers et al., 2001).
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1.3.3 Other Cell Cycle Checkpoints
Recent studies in mammalian cells suggest an additional checkpoint may exist at
G1 which halts S phase in response to defects in histone synthesis and/or chromatin
assembly. Newly replicated DNA is promptly assembled into nucleosomes which
are important for the preservation of locus specific chromatin structure and
chromatin-based epigenetic control of gene expression. It has been suggested that
delayed or defective chromatin assembly causes stalling at replication forks, the
generation of double strand breaks and activation of the Gl/S DNA damage
checkpoint. Thus mutations in chromatin assembly factor genes may be a further
cause of CIN in cancers if they allow chromatin structure abnormalities to escape
detection by the S phase checkpoint (Ye and Adams, 2003).
A further checkpoint exists at the S/G2 boundary which prevents mitotic spindle
elongation for chromosome capture until DNA replication is complete. These two S-
phase processes are usually co-ordinated by a timing mechanism as DNA replication
takes only half the time of spindle formation. However, hydroxyurea inhibition of
DNA replication arrests cells with short spindles and upon release, spindle
elongation is delayed until the DNA is fully replicated. This checkpoint may also
ensure cohesion, established in early S phase, is maintained until its degradation at
anaphase ofmitosis. This checkpoint is not yet well defined in mammalian cells but
may involve many of the proteins involved in the G1 DNA damage checkpoint
including ATR, BRCA1, BLM and CHK1 and 2, mutations in which are implicated
in cancer pre-disposition syndromes. PDS1, a protein involved in mitotic
progression may also be involved in this checkpoint and the PDS1 protein has been
found to be dysfunctional in tumours (Smith et al., 2002).
DNA replication produces two sister strands of DNA which are tangled together
or catenated. TOPO II removes these catenations to allow chromosomes to
accurately condense. It has been proposed that a G2 checkpoint, separable from that
involved in monitoring DNA damage, prevents completion of chromatid
condensation in the absence of TOPO II and in response to catenation. Again, this
checkpoint is thought to involve some of the G2/M DNA damage checkpoint
proteins including ATR, CHK1 and BRCA1 proteins but utilises a distinct signalling
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cascade to mediate cell cycle arrest. TOPO II activity is also required for sister
chromatid resolution, to complete chromatid condensation and for sister chromatid
separation in mitosis (Clarke and Gimenez-Abian, 2000).
Additional checkpoints operate during mitosis to ensure accurate chromosome
segregation. These will be discussed in more detail later.
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Figure 1.3 The cell cycle and its checkpoints
The cell cycle is controlled by a series of checkpoints which ensure an
ordered progression through the stages of the cell cycle and maintenance of
the fidelity of the genome. The cycle consists of two basic stages; Interphase
and Mitosis. During G1 of interphase the cell prepares for cell division
through intense protein synthesis. Once the start (or restriction point) of G1
has been passed the cell can no longer respond to external stimuli from the
environment to halt division and progression to S phase and DNA replication
is irreversible. After S phase activity the cell has a further preparatory phase,
G2, before segregation of chromosomes and cell division during mitosis.
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1.3.4 Proteolysis and the Cell Cycle
The cyclins, CDKs and CDKI proteins which ensure the accurate onset of each
phase of the cell cycle also activate their own destruction. This cleverly ensures a
precisely regulated order of events, where the proteins produced at each stage both
initiate the next phase and ensure destruction of those required for the current phase,
achieving a rapid and irreversible transition. For example in the Gl/S transition
cyclin E is activated by proteolytic destruction of its inhibitor p27. In turn CDK2-
cycE initiates S phase DNA replication and also initiates onset of its own destruction
to ensure the cell cannot return to G1.
Many of the cyclins involved in cell cycle progression, including p27 and cyclin
E, are degraded by the addition of a ubiquitin chain destruction tag and degradation
by the 26S proteasome. This process is summarised in figure 1.4.
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Figure 1.4 Ubiquitin mediated proteolysis
Cell cycle proteins are regulated by destruction by the 26S proteasome. To be
recognised by the proteasome, target proteins must be tagged by a chain of
ubiquitin molecules. This process involves a series of enzymatic reactions.
An El ubiquitin conjugating enzyme actively binds to a ubiquitin molecule.
This ubiquitin molecule is then transferred to an E2 ubiquitin ligase. An E3
ubiquitin conjugating enzyme transfers this to a target protein through
interaction with both the target protein and the E2 enzyme. The E3 then
catalyses the addition of further ubiquitin molecules to form a ubiquitin chain
on the target protein. Ubiquitin tagged molecules are degraded by the 26S
proteasome and the ubiquitin molecules are recycled.
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Ubiquitin is activated by an El ubiquitin-activating enzyme by formation of a
thioester bond between a cysteine residue on the surface of the El and the ubiquitin
molecule. Active ubiquitin is then transferred to an E2 ubiquitin-conjugating
enzyme forming a second high energy thioester bond. Finally an E3 ubiquitin-ligase
enzyme interacts with the E2 and the target protein and catalyses formation of an
isopeptide bond between the ubiquitin COOH terminus and a lysine residue on the
target protein. The E3 enzyme then catalyses the addition of further ubiquitin
molecules to the target protein to form longer ubiquitin chains which act as a marker
for destruction by the 26S proteasome. The ubiquitin molecules are recycled to tag
further proteins for destruction. Most cells contain a single conserved El enzyme
but several related E2 enzymes and multiple E3 enzymes. Some E3 enzymes are
made up of large multi-subunit complexes, including the SCF ligase complex, which
degrades cyclins, and the anaphase promoting complex or cyclosome (APC/C)
involved in degradation of important mitotic proteins (Doherty et al., 2002).
Proteins involved in ubiquitination and the proteolytic degradation pathway may
also be candidate cancer and more specifically candidate CIN genes. SKP2, part of
the SCF ubiquitin ligase complex is over-expressed in breast and gastric tumours
(Signoretti et al., 2002; Masuda et al., 2002) and mice lacking SKP2 show
centrosome defects and polyploidy (Nakayama et al., 2000). Genetic alterations have
also been reported in several components of the APC/C in colorectal cancer cells.
Expression of a truncation mutant form of the APC8 subunit in colon epithelial cells
results in abnormal levels of APC/C targets and perturbed mitotic progression
suggesting they have a deleterious role in CRC (Wang et al., 2003a). The protein c-
CBL is another E3 ubiquitin ligase which targets receptor tyrosine kinases involved
in growth factor initiation of the cell cycle, for degradation. CHFR, a mitotic
checkpoint gene in which mutations have been reported in colorectal tumours, is also
an E3 ubiquitin ligase (Scolnick and Halazonetis, 2000; Kang et al., 2002)
1.3.5 The Anaphase Promoting Complex: a 20S Subunit of the
Proteasome
The anaphase promoting complex or cyclosome (APC/C) is key in co-ordinating
the events of the cell cycle. It is a complex of proteins which act as an E3 ubiquitin
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ligase and is involved in the destruction of mitotic cyclins and the initiation of sister
chromatid separation. The complex was initially identified in 1995 as a large
complex of 150 kDa with cyclin ubiquitination activity targeting cyclins A and B for
destruction at the end of mitosis (Sudakin et ah, 1995). Fractionation of the APC/C
revealed it to be a 20S complex containing CDC 16 and CDC27 which co localise to
the centrosome and to the mitotic spindle during mitosis (Irniger et ah, 1995; King et
ah, 1995; Tugendreich et ah, 1995). It is a complex of 8-12 proteins including
CDC26, cullin proteins APC1-8, APC10 and APC11 and homologues of the APC/C
proteins have been identified in S.cerevisiae (Sudakin et ah, 1995), humans
(Jorgensen et ah, 2001), Xenopus levi (Li et ah, 1997), Schizosaccharomyces pombe
(Yamashita et ah, 1996), C.elegans (Furuta et ah, 2000), Drosophila (Huang and
Raff, 2002) and Aspergillus (Lies et ah, 1998) suggesting the APC/C is conserved in
all eukaryotes. The APC/C complex is an E3 ubiquitin ligase enzyme which targets
proteins for destruction by the 26S proteasome, acting as a 20S subunit (King et ah,
1995). The cell cycle specific target proteins contain at least one peptide motif either
a destruction box (D-box), or a KEN box or both, often at the N-terminal and often
other motifs also promote proteolysis. As many of the APC/Cs protein targets are
involved in cell cycle regulation, the activity of the APC/C is itself carefully
regulated. This is achieved by association with proteins which contain seven WD40
repeats in their carboxy terminus, such as Cdc20p and Cdhlp which were initially
identified in budding yeast (Visintin et ah, 1997) and Drosophila (Dawson et ah,
1993; Dawson et ah, 1995; Sigrist et ah, 1995). These WD40 repeats are essential to
mediate the interactions between APC/C and the regulatory factors. Cdc20p and
Cdhlp have homologues in many organisms including S. pombe (Matsumoto, 1997;
Yamaguchi et ah, 1997; Kitamura et ah, 1998; Kominami et ah, 1998) and humans
(Weinstein, 1997). These association factors activate the APC/C and also ensure
specificity to the target protein, important for cell cycle progression. Mitotic kinases
and phosphatases and spatial effects have also been shown to influence the activity of
the APC/C.
The APC/C is present but inactive during interphase and is activated early in
mitosis by the cyclinB-cdc2 complex or Mitosis Promoting Factor (MPF). The
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stability of the MPF varies through out mitosis, suggesting that APC/C activity does
likewise, both being deactivated at G1 (Wolf and Jackson, 1998).
One of the key functions of the APC/C is to induce chromosome segregation at
anaphase. In S.cerevisiae this is achieved by proteolytic degradation ofPdslp which
leads to the destruction of cohesin. This initiation of anaphase is achieved by
association of the APC/C with a WD protein, Cdc20p, which activates its proteolytic
function. This is described in more detail below. In budding yeast, cdc20 mutants
fail to destroy Pdslp and arrest at metaphase with unseparated sister chromatids.
This phenotype can be bypassed by deleting the PDS1 gene producing chromosome
segregation defects. These cdc20tpdsl double mutants also have errors in spindle
disassembly, cytokinesis and subsequent S phase entry suggesting Cdc20 is also
required in late mitosis.
The APC/C is also responsible for degradation of Clb2p in late mitosis which
initiates mitotic exit, cytokinesis and S phase entry. This degradation by APC/C
relies on its interaction with another WD protein, Cdhlp. Budding yeast cdhl
mutants have high levels of the Clb2p mitotic cyclin and are delayed in late mitosis
due to errors in its proteolysis. Similar Drosophila fizzy related (fzr) mutants and
fission yeast cdhl mutants also accumulate mitotic cyclins. Over-expression of
Cdhlp and its homologues induces cyclin degradation indicating its importance for
proteolysis. In Xenopus egg extracts either CDC20 or CDH1 can initiate cyclin B
proteolysis indicating CDC20 may also be involved in APC/C mediated mitotic exit
(Wolf and Jackson, 1998). Other APC/C substrates include Aselp whose
degradation prompts the initiation of spindle disassembly late in mitosis and
Geminin, which inhibits DNA replication until mitosis is complete, is also degraded
by the APC/C. Another example of the many roles of the APC/C in cell cycle
regulation include its involvement in replication initiation at chromosomal
replication origins (Wolf and Jackson, 1998).
The APC/C is further regulated by a polo-like kinase in budding yeast (Cdc5p),
fission yeast (plolp), Xenopus (PLX) and mammals (PLK). Mutants in CDC5 arrest
with segregated chromosomes but chromatids do not digress to the cellular poles as
Clb2p proteolysis is defective and in Xenopus egg extracts depletion ofPLX prevents
mitotic exit and cyclin B proteolysis. The polo like kinases phosphorylate APC/C
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subunits in mammalian cells, initiating its degradation of cyclin B. However to do
this they themselves must be phosporylated by MPF. The APC/C is negatively
regulated by PKA, a cAMP-dependent protein kinase. PKA activity also fluctuates
during mitosis, generally in an inverse manner to PLK's. Regulatory control is
heightened by auto regulatory mechanisms by which Polo like kinases, CDC20 and
MPF not only regulate APC/C activity but are also its targets. They contain
destruction box motifs and accumulate through the cell cycle to peak at mitosis, after
which they are destroyed by the APC/C. The accumulation, destruction and stability
of the association factors are essential in regulating the APC/C and therefore
ensuring mitotic control (Peters, 2002; Yen, 2002; Wolf and Jackson, 1998).
Alterations of APC/C subunit genes including APC6 and APC8 have been found
in colorectal cancer cells. The experimental expression of the APC8 truncation
mutants resulted in increased levels of APC/C targets such as cyclin B1 and
abrogation ofmitotic progression (Wang et al., 2003a).
1.3.6 Sister Chromatid Cohesion and Chromosome Segregation
For accurate inheritance of a chromosome complement it is essential that the
duplicated sister chromatids remain tightly associated until they are attached to the
microtubule spindle. The chromatids then divide and promptly dissociate at
anaphase for cell division to occur. This tight association is ensured through cohesin,
a protein complex which assembles onto DNA during S phase and holds sister
chromatids together until chromosome segregation at anaphase. Cohesin subunits
vary between cell types but generally there are 4 subunits in budding yeast; two
structural maintenance of chromosome proteins, Smclp and Smc3p (Strunnikov et
al., 1993; Michaelis et al., 1997) and two sister-chromatid cohesion proteins, Scclp
and Scc3p (Guacci et al., 1997; Michaelis et al., 1997). Additional protein factors
are required to establish cohesin on chromatin (Ciosk et al., 2000). Homologues of
these have been identified in other organisms including fission yeast (Birkenbihl and
Subramani, 1995; Tomonaga et al., 2000) and vertebrates (Losada et al., 1998).
Alternative subunits are involved in meiotic chromatids, thus vertebrates have three
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Scc3 subunits; SA1 which predominates in somatic tissues, SA2 which is involved in
Xenopus embryos and SA3 which is meiosis specific (Reviewed in Amon, 2001).
In 1999 Uhlmann et al., first showed that cleavage of one of the cohesin subunits,
Scclp is required for chromosome segregation (Uhlmann et al., 1999). They
demonstrated that Scclp is also cleaved at two sites showing sequence homology.
Mutation of these two sites blocks cleavage of Scclp and sister chromatid separation
(Uhlmann et al., 1999). Replacement of one of the cleavage sights in Scclp with a
Tobacco-etch virus (TEV) protease site ultimately allowed chromosome separation
through expression of the TEV protease, demonstrating that cleavage of Scclp could
induce sister chromatid separation (Uhlmann et al., 2000). Cleavage of Scclp
produces a 33kDa fragment which is cleared via the Proteasome-dependent N rule
degradation pathway (Rao et al., 2001). Failure to destroy this fragment results in an
increase frequency of chromosome loss, suggesting it may interfere with sister
separation (Rao et al., 2001). Cohesin is also phosphorylated at serine residues
adjacent to its cleavage sites by a polo kinase which is thought to promote its
cleavage (Alexandra et al., 2001). Scclp's cleavage and the dissociation from
chromosomes both in vitro and in vivo depends on a protease Esplp, often called
Separin (Uhlmann et al., 1999). Further experiments by Uhlmann et al. demonstrate
the C-terminal of Espl shows homology to cysteine proteases of clan CD and
purified Esplp can cleave recombinant Scclp in vitro. Mutating the active site or
addition of peptide inhibitors which covalently bind the active site of Esplp prevent
Scclp cleavage (Uhlmann et al., 2000). During most of the cell cycle Esplp is
bound and inhibited by Pdslp, or Securin (Yanagida et al., 2000) ensuring Espl is
localised to the spindle (Jensen et al., 2001). However, shortly before anaphase,
Pdslp is ubiquitinated by the APC/C-Cdc20, targeting it for degradation by the 26S
proteasome (Irniger et al., 1995; Cohen-Fix et al., 1996; Yamamoto et al., 1996).
This destruction is dependent on association of Cdc20p with the APC/C (Hilioti et
al., 2001). Esplp is released from its inhibitor in an activated form which can cleave
Scclp. The cleavage of Scclp causes cohesin to dissociate from sister chromatids,
removing the force opposing poleward movement of chromatids and promoting sister
separation (Ciosk et al., 1998; Uhlmann et al., 1999). This mechanism for








Figure 1.5 Chromosome segregation
Sister chromatids are attached together by a Cohesin complex of four
proteins. At the metaphase to anaphase transition the Sccl subunit of cohesin
is cleaved and cohesin dissociates. The cleavage of Sccl is achieved by the
ubiquitination of the Separin inhibitor Securin by the APC/C-Cdc20 complex,
targeting it for degradation. This releases Separin to allow it to cleave Sccl.
The poleward forces acting on the chromosomes, due to the pull of
microtubules on them, then cause the chromosomes to segregate to the poles
of the cell in Anaphase.
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This mechanism appears to be conserved in fission yeast (Tomonaga et al., 2000;
Funabiki et al., 1996a; Funabiki et al., 1996b; Uzawa et al., 1990) and higher
eukaryotes (Zou et al., 1999; Leismann et al., 2000). Studies in vertebrate cells show
that cohesin associates with the centromeres of metaphase chromosomes but is lost
during anaphase, consistent with this model (Losada et al., 2000; Waizenegger et al.,
2000). Furthermore fragments of SCC1 are present during anaphase but not before
and only after activation of APC/C-CDC20 and degradation of PDS1. Purified
human ESP1 was shown to cleave SCC1 in vitro, when PDS1 is first removed by its
preincubation with mitotic extracts with active APC/C-CDC20 (Waizenegger et al.,
2000). Recent experiments have demonstrated degradation of PDS1 upon
satisfaction of the spindle checkpoint in human cells and that the destruction of PDS1
can be halted upon re-activation of the checkpoint (Hagting et al., 2002). This
destruction of PDS1 is also shown to be dependent on a KEN box in the amino
terminal of PDS1 and a destruction box which inhibits sister chromatid segregation if
mutated (Hagting et al., 2002). Further experiments in budding yeast and Xenopus
suggest a similar mechanism operates in meiosis (Buonomo et al., 2000; Peter et al.,
2001).
Esplp and Pdslp also appear to have other mitotic functions including roles in
spindle elongation (Jensen et al., 2001) and mitotic exit (Sullivan et al., 2001).
Fission yeast mutants sccl and scc2 have been shown to activate the spindle
checkpoint and are hyper-sensitive to microtubule poisons suggesting cohesin
subunits may also mediate microtubule-kinetochore interactions (Toyoda et al.,
2002).
The human securin gene is identical to the oncogene PTTG (Pituitary Tumour
Transforming Gene) which is highly expressed in some tumours including colorectal
tumours (Heaney et al., 2000; Jallepalli and Lengauer, 2001). Over-expression of
PTTG can transform cell lines (Zou et al., 1999), immortalises mouse fibroblasts and
allows them to form tumours in nude mice (Jallepalli and Lengauer, 2001). Mouse
and colorectal cancer cell lines in which PTTG is absent are viable but exhibit
chromosome loss and sister chromatid separation defects (Jallepalli and Lengauer,
2001; Mei et al., 2001) consistent with a role for securin in tumourigenesis.
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Furthermore RNA inhibition (RNAi) of human separin causes the formation of
polyploid cells (Waizenegger et al., 2002).
1.3.7 Mitosis and Mitotic Checkpoints
During mitosis the newly replicated sister chromatids condense, line up on the
equator of the cell and are equally segregated prior to cell division. Mitosis can be
described in five stages; prophase, prometaphase, metaphase, anaphase and telophase
or classed together as the G2/M progression. In prophase the duplicated centrosomes
of the cell move to the poles of the cell and assembly of a bipolar microtubule
spindle in the cytoplasm between them is initiated. The chromosomes condense and
the nuclear envelope breaks down, initiating prometaphase during which the
chromosomes line up along the equator of the cell and attach to the forming spindle
producing a metaphase plate. The cells are now considered to be in metaphase. In
anaphase the cohesin holding together the sister chromatids is degraded and they
separate to the poles of the cell as the spindle elongates. Finally, in telophase
adjacent chromosomes fuse to form the two daughter nuclei. The envelope reforms
and the spindle forms a microtubule based midbody at the equator which participates
in cytokinesis (Pines and Rieder, 2001; Cortez and Elledge, 2000).
At least 5 checkpoints are thought to monitor the stages ofmitosis.
The earliest mitotic checkpoint regulates entry into prophase of mitosis in
response to DNA damage through a p53 related mechanism discussed in 1.3 (Clarke
and Gimenez-Abian, 2000; Taylor and Stark, 2001). Abrogation of this checkpoint
causes gross chromosome rearrangements and aberrant chromosome segregation due
to defects in genes such as ATM, ATR, BRCA1 and 2, and p53, all associated with
both familial and sporadic tumours (Lengauer et al., 1998; Hartwell and Kastan,
1994).
The CHFR protein (checkpoint protein with forkhead-associated and ring finger
domains) mediates the second checkpoint, at the prophase to prometaphase
transition, and delays chromosome condensation in response to microtubule poisons
which disrupt spindle formation and centrosome separation. CHFR is an E3
ubiquitin ligase which activates the checkpoint through ubiquitination of polo-like
kinase 1 (PLK1) and delay of CDC2 activation (Kang et al., 2002; Chaturvedi et al.,
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2002). The checkpoint was defective in 4 out of 8 human tumour cell lines
examined, 3 of which do not express the CHFR protein and the other contains a
missense mutation in the CHFR gene. Transfecting the wild type protein into these
cell lines can restore the checkpoint, suggesting the abrogation of the checkpoint may
contribute to tumourigenesis. However, only two of the cell lines with defective
CHFR checkpoints exhibit aneuploidy, and then at only a low level and the
frequency of CHFR inactivation in primary tumours has not yet been determined
(Scolnick and Halazonetis, 2000; Cortez and Elledge, 2000). Additionally the CHFR
gene is frequently methylated in tumours and cancer cell lines and evidence of age
related methylation has been reported in colon cancer. Methylation was associated
with loss of CHFR protein expression in cancer cell lines and treatment with
demethylating agents restored its expression and checkpoint function. (Corn et al.,
2003).
It has been hypothesised that in vertebrates, homologues of ROD and ZW10,
initially identified in Drosophila melanogaster, may be involved in an additional
branch of the spindle checkpoint monitoring congression to and alignment on the
metaphase plate. Drosophila mutations in the genes coding for these proteins exhibit
a similar but milder phenotype to bubl spindle checkpoint mutants, consistent with
slightly later checkpoint failure. This was supported by the antibody depletion of
homologues of these proteins in human cells, causing abnormal cell division and
lagging chromosomes in anaphase. In addition, no ROD or ZW10 homologues have
been identified in yeast, in which a true metaphase plate does not exist. These
proteins also associate with dynein, a microtubule motor probably involved in
chromatid congression to the metaphase plate but dynein cannot be detected at the
kinetochores of ZW10 or ROD mutants (Basto et al., 2000; Chan et al., 1999). It has
been proposed that ROD and ZW10 activate metaphase arrest in response to
metaphase plate defects and that dynein inactivates the checkpoint upon their repair
by removal of the ROD/ZW10 complex from the kinetochore. Dynein is thought to
have a similar switching off role in the spindle checkpoint by removal of key
checkpoint proteins (Wojcik et al., 2001).
The spindle checkpoint delays the metaphase to anaphase transition allowing
correct attachment of all sister chromatids to the bipolar microtubule spindle. A
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combination of presence of unattached kinetochores, and lack of tension at unbound
microtubules, initiates the assembly of protein complexes of the Mitotic Arrest
Defective (MAD) and Budding Uninhibited by Benzimidazole (BUB) proteins
initially identified in S.cerevisiae. These complexes inhibit the APC/C preventing
the cleavage of cohesin, required for chromatids to move poleward (Hardwick,
1998). This checkpoint has been found to be defective in human colorectal cancer
cell lines showing CIN. Mutations in human homologues of the S.cerevisiae genes,
BUB1 and BUBR1 genes have also been identified and in a number of diploid
colorectal tumour cell lines these mutations have been shown to induce CIN. (Cahill
et al., 1998). The spindle checkpoint and its role in cancer is the focus of this thesis
and will be discussed in detail later.
Gachet et al propose the existence of a distinct checkpoint at the metaphase to
anaphase transition in S.pombe. The checkpoint is imposed by a stress activated
MAP kinase (SAPK) which delays sister chromatid separation and mitotic exit in
response to damage to the actin cytoskeleton and aberrant spindle pole alignment.
Abrogation of this checkpoint may represent a further candidate which could be
bypassed in human tumour cells (Gachet et al., 2001).
A separate mitotic exit checkpoint is functional, at least in yeast, at the anaphase
to telophase transition inhibiting mitotic exit and cytokinesis in response to spindle
damage, through a Bub2p protein network (Bardin and Amon, 2001). The Septation
Initiation Network (SIN) in Schizosaccharomyces pombe, and the Mitotic Exit
Network (MEN) in Saccharomyces cerevisiae, act to delay nuclear migration and
cytokinesis in the presence of defects in the actin cytoskeleton and microtubule
spindle. This checkpoint has not yet been established in mammalian cells although
they do appear to delay mitotic exit in the presence of mis-orientated spindles
(McCollum and Gould, 2001). Activation of the spindle checkpoint also inhibits
mitotic exit into Gl, through inhibition of cyclin B degradation by the APC/C. In a
normal budding yeast mitosis the dephosphorylation of Cdhlp, Siclp and Swi5p (the
Mitotic exit network, MEN) by Cdcl4/Temlp allows Cdhlp to act as an association
factor with the APC/C, activating the ubiquitination and proteolysis of cyclin B and
thus mitotic exit. Bub2p is believed to act in a complex with Byr4p, forming a
GTPase activating protein (GAP), hydrolysing Teml-GTP and inactivating it in the
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Cdcl4/Temlp complex. Thus Cdhlp cannot activate the APC/C and the retained
high levels of Cyclin B and Cdc5p inhibit mitotic exit. In addition Pdslp probably
has a role in inhibiting Cyclin B proteolysis and mitotic exit through inhibition of
Cdhlp (Alexandra et al., 1999; Wang et al., 2000c)
The mitotic checkpoints are summarised in figure 1.6.
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Figure 1.6 Mitosis and the mitotic checkpoints
Progression through the stages of mitosis is controlled by at least 4
checkpoints which block entry into the next stage if defects in the previous
stage occur. This ensures the fidelity of chromosome segregation. Mitotic
Checkpoint defects are common in cancers, allowing abberant chromosome
segregation and aneuploidy.
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The disruption of cell cycle checkpoints allow cells to bypass these tight growth
controls. Checkpoint defects impart a growth advantage on the cell and can result in
genetic instability, a characteristic phenotype of cancer. Cell cycle checkpoint
defects can be seen to offer a solution to the genetic instability versus growth
advantage debate as they impart both of these phenotypes on a cell which may
explain the propensity for alterations in cell cycle genes and proteins in cancers
(Molinari, 2000; Clarke and Gimenez-Abian, 2000). Furthermore, the recent
identification of 'new' checkpoints may reveal further candidate genes involved in
the induction of aneuploidy in tumours.
1.4 The Spindle Assembly Checkpoint
Insight into the mechanism of the spindle checkpoint has initially come from
studies in the budding yeast, Saccharomyces cerevisiae. The Madl, 2 and 3 and
Bubl, 2 and 3 proteins, which act in the spindle checkpoint, were identified from
yeast mutants which failed to arrest in mitosis in response to microtubule poisons (Li
and Murray, 1991; Hoyt et al., 1991). The Mpslp (monopolar spindle) protein was
identified later due to its essential nature, initially as a protein involved in spindle
pole body duplication (Winey et al., 1991) but was later shown to be important in the
spindle checkpoint (Weiss and Winey, 1996). Of the 7 spindle checkpoint
components identified, 6 are known to act in a pathway to delay metaphase to
anaphase transition in the presence of spindle and kinetochore defects whereas
Bub2p acts in a distinct checkpoint to delay mitotic exit and cytokinesis (Alexandru
et al., 1999).
1.4.1 Detection of Spindle Defects
The spindle checkpoint monitors the assembly of the mitotic spindle and bipolar
attachment of the chromatids to microtubules and detects any defects in these
processes, delaying chromosome segregation and anaphase until they are corrected.
The checkpoint can detect a variety of errors including mass spindle disruption such
as that caused by microtubule poisons, the presence of a single unattached
kinetochore and defects in the centrosomes, centromeres and also microtubule
motors. All these faults affect the attachment of kinetochores to microtubules
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implying unattached kinetochores generate an inhibitory signal to halt mitosis
(Rudner and Murray, 1996).
Kinetochores are multiprotein complexes which assemble on the centromeric
DNA of the chromosome and are the site of interaction between the chromosome and
the microtubule spindle (Rieder and Salmon, 1998). Attachment of the kinetochores
to the mitotic spindle probably involves kinesin-like or dynein-like microtubule
motors. Once the kinetochores attach to a microtubule emanating from each pole a
tension is generated across the chromatids by the force pulling them towards the
poles against the cohesin holding them together. This tension can be visualised as an
increased distance between the kinetochores (Zhou et al., 2002a). There is evidence
that the spindle checkpoint is activated in two ways. Firstly through detection of
kinetochore unattachment and secondly due to a lack of the tension usually created
on microtubules by their bipolar attachment to kinetochores.
The evidence that kinetochore attachment is important is that anaphase will not
proceed until the last kinetochore on a lagging chromosome attaches to a microtubule
as demonstrated in a rat kangaroo kidney cell line PtKl, but destruction of this
remaining kinetochore by a laser microbeam, abolishes this delay. This suggests the
presence of an unattached kinetochore is necessary to activate the checkpoint as
tension on the sister kinetochores was absent in this case but anaphase still ensued
(Reider et al., 1995; Rudner and Murray, 1996). Further experiments in PtKl cells
showed that MAD2 staining at kinetochores, indicative of spindle checkpoint activity
relied on attachment not tension (Waters et al., 1998). Similarly, in maize, loss of
MAD2 staining at kinetochores correlates with their attachment to spindle
microtubules (Yu et al., 1999). In addition, some yeast mutants enter mitosis without
undergoing chromosome replication yet have an intact checkpoint. These
kinetochores cannot form bipolar spindle attachments but exit mitosis without delay,
indicating lack of tension does not activate the checkpoint in these cells (Flardwick,
1998). A similar phenomenon is seen in mammalian cells where a single attached
kinetochore lacking a sister, and therefore bipolar tension, does not activate the
checkpoint (Rudner and Murray, 1996).
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However, other evidence suggests that the spindle checkpoint monitors tension on
microtubules, generated by their attachment to kinetochores, at least in meiotic cells
and certain cell types. In insect spermatocytes, chromosomes attached to only one
pole can arrest cells in mitosis for up to 9 hours. Application of tension at the mono-
orientated chromosome using a micro needle induces premature anaphase (Li and
Nicklas, 1995). These experiments introduced the idea that the absence of tension on
unattached chromosomes might activate the spindle checkpoint. It is not clear
whether tension and attachment are exclusive stimuli or in fact closely linked, as
tension stabilises kinetochore-microtubule attachment and increases the number of
attached chromosomes by slowing microtubule-kinetochore turnover (Rudner and
Murray, 1996; Nicklas, 1997; King and Nicklas, 2000; Nicklas et al 2001; Zhou et
ah, 2002b). Thus application of artificial tension could have initiated the
accumulation of microtubules at the kinetochore and inactivated the checkpoint
through an attachment dependent mechanism (Li and Nicklas, 1995; Rieder and
Khodjakov, 1997).
In contrast to Hardwick et ah, 1998, Stern and Murray recently demonstrated that
budding yeast cells which enter mitosis without prior DNA replication, and therefore
have tension free kinetochores do arrest at the spindle checkpoint (Stern and Murray,
2001). Similar experiments which reduce tension across kinetochores but retain
attachment by inhibiting DNA replication and sister chromatid cohesion also activate
the checkpoint (Biggins and Murray, 2001). In meiotic budding yeast in which
homologues were attached to the same pole and kinetochores lacked tension,
anaphase onset was delayed but proceeded once bipolar attachment and tension were
restored (Shonn et ah, 2000). These studies indicate the importance of tension in
spindle checkpoint activation.
Interestingly, upon treatment with nocodazole, which induces microtubule
detachment, budding yeast cells exhibit a long term block at the spindle checkpoint
whereas loss of tension induces only a delay. Perhaps the monitoring of tension and
attachment at kinetochores have different functions. Kinetochore tension indicates
bipolar attachment whereas attachment may be unipolar. Perhaps, a lack of tension
indicates both sister kinetochores are attached to microtubules from the same pole
causing the release of one kinetochore in search of a microtubule emanating from the
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opposite pole (Zhou et al., 2002b). This is consistent with the nocodazole induced
checkpoint delay noted in response to loss of tension compared to a prolonged block
through lack of attachment.
Tension may also provide a stabilising mechanism for kinetochore microtubule
attachment which may be important in chromosome alignment on the metaphase
plate. This is indicated by the proteins involved in the tension response such as
BUB1 and BUBR1 remaining at kinetochores longer than MAD2, which is involved
in the unattachment response. This is also consistent with a further role for
kinetochore tension in chromosome alignment at the metaphase plate (Hoffman et
al., 2001; Skoufias et al., 2001; Zhou et al., 2002b).
Another hypothesis suggests tension may be the detection method in meiotic cells,
whereas kinetochore attachment may dominate in mitotic cells, supported by
correlation ofMAD2 kinetochore staining with attachment in mitotic maize cells but
with tension in meiotic ones (Yu et al., 1999).
Tension and attachment may represent different mechanisms of spindle
checkpoint activation. The combination and type of detection methods probably
vary between cell types and organisms. In higher eukaryotes both tension and
attachment are probably monitored although their relative contributions to activating
the checkpoint are not clear.
Attachment and tension may indicate two mechanisms of detecting free
kinetochores with identical methods of checkpoint arrest or they could be
independent mechanisms which recruit different protein complexes. This is
supported by the localisation of human BUB1 and BUBR1 to kinetochores that have
lost tension but of MAD2 only on loss of kinetochore microtubule attachment, a
result of treatment with higher levels of microtubule poisons (Skoufias et al., 2001).
Indeed in a previous study loss of tension at kinetochores was insufficient to
universally recruit MAD2 (Waters et al., 1998). This suggests that there are 2
pathways of activation of the spindle checkpoint in higher eukaryotes, recruiting
MAD2 in response to unattached kinetochores and BUBR1 and BUB1 upon loss of
tension. This is consistent with the ability of both MAD2 and BUBR1 to inhibit the
CDC20-APC/C complex and anaphase onset. However, in vitro evidence indicates
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BUBR1 is a more potent inhibitor of APC/C than MAD2 (Sudakin et ah, 2001; Tang
et al., 2001; Fang, 2002). This is not consistent with the reduced intensity of arrest
seen in response to loss of tension, thought to be mediated through BUBR1,
compared to unattachment, mediated through MAD2. Further controversy is added,
as in PtKl cells the average amount of BUBR1 at metaphase chromosome does not
fluctuate as the tension on them alters (Hoffman et al., 2001). In addition, BUB1 and
BUBR1 respond differently to microtubule poison induced alterations in kinetochore
attachment and tension disagreeing with their involvement in the same mechanism
(Taylor et al., 2001). Furthermore, studies in PtKl cells have observed a disruption
in spindle checkpoint arrest in response to loss of tension upon injection of either
BUBR1 or MAD2 antibodies. This suggests both BUBR1 and MAD2 respond to
loss of tension and that there is overlap between the pathways, although this may be
downstream of detection (Shannon et al., 2002).
Activation of the checkpoint through attachment results in alteration in chemistry
at the kinetochore and attraction of the checkpoint signalling proteins. The
mechanism of checkpoint activation by lack of tension is less clear. It is thought to
involve tension-sensitive kinetochore protein phosphorylation (Gorbsky et al., 1995;
Nicklas et al., 1995; Nicklas, 1997) and may involve a phosphorylated kinetochore
protein recognised by the 3F3/2 antibody (Gorbsky and Ricketts, 1993; Nicklas et al.,
1995; Campbell and Gorbsky, 1995; Nicklas, 1997). The 3F3/2 antibody recognises
a phosphoepitope at the kinetochore during prophase and prometaphase but this
signal, and presumably the phosphoepitope, is lost in the metaphase to anaphase
transition. The 3F3/2 antibody stains unattached kinetochores but is much weaker at
attached kinetochores in mitotic PtKl cells (Gorbsky and Ricketts, 1993). In meiotic
grasshopper and mantid spermatocytes the phosphorylated kinetochore epitope is
shown to be regulated by tension (Nicklas et al., 1995; Nicklas, 1997). Application
of tension to the kinetochores either by mitotic forces or through micromanipulation
causes loss of the phosphoepitope and anaphase onset (Nicklas et al., 1995; Li and
Nicklas, 1995; Nicklas, 1997). Injection of the 3F3/2 antibody to maintain the
epitope, delays anaphase onset indicating the presence of the phosphorylated epitope
activates the metaphase checkpoint (Campbell and Gorbsky, 1995) and suggests that
phosphorylation of the epitope is the transmitter of tension related defects.
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Recently, a third mechanism of checkpoint activation has been suggested. In
budding yeast an aurora kinase Ipllp was required for spindle checkpoint activation
in response to loss of tension at kinetochores but not in response to unattachment
(Biggins and Murray, 2001). In addition Ipllp is important in establishing bipolar
kinetochore attachment through re-orientation of sister chromatids. This is consistent
with the theory that the transient mitotic block in response to abolition of tension is
important in ensuring attachment is bipolar (Tanaka, 2002). Ipllp may be involved
in phosphorylation at the kinetochore in response to lack of tension, perhaps of the
3F3/2 epitope or of BUBR1 which is thought to be phosphorylated by AuroraB
(Ditchfield et al., 2003). The vertebrate homologue of Ipllp is auroraB.
In summary, it is likely that tension and unattachment both play a part in
checkpoint activation and may reflect variation in the primary sensors of the
checkpoint in response to different defects, in different cell types, or in different
organisms. They may recruit different checkpoint proteins and also initiate different
downstream pathways.
1.4.2 Spindle Checkpoint Proteins
The spindle checkpoint proteins are generally well conserved evolutionarily.
They have been well studied in budding and fission yeast, Xenopus, mouse, humans,
Caenorhabditis elegans and Drosophila melanogaster (He et al., 1998; Chan et al.,
1999; Basu et al., 1999). Much of the early genetic and biochemical studies on the
spindle checkpoint have been carried in budding yeast due to the availability of the
genome sequence and genetic tractability of this model system. More recently this
has been accompanied by extensive work in fission yeast and in higher eukaryotes
which have allowed localisation studies and more complex biochemical
investigations. A wealth of information is now published on the spindle checkpoint
components and their interactions, although the mechanism of checkpoint activity is
by no means fully elucidated. In this introduction I will briefly describe studies
which have furthered our knowledge of the 6 spindle checkpoint proteins before
discussing our current knowledge of the spindle checkpoint mechanism.
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1.4.2.1 Madlp
Homologues to budding yeast Madlp have been identified in Xenopus (Chen et
ah, 1998), human (Campbell et ah, 2001), fission yeast (Millband and Hardwick,
2002) and C. elegans (Kitagawa and Rose, 1999).
Madlp is a coiled-coil phosphoprotein which is hyperphosphorylated upon
checkpoint activation in budding yeast in a Mad2p, Bublp and Bub3p dependent
manner (Hardwick and Murray, 1995). In in vitro assays, Madlp is phosphorylated
by Mpslp and over-expression of Mpslp in S.cerevisiae causes
hyperphosphorylation ofMadlp both in wild type and mad and bub mutant strains.
This is accompanied by mitotic arrest in wild type strains only, suggesting that arrest
is dependent on the other spindle checkpoint proteins, however Madlp
phosphorylation is not carried out by the Bublp or Bub3p kinases (Hardwick et al.,
1996). The immunodepletion of MPS1 in Xenopus prevents phosphorylation of
MAD1, its localisation to the kinetochore and spindle checkpoint activation and thus
it has been demonstrated that kinase activity of MPS1 is essential for these
observations (Chen et ah, 1998; Abrieu et ah, 2001). Together these studies indicate
that phosphorylation of MAD1 by MPS1 and recruitment of MAD1 to the
kinetochore are probably early events in checkpoint signalling.
Residues 1-445 at the amino terminus ofXenopus MAD1 have been shown to be
sufficient for targeting ofMAD 1 to kinetochores. This part ofMAD 1 does not bind
to BUB1 or MAD2 and is a good candidate for direct interaction with a kinetochore
protein (Chung and Chen, 2002). Human MAD1 is found at kinetochores during
prometaphase but is lost from them at metaphase and anaphase upon microtubule
attachment to kinetochores and metaphase plate alignment (Campbell et al., 2001).
Residues 501-522 and 557-571 of human MAD1 form leucine zipper domains and
are thought to mediate its interaction with MAD2 (Iwanaga et al., 2002).
MAD1 is a likely candidate for the 3F3/2 phosphoepitope, which is recognised
upon lack of kinetochore tension and attachment and may act as a docking site for
spindle checkpoint proteins. MAD1 shares some properties with the 3F3/2 epitope:
the Xenopus laevis homologue ofMAD1 localises to the kinetochore; in S.cerevisiae
Madlp is hyperphosphorylated when the checkpoint is activated and Madlp recruits
checkpoint proteins to the kinetochore (Hardwick and Murray, 1995). Thus MAD1
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could provide a scaffold onto which other spindle checkpoint proteins assemble in
response to lack of tension and attachment.
MAD1 resides predominantly at the nuclear pore complex throughout the cell
cycle and associates with nucleoporins there including Nup53, Nupl70 and Nupl57.
Spindle checkpoint activation results in changes in the interaction with the nuclear
pore, release ofMAD2 and Nup53 dependent hyperphosphorylation ofMAD 1 (Iouk
et ah, 2002). In higher eukaryotes the association of spindle checkpoint complexes
with the nuclear pore may be important in detecting the onset of mitosis when the
nuclear envelope disintegrates.
MAD1 complexes tightly with MAD2 both in S.cerevisiae and in Xenopus
forming a constitutive complex which localises to free kinetochores in metaphase
(Chen et al., 1998; Chen et al., 1999). The recruitment ofMAD2 to free kinetochores
is thought to be an important function of MAD1. madl and mad2 budding yeast
mutants show similar benomyl sensitivity and elevated rates of chromosome loss
indicative of their linked function (Warren et al., 2002).
Madlp is also found in a signalling complex with Bublp and Bub3p upon
checkpoint activation in budding yeast (Brady and Hardwick, 2000) and the same
complex of human proteins is detected in vitro (Seeley et al., 1999). Formation of
this complex requires the Arg-Leu-Lys protein motif in Madlp (Brady and
Hardwick, 2000). In humans, this complex has kinase activity dependent on the
BUB1 kinase motif resulting in autophosphorylation of BUB 1 and phosphorylation
of MAD1 (Seeley et al., 1999). The complex forms at mitosis during every cell
cycle but is found at elevated levels upon checkpoint activation and may have an
important signalling role in the checkpoint (Brady and Hardwick, 2000).
MAD1 has also been shown to be essential for BUBR1 localisation and
phosphorylation at the kinetochore in Xenopus and for BUBR1 interaction with
BUB3 and CDC20 in an effector complex (Chen, 2002). The role of these
complexes will be discussed in more detail later.
1.4.2.2 Mad2p
Mad2p homologues have been identified in S.pombe (He et al., 1997), Xenopus
(Chen et al., 1996), mouse (Pangilinan et al., 1997), C. elegans (Kitagawa and Rose,
1999) and 2 homologues have been identified in humans (Li and Benezra, 1996;
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Pfleger et al., 2001; Chen and Fang, 2001). Xenopus MAD2 antibodies also
recognise proteins at kinetochores in prometaphase Drosophila spermatocytes (Basu
et ah, 1998; Basu et ah, 1999).
Localisation ofMAD2 to free kinetochores by MAD1 is important for checkpoint
function. Xenopus MAD2 was the first spindle checkpoint component to be localised
to unattached kinetochores (Chen et ah, 1996) in a MAD1 dependent manner (Chen
et ah, 1998) and this has also been observed in human HeLa cells (Li and Benezra,
1996) and in fission yeast (Garcia et ah, 2001). In vertebrates MAD2 is detected on
kinetochores following chromosome condensation but is lost upon chromosome
alignment on the metaphase plate. MAD2 has also been shown to have a transient
localisation at the kinetochore of 24-28 seconds in PtKl cells using Fluorescence
recovery after photo-bleaching (Flowell et ah, 2000). This turnover of MAD2 at
kinetochores is thought to be important in its function as APC/C inhibitor. MAD2
has long been thought to be the major effector of the spindle checkpoint although
recent studies have indicated that it is not the only inhibitor of the APC/C in the
spindle checkpoint. Excess MAD2 can inhibit the APC/C and arrest cells at
metaphase in many systems (Fang et ah, 1998). Mad2p also interacts with Mad3p in
budding yeast (Hardwick et ah, 2000) and is found in a complex with BUBR1 and
BUB3 in mammalian cells (Sudakin et al., 2001). Furthermore, MAD2 can exist in a
tetrameric complex and as a monomer (Fang et al., 1998) and in both phosphorylated
and unphosphorylated forms (Wassmann et al., 2003). These changes in turnover,
concentration, complex formation, conformation and modification may all be
important in MAD2's APC/C inhibiting activity.
This downstream function ofMAD2 will be discussed in more detail later.
Over-expression ofMAD2 generates a metaphase arrest (He et al., 1998). Upon
depletion ofMAD2, checkpoint arrested frog extracts exit mitosis prematurely, as do
budding yeast mad2 mutants (Chen et al., 1996; Chen et al., 1999). The human
homologue of MAD2 is essential in the checkpoint and localises to the kinetochore
in cells mitotically arrested with nocodazole (Li and Benezra, 1996). Mouse
knockouts of MAD2 are embryonic lethal (Dobles et al., 2000) and MAD2+/~ mice
develop lung tumour at high rates indicating haploinsufficiency (Michel et al., 2001).
These studies indicate the important role ofMAD2 in the spindle checkpoint.
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Additionally, a second homologue of MAD2, has been isolated in mammalian
cells. The second human homologue, MAD2L2 shows 26% identity and 48%
similarity to MAD2 in conserved regions, and is located on lp36, a region frequently
deleted in cancers. MAD2L2 may be involved in inhibition of anaphase to telophase
transition by inhibiting proteolytic activity of Cdhl-APC/C, analogous to the role of
MAD2 in the metaphase to anaphase transition (Pfleger et al., 2001). However,
MAD2L2 does not bind MAD1 and its role in mitotic checkpoints remain unclear
(Chen and Fang, 2001).
In summary, MAD1 is probably important for localising MAD2 to the
kinetochore where MAD2 inhibits the APC/C through sequestering its association
factor CDC20.
1.4.2.3 Mad3p /BUBR1
In human, mouse and Xenopus, BUBR1 is thought to be the homologue of
budding and fission yeast Mad3p, although structurally Mad3p lacks the BUB 1-like
C-terminal kinase domain of BUBR1.
Mad3p shares significant homology with BUB1, and human BUBR1 is
homologous to both BUB1 and Mad3p. Budding yeast Mad3p is homologous to
yeast Bublp in two conserved domains; CD1 showing 46% homology, containing
the GIG domain involved in the CDC20 interaction; and CD2, 47% homologous,
which binds Bub3p through E482 and the GLEBS domain (Hardwick et al., 2000).
Human BUB1 and BUBR1 also contain these conserved domains and show 81%
homology between the human protein domains (Cahill et al., 1998). Human
BUBR1, unlike Mad3p also contains a kinase domain similar to that of BUB1,
suggesting Mad3p may have lost a kinase domain during evolution. The conserved




































Figure 1.7 Homology between spindle checkpoint proteins
There is considerable homology between the Bublp and Mad3p homologues
in yeast and humans. The homology is particularly strong in two conserved
functional domains which are important in interactions with other checkpoint
proteins. Additionally the kinase domains ofBUB 1 and BUBR1 are probably
involved in interactions with kinetochore associated proteins of the CENP
family.
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The yeast Mad3p and mammalian BUBR1 proteins form interactions with BUB3,
CDC20 and MAD2 (Fraschini et ah, 2001; Taylor et ah, 1998). The interaction with
BUB3 is thought to be important in the localisation of BUBR1 to kinetochores
during the early stages ofmitosis in humans and mice (Taylor et ah, 1998; Jablonski
et ah, 1998). The S.cerevisiae Mad3p protein also complexes with Bub3p (Hardwick
et ah, 2000). The interactions with Mad2p and Cdc20p were also initially identified
in S.cerevisiae (Hardwick et ah, 2000; Wu et ah, 2000; Sudakin et ah, 2001) and a
Bub3p-Mad3p-Mad2p-Cdc20p complex is thought to be important in APC/C
inhibition during checkpoint activation in yeast (Fraschini et ah, 2001). In human
HeLa cells, BUBR1 is found in a complex with BUB3 and CDC20 (Tang et ah,
2001; Sudakin et ah, 2001). Sudakin et ah, also identified MAD2 as part of this
complex, although this is not found in the Tang study. All these studies agree that
BUBR1 behaves as an inhibitor of APC/C-CDC20 in this complex. Mammalian
BUBR1 has also been reported to interact with the APC/C subunits CDC20 and
CDC27 (Wu et ah, 2000). Interestingly, Mad3p has not been shown to inhibit APC/C
activation in budding yeast (Hardwick et ah, 2000). Inhibition of the APC/C-
CDC20 is thought to be a major role of BUBR1 in the checkpoint which will be
discussed in more detail later.
In mouse and human cells, BUBR1 is cytoplasmic during interphase but BUBR1
localises to kinetochores in human cells at prophase and remains there until anaphase
(Chan et ah, 1999). In mouse cells the localisation pattern is similar except it
localises to the kinetochores at prometaphase (Taylor et ah, 1998; Jablonski et ah,
1998). In budding yeast Mad3p localises to the kinetochore when over-expressed
(Hardwick et ah, 2000). These observations are consistent with the role of
Mad3p/BUBR1 as a spindle checkpoint protein.
The role of BUBRl's kinase domain is not clear. One study of human BUBR1
reports the kinase domain to be essential to BUBR1 function, as depletion or
expression of a kinase-dead mutant form of human BUBR1 induced a mitotic defect
producing aberrant cells with lagging chromosomes (Chan et ah, 1999). However, in
another study, recombinant human BUBR1 with a truncated kinase domain can bind
and inhibit CDC20 in vitro as efficiently as the intact protein. Similarly, in Xenopus,
kinase dead mutants of BUBR1 can still support checkpoint function, suggesting the
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kinase domain may not be essential (Chen, 2002). BUBR1 is capable of
autophosphorylation in vitro but is hyperphosphorylated by other kinases in vivo (Li
etal., 1999).
The presence of a kinase domain in BUBR1 has suggested it may be a BUB1
homologue rather than a Mad3p homologue. However, Mad3p and BUBR1 share an
N terminal extension containing a putative KEN box motif which is not seen in
BUB1 proteins (Millband and Hardwick, 2002).
Xenopus BUBR1 was shown to be phosphorylated when localised to metaphase
chromosomes but not when cytosolic, suggesting this modification may be important
for the checkpoint (Chen, 2002). Human BUBR1 has also been reported to be
hyperphosphorylated on spindle checkpoint activation (Chan et al., 1999; Li et al.,
1999). Paradoxically, a later study reported phosphorylation of human BUBR1
during a normal mitosis and this is not increased upon treatment with microtubule
poisons (Taylor et ah, 2001). Co-localisation and immunoblot experiments in
Xenopus egg extracts indicate that the presence of BUBR1 is important for
kinetochore localisation of BUB 1, MAD1, MAD2 and CENP-E (Chen, 2002). Both
phosphorylation of BUBR1 and its localisation to kinetochores relies on MAD1 in
Xenopus egg extracts indicating the complexity of interactions between the spindle
checkpoint proteins at the kinetochore (Chen, 2002). In addition phosphorylation of
BUBR1 is inhibited in mammalian cells by inhibition of Aurora B kinase (the yeast
homologue of Ipl-1). This is accompanied by a reduction in the kinetochore
localisation of BUBR1, MAD2 and CENP-E and inhibition of both the spindle
checkpoint and chromosome alignment and indicates the importance of BUBR1
phosphorylation for its localisation and function (Ditchfield et al., 2003).
BUBR1 has also been shown to interact with the centromere associated kinesin-
like motor protein CENP-E during mitosis. CENP-E is important in the
establishment of bipolar attachments at metaphase and alignment on the metaphase
plate and its interaction with BUBR1 may be important in monitoring this (Chan et
al., 1998; Yao et al., 2000). This will be discussed in more detail later in this
chapter.
Inhibition of BUBR1 in mammalian cells by antibody injection or RNAi, inhibits
the spindle checkpoint (Chan et al., 1999; Ditchfield et al., 2003). In the RNAi
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experiments the number ofmetaphase cells were reduced and many cells in anaphase
exhibited lagging chromosomes (Ditchfield et al., 2003). These cells also exhibited
defects in chromosome alignment. Inhibition of Aurora B kinase produces a similar
phenotype, suggesting phosphorylation of BUBR1 is involved in chromosome
alignment (Ditchfield et ah, 2003). This is consistent with previous studies which
describe a role for Aurora B, and the budding yeast homologue Ipllp, in the
correction of syntenic attachments (when sister chromatids are attached to the same
pole), chromosome alignment and spindle checkpoint maintenance in response to a
lack of tension (Biggins and Murray, 2001; Nigg, 2001). Potentially BUBR1 is
important in some or all of these roles, indicated by its ability to interact with CENP-
E and other microtubule associated proteins and its perceived role in linking lack of
tension and the spindle checkpoint (Chan et ah, 1998; Skoufias et ah, 2001).
1.4.2.4 Bublp
Bublp is a serine-threonine protein kinase (Roberts et ah, 1994; Taylor and
McKeon, 1997) with known homologues in S.cerevisiae (Li and Murray, 1991; Hoyt
et ah, 1991), S.pombe (Bernard et ah, 1998), Xenopus (Sharp-Baker and Chen, 2001),
Human (Jablonski et ah, 1998; Ouyang et ah, 1998) and Mouse (Taylor and
McKeon, 1997).
Bublp contains the same two conserved domains as Mad3p; CD1 and CD2 (see
Figure 1.7). The CD2 domain is known to interact with Bub3p, an interaction seen
in budding yeast and mammalian cells (Roberts et ah, 1994; Taylor and McKeon,
1997; Taylor et ah, 1998). As it contains a CD1 domain, Bublp might be expected
to bind Cdc20p but although this is achieved in vitro, co-immunoprecipitation
experiments isolate no Bublp-Cdc20p complex in wild type budding yeast strains.
However, a Bublp-Cdc20p complex was found in mad3 mutant extracts (Hardwick
et ah, 2000), suggesting Cdc20p has a higher affinity for Mad3p than Bublp but that
Bublp may be able to carry out at least some of its functions when absent. Such
redundancy between Bublp and Mad3p would be explained by the homology
between conserved domains of the proteins. Mad3p however, lacks homology to the
C terminal region of Bublp and would be unable to compensate for its kinase
activities consistent with a more severe chromosome segregation defect in bubl than
in mad3 budding yeast mutants (Warren et ah, 2002). This would not be true of the
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human homologues of the proteins, as human BUBR1 has retained the kinase domain
and thus may provide some redundancy with human BUB1. This is consistent with
the identification of mutations in human BUB1 and human BUBR1 in tumours,
whereas mutations in other checkpoint proteins, which do not share redundancy, may
not be seen due to lethality. However, human BUBR1 and human BUB1 are not
completely redundant as neither can maintain the checkpoint alone (Chan et al.,
1999).
The protein kinase BUB1 binds to BUB3, an interaction first described in budding
yeast (Roberts et al., 1994) but which also exists in mouse cells and is important in
localisation of BUB1 to the kinetochore during mitosis (Taylor and McKeon, 1997;
Taylor et al., 1998). BUB1 has also been identified in human cells and localised to
the kinetochore in interphase, prophase and upon nocodazole activation of the
spindle checkpoint (Ouyang et al., 1998). Contrary to these reports, studies by
Jablonski et al. report that human BUB1 is loaded onto kinetochores during early
prophase and remains there throughout mitosis with reduced concentrations from
anaphase onwards (Jablonski et al., 1998). A similar phenomenon was observed in
fission yeast (Bernard et al., 1998) and Xenopus (Sharp-Baker and Chen, 2001).
Over-expression of the protein kinase Bublp in S.cerevisiae constitutively
activates the checkpoint but does not accumulate hyperphosphorylated Madlp, and is
probably involved early in the signalling cascade (Farr and Hoyt, 1998). This is
supported by studies in Xenopus in which MAD1, MAD2, BUB3 and CENP-E
localisation all require BUB1 localisation to kinetochores (Sharp-Baker and Chen,
2001) indicating it may act as a scaffold onto which other proteins associate.
However, other studies suggest Bub3p may act as this scaffold protein (Fraschini et
al., 2001). This is consistent with the greater checkpoint defects seen in bubl and
bub3 budding and fission yeast mutants (Warren et al., 2002; Bernard et al., 1998).
Perhaps BUB1 acts as a scaffold at the kinetochore in response to lack of tension and
MAD1 acts similarly in response to unattachment. However BUB1 has been shown
to localise specifically to the unattached kinetochore when chromosomes form
unipolar attachments (Taylor et al., 2001) and thus may be involved in responses to
both lack of tension and attachment.
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BUB1 is a protein kinase with a conserved C-terminal protein kinase domain.
Examination of the kinase activity of BUB 1 has produced variable results. Bublp
has been found to be phosphorylated itself and Bub3p in vitro assays (Roberts et al.,
1994) and can also phosphorylate MAD1 in humans (Seeley et al., 1999). The
formation of the Bublp-Bub3p complex is thought to stimulate Bublp kinase activity
(Roberts et al., 1994). However these observations are disputed in mouse studies
(Martinez-Exposito et al., 1999) and in vivo phosphorylation of BUB3 by BUB1 has
not been shown. In the Xenopus experiments mentioned above a kinase dead mutant
of BUB1 is still fully functional in localisation of other checkpoint associated
proteins to the kinetochore (Sharp-Baker and Chen, 2001). However, in another
Xenopus study BUB1 kinase activity is required for metaphase arrest (Tunquist et al.,
2002). Mutation of the kinase domain in budding yeast also caused a checkpoint
defect (Roberts et al., 1994). Kinase activity has not yet been demonstrated in fission
yeast (Vanoosthuyse and Hardwick, 2003) but kinase-dead mutants of Bublp and
truncation mutants lacking the kinase domain have a reduced spindle checkpoint
function (Yamaguchi et al., 2003). Thus Bublp kinase activity does not appear to be
required for its localisation to the kinetochore, nor is it required to localise Mad2p to
the kinetochore (Yamaguchi et al., 2003) although it has been shown to
phosphorylate Mad2p.
Bublp can autophosphorylate in vitro through its kinase activity (Roberts et al.,
1994). One study shows Xenopus BUB1 is phosphorylated constitutively (Sharp-
Baker and Chen, 2001) but another shows BUB1 fractions associated with metaphase
chromosomes are substantially modified compared to cytosolic BUB1 suggesting
phosphorylation of BUB 1 may be important for checkpoint function (Chen, 2002).
This phosphorylation of BUB1 is not due to BUBR1 kinase activity (Chen, 2002).
Bublp is hyperphosphorylated in mitosis in budding yeast (Brady and Hardwick,
2000) and upon spindle damage in humans (Taylor et al., 1998) and fission yeast
(Yamaguchi et al., 2003). Fission yeast Bublp has four putative CDK
phosphorylation sites in its central region; T340, T423, T455 and S466 (Yamaguchi
et al., 2003). Bublp is phosphorylated throughout the cell cycle and is
hyperphosphorylated upon checkpoint activation at these sites in a Cdc2p dependent
manner. Elimination of this phosphorylation confers a reduced checkpoint activity
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although Bublp still localises to the kinetochore. Bublp is also phosphorylated by
other kinases at distinct sites (Yamaguchi et al., 2003) perhaps by the Mpslp
homologue Mphlp (He et al., 1998). This is consistent with studies showing human
BUB1 is also phosphorylated upon checkpoint activation (Taylor et al., 2001).
Similar residues for CDK phosphorylation can be found in human, budding yeast,
mouse, Drosophila and Xenopus BUB1, although the location of these are not
conserved. Xenopus BUB1 has also been shown to be directly phosphorylated by
CDC2 in vitro (Schwab et al., 2001). In both Xenopus and fission yeast,
phosphorylation of BUB 1 by CDC2 does not seem to affect its own kinase activity
(Schwab et al., 2001; Yamaguchi et al., 2003). One hypothesis is that
phosphorylation of Bublp affects signalling to downstream effectors such as Mad3p
(Millband et al., 2002) or may be required for interaction with other spindle
checkpoint proteins in a similar way to the requirement of Mpsl for formation of
Madlp-Bublp-Bub3p complex (Brady and Hardwick, 2000).
Thus it seems a BUB1-BUB3 complex is important at the kinetochore in response
to lack of tension and possibly also to attachment, but the role of BUBl kinase
activity and the phosphorylation states are uncertain. BUBl also interacts with
MAD1, probably in the same complex as with BUB3 when the spindle checkpoint is
activated. This complex is thought to be involved in signalling and formation of the
APC/C inhibitory complex, although it is not actually a member of the effector
complex (Brady and Hardwick, 2000; Seeley et al., 1999). This will be discussed in
more detail later in this chapter.
Bublp has recently been shown to interact with a centromere component Skplp in
budding yeast and this interaction is essential for the checkpoint response to lack of
tension at kinetochores (Kitagawa et al., 2003). BUBl has also been shown to
interact with the adenomatous polyposis coli protein (APC; not to be confused with
the Anaphase promoting complex or APC/C) and with CENP-F, both involved in
microtubule dynamics and this will be discussed later .
1.4.2.5 Bub3p
BUB3 is a WD repeat structure protein with a propeller structure of 7 P sheet
blades (http://alanine.ucdavis.edu/~dave/wilsonlab/). It is important in localisation
of BUBl and BUBR1 to the nucleus and the kinetochore through interaction with
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their GLEBS motifs. Xenopus studies indicate BUB3 is diffusely localised
throughout the nucleus during interphase but localises to kinetochore during early
mitosis in Xenopus (Campbell and Hardwick, 2003), Drosophila (Basu et al., 1998),
mice (Martinez-Exposito et al., 1999) and humans (Taylor et al., 1998). Mouse
studies report BUB3 is recruited during prophase and lost as the chromosomes align
on the metaphase plate, remaining only on lagging chromosomes (Martinez-Exposito
et al., 1999). This is consistent with studies in Xenopus and Drosophila but in
human cells BUB3 is lost from kinetochores at metaphase. In mammalian cells
BUB3 is required for kinetochore localisation of BUB 1 (Taylor et al., 1998). Bub3p
is also involved in a signalling complex with Bublp and Madlp (Brady and
Hardwick, 2000). BUB3 is essential to establish and maintain spindle checkpoint
arrest in Xenopus egg extracts and addition of antibodies to BUB3 abrogates the
spindle checkpoint but does not interfere with BUB3, BUB1 or MAD2 localisation at
kinetochores consistent with its role in downstream signalling (Campbell and
Hardwick, 2003). Mouse knock outs of BUB3 are embryonic lethal, indicative of its
essential nature in the checkpoint (Kalitsis et al., 2000).
1.4.2.6 Mpslp
Mpsl (mono-polar spindles) is a protein kinase initially identified through its
involvement in spindle pole body duplication in budding yeast (Winey et al., 1991).
The involvement of Mpslp in the spindle checkpoint became apparent after the
isolation of other spindle pole body mutants in which the spindle pole body fails to
duplicate but cells arrest at the spindle checkpoint. This arrest is not seen in mpsl
mutants despite the presence of a monopolar spindle (Weiss and Winey, 1996).
Subsequent experiments showed over-expression of Mpslp activates the spindle
checkpoint in the absence of spindle damage (Hardwick et al., 1996).
Mpslp homologues have been identified in fission yeast (He et al., 1998), mouse
(Fisk and Winey, 2001), humans (Stucke et al., 2002) and Xenopus (Abrieu et al.,
2001). Studies in these organisms show MPS1 localises to the kinetochore and
functions early in the spindle checkpoint, probably by the phosphorylation and
recruitment of MAD1 and hence MAD2 to the kinetochore (Hardwick et al., 1996;
Fisk and Winey, 2001; Abrieu et al., 2001; Liu et al., 2003a). Although kinase dead
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MPS1 can still localise to the kinetochore itself, its kinase function has been shown
to be essential for localisation of MAD 1, MAD2 and CENP-E to the kinetochore in
Xenopus and for checkpoint function (Abrieu et al., 2001). Human MPS1 is
phosphorylated itself upon activation of the checkpoint and its activity is greatest
when the checkpoint is switched on (Stucke et al., 2002). Human MPS1 is essential
for spindle checkpoint activation but is not required for centrosome duplication as
shown in yeast (Stucke et al., 2002) although it has been shown to localise to both
centrosomes and kinetochores (Liu et al., 2003a).
Human MPS1 localises to nuclear pores and is required for spindle checkpoint
activation in response to spindle and kinetochore defects in CENP-E defective cells.
MPS1 is required for localisation of MAD 1 and MAD2 to kinetochores but not for
BUB1, BUBR1 or ROD suggesting it responds to reduced microtubule occupancy
rather than kinetochore tension (Liu et al., 2003a). This is consistent with the
hypotheses that MAD1-MAD2 respond to unattachment while BUB1-BUBR1
respond to lack of tension. MPS1 has also been shown to interact with the APC/C
indicating additional checkpoint functions (Liu et al., 2003a).
A summary of the functions and homologues of the described spindle checkpoint
proteins is shown in table 1.3.
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Table 1.3: A Summary of Spindle Checkpoint Proteins and Functions
Protein Interactions Comments
madl Coiled-coil phosphoprotein.
Hyperphosphorylated upon checkpoint activation by Mpsl.
3F3 phosphoepitope?
mad2 Constitutive complex, localises to unattached kinetochores.
bub3 +bub1 In signalling complex through Arg-Leu-Lys domain.
mad2 Mouse knockouts are embryonic lethal.
Shows hapolinsufficiency.
MADl Constitutive complex, recruited to unattached kinetochores by MADl
and required for MADl phosphorylation.
cdc20 Complex inhibits APC/C.
mad3/bubr1 In inhibitory complex with Cdc20?
mad3/ bubRI has a C-terminal kinase domain.
bubrl Phosphorylates APC.
bub3 Constitutive complex, recruited to kinetochores not under tension .
mad2 In inhibitory complex with CDC20 and possibly BUB3.
cdc20 Complex inhibits APC/C.
apc/c Associates with APC/C subunits in vitro.
cenp-e Involved in detecting loss of tension and in checkpoint silencing?
bub 1 Serine Threonine protein kinase.
Phosphorylates APC.
Kinase domain not required for checkpoint arrest.
bub3 Direct binding, constitutive complex for kinetochore localisation.
MADl In signalling complex with bub3.
cenp-f Essential for CENP-E localisation.
bub3 WD repeat protein resembling a P propeller.
Knockout mice die early in embryogenesis.
Phosphorylated by bubl in vitro.
bubI Constitutive complex, recruits BUBl to kinetochore.
BUBRl Constitutive complex, responds to lack of kinetochore tension and in
Mitotic checkpoint complex (MCC) to inhibit APC/C.
mpsl Serine threonine protein kinase.
Involved in centrosome duplication .
Phosphorylates MADl.
Over-expression activates the checkpoint.
apc/c Proteolytic complex of 11 proteins.
E3 Ubiquitin ligase.
cdc20/cdh1 Initiates proteolytic degradation during the cell cycle.
Specificity dependent on association factors.
cdc20 APC/C association factor.
bub3+mad3+mad2 Inhibits APC/C degradation of Pdslp.
apc Regulates cytoplasmic pool of P-catenin.
EBl Stabilises and bundles microtubules.
BUB 1-BUBRl-BUB3 Phosphorylated by GSK3P and BUBl and BUBRl.
cenp-e Plus ended microtubule motor involved in chromosome alignment.
Involved in checkpoint function and silencing.
Conformation changes upon loss of kinetochore tension.
BUBRl Acts as motor-kinase complex to transduce loss of tension.
BUBl? BUB 1 required for its kinetochore localisation.
cenp-f BUBl Interacts with kinase domain, recruited to kinetochore by BUBl.
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1.4.3 Complexes at the Kinetochore
Three complexes of spindle checkpoint proteins exist constitutively in cells:
MAD1-MAD2; BUB1-BUB3 and BUB3-MAD3. Upon activation of the spindle
checkpoint by detection of lack of tension or attachment, these three complexes are
recruited to the free kinetochore where they are thought to initiate spindle checkpoint
activation and arrest chromatid separation. The localisation of the complexes to the
kinetochore is thought to promote the formation of multiprotein complexes,
phosphorylation effects and controlled turnover of essential proteins. Ultimately,
there is initiation of a signalling complex which in turn produces inhibitory
complexes to bind CDC20 and prevents it from activating the APC/C. The APC/C is
inhibited from cleaving sister chromatid cohesion and separating the chromosomes,
halting metaphase to anaphase progression. The inhibitory signal is conveyed from
the initiating free kinetochore to all the kinetochores of the cell to generate an
anaphase wait signal, possibly through soluble pools of non-kinetochore bound
checkpoint proteins (Millband et al., 2002).
1.4.3.1 MAD1-MAD2 Complex
Madlp complexes tightly with Mad2p both in S.cerevisiae and in Xenopus
forming a constitutive complex. Studies in budding yeast and Xenopus indicate the
complex forms independently of other checkpoint proteins and of cell cycle position
(Chen et al., 1999; Chen et al., 1998). During mitosis this association seems to be
important to recruit MAD2 to unattached kinetochores (Chen et al., 1998). The
human homologue of MAD1 is also found at kinetochores during prophase but
dissociates from them during metaphase and anaphase and upon microtubule
attachment (Campbell et al., 2001). The crystal structure of this MAD1-MAD2
complex has been elucidated. It consists of an asymmetric tetramer in which the
MAD1 monomers are elongated coiled coils to interact with MAD2. The C-terminal
tails of MAD2 are hinged ligand binding elements which are regulated to interact
with MAD1 or CDC20 in effector complexes (Sironi et al., 2002). This complex is
highly stable.
The interaction between MAD1 and MAD2 is mediated via two leucine zipper
domains in human MAD1 (amino acids 501-522 and 557-571). A polymorphism at
amino acid 558 perturbs the coiled coil structure of MAD1 and reduces the
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interaction with MAD2 4.5 fold (Iwanaga et al., 2002). This polymorphism may
have relevance to cancer predisposition.
The MAD1-MAD2 complex has been reported to localise to the nuclear envelope
during interphase in Xenopus (Chen et al., 1998). Biochemical and localisation
studies in human cells and rats indicate that this complex actually localises to the
nuclear pores (Campbell et al., 2001) and electron microscopy reveals human MAD1
localisation to the nuclear face of the nuclear membrane (Campbell et al., 2001).
Biochemical studies with purified metaphase chromosomes from Xenopus egg
extracts found little MAD1-MAD2 complex associated with them but that the
amount of this complex increased greatly upon activation of the checkpoint with
nocodazole (Chen, 2002).
Thus the MAD1-MAD2 complex probably exists constitutively in the cell,
localising to the nuclear pore during interphase. At metaphase it is recruited to free
kinetochores in response to a lack of tension on them. MAD1 is also phosphorylated
by MPS1 either before kinetochore localisation or as a result of it and the
phosphorylated MAD1-MAD2 complex may then act as a docking site for further
checkpoint proteins and is involved in downstream checkpoint signalling functions.
1.4.3.2 BUB1-BUB3 Complex
The protein kinase Bublp associates with Bub3p, an interaction first described in
budding yeast (Roberts et al., 1994). A small stretch of amino acids in the N
terminal of mouse BUB1 mediates an interaction with human BUB3 and is co¬
incident with the murine BUB1 kinetochore localisation domain suggesting it is
interaction with BUB3 which localises BUB1 to the kinetochore during mitosis
(Taylor and McKeon, 1997; Taylor et al., 1998). The interaction with BUB3 is
important for BUB1 localisation to the kinetochore upon checkpoint activation and
this has been observed in several species (Ouyang et al., 1998; Jablonski et al., 1998;
Bernard et al., 1998; Sharp-Baker and Chen, 2001).
1.4.3.3 MAD3-BUB3 Complex
Studies show BUB3 is localised to the kinetochore in early mitosis in several
organisms (Campbell and Hardwick, 2003; Basu et al., 1998; Martinez-Exposito et
al., 1999; Taylor et al., 1998). BUB3 acts as a nuclear import and kinetochore
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recruitment factor for MAD3 (and BUBR1) in the same way as it does for BUB1. A
BUB3-MAD3 or BUB3-BUBR1 complex has been reported in humans, budding and
fission yeast and Xenopus (Taylor et al., 1998; Roberts et al., 1994; Hardwick et al.,
unpublished data; Chen, 2002). MAD3 binds BUB3 through a CD2 domain
conserved between MAD3 and BUB1 and between species, an interaction important
for checkpoint function (Roberts et al., 1994; Amon, 1999; Hardwick et al., 2000)
and kinetochore localisation in humans (Roberts et al., 1994; Amon, 1999). In
Xenopus the interaction between BUB3 and BUBR1 was shown to be constitutive
and to localise to the kinetochore upon checkpoint activation (Chen, 2002).
Phosphorylation of BUBR1 may also be important for this localisation (Chen, 2002;
Chan et al., 1999). Localisation of MAD3 to the free kinetochore by BUB3 is
probably important to mediate interactions between MAD3 and the other checkpoint
proteins in the effector complex. In support of this a Mad3p-Cdc20p-Mad2p
complex cannot be isolated from bub3 mutant budding yeast strains (Hardwick et al.,
2000).
Thus studies in yeast and vertebrates have localised MAD1, MAD2, BUB1,
BUB3 and MAD3 to unattached kinetochores during prophase and prometaphase, in
at least three complexes: MAD1-MAD2, BUB1-BUB3 and MAD3-BUB3 (human
BUBR1-BUB3). The recruitment of these three complexes to the kinetochore may
be important to promote interactions between the proteins or post translational
modification of them to activate the checkpoint.
1.4.4 Signalling Complexes
Experiments in S.cerevisiae have shown that a Madlp-Bublp-Bub3p complex is
formed at a regulated time in the cell cycle and that treatment with nocodazole
resulted in higher levels of this complex. Disruption of the RLK motif in Madlp,
which is necessary to form this complex, conferred a checkpoint defect showing the
importance of the complex in normal checkpoint function. This indicates firstly that
the Madlp-Bublp-Bub3p complex is involved in the spindle checkpoint and
secondly that the checkpoint is activated every cell cycle, during the formation of
kinetochore microtubule interactions, producing an anaphase wait signal. The
formation of this complex is dependent on Mad2p, Bub3p and Mpslp but not on
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Bub2p or Mad3p, suggesting roles for Mpslp and Mad2p in phosphorylating these
proteins and localising them to the kinetochores respectively and indicative of a
downstream role for Mad3p. The ability of the complex to form in strains containing
only kinase dead Bublp indicates the kinase activity of Bublp is not essential for the
complex, although Bublp was found at lower levels in the complex in the kinase
dead mutants (Brady and Hardwick, 2000). The same complex of human proteins is
detected in vitro in which MAD1 and BUB1 are phosphorylated (Seeley et al., 1999).
This study is consistent with the hypothesis that Madlp and Bublp are important
in a signalling complex from which Mad2p is released in an activated form to inhibit
the APC/C, by interacting with Cdc20p, but do not actually exist in inhibitory
complexes themselves (Musacchio and Hardwick, 2002).
1.4.5 Complexes Inhibiting the APC/C
Initial studies in yeast suggested Mad2p was the major effector in the spindle
checkpoint. MAD2 has been shown to associate with the APC/C and to inhibit its
ubiquitin ligase activity in Xenopus egg extracts (Li et al., 1997). MAD2 is rapidly
turned over at kinetochores (Howell et al., 2000) and may be released from its
kinetochore complex with MAD1 in a modified state, to inhibit Cdc20-APC/C, a
complex which has been detected in yeast (Fang et al., 1998). This modification may
involve oligomerisation, phosphorylation or interaction with other proteins.
Oligomerisation has been seen in recombinant MAD2 in vitro (Fang et al., 1998), A
monomeric point mutant of MAD2 still activates the checkpoint, suggesting
oligomerisation is not the only method of checkpoint activation (Sironi et al., 2001).
Structural analyses reveal MAD1 and CDC20 share a common MAD2 binding site
and complex formation with peptides mimicking this site causes MAD2 to undergo a
major conformational change which might also represent activated MAD2 (Luo et
al., 2002). The crystal structure of the MAD1-MAD2 complex revealed that the
tetrameric complex of MAD1-MAD2 is very stable. However, as a dimeric
complex, MAD2 is slowly released to bind CDC20 (Sironi et al., 2002). High levels
of MAD1 inhibit CDC20-MAD2 binding in vitro but MAD1 is required for
formation of the CDC20-MAD2 complex in vivo in yeast. Thus it appears MAD2
recruitment to kinetochores is by formation of a tight tetrameric complex with
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MAD1. This complex may be destabilised at the kinetochore to a dimeric complex
through conformational changes, interaction with other proteins such as BUB1 and
BUB3 or both. The 1:1 MAD1-MAD2 complex then slowly releases MAD2
allowing its efficient transfer to CDC20 and checkpoint arrest (Sironi et ah, 2002).
The phosphorylation state ofMAD2 may represent another checkpoint regulatory
mechanism. Wassmann et al. recently showed that in vitro MAD2 is phosphorylated
on multiple C-terminal serine residues in HeLa cells. This phosphorylation is cell
cycle dependent and is lowest during spindle checkpoint activation. Mutation of the
serine residues to aspartic acid residues, which mimic phosphorylation, prevents
MAD2 binding to MAD1 and from complexing with APC/C-CDC20, preventing
metaphase arrest in stable cell lines (Wassmann et al., 2003). C-terminal deletion
mutants ofMAD2 also show an aberrant spindle checkpoint response and are unable
to interact with CDC20 and MAD1 (Fang et al., 1998; Sironi et al., 2001), the region
having previously been shown to be involved in interacting with APC/C-CDC20
(Luo et al., 2000). NMR structural analyses have also indicated that MAD2 interacts
with a common structural motif in CDC20 and MAD1 and that this interaction
causes a structural rearrangement of the C-terminus of MAD2 (Luo et al., 2002;
Sironi et al., 2002). These results have lead to a new hypothesis in which MAD2 is
recruited to free kinetochores by association with MAD1, where it is phosphorylated,
perhaps through formation of a MAD1-MAD2-BUB1-BUB3 signalling complex.
Phosphorylation ofMAD2 may represent a mechanism by which it could be released
from the tight complex with MAD1 (Wassmann et al., 2003; Sironi et al., 2002). A
dephosphorylation event would be required to allow MAD2 to interact with CDC20-
APC/C and inhibit the destruction of cohesion. This model is supported by
coimmunoprecipitation experiments in which only unphosphorylated MAD2 binds
CDC20-APC/C (Wassmann et al., 2003). The phosphorylation of CDC20 has also
been shown to be important for spindle checkpoint function through APC/C
inhibition and disruption of one of four phosphorylation sites in CDC20 disrupts
checkpoint response in Xenopus laevi (Chung and Chen, 2003).
Experiments in mammalian and Xenopus systems argue that BUBR1 is a more
potent inhibitor of the APC/C-CDC20 than MAD2 and is therefore a more likely
effector for the spindle checkpoint complex (Tang et al., 2001; Sudakin et al., 2001;
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Chen, 2002). Two groups have recently isolated complexes with APC/C inhibitory
activity from HeLa cells (Tang et al., 2001; Sudakin et ah, 2001). Tang et ah, purify
a mitotic checkpoint complex (MCC) from nocodazole arrested HeLa cells
containing BUB3, BUBR1 and CDC20. This complex was found to inhibit the
activity of the APC/C at physiological mitotic concentrations and at concentrations
lower than those required for MAD2 inhibition of the APC/C. This inhibition
appeared to be mediated by preventing CDC20 associating with the APC/C and the
inhibitory effects were less powerful on CDC20 already bound to the APC/C (Tang
et ah, 2001).
The second study by Sudakin et ah, also isolated an APC/C inhibitory complex
using a slightly different purification technique (Sudakin et ah, 2001). The MCC
isolated in this study contained BUB3 and BUBR1 and also MAD2. Again this
complex was found to have superior inhibitory activity compared to recombinant
MAD2 alone. Surprisingly this complex was present throughout the cell cycle but
mitotic APC/C was significantly more sensitive to inhibition by the MCC than
interphase APC/C. BUBR1 was found to associate preferentially with a
phosphorylated form of the APC/C subunit CDC27. As APC/C subunits are often
hyperphosphorylated during mitosis this suggests a method by which APC/C is
sensitised to inhibition by the MCC. In addition it has been reported that BUBR1,
MAD2 and CDC20 preferentially bind to mitotically phosphorylated APC/C (Fang et
al., 1998; Kallio et al., 1998; Kotani et al., 1999; Wu et al., 2000). Further evidence
shows the MCC activity is not affected by chromosomes in vitro and that it may be
that the presence of unattached kinetochores which sensitises the APC/C to inhibition
by the MCC (Sudakin et al., 2001).
A similar complex containing BUBR1, BUB3, CDC20 and MAD2 has been
isolated from mitotic Xenopus egg extracts (Chen, 2002). Unlike in the study by
Sudakin et al., this complex could not be isolated from interphase cells and the
interaction between CDC20 and the other proteins was stronger in extracts prepared
from nocodazole treated cells. Depletion of either MAD2 or BUBR1 severely
reduced the amount of the other protein found bound to CDC20, although this could
be due to defects in the formation of localisation complexes at the kinetochore
(Chen, 2002).
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Further immunoprecipitation studies on HeLa cell extracts detected two separate
complexes containing CDC20; one in which CDC20 interacts with BUB3 and
BUBR1 and one in which CDC20 interacts with MAD2 (Fang, 2002). The BUBR1-
BUB3-CDC20 complex is shown to interact with APC/C and both MAD2 and
BUBR1 are shown to inhibit the ability of CDC20 to activate APC/C in vitro but
neither can inhibit a pre-formed APC/C-CDC20 complex, consistent with previous
studies (Tang et ah, 2001). Again this study agrees with those above that BUBR1 is
a more potent inhibitor ofCDC20 than MAD2 (at least 12fold) but the two inhibitory
molecules act synergistically in that they can both inhibit the same pool of CDC20
(Fang, 2002). Further investigations indicate that the interaction between MAD2 and
CDC20 promotes the inhibitory function ofBUBR1 and vice versa, at least at certain
concentrations (Fang, 2002). Thus both BUBR1 and MAD2 interact with and inhibit
the CDC20 in the spindle checkpoint and these probably have an additive effect in
the cell.
The evidence for the involvement of BUBR1 in APC/C-CDC20 inhibition in
vertebrate systems is strong but in yeast cells the role for Mad3p in Cdc20p
inhibition is less clear cut. Yeast two hybrid assays and immunoprecipitation
experiments do reveal a Mad2p-Mad3p-Cdc20p complex which is essential for
checkpoint function in wild type strains. Although the Mad3p-Mad2p and Mad3p-
Cdc20p complexes are dependent on other checkpoint proteins, a Mad2p-Cdc20p
complex can be isolated from mad3 mutants which may indicate a lesser role for
Mad3p in Cdc20p inhibition compared to Mad2p (Hardwick et ah, 2000; Brady and
Hardwick, 2000). The co-immunoprecipitation of the Mad2p-Cdc20p complex is
only moderately affected in bub3 and bubl mutants suggesting Bub3p may not be
part of this complex (Flardwick et ah, 2000). In a separate study, a Bub3p-Mad3p-
Mad2p-Cdc20p complex has been isolated from budding yeast but the role of this
complex in APC/C inhibition has not been investigated (Fraschini et ah, 2001).
Incidentally this complex is not dependent on kinetochores, consistent with previous
studies by Sudakin et ah (Fraschini et ah, 2001; Sudakin et ah, 2001). Additionally,
over-expression ofMad2p in budding yeast causes a spindle checkpoint arrest but no
specific phenotype is associated with Mad3p over-expression (Millband and
Hardwick, 2002). Human BUBR1 has been reported to bind the APC/C in mitotic
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cells but there is no evidence to support this in its budding yeast counterpart (Chan et
al., 1999; Hardwick et ah, 2000). However, in fission yeast, a Mad2p-Mad3p-
Bub3p-Cdc20p complex is also detected and Mad3p is essential for a checkpoint
arrest initiated by over-expression of Mad2p consistent with a role for Mad3p in
Cdc20p inhibition (Millband and Hardwick, 2002).
These studies have altered our previous ideas about how the checkpoint inhibited
the APC/C in two ways. Firstly, it seems MAD2 is not the only inhibitor of the
APC/C but a complex involving BUBR1 can also inhibit the APC/C and probably
more efficiently than MAD2. Secondly, as the MCC can be isolated from interphase
cells, it may not be recruitment of the spindle checkpoint complexes to the
kinetochore which causes the MCC to form. A revised model might suggest the
spindle checkpoint complexes which form at unattached kinetochores are important
either in modifying the APC/C to sensitise it to inhibition by the MCC or in
modification of the MCC itself. Another theory could be that the checkpoint proteins
assembled at the kinetochore are important in establishing signalling and effector
complexes which act locally to initiate an anaphase wait signal, perhaps through
modification of the APC/C. This signal could then be communicated to the soluble
pool ofMCC to ensure each and every chromosome arrests. The local and diffuse
signals could be mediated by different MAD2 and BUBR1 CDC20-inhibiting
complexes which would be consistent with discrepancies in different studies and
organisms.
MAD2 and BUBR1/Mad3p may work in combination in the checkpoint. Mad2p
complexes with Bub3p, Mad3p and Cdc20p in budding yeast (Hardwick et ah, 2000;
Fraschini et ah, 2001) and in vertebrate cells, probably acting to inhibit Cdc20p-
APC/C activity and anaphase onset in both (Chen, 2002; Tang et ah, 2001; Skoufias
et ah, 2001). The effects of MAD2-CDC20 and BUBR1-CDC20 interactions on
APC/C inhibition have been reported to be additive (Tang et ah, 2001; Fang, 2002).
Alternatively they may act in response to different tension and attachment stimuli at
the kinetochore; MAD2 in response to detachment and BUBR1 in response to a loss
of tension (Skoufias et ah, 2001; Waters et ah, 1998). A further hypothesis is that
one of the two CDC20 inhibitors acts at the kinetochore to inhibit CDC20 locally and
that this in turn activates the other to inhibit CDC20 throughout the cell. Both
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BUBR1 and MAD2 localise to unattached kinetochores but MAD2 has a short half-
life there so may initially be activated there before it diffuses away and inhibits the
cellular pool ofCDC20 (Tang et al., 2001; Fang, 2002).
The differences between yeast and vertebrate systems could represent additional
complexity required for higher eukaryotes. It is not a result of the lack of a kinase
domain in Mad3p as BUBR1 proteins which have mutant or truncated kinase
domains can still interact with CDC20 and activate the checkpoint in Xenopus and
mammalian systems (Chen, 2002; Tang et al., 2001). BUBR1 is able to
phosphorylate CDC20 in a cell cycle dependent manner but its kinase activity has no
effect on APC/C function (Fang, 2002).
1.4.6 How do the Effector Complexes Delay the Metaphase to
Anaphase Transition?
APC/C controls sister chromatid separation by initiating Pdslp destruction. This
in turn activates the Esplp protease to cleave Cohesin, removing the glue which
holds sister chromatids together, thus allowing them to separate. To destroy Pdslp,
APC/C must be associated with Cdc20p which activates it. Upon activation of the
spindle checkpoint an inhibitory complex probably involving Mad2p and Mad3p
binds and inhibits Cdc20p preventing its interaction with the APC/C and hence
chromatid separation (Biggins and Murray, 1999; Hartman et al., 2000; Tanaka et al.,
2000; Uhlmann et al., 2000).
Overlapping motifs have been identified in mammalian CDC20 which interact
with APC/C and MAD2. A CDC20 truncation mutant able to bind MAD2 but not
APC/C, induces the formation of multinucleated cells, by bypassing the checkpoint
and these cells are more sensitive to microtubule drug induced apoptosis (Zhang et
al., 2001).
In budding yeast over-expression mutants of Cdc20p avoid activation of the
spindle checkpoint and no longer bind Mad proteins, suggesting Cdc20p has a
greater affinity for APC/C than for Mad2p (Hwang et al., 1998).
Mammalian CDC20, p55CDC, has co-immunoprecipitated with the human
homologue of MAD2 and components of the APC/C and injection of anti-p55CDC
antibodies into mammalian cells induces metaphase arrest (Kallio et al., 1998).
Additionally, human BUBR1 has been found to associate with the APC/C in
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mitotically arrested cells, but not in interphase cells, through co-immunoprecipitation
experiments (Chan et ah, 1999).
In Xenopus cells MAD2 also interacts with the APC/C when the mitotic
checkpoint is activated and injection of purified MAD2 induces metaphase arrest and
inhibits the APC/C (Li et ah, 1997).
Finally, recent experiments in human cells show human securin destruction is
activated when the spindle checkpoint is satisfied by kinetochore attachment and that
reactivation of the spindle checkpoint prevents securin degradation and sister
chromatid separation (Hagting et al., 2002). This destruction of securin is dependent
on destruction motifs within the protein which allow it to be targeted by the anaphase
promoting complex- the KEN box and the D-box. Mutation of this D-box prevents
sister separation and generates a cut phenotype where one cell can inherit both copies
of the genome, consistent with aneuploidy in tumours (Hagting et al., 2002).
1.4.7 Additional Checkpoint Components in Multicellular Organisms
CENP-E is a kinetochore motor involved in chromosome alignment and is
essential in maintaining kinetochore-microtubule attachments at monopolar
chromosomes to allow them to become bipolar and align at the equator (Schaar et al.,
1997; McEwen et al., 2001). Depletion of CENP-E in Xenopus egg extracts suggest
it plays an essential role in activation of the spindle checkpoint in response to spindle
damage (Abrieu et al., 2000). However CENP-E is also implicated in checkpoint
silencing, as human CENP-E depletion by antibodies or antisense oligonucleotides
causes chronic arrest of mitosis (Yao et al., 2000). CENP-E is a kinesin-like protein
that undergoes microtubule dependent conformational changes, a mechanism which
could convey alterations in kinetochore tension to BUBR1 to mediate both these
effects.
In mammalian metaphase cells, CENP-E staining was observed in association
with human BUBR1 in the mitotic cytosol and again with BUB1 at the kinetochore
plate, and appeared stronger at unaligned chromosomes (Jablonski et al., 1998).
CENP-E and BUBR1 levels are reduced upon kinetochore-microtubule attachment
suggesting CENP-E may mediate the loss of tension at kinetochores to BUBR1. In
support of this transducer function of CENP-E, Xenopus BUBR1 autokinase activity
is stimulated by interaction with CENP-E in vitro, an interaction induced by free
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kinetochores and important for recruitment of MAD2 (Mao et al., 2003). Antibody
inhibition of CENP-E in Xenopus egg extracts inhibits its activation of BUBR1
kinase and abrogates checkpoint function (Mao et al., 2003). Localisation studies
suggest sequential assembly of proteins at human kinetochores in the order BUB1,
CENP-F, BUBR1; detectable at prophase prekinetochores, followed by CENP-E,
thought to interact with all three of these proteins, detectable at prometaphase (Li et
al., 1999). Thus human BUBR1 is likely to localise CENP-E to the kinetochore,
where they may form a motor-kinase complex, allowing BUBR1 to monitor
microtubule tension for checkpoint function and silencing (Chan et al., 1999).
In humans BUB1 and BUBR1 remain at kinetochores until late anaphase at
reduced levels so perhaps a threshold level or modification of these proteins is
necessary for checkpoint activation. In support of this, the phosphorylation state of
human BUBR1 is dependent on the number of kinetochore microtubules attached to
CENP-E (Li et al., 1999). This is consistent with the following model: BUBR1
recruits CENP-E to kinetochores where it could act as a sensor undergoing a
conformational change in response to lack of tension. This could result in BUBR1
phosphorylation, possible induction of BUBR1 kinase activity and checkpoint
activation (Jablonski et al., 1998; Chan et al., 1998; Chen, 2002). A further
conformational change in the CENP-E-BUBR1 complex upon kinetochore tension
may dephosphorylate or inhibit BUBR1 for checkpoint silencing.(Hoffman et al.,
2001; Yen et al., 1991)
The interaction with CENP-E is thought to be mediated through BUBRl's kinase
domain. As yeast MAD3 lack this domain it may be devoid of these CENP-E
associated functions consistent with reduced chromosome loss rates in MAD3
mutants compared to other spindle checkpoint mutants (Chan et al., 1999). This is
also supported by the lack of a known CENP-E homologue in yeast (Abrieu et al.,
2000) and the ability of the kinase domain of BUB1, which shows similarity to
BUBR1 kinase domain, to bind another kinesin motor, CENP-F (Jablonski et al.,
1998).
CENP-F, is also involved in kinetochore assembly (Liao et al., 1995). Yeast two
hybrid studies indicated that the kinase domain of BUB1 and the kinetochore
localisation domain of CENP-F interact. Thus BUB1 may facilitate CENP-F binding
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to the kinetochore, either by direct interaction or through phosphorylation or
recruitment of intermediate proteins. CENP-F may then be important in the
recruitment of human BUBR1 and CENP-E to the kinetochore. This may be part of
BUBl's spindle checkpoint role or may represent a second role of BUB1 in
kinetochore assembly; consistent with observations in yeast, that deletion of the
BUB1 kinase domain can result in chromosome loss (Jablonski et al., 1998) and with
severe chromosome segregation defects seen in budding yeast bubl mutants (Warren
et ah, 2002). Okplp and Slkl9p are possible S.cerevisiae homologues of CENP-F.
CENP-I has also been shown to be important in maintenance of spindle
checkpoint arrest and for the localisation of MAD1, MAD2 and CENP-F to
kinetochores (Liu et ah, 2003b).
Overall, human BUB1 and human BUBR1 seem to have additional functions in
kinetochore assembly that may link them with the spindle checkpoint and be
important in localisation of checkpoint proteins to the kinetochore.
1.4.8 Adenomatous Polyposis Coli (APC) in the Spindle Checkpoint
The APC gene is involved in hereditary colorectal cancer and is somatically
inactivated in the majority of colorectal tumours (Rosin-Arbesfeld et ah, 2000).
Recent studies have clarified an additional role for APC, in microtubule
presentation to the kinetochores and the detection of failure to do so through the
spindle checkpoint. APC contains microtubule binding regions and is known to bind
EB1, a protein which also interacts with microtubules (Berrueta et ah, 1998;
Munemitsu et ah, 1994; Smith et ah, 1994). APC localises to the ends of
microtubules, and interacts with kinetochores at the outer kinetochore plate,
stabilising the kinetochore-microtubule interactions and promoting microtubule
polymerisation (Zumbrunn et ah, 2001; Nakamura et ah, 2001). APC co-
immunoprecipitates with BUB1-BUB3 and BUBR1-BUB3 and is phosphorylated by
them in vitro in the central and C-terminal portions of the protein which is
interspersed with GSK3[3 phosphorylation sites. This is dependent on prior
phosphorylation by GSK3f3 and other kinases. This phosphorylation may regulate
attachment of kinetochores to microtubules, as phosphorylation of APC causes a
decrease in its affinity for microtubules (Kaplan et ah, 2001). Thus APC seems to
have a role in the formation and stabilisation ofmicrotubule-kinetochore interactions.
65
This may be linked to the spindle checkpoint or proposed kinetochore assembly
functions of human BUB1 and BUBR1 or may be important in the repair of defects
in the mitotic spindle or kinetochore. However, APC is not essential for the spindle
checkpoint as Min/Min mouse embryonic cells have a functional mitotic arrest in
response to microtubule disruption. APC mutations removing the C-terminal
microtubule and EB1 binding domains but which leave the (3-catenin associated
regions unaffected, cause chromosomal instability in mouse ES cells, through
aberrant chromosome segregation (Fodde et al., 2001; Kaplan et al., 2001). An N-
terminal APC mutant mis-localised to the centrosome and compromised checkpoint
arrest, perhaps due to an inability to bind microtubules. Thus APC truncation
mutations may interfere with chromosome segregation and generate CIN in
colorectal cancers, in addition to interfering with Wnt signalling. In this way APC
mutations could impart both genetic instability and a growth advantage on the cell,
accelerating tumourigenesis. In support of this, adenomas harbouring mutations in
APC are more likely to grow and progress to invasive stages than those with 13-
catenin mutations, perhaps due to an additional defect in microtubule capture. Plus
many colorectal cancer cell lines with APC mutations described to date show a CIN
phenotype (Fodde et al., 2001). APC mutations and aneuploidy are both frequent
characteristics of colorectal tumours, and it now appears APC mutations may
contribute to aneuploidy (Tighe et al., 2001). Additionally mutations in BUB1 and
BUBR1 in tumours may affect APC phosphorylation and hence kinetochore-
microtubule binding as well as spindle checkpoint function.
1.4.9 Checkpoint Silencing
As the last chromatid attaches to microtubules, creating microtubule tension and
the chromosomes align on the metaphase plate, the sensor complexes dissociate from
kinetochores. In HeLa cells, the concentration of BUB 1, BUBR1 and MAD2 have
been shown to decrease 3.7, 3.9 and 152-fold respectively upon kinetochore
attachment (Zhou et al., 2002b). BUB3 kinetochore localisation is thought to drop at
least 5 fold upon kinetochore attachment in Xenopus egg extracts (Campbell and
Hardwick, 2003) and 3-5 fold in mice (Martinez-Exposito et al., 1999). This
prevents the formation of the signalling complex MAD1-MAD2-BUB1-BUB3 and
the effector complexes. This allows CDC20 to interact with the APC/C and activate
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cohesin destruction. The chromosomes then separate and digress to the poles of the
cell during anaphase (Chen et al., 1996; Chen et al., 1998; Jin et al., 1998; Li and
Benezra, 1996; Taylor et al., 1998).
The mechanism by which these complexes dissociate is beginning to be
investigated. The rapid turnover of MAD2 at kinetochores contributes to
dissociation of the complexes (reviewed in Musacchio and Hardwick, 2002). Other
proteins which have been implicated in spindle checkpoint function are thought to
have a role in movement of proteins away from the kinetochore along spindle fibres.
Consistent with this MAD2 has been reported to move onto spindles late in mitosis
in fission yeast (Ikui et al., 2002).
Recent studies suggest dynein and dynactin are involved in the removal of
kinetochore localised spindle checkpoint proteins when the checkpoint is inactivated.
Dynein and dynactin are motor proteins which act on microtubules, transporting
proteins along the spindle fibres from kinetochores to the poles of the cell and vice
versa. They may act to assist transport of spindle checkpoint proteins including
MAD2, BUBR1 and CENP-E from the kinetochore along the microtubule spindles
towards the centrosomes, as inhibition of dynein and dynactin activity has been
shown to prevent the transport of these proteins in PtKl cells (Howell et al., 2001).
Removal of these proteins upon kinetochore attachment is required to switch the
checkpoint off (Wojcik et al., 2001; Howell et al., 2001). MAD2, BUBR1, CENP-E,
the 3F3/2 phosphoantigen and ROD are continuously cycled while the checkpoint is
active by removal from the kinetochore through a dynein dependent mechanism and
replenished by an ATP-dependent mechanism (Howell et al., 2000; Wojcik et al.,
2001). This continued remove and replenish cycle at free kinetochores would allow
the checkpoint to be deactivated by inhibition of replenishment upon attachment of
the final kinetochore, whilst the motor proteins would remove any checkpoint
proteins remaining at the kinetochore. ZW10 and ROD are also thought to be
involved in this process of silencing the checkpoint. These proteins are required to
localise dynein to kinetochores, essential for checkpoint function, consistent with the
model for checkpoint silencing (Howell et al., 2001). Thus ZW10 and ROD mutants
would be expected to show prolonged activation of the checkpoint but actually
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depletion ofROD and ZW10 prevents activation of the spindle checkpoint providing
evidence of a parallel metaphase checkpoint (Chan et ah, 2000; Basto et al., 2000).
CENP-E, another kinetochore motor protein has also been linked with checkpoint
silencing. In cells depleted of human CENP-E chromosomes attached to
microtubules stain brightly for MAD2 and the spindle checkpoint remains active
(Yao et al., 2000; McEwen et al., 2001). CENP-E has also been shown to interact
with BUBR1 and this complex may undergo a conformational change when
kinetochores are under tension to inhibit BUBR1 checkpoint activity and switch off
the checkpoint (Yao et al., 2000).
Increased localisation of dynein is seen at CENP-E depleted kinetochores,
suggesting they compete for kinetochore binding sites and consistent with a role for
CENP-E in checkpoint silencing and checkpoint function (Chan et al., 1999).
However, CENP-E has also been shown to be have additional roles in checkpoint
activation, maintenance and spindle checkpoint protein kinetochore localisation (Yao
et al., 2000). These different functions may represent alternative conformations or
separable pools of CENP-E.
Removal from the kinetochore of checkpoint protein complexes will halt
activation of the spindle checkpoint and prevent formation of MCC and the
checkpoint inhibitory complexes. However, for the checkpoint to be fully
inactivated the existing effector complexes must dissociate. The break up of these
complexes may be spontaneous or may be through an, as yet unidentified, assisted
mechanism. There is a little evidence for assisted dissociation. Structural studies
reveal the partial unfolding of MAD2 is required for dissociation of the MAD2-
CDC20 complex. This is likely to inhibit or slow spontaneous break up, posing a
kinetic barrier for dismantling the MCC (Luo et al., 2002; Sironi et al., 2002).
Additionally, studies in PtKl cells which possess two spindles show that the
presence of an unattached kinetochore to one spindle does not inhibit anaphase onset
on the other spindle (Rieder and Khodjakov, 1997). This suggests the inhibitory
signals generated by the checkpoint can only travel a limited distance and this is
consistent with an active mechanism for dissociation of inhibitory complexes in the
cytosol (Yu, 2002).
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1.4.10 A Summary of the Current Model for the Spindle Checkpoint
Current models of the spindle checkpoint propose that three complexes of
checkpoint proteins exist throughout the cell cycle, MAD1-MAD2, BUB3-BUB1
and BUB3-MAD3 (or BUB3-BUBR1). On activation of the checkpoint in response
to defects in chromosome attachment, these are recruited to kinetochores that have
yet to bind microtubules; MAD1-MAD2 in response to the presence of unattached
kinetochores and BUB3-BUB1 to loss of tension. Modification of these complexes,
probably involving the kinase activities of MPS 1 and possibly BUB1, result in the
formation of a BUB3-BUB1-MAD1-MAD2 complex. From this signalling complex,
MAD2 is released in an activated form, perhaps as an oligomer or through
phosphorylation. Activated MAD2 then associates with CDC20 and probably
MAD3/BUBR1 and APC/C, inhibiting APC/C mediated degradation of PDS1.
PDS1 continues to inhibit ESP1 cleavage of the SCC1 cohesin subunit and the sister
chromosomes remain joined. Thus the metaphase to anaphase transition is delayed
(Brady and Hardwick, 2000).
Upon attachment of the last kinetochore to the bipolar spindle, the complexes are
perceived to dissociate from the kinetochore and each other in some cases through
spontaneous and assisted means. A reduced local concentration of MAD2 and
MAD3/BUBR1 may allow CDC20 to be released and interact with APC/C, for
which it has a higher affinity. APC/C-CDC20's proteolytic activity would be
restored allowing it to degrade PDS1 and initiate anaphase. This model is








Figure 1.8 A model of the spindle checkpoint
Three constitutive complexes of spindle checkpoint proteins are recruited to
free kinetochores. Their close localisation and possible modification catalyses
formation of a signalling complex from which an activated form of Mad2p
indicated by the star is released. This interacts with other checkpoint proteins
to inhibit the Cdc20p from activating APC/C both locally at the kinetochore
and throughout the cell. This generates the anaphase wait signal which delays
chromosome segregation and the metaphase to anaphase transition.
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1.5 The Role of the Spindle Checkpoint in Disease
Mutations in components of the mitotic spindle checkpoint have been implicated
in tumourigenesis through the generation of aneuploidy. Defects in mitotic and
meiotic spindle checkpoints may also be involved in birth defects, down syndrome,
spontaneous foetal abortion and bone marrow failure (Matsuura et ah, 2000; Nicklas,
1997; Shonn et ah, 2000; Yamaguchi et ah, 2003).
1.5.1 Defects in the Spindle Checkpoint
Knockout mice have been created for two spindle checkpoint components; BUB3
and MAD2. BUB3 mutant embryos fail to survive beyond day 6.5-7.5, accumulating
mitotic errors from day 4.5, indicative of chromosome segregation defects.
Treatments of null embryos with microtubule poisons show that the mitotic
checkpoint is defective (Kalitsis et ah, 2000).
MAD2 knockout mice grow normally to day 5.5 despite an absence of mitotic
arrest response. The rapid cell division stage at E6.5 results in widespread
chromosome mis-segregation and apoptosis in the absence of a functional checkpoint
consistent with a role of spindle checkpoint defects in spontaneous abortion (Dobles
et ah, 2000).
Thus it appears knockout mutations in spindle checkpoint genes may be lethal at
least in development. To address this, Michel et al generated cancer cell lines and
murine primary embryonic fibroblasts deleted in one allele ofMAD2 and found that
MAD2 shows haploinsufficiency. MAD2+'~ cells are checkpoint defective and show
elevated levels of chromosome mis-segregation. MAD2+,~ mice develop lung
tumours suggesting mutations rendering checkpoint proteins null are lethal whereas
partial disruption of the checkpoint may allow chromosomal instability while
avoiding apoptosis and therefore contribute to tumourigenesis. The mice develop
tumours in their lungs which is unexpected as mutations in spindle checkpoint genes
are rarely found in lung tumours (Michel et ah, 2001).
In Xenopus, partial depletion ofBUB3 abrogates spindle checkpoint establishment
and maintenance during mitosis but BUB3 is not required for maintenance of a
meiotic metaphase arrest (Campbell and Hardwick, 2003). Xenopus BUB1 has been
shown to be required for meiotic metaphase arrest (Tunquist et ah, 2002) and
immunodepletion ofXenopus BUB1 and BUBR1 interferes with localisation of other
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checkpoint proteins (Sharp-Baker and Chen, 2001; Chen, 2002). These Xenopus
experiments suggest mechanisms of checkpoint abrogation which may be responsible
for the phenotypes seen in the mouse knockout mutants.
Studies of spindle checkpoint mutants show these proteins are not essential in
yeast. Warren et al. examined the phenotypes of spindle checkpoint mutants and
found that while all the spindle checkpoint mutants, excluding bub2, exhibited
sensitivity to microtubule poisons and an elevated chromosome loss frequency, the
extent of these phenotypes varied between the mutants, probably in relation to their
contribution to checkpoint function (Warren et al., 2002). bub3 and bubl were found
to show the greatest checkpoint defects followed by madl, mad2 and mad3
respectively, which all showed significantly reduced phenotypes. These experiments
provide a system for quantifying the function of checkpoint proteins and their
domains in budding yeast (Warren et al., 2002).
Although evidence in yeast suggests the proteins are not essential spindle
checkpoint proteins do appear to be essential in mammalian systems and complete
loss of their function is likely to be lethal. However, spindle checkpoint mutations
which inactivate one allele or alter expression levels are likely to be less severe and
may impact on diseases such as cancer.
1.5.2 The Spindle Checkpoint in Tumourigenesis
Over the last few years numerous studies have examined the role of spindle
checkpoint defects in tumourigenesis and aneuploidy. The treatment of colorectal
cancer cell lines with microtubule poisons show that those exhibiting CIN behave
differently to those with MIN at the G2/M checkpoint. Cell lines of both types,
arrested with DNA contents indicative of a G2 block and the MIN and normal cells
maintained this block, resulting in a characteristic mitotic profile with a peak in
mitotic index at 12-24 hours. However, CIN cells displayed an abnormal profile
with no true peak and a lesser decrease in mitotic index indicative of an incomplete
block and re-entry into mitosis. This suggests CIN cell lines harbour defects in
mitotic checkpoints and some of these cell lines were shown to harbour mutations in
spindle checkpoint genes (Cahill et al., 1998). Recent reports show some CIN cell
lines to have an intact G2/M arrest in response to microtubule drugs, with reduced
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maximum mitotic index compared to the MIN cells suggesting partial
compromisation at the spindle checkpoint (Tighe et al., 2001). This could be due to
mutations in genes less directly involved in the spindle checkpoint or in microtubule
dynamics or spindle positioning. Indeed transfection of a truncated form of the APC
gene into MIN cell lines does mimic the CIN response and APC truncation mutations
are frequently found in CIN cell lines. Interestingly, studies of breast cancer cell
lines show variation in the chromosomal instability observed with the highly unstable
cell lines showing defective mitotic checkpoints, whereas those with moderate
instability have intact checkpoints (Yoon et al., 2002) and this may account for the
discrepancies observed between the Cahill and Tighe reports.
Analysis of spindle checkpoint genes in tumours has revealed fewer mutations
than expected. In early studies, examination of the human BUB I gene in 19 CIN
colorectal cancer cell lines, revealed heterozygous somatic mutations in two of the
cell lines. The first, a G—»A transition at a canonical splice donor site, results in a
197bp deletion at the RNA level, removing part of CD1 and the second involved a
missense mutation substituting a tyrosine for a conserved serine. Over-expression of
these mutant alleles in MIN cell lines produced a phenotype similar to CIN cell lines
in response to microtubule poisons, indicative of a dominant negative effect. Over-
expression of the wild type allele had no effect. Similarly co-expression of the wild
type and mutant alleles abrogated the checkpoint. Analysis of the human BUBR1
gene in the same panel of cell lines showed that all 19 cell lines produce the protein
although two produce mutant RNA transcripts. The first of these resulted from a
germline C—»T transition substituting a methionine for a threonine in an unconserved
region and the second was a somatic deletion of a T causing truncation of the protein
in the kinase domain. Functional analysis of these was not reported (Cahill et al.,
1998). No further mutations were found in these cell lines in any of the following
spindle checkpoint genes; MAD2, MAD2L2, MAD1, BUB3, TTK (MPS1),
P55CDC20 (Cahill et al., 1999).
Since these early studies spindle checkpoint genes have been analysed in a variety
of tumours for mutations and alterations in expression levels, particularly in cancers
in which aneuploidy is common. These are summarised in table 1.4.
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Many of the tumour cell lines examined were shown to be defective in checkpoint
arrest (Cahill et ah, 1998; Takahashi et ah, 1999; Wang et ah, 2002; Wang et ah,
2000a; Saeki et ah, 2002; Kasai et ah, 2002; Ouyang et ah, 2002; Hempen et ah,
2003). Interestingly, many of the variants identified were altered in conserved
domains and important functional domains of the protein supporting their
pathogenicity (Hempen et ah, 2003; Saeki et ah, 2002; Ru et ah, 2002). Deletions
and truncating mutations were relatively rare (Cahill et ah, 1998; Percy et ah, 2000;
Tsukasaki et ah, 2001; Ohshima et ah, 2000; Ru et ah, 2002; Ouyang et ah, 2002) but
single base mutations were more frequent. Polymorphisms were frequently seen and
combinations of these may confer an increased cancer risk. There is evidence that
some spindle checkpoint gene polymorphisms do confer an increased cancer risk
(Iwanaga and Jeang, 2002). Alterations in protein levels may also be important in
cancer susceptibility and these may be a result of alterations in the promoter or
untranslated regions of checkpoint proteins or methylation of checkpoint genes.
In addition, Adult T-cell leukaemia and lymphoma (ATLL) is caused by the
human T-cell leukaemia virus type I (HTLV-I) which integrates randomly into the
genome and produces an oncoprotein Tax that interacts with and inhibits MAD1,
inducing chromosome instability (Jin et ah, 1998).
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Table 1.4: Spindle Checkpoint Genes in Tumourigenesis
Cancer type and Genes Results % Reference
number analysed mt
19 Colon (CIN) BUB] 1 missense mutation, 1 deletion 10.5 Cahill et al.,
BUBR1 1 missense mutation , 1 deletion 10.5 1998;
MADI 0 mutations 0 Cahill etal., 1999
MAD2 0 mutations 0
MAD2L2 0 mutations 0
BUB3 0 mutations 0
TTK 0 mutations 0
Cdc20 0 mutations 0
6 Colon (CIN) - All checkpoint Defective - Cahill et al.,1998
40 Colon BUB1 0 mutations, 0 SNP 0 Jaffrey et al.,
2000
32 Digestive tract MAD2 0 mutations 0 Imaietal., 1999
BUB] CDs 1 missense mutation 3.1
43 Gastric BUB1 Protein expression upregulated in 84% - Grabsch et al.,
(81% aneuploid) BUBR1 Protein expression upregulated in 68% - 2003
BUB3 Protein expression upregulated in 79% -
All 3 Protein expression upregulated in 61% -
Did not correlate with aneuploidy
8 Gastric BUB1 Several point mutations, unconfirmed at - Nakagawa et al.,
genomic level 2002
20 Lung NSCLC BUBJ 0 mutations, 1 SNP 0 Jaffrey et al.,
2000
31 Lung HNSCC BUB1 1 silent mutation, 0 SNP, all expressed protein 3.2 Yamaguchi et al.,
1999
46 Lung MAD2 0 mutations, some SNP, all expressed protein 0 Takahashi et al.,
p55Cdc20 0 mutations, some SNP, all expressed protein 0 1999
9 Lung - 4 checkpoint defective - Takahashi et al.,
1999
88 Lung BUB1 (not 1 missense mutation, 11 SNP, protein 1.1 Sato et al., 2000
Mesothelioma exl) expressed in 31 cell lines tested
47 Lung BUBR1 0 mutations, frequent silent SNP, protein 0 Sato et al., 2000
Mesothelioma expressed in 31 cell lines tested
44 Lung BUB1 0 mutations, some SNP 0 Haruki et al.,
BUBR1 0 mutations, some SNP, protein upregulated 0 2001
BUB3 1 missense mutation (5' UTR), some SNP 2.3
60 Lung MAD2 1 silent mutation, 1 missense SNP, reduced 1.7 Gemma et al.,
protein expression 2001
49 Lung MADI 2 missense mutations, several missense and 4.1 Nomoto et al.,
silent SNP 1999
8 Lung BUBR1 Protein expression upregulated in all 8 - Seike et al., 2002
4 Lung MADI 0 mutations, SNP 0 Tsukasaki et al.,
2001
48 Breast MAD2 1 silent mutation, 0 SNP 2.1 Gemma et al.,
2001
21 Breast MAD2 1 deletion mutation, 2 missense mutations (3' 14.3 Percy et al., 2000
UTR), 0 SNP, altered protein expression in
3/13, upregulated in deletion
19 Breast BUB1 0 mutations, 9 missense and silent SNP, 0 Myrie et al., 2000
BUBR1 variable protein levels
7 Breast BUB1 0 mutations, some previously reported SNP 0 Ru et al., 2002
26 Breast MADI 2 missense, 1 silent mutations, SNP 11.5 Tsukasaki et al.,
2001
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Cancer type and Genes Results % Reference
number analysed mt
7 Ovarian MAD2 3 checkpoint defects + reduced MAD2 expression - Wang et al., 2002
22 Glioblastomas BUBI 1 silent mutation 4.5 Reis et al., 2001
BUBR1 9 silent mutations 40.9
BUB3 4 missense SNP upstream of initiation codon
18 Giant cell BUB1 2 silent mutations 11.1 Reis et al., 2001
Glioblastomas
5 NPC MAD2 2 checkpoint defective with reduced protein
expression
- Wang et al., 2000
86 Hematopoietic MADI 1 missense, 1 nonsense, 3 silent mutations, SNP 5.8 Tsukasaki et al.,
2001
39 Prostate MAD1 3 missense, 1 deletion, 1 silent mutation, SNP 12.8 Tsukasaki, 2001
5 Osteosarcoma MADI 0 mutations, SNP 0 Tsukasaki, 2001
17 Glioblastoma MADI 0 mutations, SNP 0 Tsukasaki, 2001
21 Bladder BUB1 2 silent SNP - Olesen et al.,
BUBR1 23 silent SNP, 13 missense SNP - 2001
BUB3 0 SNP -
TTK 4 silent SNP, 22 missense SNP -
44 Bladder MAD2 1 missense mutation, 3 silent SNP 2.3 Hernando et al.,
2001
52 Bladder BUB1 3 silent SNP - Hernando, 2001
9 Bladder BUB3 0 SNP - Hernando, 2001
42 Sarcoma MAD2 3 silent SNP - Hernando, 2001
10 Hepatocellular MAD2 2 silent SNP - Hernando, 2001
58 Hepatocellular BUB1 0 mutations, 2 missense SNP 0 Saeki et al., 2002
BUBR1 Omutations, 2 silent, 1 missense SNP 0
MAD2L2 0 mutations, 0 SNP 0
Cdc20 0 mutations, 1 silent 2 missense SNP 0
BUB3 0 mutations, 0 SNP 0
8 Hepatocellular BUB1 All aneuploid, 5 Checkpoint defect, 0 mutations - Saeki et al., 2002
10 ATLL BUB1 1 missense mutation 10 Ohshima et al.,
BUBR1 3 missense, 1 deletion, 1 silent mutation 40 2000
8 HTLV-1 BUB1 0 mutations 12.5 Ohshima et al.,
BUBR1 1 nonsense mutation 2000
6 ATL MADI
MAD2
All checkpoint defective with MAD 1 and MAD2
mislocalisation
- Kasai et al., 2001
8 Leukemia BUB1 2 deletion, 1 missense mutation 50 Ru et al., 2002
2 ALL BUB1 1 heterozygous deletion mutation 50 Ru et al., 2002
2 Hodgkins BUBI 2 deletion mutations 100 Ru et al., 2002
Lymphoma
2 AML BUB1 0 mutations 0 Ru et al., 2002
1 CML BUBI 0 mutations 0 Ru et al., 2002
9 Oral cancer Partial
BUBI
0 mutations in exons 8,10,12,15 or kinase domain 0 Nakagawa et al.,
2002
8 Thyroid - 2 checkpoint defects - Ouyang et al.,
2002
19 Thyroid BUBI 1 deletion mutation, 1 silent SNP 5.3 Ouyang et al.,
BUBR1 0 mutations, 1 silent SNP 0 2002
4 aneuploid
Pancreatic
- All checkpoint defective - Hempen et al.,
2003
18 Pancreatic BUBI 2 missense mutations in NLS 11.1 Hempen et al.,
BUBR1 0 mutations 0 2003
23 various MADI 12 silent SNP, 9 missense SNP (affect not
analysed), 12 with pathogenic missense SNP
- Iwanaga et al.,
2002
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Together these studies suggest that spindle checkpoint gene defects are important
in a subset of aneuploid cancers. Mutations appear to be rare in cancers which are
largely influenced by carcinogens such as lung cancer (only 6 mutations in 523
cancers analysed) whereas they are more frequent in colon and digestive tract
cancers (5/256 cancers), prostate cancers (5/39), leukemias (13/51) and breast
cancers (7/140). This indicates alternative pathways of carcinogenesis may act in
these two groups of tumours where spindle checkpoint mutations may act as an
alternative mechanism to artificial carcinogens in the induction of CIN (Li et al.,
2000).
Alternatively the rare occurrence of mutations, and the prevalence for missense
mutations may reflect the essential nature of the spindle checkpoint proteins.
Mutations which nullify the protein, such as large deletions or truncating mutations,
may be lethal as shown in mouse knockouts. More subtle changes such as single
amino acid changes and combinations of polymorphisms, may compromise the
checkpoint, resulting in aberrant chromosome segregation and transformation. Most
spindle checkpoint gene variants reported are single nucleotide polymorphism (SNP)
and point mutations. Thus extensive studies into the occurrence ofpolymorphisms in
spindle checkpoint genes in individuals with and without aneuploid tumours may
clarify their role in cancer predisposition.
Variations in expression levels of spindle checkpoint proteins, seen in several of
the tumours analysed, may also contribute to tumourigenesis through subtle effects.
Mutations and polymorphisms have been identified in the untranslated regions of
spindle checkpoint genes, including the 3' UTR and in the sequence between the
Kozak sequence and the initiation codon, and although no functional work has been
done on these, they may contribute to tumourigenesis by altering the protein
expression levels. Alterations in the promoters or methylation status of the genes
may also play a role.
Repeat sequence instability at the 2q locus containing the BUB1 gene was found
in 62.5% of colon cancers with 14.5% showing instability within the BUB1 gene
itself. Microsatellite instability in promoter regions has been linked to down-
regulation of genes, with instability in coding sequences and introns appearing to
influence gene transcription and suggests an alternative mechanism for
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compromising the spindle checkpoint. No allelic instability was found in this region
in Non-small Cell Lung Cancers (NSCLC) consistent with the infrequent
involvement of the spindle checkpoint in lung cancers (Jaffrey et ah, 2000)).
Alternatively, lethality of mutations may be avoided through overlapping
functions between checkpoint proteins. There are several levels of redundancy in the
spindle checkpoint. For example, the checkpoint proteins BUB1 and BUBR1 show
good homology to each other and evidence suggests partial redundancy. In addition
the checkpoint can be activated either by loss of attachment or tension and there are
multiple checkpoint sensor and effector complexes. Furthermore some components
of the spindle checkpoint have more than one homologue in human cells. There are
two human homologues of MAD2, and BUBR1 was initially identified as a
homologue of BUB1. Defects in only one of these might reduce checkpoint fidelity
and generate low level aneuploidy insufficient to activate apoptosis and may
contribute to carcinogenesis (Brady and Hardwick, 2000). Thus mutations in these
would also allow compromisation but not elimination of the checkpoint, avoiding
lethality. In addition, this homology may suggest a way in which polymorphisms in
homologous proteins may combine to reduce checkpoint efficiency.
The avoidance of apoptosis is an important phenotype in cancer cells.
Transfection of a dominant negative murine BUB1, N-BUB1, containing only the
kinetochore localisation domain into HeLa cells suggests spindle checkpoint mutants
may bypass apoptotic pathways. After treatment with microtubule poisons, the N-
BUB1 transfectants and parent cells both exhibited mitotic arrest but the N-BUB1
cells exited mitosis prematurely and continued into a second mitosis, producing cells
with 8N DNA content, indicative of irregular chromosome segregation. The parent
cells however, were blocked at mitosis for a longer period before exiting with DNA
contents less than 4N, indicative of apoptosis. It was hypothesised that spindle
checkpoint mutations may allow cells to bypass both checkpoints and apoptosis in
response to chromosome segregation abnormalities (Taylor and McKeon, 1997).
However, this is not consistent with studies of BUB3 and MAD2 mutant mice, which
undergo lethal mass apoptosis in embryonic stages, but this could reflect the
intolerance for apoptosis in development. These mice were completely depleted of
the proteins and mutations only affecting part of the protein function may achieve
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this escape. Obviously the mutations shown to be involved in tumourigenesis must
be able to avoid apoptosis but this may be due to the accumulation of mutations in
apoptotic genes, such as p53, as a result of the chromosomal instability. p53 is
activated in response to microtubule poisons through MAP and ERK kinases, which
are localised at unattached kinetochores and may induce G1 arrest and apoptosis to
protect from aneuploidy (Sablina et al., 2001). Clarification of the mechanism
involved in spindle checkpoint associated apoptosis will be needed before the
contribution of spindle checkpoint mutations in bypassing apoptosis can be
determined.
Finally, how do spindle checkpoint mutations fit into the sequential model of
tumour progression shown in figure 1.1? Gascoyne et al., have very recently shown
that in fibrosarcoma development the spindle checkpoint is active in mild
fibromatosis but is abolished in aggressive fibromatosis and fibrosarcoma lesions
(Gascoyne et al., 2003). This suggests spindle checkpoint inactivation occurs early
in tumourigenesis, contributing to the chromosome instability required for tumour
progression.
1.5.3 Spindle Checkpoint Mutations and Cancer Treatment
There is evidence that cells with defects in chromosome segregation, be it through
spindle checkpoint protein abnormalities or otherwise, are more susceptible to certain
chemotheraputic agents. MIN and CIN cell lines exhibit resistance to different types
of carcinogens, with the MIN cells generating resistance to the alkylating agent N-
methyl-N'nitro-N-nitroguanidine (MNNG) and treatment with a bulky adduct
forming agent 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) generating
CIN cells with resistance to the drug. A MIN cell line transfected with a human
BUB1 mutant exhibited a CIN phenotype and was resistant to PhIP carcinogens
which affected the parental MIN cell lines (Bardelli et al., 2001; Weitzel and Vandre,
2000). This demonstrates that cells with different types of instability are resistant to
different drugs. Interestingly PhIP is the major dietary carcinogen in cooked meat
and chicken, suggesting a diet rich in meat may contribute specifically to aneuploid
tumours, a factor consistent with the frequency of aneuploid tumours in westernised
societies (Bardelli et al., 2001). These variations in resistance to carcinogens may
have important implications for development of chemotherapeutic agents.
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It has been suggested that using a combination of mitosis arresting drugs with
cytotoxic treatments which target cycling cells would affect only the checkpoint
defective, tumour cells, leaving normal cells unharmed (Hardwick et al., 1996).
Thus the identification of patients with mutations in these pathways could allow the
tailoring of chemotherapy and treatment to those aneuploid tumours associated with
poorer prognosis.
Although searches for mutations in checkpoint genes have resulted in a relatively
small number identified in most cases, there is evidence that they do contribute to a
subset of aneuploid tumours. Some mutations have been reported to date and most
appear to be somatic but changes in the non-coding regions of checkpoint genes,
combinations of polymorphisms and epigenetic alterations may also contribute to the
loss of the checkpoint in sporadic and familial tumourigenesis. Clarification of the
involvement of these in aneuploid colorectal cancer will ultimately aid the clinical
surveillance, prevention and treatment of colon cancer. It is becoming increasingly
likely that different genes are involved in subsets of cancers and that in the future,
treatment may depend upon the genotype of the tumour. CIN cancers are probably a
heterogeneous population with each CIN candidate gene being altered in a small
proportion of aneuploid tumour cases. If a large number of genes are each
responsible for a subset of cases, this may explain the frequency of aneuploid
tumours. Thus by identifying the genotype of tumours we may be able to match the
most suitable treatment to the patient. Unfortunately tailoring therapies to individual
tumour genotype is expensive in terms of health service resources.
The advantage of genetic instability is that it differentiates cancer cells from their
normal counterparts and may be utilised in therapy. As cancers with genetic
instabilities harbour defects in cellular processes which maintain genomic integrity,
they may be sensitive to particular chemical agents. For example NER defective
cells are sensitive to UV light, BRCA mutant cells are hypersensitive to ionising
radiation and cells with mitotic checkpoint defects are sensitive to taxanes including
Paclitaxel and microtubule poisons (Lengauer et al., 1998; Jallepalli and Lengauer,
2001). Drugs such as taxanes and vinca alkaloids might act preferentially on cells
with spindle checkpoint defects, i.e. tumour cells, by activating the spindle
checkpoint and elevating missegration rates in tumours to the extent that cells are no
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longer viable (Jallepalli and Lengauer, 2001). This is consistent with the increased
sensitivity to microtubule poisons such as Benomyl seen in budding yeast spindle
checkpoint mutants (Warren et ah, 2002). Indeed studies have indicated that tumours
over-expressing MAD2 may respond more successfully to treatment with
microtubule poisons (Zhang et al., 2001). A nasopharyngeal carcinoma cell line
over-expressing MAD2 was more sensitised to the microtubule poison vincristine
perhaps through phosphorylation of apoptosis associated protein BCL-2 (Wang et ah,
2003b). Prostate cancer cell lines with cell cycle checkpoint defects, were shown to
be sensitive to the antiproliferative effects of the chemotherapeutic drug paclitaxel,
although the cell cycle response at mitotic checkpoints and the speed of subsequent
cell death by apoptosis varied in different cell lines (Lanzi et ah, 2001). Thus it
seems tumour cells with mitotic checkpoint defects may respond favourably to
existing anticancer drugs.
Genetic instability may also be used to identify novel anti-cancer drugs and to
target therapies to CIN tumours by exposing paired normal and tumour cell lines to
different anti-tumour compounds and assessing cell death. In this way the paired
cultures can be used to identify drugs with selective activity against CIN tumour cell
lines. A technique based on this approach and incorporating fluorescent markers, is
being used to identify new anticancer drugs using high throughput technology
(Torrance et ah, 2001).
1.6 Previous Work
Farrington and colleagues analysed a panel of thirty aneuploid colorectal tumours
for mutations in human BUB1 and BUBR1 initially using RT-PCR. A novel
alteration in human BUBR1 was identified in -20% of these tumours (Farrington et
ah, unpublished). This change is a 197bp deletion removing all of exon 5, in a
conserved domain of the protein involved in interaction with CDC20 (CD1). The
deletion is referred to as AE5 throughout this thesis. Alignment of the BUB1 and
BUBR1 DNA sequences indicate the deletion shows identity to a BUB1 mutation
V400 previously reported in a colorectal cancer (Cahill et ah, 1998). The same
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change has been identified in a lymphoblastoid cell line from a family with early
onset colorectal and other cancers. Karyotypic analyses of cell lines and peripheral
blood lymphocytes from members of the family, revealed low level aneuploidy in a
proportion of the samples, with both losses and gains of chromosomes being
observed. A number of these cell lines were also investigated for functional defects
at the G2/M check-point and preliminary results indicated that the mitotic index after
spindle disruption was found to be aberrant when compared with control CIN and
MIN tumour cell lines. Thus, initial results indicate that the change may play a
major role in tumour formation, predisposing patients to the formation of aneuploid
cells. Attempts to identify the genomic change associated with the altered cDNA
transcript have not yet been successful, suggesting this may be a larger genomic
deletion, well documented in cancer or possibly an alternative splicing effect.. The
pathogenic effect of alternative splicing of the WT1 gene is well documented in
disease indicating alternatively spliced transcripts do impact on carcinogenesis (Lee
and Haber, 2001; Philips and Cooper, 2000; Klamt et al., 1998; Kikuchi et ah, 1998;
Schneider et al., 1993). However, a recent study on alternative splicing in the human
genome predicted none to occur in human BUBR1 (Modrek et al., 2001).
The previously reported BUB1 V400 mutation was shown to abrogate the spindle
checkpoint consistent with induction of tumourigenesis (Cahill et al., 1998). These
checkpoint defects would be expected to allow cells to accumulate chromosomal
instabilities through a bypass of the checkpoint and consequently amass transforming
mutations creating an aneuploid tumour.
1.7 PhD Aims and Methodology
The aim of this work has been to clarify the involvement of spindle checkpoint
mutations in colorectal tumourigenesis. This has been approached in two ways:
1. Use of a budding yeast model system to investigate the effects of the
BUBR1AE5 and BUB1V400 mutations on the spindle checkpoint and chromosome
segregation.
82
S.cerevisiae has been used extensively in studies on spindle checkpoint function
due to the availability of the complete genome sequence and genetic tractability of
this model system.
The equivalent of the AE5 mutations were constructed in the S.cerevisiae MAD3
and BUBI genes on plasmid constructs. These were transformed into mad3 or bubl
mutant strains and the transformants were analysed for sensitivity to microtubule
poisons, spindle checkpoint activity and frequency of chromosome loss. The ability
of the mutant spindle checkpoint proteins to interact with other checkpoint proteins
and to form signalling and effector complexes was also investigated. The abilities of
the mutant proteins to exert dominant negative effects were also analysed.
2. Further analysis of the BUBR1 and BUB1 AE5 deletions in human cells.
The AE5 mutations are ultimately to be investigated in human tumour cell lines.
The human BUBR1 AE5 deletion is to be constructed in plasmid form and used in
over-expression studies in an inducible form in MIN cell lines. The ability ofAE5 to
abrogate the metaphase to anaphase checkpoint would then be investigated.
Construction ofGreen Fluorescent protein (GFP) fusions of the AE5 and wild type
proteins would allow analysis of the effect of the deletion on the localisation and
protein interactions of BUB1 and BUBR1. Additionally, antibodies to the N-
terminal of BUB1 and BUBR1 were generated for use in immunofluorescence
experiments.
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Chapter 2: Materials and Methods
The following chapter documents the methods used during the work described in
this thesis. Specific detail is also included in the relevant results chapters where
appropriate.
2.1 General Information
Standard safety procedures and COSHH regulations have been adhered to through
out this work in accordance with the MRC health and safety policies. Stock
solutions and media marked with an asterisk(*) were prepared and sterilised by
autoclaving by the MRC HGU technical services department. Those solutions
marked with a hash(#) were prepared by the solution and media preparation service at
the Institute of Cell and Molecular Biology (ICMB), University of Edinburgh.
Solutions and media were typically sterilised either by autoclaving for 15 minutes at
120°C and 15 pounds/inch2 or by filtration, through 0.45 jam acrodisc syringe filters
for small volumes (Gelman Sciences), or through 250 or 500ml 0.45jam filter units
for larger volumes (Nalgene). Glassware was dry sterilised by baking in an oven at
250°C for 16 hours. The pH of solutions was adjusted by the addition of conc. HC1
or Na OH as appropriate and monitored using a microprocessor pH meter (Harrna
Instruments).
A list of Suppliers is shown in table 2.1
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Table 2.1: List of Suppliers for Reagents and Chemicals
Supplier Location Items supplied
Roche Lewes, UK DNA polymerases, Restriction
Enzymes
Fisher Scientific UK Chemicals
VWR Poole, UK Chemicals, Filter units
Melford UK Chemicals
Sigma Dorset, UK DNA Polymerases
New England Biolabs Hitchin, UK Restriction Enzymes, Ligase
Promega Southampton, UK Chemicals, Enzymes
Qiagen Crawley, UK DNA purification kits
Stratagene Netherlands Enzymes
Biogene Kimbolton, UK Growth Media Reagents
Difco UK Growth Media Reagents
Gibco BRL UK Growth Media Reagents
Oxoid Basingstoke, UK Growth Media Reagents
Nalgene Nerijse, Belgium Filter units
SLS Strathclyde, UK DNA Extraction Kits
Anachem Luton, UK SDS PAGE Apparatus
Cambio Cambridge, UK Molecular Biology Kits
USB Corporation USA Enzymes
Invitrogen Paisley, UK Competent Cells
Clontech Oxford, UK Plasmids
PE Applied Biosystems Cheshire, UK Enzymes
MWG Biotech Milton Keynes, UK Oligonucleotides
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2.2 DNA Samples
The following samples were obtained directly as DNA samples. Where samples
are prefixed with MD- this represents the laboratory identification code used.
2.2.1 Constitutional DNA from Colorectal Cancer Patients
Prof. M. Dunlop and Dr. S. Farrington have previously collected a panel of
constitutional DNA from the blood, normal mucosa and tumours of patients with
CRC. These were available as a laboratory resource and were used at a
concentration of approximately lOOng/pl.
2.2.2 Plasmid Samples
Plasmid samples were originally obtained from a number of different laboratories
and suppliers. These are shown in Table 2.2 alongside the source. Plasmids
constructed by myself are listed and cloning strategy will be discussed in the relevant
chapter.
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Table 2.2: Plasmids Used in this Thesis
Plasmid Name Description Source
YCPLac22 Yeast/E.coli shuttle vector Gietz and
Sugino 1988





pMAD3 S.cerevisiae MAD3 Wild Type- YCPLac22 Warren et al
2002
pMAD3-AE5 S.cerevisiae MAD3 AE5- YCPLac22 This Study




pMET:MAD3-AE5 S.cerevisiae MAD3 AE5 over-expression This Study
pBUBl S.cerevisiae BUB1 Wild Type- YCPLac22 Warren et al
2002
pBUBl-AE5 S.cerevisiae BUB1 AE5- YCPLac22 This Study




pMET:BUBl-AE5 S.cerevisiae BUBI AE5 over-expression This Study
pcDNA-3 Myc hMAD3 Human BUBR1- pcDNA-3 myc tagged Taylor 2001
BVWT Human BUB1- pBI-GFP Cahill 1998
V400 Human BUB1 Deletion mutant- pBI-GFP Cahill 1998
V429 Human BUBlMissense mutant-pBI-GFP Cahill 1998
pKS+ V400 Human BUB1 Deletion mutant- pBluescript This Study
pKS+ V429 Human 5/7S7Missense mutant- pBluescript This Study
pKS+ BVWT Human BUBIWAA Type- pBluescript This Study
pKS+ BUBR1 Human BUBRlWild Type- pBluescript This Study
pBI BUBR1 Human BUBR1WM Type- pBI-GFP This Study
EGFP-5J757 Human BUB1 Wild type- EGFP-C1 This Study
EGFP-C1 GFP fusion vector Clontech
PTet-On Tetracycline regulatory element Clontech
PTRELuc Tetracycline responsive element coupled to
luciferase
Clontech
pCMV-P [3-gal plasmid Clontech
pTK-Hyg Hygromycin resistant plasmid Clontech
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2.3 DNA and RNA Purification Protocols
2.3.1 Purification of DNA from Cell lines and Blood Lymphocytes
Isolation of genomic DNA from cell cultures and blood was carried out using a
Nucleon II extraction kit (SLS) according to the manufacturer's instructions. This
procedure was carried out in a class 2-containment hood.
2.3.2 Phenol Chloroform Extraction and Ethanol Precipitation
Solutions
1 x Tris EDTA (TE)*
lOmM Tris (pH 7.7),
ImM Na2EDTA (pH8.0)
3M Sodium acetate (NaOAc)
3M Na0Ac-3H20
pH4
Phenol Chloroform extraction was carried out in a biological class 2 cabinet. An
equal volume of phenol chloroform solution (Gibco BRL) was added to the DNA
solution. This was inverted and spun for 5 minutes at 2000rpm in a Wifug lab
centrifuge. Supernatant containing the DNA was carefully removed with a pipette.
An equal volume of chloroform was then added to the supernatant, inverted and spun
for 5 min at 2000rpm. The supernatant was again removed. Phenol chloroform was
disposed of as liquid waste due to its hazardous nature.
For ethanol precipitation a 1:10 volume of 3M NaOAc (pH4) was added to the
DNA solution along with 2-3 volumes of 100% ethanol. The solution was incubated
for 30min at -70°C and then centrifuged for 15min at 2000rpm a Wifug lab
centrifuge. The residual DNA pellet was re-suspended in an appropriate volume of 1
x Tris EDTA pH7.7.
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2.3.3 Purification of DNAfrom Bacterial Plasmids
Plasmid DNA was extracted on small, medium and large scales using QIAprep
miniprep, midiprep and maxiprep kits respectively (QIAGEN) according to the
manufacturer's instructions.
For small scale DNA extraction from a large number of plasmid samples in
96well plates, a BioMek® 2000 workstation robot was used, operated by Dr. Stewart
McKay (MRC, Human Genetics Unit, Edinburgh) according to the manufacturer's
instructions.
2.3.4 Estimation of DNA Concentration
5pl of genomic and plasmid DNA samples were run on an agarose gel (see 2.4.4
for agarose gel electrophoresis) at stock concentration and 1:10 dilution and
compared to DNA standards of known concentration (lpg/pl, 750ng/pl, 500ng/ul,
250ng/pl, 100ng/pl).
2.4 PCR Protocols
Manipulation of oligonucleotides and all PCR techniques were carried out in a
biological class 2 cabinet designated for PCR. Equipment designated specifically for
PCR use was employed to minimise contamination ofPCR products.
2.4.1 Oligonucleotides for PCR
Primers were supplied by MWG Biotech as precipitates and resuspended in sterile
dH20 to a stock concentration of lpg/pl. Amplification was performed using an
Omnigene PCR system thermal cycler (Hybaid) under the following standard
conditions: 94°C for 3 min for 1 cycle; 94°C for 1 min, 55°C for 1 min, 72°C for 1
min for 35 cycles; 72°C for 5 min for 1 cycle. Primers were specifically designed
unless referenced (Tables 2.3 and 2.4).
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Table 2.3: S.cerevisiae Oligonucleotides Used for PCR
Primer Sequence 5'-3' 5'RE
site
MAD3
seel for GATCGAGCTCCCTGCATTAAGCGACCCAATTAC SacI
seel rev GATCCGTCTCGGATGAAAAAGTTCTATGTACCAAAACC BsmBI
sec2 for GATCCGTCTCGCATCTCCTGAGAGAACTGGGGGAG BsmBI
sec2 rev GATCTCTAGAAATTGCCAAGACTTCTTCTAGCG Xbal
BUB1
seel for GATCGAATTCTCTACTAATTAATGCTCAATAGCTGG EcoRI
seel rev GATCGCAGTGAAACAAATTTATATACCAAATCC BtsI
sec2 for GATCGCAGTGTTAATTATGAAGACAGACTCCGAG BtsI









Table 2.4: Human Oligonucleotides used for PCR
Primer Sequence 5'-3' 5' RE site
BUBR1
Seclf GATCGCGGCCGCATGGCGGCGGTGAAGAAGG Not I
Seclr GATCGCAGTGTAATTTAAGCCAGAGATTGAG Bts I



































Sec 2r GATCGGATCCTTTTACATGGAAATATTCCATGGG BamHI
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2.4.2 Standard PCR
PCR reactions were performed either in a final volume of 50pl using the Expand
Long Template PCR or AmpliTaq systems (Roche) or in a 25pi final volume using
the Expand High Fidelity PCR system (Boehringer Mannheim).
Final reaction concentrations for the Expand Long Template system were lxPCR
buffer I, II or III as manufacturer's recommendations, 0.2mM dNTP's, lOOng each
oligonucleotide primer, lOOng DNA and 2.5 Units of Expand High Fidelity PCR
mix.
Final reaction concentrations for the AmpliTaq system were lx AmpliTaq PCR
buffer, 2.5mM MgC12, 0.2mM dNTP's, lOOng each oligonucleotide primer, lOOng
DNA and 1.25 units ofAmpliTaq.
Final reaction concentrations for the Expand High Fidelity system were 1 x PCR
buffer II, 0.2mM dNTPs, lOOng each oligonucleotide primer, lOOng DNA and 0.87
Units ofExpand High Fidelity PCR mix.
2.4.3 Colony PCR
Bacterial plasmid DNA was analysed on a large scale in 96 well plates in 20pl
AmpliTaq PCR reactions. Bacterial colonies were stabbed into PCR reaction
reactions using a sterile p200 pipette tip. The colony was then streaked onto the
appropriate square of a gridded L-Agar plate for growth and storage.
2.4.4 Gel Electrophoresis
Solutions
10 x Tris-Acetate EDTA (Kitaeva et ah, 1997)*
2M Tris




0.25% w/v Bromophenol blue
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30% w/v Sucrose.
Standard agarose gels were prepared using 'Hi Pure' low EEO agarose (Biogene)
and lx TAE electrophoresis buffer. Separation of large fragments required low
percentage gels (typically 1.5%) whereas smaller fragments were separated on higher
percentage gels (typically 3%). If DNA fragments were being isolated from the gel
for sequencing or plasmid construction, a 1-3% ultra pure Low Melting Point agarose
(Gibco BRL) gel was prepared using lx TAE electrophoresis buffer.
5-lOp.l standard PCR products were loaded onto the gel with 2pl of loading
buffer. Size markers used were generally a lkb ladder (Gibco BRL) or a lOObp
ladder (Promega). The DNA was electrophoresed at 20-60V until the dye front was
lcm from the end of the gel although this varied with the size of fragments being
investigated. The DNA was visualised by staining with ethidium bromide (Biorad)
followed by UV trans-illumination using a Herolab trans-illuminator (Herolab,
Wiesloch). Images were captured using a Herolab Camera and Easywin 32 version
2.00 software.
2.5 Cloning and Bacterial Culture
Media and additives
Luria Broth (L-broth)*
0.1% w/v Tryptone (Difco)
0.05% w/v Yeast extract (Difco)
171mM NaCl
Luria Agar (L-agar)*
0.1% w/v Tryptone (Difco)
0.05% w/v Yeast extract (Difco)
171mM NaCl
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2.5.1 Growth of Bacterial Cultures
Overnight cultures were prepared by inoculating 15ml cultures of L-broth
containing 50pg/ml ampicillin or 30pg/ml kanomycin. They were incubated at 37°C
and shaken at 225rpm for approximately 16 hours. These cultures were used for
small-scale bacterial plasmid DNA extraction, to inoculate larger cultures for
medium and large-scale bacterial plasmid DNA extraction (see 2.3.3) or to prepare
glycerol stocks for long term storage (see 2.5.3).
2.5.2 Chemical Transformation into E.coli
Plasmids were transformed into either TOP 10 (Invitrogen), DH5a (GibcoBRL) or
SURE® (Stratagene) chemically competent E.coli strains. 1 pi of plasmid minprep or
ligation mixture was added to a lOOpl aliquot of competent cells and incubated on
ice for 1 hour. The cells were heat shocked at 37°C for 1 min and incubated again on
ice for 2 mins. 200pl of SOC media (Invitrogen) was added and the cells incubated
at 37°C with shaking at 200rpm for 1 hour. lOOpl were plated onto L-agar plates
with appropriate selection and these were incubated upturned at 37°C overnight.
Colonies were analysed for the presence of the plasmid by colony PCR (see 2.4.3).
2.5.3 Colony Selection and Storage
Colonies growing on antibiotic selection plates, indicative of positive
transformants, were picked using sterile p200 pipette tips. Presence of a correct sized
insert was determined by Colony PCR amplification using appropriate primers as
described above (2.4.3). Bacterial colonies were stabbed into PCR reactions before
being streaked onto L-Agar selection plates marked with a 96 square grid, for
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storage. The plates were incubated upturned at 37°C for approximately 16 hours and
stored at 4°C.
Stocks for long-term storage were made by centrifugation of 1ml of overnight
culture at 2000rpm for 5 mins in a Wifug lab centrifuge. The cell pellet was re-
suspended in 1ml of L-Broth with 15% sterile glycerol (Sigma). The cell suspension
was then transferred to a cryovial and stored at -70°C. Stored stocks were recovered
by scraping off a small amount of the frozen stock, streaking out onto selection plates
and incubating the plates upturned at 37°C overnight.
2.5.4 Restriction Digestion
Restriction digestion reactions were performed in a final volume of 50pl with
final reaction concentrations of lpg plasmid DNA or PCR product, lx restriction
enzyme buffer, 5p.g BSA if recommended by manufacturer and 5 units restriction
enzyme. The reaction was incubated at manufacturer's recommended temperature
for 1-2 hours. In the event of a digestion with 2 enzymes being required, a
compatible buffer was used as recommended by the manufacturer or if no buffers
were compatible the digested DNA was ethanol precipitated between digests as
above (2.1.2) and re-suspended in sterile dfTO before the second digest.
For enzymes used, their suppliers, buffers and temperatures, see table 2.5.
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BspEI T*CCGGA Buffer 3 37°C NEB
Bts I GCAGTG NN*
CGTCAC.NN
T
Buffer 4 37°C +BSA NEB
Ahdl GACNNN^NNGTC Buffer 4 37°C +BSA NEB
BsaBI GATNN^NNATC Buffer 2 60°C NEB
SacII CCGC^GG Buffer 4 37°C NEB




Buffer 3 55°C NEB
BstUI CG^CG Buffer 2 60°C NEB
Kpnl GGTAC*C Buffer L 37°C +BSA Roche
SacI GAGCT^C Buffer A 37°C Roche
BamHI G*GATCC Buffer B 37°C Roche
EcoRI G^AATT C Buffer H 37°C Roche
Xbal T*CTAGA Buffer H 37°C Roche
Sail G*TCGAC Buffer H 37°C Roche
NotI GC^GGCCGC Buffer H 37°C Roche
Smal CCC*GGG Buffer A 25°C Roche
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2.5.5 Purification of Digested Fragments
Restriction Digests were visualised by agarose gel electrophoresis on a 1-3 %
Ultra pure Low Melting Point agarose gel (Gibco BRL). DNA fragments of the
required size were removed in slices of agarose using a clean scalpel blade. The
DNA fragments were purified from the agarose using either a QIAquick gel
extraction kit (QIAGEN) or an UltraClean DNA Purification Kit (CamBio), both
according to manufacturer's instructions.
2.5.6 Ligation
Ligation reactions were carried out in a final volume of 20pl containing 5pi gel
purified DNA fragment, l-2pl digested plasmid DNA, lx T4 DNA ligase buffer and
10 units T4 DNA ligase (New England Biolabs Inc.). Ligation reactions were
incubated at 16°C for 16 hours.
2.6 Sequence Analysis
2.6.1 Purification of PCR Products
Small numbers of PCR products were cleaned for sequencing using a
QIAquick PCR purification kit with a microcentrifuge (QIAGEN) according to
manufacturer's instructions.
On a large scale (96-well plate format) PCR products were cleaned using
Shrimp Alkaline Phosphatase and Exonuclease I. The final reaction volume was 8pi
with 10 units of Exonuclease I (USB Corporation) and 2 units of Shrimp Alkaline
Phosphatase (USB Corporation) and 400ng of DNA. The reactions were purified in
a Omnigene PCR system thermal cycler (Hybaid) under the following conditions; 1
cycle at 37°C for 15mins, 1 cycle at 80°C for 15mins.
2.6.2 DNA Sequencing
All sequencing reactions were performed using ABI PRISM Ready Big Dye
Terminator cycle Sequencing Kit with AmpliTaq DNA polymerase FS (PE Applied
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Biosystems) and Applied Biosystems DNA sequencer models 373A, 377 or 3700 for
96 well format.
Sequencing of purified PCR products was carried out in lOpl reactions using
lOOng purified DNA, lOOng primer and 4pi big dye terminator (PE Applied
Biosystems). Amplification was performed on a PCR system thermal cycler (Hybaid)
at 96°C for 30sec, 50°C for 15sec, 60°C for 4min for 25 cycles.
Sequencing of plasmid DNA was carried out in 20pl reactions using
approximately lOOng plasmid DNA, lOOng primer, 4pl Big Dye (PE Applied
Biosystems) and 0.36mM MgC^. Amplification was performed on a PCR system
thermal cycler (Hybaid) at 96°C for 5min for 1 cycle, 96°C for 30sec, 55°C for
15sec, 60°C for 4min for 25 cycles. All sequencing reactions were stored at 4°C prior
to precipitation
2.6.3 Precipitation of DNA from Sequencing Reactions
After amplification, standard precipitation of sequenced DNA was carried out by
adding 55pl 95% ethanol and 2pi 3M NaOAC pH 4 to the sequencing reaction mix.
The mixture was incubated on ice for lOmin and then spun at 15000rpm in an IEC
Micromax centrifuge for 30min. The DNA pellet was re-suspended in 70% ethanol
and spun at 15000rpm for a further lOmin. Ethanol was removed and the DNA pellet
dried at room temperature ensuring complete evaporation of the alcohol. The cell
pellet was stored at -20C.
For precipitation of DNA in 96 well format the above procedure was carried out
as above except samples were incubated at room temperature for 30 mins. Plates
were spun in a Sorvell RT6000 centrifuge at 2000rpm for 30 minutes and supernatant
was removed by inverting the plate and pulse spinning the upturned plates on paper
towels at 800rpm. 70% ethanol was added to the cell pellets down the side of each
well and rapidly inverting the plate immediately. The pellets were dried by a further
pulse spin at 800rpm in a Sorvell RT6000 centrifuge. Cell pellets were again stored
at -20°C.
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2.6.4 Gel Electrophoresis of Sequenced DNA
Precipitated cell pellets were re-suspended in 2-4pl loading dye (PE applied
Biosystems) and heated at 90°C for 2min by Agnes Gallagher (MRC, Human
Genetics Unit, Edinburgh). Samples were then incubated on ice until loading.
Samples were analysed using Applied Biosystems DNA sequencer models 373A,
377 or in the case of analyses of samples in 96 well formats an ABI 3700 all
according to manufacturer's instructions.
2.6.5 Analysis of Sequence Data
Raw sequence data was analysed using Sequencing Analysis Version 3.0 (PE
Applied Biosystems). For alignment of multiple sequences of the same fragment,
sequence data was imported into the Sequencher program Version 3.0.1 (Gene Codes
Corp., Michigan). Up to 100 fragments at a time were aligned with the default
assembly parameters adjusted to allow 75-85% minimum match. The relevant
reference sequence was also imported from GenBank and incorporated in alignments
to allow comparison of the sequenced fragments to the published sequence.
Alignments were trimmed of vector sequence and poor quality end sequences
prior to further analysis. Individual base pairs highlighted by the Sequencher
program as showing mutation, deletions or ambiguous sequence were then manually
curated.
2.7 Saccharomyces cerevisiae Culture
2.7.1 S.cerevisiae Strains
The S.cerevisiae strains used during this work are listed in table 2.6. They are
derived from either W303-la (Rothstein) or S288c (Warren et ah, 2002).
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YPH278 a ura3-52, lys2-801, ade2-101, his3A200,
leu2Al, CFI11, URA3, SUP11
Warren et al
2002
YLB1 a Cdc20-(myc)is::LEU2, ura3-l, leu2,3-112,
his3-ll, trpl-1, ade2-l, canl-100
This Study
YLB2 a bublA::HIS3, Cdc20-(myc)IS::LEU2, ura3-l,
leu2,3-l 12, his3-l 1, trpl-1, ade2-l, canl-100
This Study
YLB4 a mad3A::URA3, Cdc20-(myc)ip:LEU2, ura3-
1, leu2,3-l 12,his3-l 1, trpl-1,ade2-l,canl-100
This Study
KH228 a BUB3-(myc)/3::G4\8, ura3-l, leu2,3-112,
his3-l 1, trpl-1, ade2-l, canl-100
Hardwick et
al 2000
KH238 a bublA: :HIS3, BUB3-(myc;/i::G418. ura3-l,
leu2,3-112, his3-ll, trpl-1, ade2-l, canl-100
Hardwick et
al 2000
YRJ 10 a mad3A.2, BUB3-(myc) 13: :G4\H>, ura3-l,
leu2,3-112, his3-ll, trpl-1, ade2-l, canl-100
Hardwick et
al 2000
YRJ111 a mad3A::URA3, ura3-l, leu2,3-l 12, his3-l 1,
trpl-1, ade2-l, canl-100, CFIII URA3 SUP11
Warren et al
2002
YRJ112 a bublA: :HIS3, ura3-l, leu2,3-112, his3-ll,
trpl-1, ade2-l, canl-100, CFIII URA3 SUP11
Warren et al
2002
YCD280 a ura3-52 lys2-801 ade2-101 hisA200 leu2Al
bubl-1::HIS3 +CFIII URA3 SUP11
Warren et al
2002
YMB111 a ura3-l leu2,3-112 his3-l 1 trpl-1 ade2-l
madlA::URA3 +CFIII URA3 SUP11
Hardwick et
al 2000
YMB113 a ura3-l leu2,3-l 12 his3-l 1 trpl-1 ade2-l
mad2A::URA3 +CFIII URA3 SUP11
Hardwick et
al 2000
KH304 a Cdc20-(myc)is::LEU2,madlA::URA3 ura3-l,
leu2,3-112, his3-l 1, trpl-1, ade2-l, canl-100
K. Hardwick
YMB003 a bub3A::LEU2, ade2-l, trpl-1, canl-100
leu2,3-112, his3-l 1, ura3-l
K Hardwick






Media used and its components are listed in table 2.7.
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Table 2.7: S.cerevisiae Media
Media Components
YPDA* 1% w/v Yeast Extract
2% w/v Bacto-peptone
2% w/v Glucose
0.003% w/v Adenine sulphate
YPD 1% w/v Yeast Extract
2% w/v Bacto-peptone
2% w/v Glucose
0.001% w/v Adenine sulphate
YMM 0.67% w/v Yeast Nitrogen Base w/o amino acids
2% w/v Glucose
1 Pellet Sodium Hydroxide/1
Sporulation 0.3% w/v Potassium Acetate
0.02% Raffmose
Low Adenine media 0.67% w/v Yeast Nitrogen Base w/o amino acids
2% w/v Glucose
1 Pellet Sodium Hydroxide/1
6mg/l Adenine
90mg/l each ofAdenine, Tryptophan, Histidine,
Lysine, Methionine, Uracil
220mg/l Leucine
87mg/l each ofCysteine, Isoleucine, Serine,
Alanine, Glutamic acid, Arginine, Threonine,
Glutamine, Tyrosine, Asparagine, Glycine,
Phenylalanine, Aspartic acid, Proline, Valine
Selective media YMM Plus amino acids required from:
90mg/l each ofAdenine, Tryptophan, Histidine,
Lysine, Methionine, Uracil
220mg/l Leucine
87mg/l each ofCysteine, Isoleucine, Serine,
Alanine, Glutamic acid, Arginine, Threonine,
Glutamine, Tyrosine, Asparagine, Glycine,
Phenylalanine, Aspartic acid, Proline, Valine
For solid media 2% w/v agar was added prior to autoclaving.
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2.7.3 S.cerevisiae Supplements
Supplements used are listed in table 2.8.
Table 2.8: S.cerevisiae Supplements
Supplement Stock Solution Final Concentration
mg/1
Benomyl (Sigma) 30mg/ml in DMSO 10-15
Nocodazole (Sigma) lOmg/ml in DMSO 15
Hydroxyurea (Sigma) lOOmg/ml in dH20 5000
2.7.4 S.cerevisiae Growth Conditions
Wild type S.cerevisiae were grown at 30°C either upturned on solid media or in
liquid media on shaking platforms to provide aeration. To maintain selection for
plasmid DNA and/or for auxotrophic markers inserted on the genome, cells were
grown on selective media lacking appropriate amino acids.
2.7.5 Storage of S.cerevisiae Strains
Strains were stored for short periods on solid media at 4°C and longer term at -
80°C in YPD supplemented with 20% v/v glycerol.

















A 5ml culture of the strain to be transformed was grown in selective media
overnight at 30°C. The culture was diluted in YPDA to attain a 50 ml culture an
OD6oo of 0.15 and grown for 4 hours at 30°C to a log phase culture with an ODgoo of
0.3-0.6. The culture was centrifuged at 2000rpm for 5minutes, washed in 1ml
LiOAc mix and transferred to an eppendorf tube. This culture was centrifuged again
at 5000rpm for 30 seconds and washed again in 1ml LiOAc mix. The centrifugation
was repeated again and the cells resuspended in 500pl LiOAc mix.
l-2p.l of the DNA to be transformed and 15jol of salmon sperm carrier DNA
(lOmg/ml) were added to a lOOp.1 aliquot of the LiOAc yeast cell mix. In addition
one transformation was set up without DNA as a negative control. 700jul of PEG
mix were added to this and mixed gently by pipetting before incubating at room
temperature for 30 minutes. The transformation mix was then heat shocked at 42°C
for 15 minutes. The mix was pelleted by centrifugation at 5000rpm for 30 seconds,
the supernatant removed and the pellet resuspended in 200pl of YPDA. The
transformation was plated onto selective media and incubated upturned at 30°C until
colonies were visible. Mixed colonies were picked and streaked onto selective media
before use in subsequent assays.
2.7.7 G2/M Arrest by Growth in Nocodazole
Nocodazole is an inhibitor of tubulin polymerisation which causes
depolymerisation of the microtubule spindle and initiates the spindle checkpoint
arresting cells at the G2/M transition.
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A 5ml culture of S.cerevisiae cells was grown overnight in selective media or
YPDA at 30°C to stationary phase. The culture was diluted in 50ml YPDA to attain
an OD6oo of 0.2 and grown for 4 hours at 30°C to mid log phase, OD6oo 0.3-0.6.
Nocodazole (Sigma) was then added to the culture to give a final concentration of
15mg/l and the cultures were incubated at 23°C for 3-4 hours.
The arrested culture was centrifuged at 3000rpm for 5 minutes and the supernatant
removed. The cell pellet was resuspended in 1ml of sterile dH20 and transferred to a
screw cap eppendorf. The cells were centrifuged again at 5000rpm for 30 seconds,
the supernatant was removed and the cell pellet sizes were equalised by eye before
storing at -80°C.
2.7.8 S-phase Arrest by Growth in Hydroxyurea
Hydroxyurea is an inhibitor of a deoxynucleotide synthesising enzyme and
therefore blocks DNA synthesis. It was used in these experiments to synchronise
cells by arresting them at S-phase.
A 5ml culture of S.cerevisiae cells was grown overnight in selective media or
YPDA at 30°C to stationary phase. The culture was diluted in 50ml YPDA to attain
an OD600 of 0.2 and grown for 4 hours at 30°C to mid log phase, OD6oo 0.3-0.6.
Hydroxyurea (Sigma) was then added to the culture to give a final concentration of
5mg/ml and the cultures were incubated at 23°C for 3-4 hours. Hydroxyurea arrests
were usually preformed concurrently with Nocodazole arrests in order to synchronise
cells with and without activated spindle checkpoints.
The arrested culture was centrifuged at 3000rpm for 5 minutes and the supernatant
removed. The cell pellet was resuspended in 1ml of sterile dH20 and transferred to a
screw cap eppendorf. The cells were centrifuged again at 5000rpm for 30 seconds.
The supernatant was removed and the cell pellet sizes were equalised by eye before
storing at -80°C.
2.7.9 Mating of Haploid Strains
S.cerevisiae strains of opposite mating types (a and a) were streaked onto YPDA
and grown overnight at 30°C. A sterile toothpick was used to pick small amounts of
each strain and mix together on a drop of sterile dH20 water on a YPDA plate. The
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mating mix was incubated at 30°C for 4 hours and examined for zygote cells
indicative ofmating.
2.7.10 Growth of Diploid Yeast Strains
4 hours after mating of haploid strains, zygotes were picked with a Singer
Instruments MSM System Series 300 micromanipulator and grown either on YPD or
on selective solid media. The colonies were tested for diploid status using a mating
test. Diploid cells fail to mate with both the a and a tester strains. The cells were
then grown in liquid sporulating media at room temperature for 3-7days. The cells
were then examined by light microscopy for sporulation and tetrad formation.
2.7.11 Tetrad Dissection
lml of the sporulated culture was centrifuged at 8000rpm for 1 minute and
resuspended in a 190pl of sterile dH20 and lOpl P-glucoronidase (76,800 Units/ml),
(ICN Biomedicals Inc.) was added and mixed gently. The cells were incubated at
room temperature for 10-15 minutes until the walls of the tetrad appeared to be
digested. 20pl of tetrad mix was dripped onto YPDA and the tetrads were dissected
using a Singer Instruments MSM System Series 300 micromanipulator and grown at
30°C until colonies were visible. The tetrads were replica plated onto selective plates
to identify and isolate the required strain genotype.
2.7.12 Benomyl Sensitivity Assay
Methyl l-(butylcarbamoyl)-2-benzimidazolecarbamate or benomyl is an inhibitor
of microtubule polymerisation which arrests wild type cells at the spindle
checkpoint. Spindle checkpoint mutants escape this arrest and divide with
incorrectly formed spindles leading to cells with lethal chromosome defects (Li and
Murray, 1991).
Transformants were freshly streaked out onto selective plates and incubated
upturned at 30°C overnight. Small amounts of the streak outs were resuspended in
200pl of sterile dPLO in the first row of a 96-well plate. The cells were diluted 1:10
and 1:100 into the second and third rows of the plate with gentle mixing. The
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serially diluted cells were stamped onto YPD plates supplemented with 0, 10, 12.5
and 15pg/ml Benomyl (Sigma) using a sterile stamper. The plates were incubated
upturned at 23°C for 3 days and growth compared and recorded photographically.
2.7.13 Microcolony Assay
Microcolony assays were carried out as previously described (Li and Murray,
1991). Small amounts of freshly streaked out transformants were picked using a
sterile toothpick and streaked onto a YPD plate supplemented with 1 Opg/ml
Benomyl. A Singer Instruments MSM System Series 300 micromanipulator was
then used to isolate 25 individual cells on the benomyl plate. The individual cells
were counted at 2 hourly intervals over a total of 12 hours to assess growth. The
plate was incubated upturned at 23°C between counting. The mean number of cells
at each time point was calculated, discounting any cells which remained single and
unbudded throughout, assuming they were dead when isolated.
2.7.14 Liquid Culture Budding Assay
Liquid culture assays were carried out as described previously (Farr and Hoyt,
1998). Freshly streaked transformants were grown and arrested in nocodazole as in
2.7.7. 1ml samples of the culture were taken before addition of nocodazole (0 hours)
and at 4, 6 and 8 hours after addition of nocodazole. The samples were centrifuged
at 5000rpm for 5minutes and the supernatant removed. The cells were fixed by
addition of ice cold ethanol while vortexing to prevent the cells aggregating. The
samples were stored at -20°C until they were scored.
The cells were centrifuged again and the supernatant removed. They were
washed 3x in sterile cold lx PBS before sonicating for 2x 15 seconds using a Sonics
and Materials Inc. Vibra-Cell1 M sonicator.
Cells were viewed using a Zeiss Axioscope II fitted with an automated CCD
camera and images were captured using SmartCaptureVP (Digital Scientific). Image
capture and counting used a 63x oil DIC lens. The number ofmulti-budded cells in a
200-cell population were counted and the proportion of multi-budded cells was
calculated as an indicator of spindle checkpoint function. Multi-budded cells
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represent those which have been unable to arrest at the checkpoint and continue to
bud are also unable to undergo cytokinesis resulting in 3 or more buds.
2.7.15 Colour Minichromosome Loss Assay
The chromosome loss assays were performed as described by Hieter et ah, 1985.
5ml cultures were prepared in selective media from freshly streaked out cultures and
incubated with constant shaking at 30 °C overnight. The cultures were diluted in 5ml
YPDA to an OD6oo of 0.3 and grown with constant shaking for 4 hours to an OD60o
of approximately 0.6. The number of cells in the culture were counted with a
haemocytometer and the culture diluted in YPDA to a concentration of
approximately 2500 cells per ml. 200pl of the diluted culture were plated onto low
adenine solid media and the plates were incubated at 30°C for 3 days until visible
colonies formed. The plates were then incubated at 4°C for up to 2 weeks to allow
the red and white sectoring to develop. The numbers of colonies were then counted
and the number of less than half red colonies and the number of at least half but not










O.lmM PMSF (added immediately before use from fresh 0.1M Stock)
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1 complete mini EDTA-free protease inhibitor tablet (Roche) per 10ml
1.5M Tris-HCl nH8.8
1.5M Tris-HCl nH 6.8
Resolving gel mixes (24ml)
Component 10% 15%
30% Acrylamide 8ml 12ml
2% bis-acrylamide 1560p.l 1032|ol
1.5M Tris-HCl pH8.8 6ml 6ml
10% SDS 240|ol 240(ol
dH20 8.2ml 4.728ml
10% ammonium persulphate to polymerise 240|ol 240pl
Temed to polymerise 24pl 25|ol
Stacking gel mix (150ml)
25ml 30% Acrylamide
20ml 2% Bis-acrylamide
18.75ml 1M Tris-HCl pH6.8
86.25ml dH20








lOOmM DTT (added immediately before use from 1M stock)
lOmM EDTA
2% w/v SDS
10pg/ml LPC (leupeptin, pepstatin and chymostatin)
2mM PMSF (added immediately before use from fresh 0.1M Stock)











5% w/v Marvel dried milk powder
lx PBS
0.02% v/v Tween
(0.5M NaCl for Bubl-G antibody)
PBST
1 x PBS
0.02% v/v Tween 20
(0.5M NaCl for Bubl-G antibody)
PBS#
110
2.8.1 Crude Extraction of Total Cellular Protein from Yeast
Cell pellet samples of arrested or stationary phase cultures were defrosted on ice
and resuspended in 300pl of sample buffer containing protease inhibitors.
Approximately 200pl of beads (0.5mm zirconia/silica beads, BioSpec Products, Inc.)
were added and the mixture was "bead-beated" for 1 minute at 4°C, incubated on ice
for 5minutes and "bead-beated" again for lminute at 4°C. The sample was heated to
95°C for 5 minutes before centrifugation at 13,000 rpm for 1 minute. The crude
protein preparation was loaded on SDS Polyacrylamide gel for analysis and excess
was stored at -80°C.
2.8.2 Co-immunoprecipitation
25 or 50 ml cultures were grown and cell pellets were collected by centrifugation
before being lysed in 800pl of lysis buffer by bead beating in a bead beater (Biospec
Products). Approximately 200pl of beads (0.5mm zirconia/silica beads, BioSpec
Products, Inc.) were added and the mixture was "bead-beated" for 1 minute at 4°C,
incubated on ice for 5minutes and "bead-beated" again for lminute at 4°C. The
samples were centrifuged at 13000rpm for 1 minute at 4°C and the supernatants
retained. DTT was added to a final concentration of ImM before 2 further clarifying
spins were performed. After the final spin a 30pl sample was removed and stored at
-80°C as the total protein input into the DP, referred to in the chapters as the total.
Affinity matrix and antibody were added as appropriate. These were typically either
30pl 50:50 slurry Protein A Sepharose™ CL-4B (Amersham) washed 3 times in
lysis buffer, plus 4pl of antibody or 30pl of c-myc antibody coupled beads (c-myc
(9E10) AC sc-40 AC mouse monoclonal IgG), Santa Cruz Biotechnology) washed 3
times in lysis buffer. Immunoprecipitations were incubated at 4°C with rotation for 2
hours before pelleting the beads by centrifugation at 8000rpm for 1 minute. A 30 pi
sample of the supernatant was taken and stored at -80°C representing the unbound
protein fraction and referred to in the chapters as the supernatant. The beads were
washed 3 times in 500pl of lysis buffer before being transferred to a clean tube and
washed twice with PBS. The last of the PBS was removed and 55pl of sample buffer
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was added to the beads which were then heated to 95°C for 5 minutes prior to loading
on SDS-PAGE gels.
2.8.3 SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gels were poured between 2 glass plated separated by
spacers and assembled in a pouring rig (Anachem). The base of the gel was sealed
with a 1cm plug of 0.05% agarose. The resolving gel solution was prepared, poured
between the plates and overlaid with water-saturated butan-l-ol. The gel was left to
set at room temperature after which the butanol was washed off with water, the
stacking gel was poured and an appropriate comb inserted to create the loading wells.
Once the gel had polymerised the comb was removed and the wells were washed
with dHbO. The gel was firmly fixed into the electrophoresis apparatus (Anachem)
and the chambers filled with lx Running Buffer. Protein samples and appropriate
molecular weight markers were then loaded and the gel was run at 180 volts for 45
minutes for small gels or for 30 volts for 16 hours followed by 300 volts for 2-3
hours for large gels, or until the coloured loading dye had run off the end of the gel.
2.8.4 Western Blot Analysis
Gels were removed from plates, the stacking gel and agarose removed and soaked
in transfer buffer for 5 minutes. 4 pieces of 3MM paper and 1 piece of Hybond
nitrocellulose membrane (Amersham) were cut to approximately the size of the gel
and also soaked in transfer buffer. The paper membrane and gel were assembled into
a sandwich as per transfer equipment manufacturer's guidelines (Pharmacia Biotech)
in which the sandwich was stacked in the order negative (black) terminal, foam plate,
2x 3MM paper, Gel, Membrane, 2x 3MM paper, foam plate, positive (white)
terminal. The proteins were transferred in a wet transfer tank (Pharmacia Biotech) at
65volts for 1 Vi hours.
Transfer was confirmed by temporary staining of the membrane with Ponceau
Stain (Sigma) at room temperature for 5 minutes. The position of the protein
molecular weight markers was recorded using a biro on the membrane and the
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membrane was cut up for antibody treatment. Ponceau stain was removed by
washing in lx PBST.
The membrane was blocked by incubating at room temperature in Blotto for 30
minutes with shaking, to prevent non-specific protein interactions. Primary
antiserum was diluted into sufficient fresh Blotto to cover the membrane as indicated
in table 2.8. Membranes were incubated in primary antibody at 4°C overnight with
constant shaking. The membrane was washed twice in lx PBST at room temperature
with constant shaking for 5 minutes each time. HRP conjugated secondary antiserum
was diluted into a further volume of fresh Blotto and applied to the membrane.
Incubations in secondary antibody were carried out at room temperature with
constant shaking for 1 hour. The membrane was then washed twice again with lx
PBST as before.
2.8.5 Immunodetection with Enhanced Chemiluminescence
(Delhommeau et al., 2002)
Equal Quantities of ECL reagents 1 and 2 (Sigma) were mixed on a sheet of
SaranWrap™. The excess fluid was blotted off the membranes using 3MM paper
and they were placed protein side down onto the ECL mix, ensuring the membrane
was uniformly covered. The membranes were incubated in the ECL mix for 1
minute at room temperature before excess ECL was removed by blotting on 3MM
paper. The membranes were assembled on a glass plate and wrapped in saran wrap
before being exposed to Kodak ML autoradiography film typically for 15 seconds, 1
minute, 5 minutes and 1 hour.
2.8.6 Antibodies to S.cerevisiae Proteins
Antibodies used are shown in table 2.9.
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Table 2.9: Antibodies to S.cerevisiae Proteins





















































































































2.8.7 Protein Phosphatase Treatment
Protein extracts showing additional modified bands by western blot analysis were
treated with Lambda protein phosphatase (LPP) to identify phosphorylation effects.
30pl of total cell extract or bead fraction from co-immunoprecipitation experiments
were resuspended in a total reaction volume of 50)4,1 containing lx LPP reaction
buffer, lx MnCL and 400 units of LPP enzyme (Sigma) as indicated by the
manufacturers' instructions. The reactions were incubated at 30°C for 30 minutes. A
control sample in which the enzyme was absent was also incubated under the same
conditions. The phosphatase treated and untreated samples were then analysed by
SDS PAGE and western blotting for modifications.
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2.9 Calculation and Statistics
The results presented graphically generally show either the mean of three
experminetal repetitions (for microcolony and liquid culture assays) or the total
cumulative data from three experimental repetitions. Statistical analysis was
generally performed on the total cumulative results of three repetitions of an
experiment. Where error bars are shown in the liquid culture assay results they
represent +/- one standard deviation about the mean.
Peter Teague and Andrew Carothers advised as to the suitability of statistical
analyses, providing statistical assistance. Results from individual experiments were
analysed by Chi-squared analysis, further details ofwhich are provided in chapter 4.
The chromosome loss assays and liquid culture assays were also analysed by
Mantel Haenszel tests, a derivative of Chi-squared analysis which takes account of
the variation between the three experimental repetitions by using the variance of each




The cell lines used in the course of this PhD are listed in table 2.10.
Table 2.10: Summary of Cell lines
Cell Line Cell type Media
(Gibco BRL)
Reference
HCT116 Colorectal Carcinoma McCoys Papadopoulos et al,. 1994
LoVo Colorectal Carcinoma RPMI Liu et al., 1995b
DLD1 Colorectal Carcinoma RPMI Dexter et al., 1979
SW480 Colorectal Carcinoma L-15 Leibovitz et al., 1976
HeLa Ovarian tumour DMEM Scherer et al., 1952
HRT 18 Colorectal Carcinoma RPMI Lee et al., 1981
F9 Mouse Embryonic DMEM Bernstine et al,. 1978
carcinoma
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2.10.2 Maintenance of Cell Lines
Media, Solutions and Additives
Freezing medium
8% w/v Dimethylsulphoxide (DMSO) in new-born calf serum
Tissue Culture Medium
RPMI/ McCoys/ L-15/DMEM (Gibco BRL)
10% Foetal Calf Serum (FCS)








Table 2.11: Tissue Culture Additives
Additive Stock Concentration Final Concentration
Geneticin (Gibco BRL) 50mg/ml 500p.g/ml
Hygromycin (Sigma) 50mg/ml 2mg/ml
Doxycycline (Sigma) 20 mg/ml 2pg/ml
Cells were cultured at 37°C, 5% CO2 in humidified incubators. All tissue culture
was carried out under sterile conditions in a class 2-containment hood. Sterile flasks,
plates, glassware, solutions and other consumables were used.
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Frozen stocks of cell lines were thawed rapidly in warm water before transferring
to 5m 1 of appropriate tissue culture media. Media was initially changed after
24hours to remove traces of DMSO followed by feeding and passaging as required.
Cells were detached from culture flasks using either a cell scraper or by washing
with PBS and incubating with l-3ml TV for 3 minutes. Fresh media was then added
accordingly. To retain the cell lines as a renewable source at least 3x 106 were split
from the main culture, centrifuged at 1200rpm in a Wifug lab centrifuge and the cell
pellet resuspended in 1.5ml of freezing medium. The cells were then sequentially
frozen at -70 and -140°C.
2.10.3 Transfection of Adherent Cells
Transfection of DNA into adherent cells was carried out using FuGene Reagent
(Roche) for generation of stable cell lines such as pTet-On stable cell lines or
LIPOFECTIN® reagent (GibcoBRL) for transient transfection for example with
pCMV-(3 and pTRE-Luc to assay pTet-On activity. Both were used as per
manufacturer's instructions using the method below.
Initially, 2x105 cells were plated into each well of a six-well plate and left
overnight or until -60% confluent. Ipg ofDNA was diluted into lOOpl Opti-MEM
reduced serum media (Gibco BRL). 5pi of FuGene6 or Lipofectin was diluted into a
further lOOpl of Opti-MEM. These mixes are left to stand at room temperature for
30-45 minutes. The 2 solutions are combined and incubated at room temperature for
10-15 minutes. Meanwhile, cells are washed with serum-free Opti-MEM. For
transfection with Fugene6, the FuGene6 mixture was added directly to the cells.
However for Lipofectin transfection, 800pl of Opti-MEM was added to the
Lipofectin mixture, which was then added to the cells. The cells are incubated at
37°C for 6 hours, after which the media was replaced with appropriate media
containing 10% FCS. After 72 hours Geneticin/Hygromycin selection was added for
stable transfections or cells were assayed for gene activity for transient transfections.
Cells were maintained under selective conditions, which killed the appropriate
control cells. Individual resistant clones were isolated by dilution cloning at 2-6
weeks post antibiotic selection. Mixed cell populations were counted, diluted and
plated into 96-well microtitre plates at estimated concentrations of 1, 2 and 3 cells
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per well. Plates were examined for colony formation after 1-2 weeks and those with
single colonies were perceived to have originated from a single cell. When colonies
covered the base of the microtitre well they were washed and removed with TV to
24-well plates. These were upgraded to 6 well dishes when appropriate cell numbers
were produced.
2.10.4 Luciferase Reporter Assay
Stable pTet-On cell lines were transiently co-transfected with pTRE-Luc and
pCMV-p. Luciferase assays were used to establish activity of the inserted pTet-On
plasmid using a Promega Luciferase Assay system as per manufacturer's instructions
summarised below.
Stable cell transfectants in 6-well plates were washed twice in PBS and incubated
at room temperature in 500 pi of lx Reporter Lysis Buffer. Cells were removed in
the lysis buffer using a cell scraper and transferred to an eppendorf. The extracts
were mixed by vortexing for 15 seconds and centrifuged at 14,000 rpm for 15
seconds to pellet cells. The supernatant was removed to a fresh tube and stored at -
70°C.
To assay luciferase activity 20pl of cell extract was mixed with 100pl of
luciferase assay reagent in a luminometer tube, both at room temperature and
luminescence was quantified for 30 seconds using a luminometer (EG&G Berthhold
Lumat LB 9507).
2.10.5 (3-Galactosidase Assay
To normalise for cell number and transfection efficiency, P-galactosidase assays
were carried out on the luciferase assay cell extracts. This assayed activity of co-
transfected pCMV-P using a /5-Galactosidase Enzyme Assay System with Reporter
Lysis Buffer (Promega). 50pl of cell extract was added to 50pl of 2x assay buffer
and incubated at 37°C for 30 minutes before adding 150pl of 1M Sodium Carbonate
to stop the reaction. Reporter lysis buffer was used as a negative control. P-
galactosidase activity was quantified by measuring the OD405 using a Lab systems
Multiskan MS plate reader.
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Chapter 3: Construction of S.cerevisiae BUB1 AE5 and
MAD3AE5
3.1 Introduction
Previous work in our laboratory has involved the screening of a panel of 30
aneuploid colorectal tumours by RT-PCR for BUB1 and BUBR1 variants. We
identified an identical deletion in BUBR1 in transcripts from 6 of these tumours. The
deletion removed part of a highly conserved domain, CD1 thought to be important in
spindle checkpoint protein interactions (Hardwick et al., 2000). Clarification of the
genomic structure of BUBR1 revealed the whole of exon 5 was removed in the
deletion and thus it was termed AE5. However extensive analysis of genomic DNA
from the tumours harbouring BUBR1AE5 mutation has so far failed to reveal any
splice site defects or intronic variants, although analysis is ongoing. Long range
PCR techniques on the genomic DNA tumour samples were unfortunately
inconclusive, so the involvement of large deletions and rearrangements has not been
eliminated. Thus clarification of the nature of the deletion requires further
characterisation at the genomic and protein levels to identify the specific genomic
alteration involved. At the transcript level, the deletion is predicted to produce a
frameshift and a stop codon would occur 43 base pairs upstream of the end of the
deletion. This would truncate the protein to one containing the first 128 amino acids
of BUBR1 followed by an additional 14 post frameshift amino acids. However the
limited availability of antibodies to the N terminal of BUBR1 and diminishing
tumour material has impaired investigations into the effect of AE5 at the protein level
(Susan Farrington, unpublished).
Another possibility is that the deletion of exon 5 is an alternative splicing effect.
The evidence would suggest that such an alternative splicing phenomenon is likely to
be pathogenic as the homologous region of the BUB1 protein is deleted in colon
cancers which are defective in cell cycle checkpoints and exhibit CIN (Lengauer et
al., 1997; Cahill et al., 1998) and similar transcripts cannot be detected in control
lymphocyte RNA (Susan Farrington, unpublished). In addition computerised
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analyses using genomic and cDNA sequence data to predict alternatively spliced
transcripts showed no evidence for alternative splicing in BUBR1 (Modrek et al.,
2001). Thus, if this was an alternative splicing effect with no functional significance
we would expect it to appear in a large proportion of normal and tumour tissue, yet
numerous analyses of spindle checkpoint gene transcripts in tumours have not
revealed this variant (Percy et al., 2000; Sato et ah, 2000; Haruki et ah, 2001).
Additionally, alternatively spliced gene variants have already been implicated in
human disease including CD44 which is aberrantly spliced in colon adenomas
(Ghigna et al., 1998) and splice variants ofATM which have been shown to affect its
function (Teraoka et al., 1999).
As stated, the equivalent of the AE5 mutation has previously been reported in
BUB1 in colon cancer, removing the same part of a conserved domain. In this case
the deletion V400 was due to a genomic defect in a splice donor site, detected in the
tumour DNA and the mutation was shown to abrogate spindle checkpoint function
when exogenously overexpressed in human cell lines (Cahill et al., 1998).
The aim of this thesis was thus to investigate the hypothesis that these BUBR1 and
BUB1 mutations are causally involved in the development of aneuploidy in
colorectal cancer. To address this hypothesis I used the yeast model system
S.cerevisiae to analyse the effect of the AE5 mutations on the spindle checkpoint and
chromosome stability. Many of the studies of the spindle checkpoint have been
carried out in the budding yeast Saccharomyces cerevisiae. In addition S.cerevisiae
is easily manipulated genetically and experiments assessing spindle checkpoint
function in yeast mutants are well established.
The first step in this analysis was the generation of the BUBR1AE5 mutant
constructs in the S.cerevisiae homologue of the gene. Human BUBR1 was initially
identified as a BUB1 related protein as it shares significant homology to BUB1 in
two conserved domains CD1 and CD2 and at the C terminal kinase domain (Cahill et
al., 1998a). However, functional analyses indicate BUB1 and BUBR1 have very
different roles in the spindle checkpoint. BUBR1 shows homology to both
S.cerevisiae Bublp and Mad3p and there has been some debate over which of these
is the budding yeast homologue of BUBR1. Indeed both Mad3p and Bublp bind to
Bub3p like BUBR1 but Mad3p and BUBR1 have both been shown to be involved in
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Cdc20p inhibition in the spindle checkpoint effector complex (Tang et ah, 2001;
Sudakin et ah, 2001). Thus it is now widely accepted that Mad3p is the yeast
orthologue of BUBR1 (Taylor et ah, 1998). However in view of this uncertainty and
in the light of identification of an identical causative mutation in BUB1 in colon
cancer, I have constructed the AE5 mutation in both S.cerevisiae MAD3 and BUB1.
Hardwick et al have previously constructed YCPLac22 yeast-El co/z shuttle vector
cassettes containing the full-length BUBJ and MAD3 genes under the control of wild
type promoters (Hardwick et ah, 2000; Warren et ah, 2002). These full-length
constructs were used to generate the AE5 mutant constructs and were also used as
controls in subsequent assays, along with the empty YCPLac22 vector. The aim was
to use these vectors to assess the functional ability of the AE5 proteins in yeast bubl
and mad.3 null mutants which normally exhibit spindle checkpoint defects and an
increased rate of chromosome loss. These phenotypes can be eliminated by
complementation with the full-length proteins and thus the YCPLac22 based MAD3
and BUB1 constructs were used to investigate whether AE5 retained this ability and
thus checkpoint function.
In addition full-length and deletion constructs were used to generate p423MET
constructs in which the MAD3 or BUB1 genes are under the control of methionine
repressible promoter, allowing them to be over-expressed. Over-expression
constructs have previously been used to examine the ability of mutant proteins to
form spindle checkpoint complexes, specifically with BUB3 (Warren et al., 2002).
The AE5 constructs generated were used in similar experiments to determine the
ability of the AE5 proteins to form spindle checkpoint complexes.
Thus the generation of AE5 constructs under the control of wild type promoters
expressing endogenous levels and the methionine inducible promoter for over-
expression levels were thought to be an essential way of analysing the functional
effect ofAE5 in the yeast model system.
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3.2 Methodological Overview
3.2.1 Generation ofWild Type Constructs
AE5 constructs under the control of their intrinsic wild type promoters were
prepared from pMAD3 and pBUB1 using PCR mutagenesis methods as described
below and named pMAD3-AE5 and pBUBl-AE5.
3.2.1.1 Polymerase Chain Reaction
Expand Hi fidelity PCR as described in 2.4.2 was used to amplify the two sections
seel and sec2, flanking the area of AE5 using the yeast section primers (for details of
primers see section 3.3.2). The pMAD3 and pBUBl plasmids (2.2.2) were used as
templates and these comprised YCPLac22 vector cassettes containing the full-length
MAD3 or BUB1 coding sequence driven by the respective wild type promoters
(Hardwick et al., 2000; Warren et al., 2002). Correct amplification of the sections
was confirmed by agarose gel electrophoresis as described in 2.4.4 and sequencing of
the PCR reactions as described in 2.6 to determine accuracy of the PCR.
3.2.1.2 Restriction Digestion
The amplified sections seel and sce2 were digested with appropriate internal
restriction enzymes compatible to the sites in the primer sequence (Btsl for BUB1
and BsmBl for MAD3) as described in 2.5.4. The digested fragments were purified
as described in 2.5.5.
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After ligation of seel and sec2 (see below) this insert was digested with enzymes
compatible to external restriction sites (EcoRl and Kpnl for BUB1 and Sacl and
Xbal for MAD3) and gel purified as described in 2.5.4 and 2.5.5. Digests with two
enzymes were performed sequentially with an ethanol precipitation step between to
remove incompatible buffers. Additionally the full-length constructs pMAD3 and
pBUB1 were digested with the same enzymes and the vector backbones were also gel
purified in the same way (2.54, 2.55).
3.2.1.3 Ligation
The fragments of seel and sec2 were ligated together as described in 2.5.6 to
produce the insert for the cassette. The insert of seel and sec2 and original vector
pMAD3 or pBUB1 were then digested as described above with restriction enzymes at
external sites. The purified insert was then ligated into the purified vector as
described in 2.5.6.
3.2.1.4 Chemical Transformation into E.coli
Ligation reactions were transformed into E.coli as described in 2.5.2 and plated
onto selective media containing ampicillin.
3.2.1.5 Colony Selection
Positive transformants were selected as described in 2.5.3 and analysed by colony
PCR (2.4.3). Positive transformants were fully sequenced to confirm the deletion
and ensure the sequence was error free, as described in 2.6.
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3.2.2 MAD3 AE5 and BUB1AE5 Over-expression Construct
The MAD3 AE5 over-expression construct was generated to examine spindle
checkpoint protein function which will be described in chapter 5. The over-
expression vector used, p423MET, is a yeast-E.coli shuttle vector with a methionine-
repressible MET25 promoter. Altering methionine concentration controls
transcription of the inserted gene. Maximum gene induction, approximately 50-fold,
is achieved in methionine free media but under standard conditions and media, the
plasmid is leaky producing 2-3 fold over-expression of the insert (Warren et al.,
2002).
The over-expression construct was generated from pMAD3-AE5 using simple cut
and paste techniques. The previously generated AE5 construct pMAD3-AE5 was
digested with appropriate enzymes for the sites flanking the coding sequence, Bam
HI and EcoRl. The over-expression vector p423MET was also digested with the
same enzymes, both as described in 2.5.4. These sites were chosen as they removed
the entire coding sequence but not the promoter regions and cut only once in both the
vector sequence and the MAD3 coding sequence. The selected restriction sites
retained the frame of the protein for correct transcription and translation.
The vector backbone and AE5 insert were purified as described in 2.5.5. They
were then ligated as described in 2.5.6. Ligation reactions were transformed into
E.coli (2.5.2) and positive transformants were selected by colony PCR (2.5.3) before
being fully sequenced (2.6) as described above.
pMET:BUBl-AE5 was generated with the help of Kevin Hardwick in parallel with
these experiments.
The full-length BUB1 and MAD3 over-expression construct pMET:BUB1 and
pMET:MAD3 have previously been constructed by Warren et al and were used along
with the empty p423MET vector as controls in subsequent functional assays.
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3.3 Results
3.3.1 Identification of the AE5 Region in the Yeast BUBR1 Orthologues
Previously published alignments of the human and budding yeast proteins were
used to identify the region deleted by AE5. Two alignments have been published and
these are not identical (Cahill et al., 1998; Hardwick et al., 2000). The AE5 start site
predicted by these two alignments would be different. Thus the start site used was
between these two predictions, retaining all the strongly conserved residues predicted
in the disputed area.
AE5 removes 197 base pairs and would be predicted to cause a frame shift and
protein truncation. A similar effect is seen if the equivalent 197 base pairs of the
yeast protein are deleted. In Mad3p a stop codon is produced through the frameshift
45 base pairs down stream of the deletion site predicting a protein fragment
containing only the 137 N terminal amino acids plus 15 amino acids after the
frameshift. In BUB1 a stop codon is produced 6 base pairs downstream of the
deletion removing most of the protein and leaving only the N terminal 118 amino
acids plus 2 amino acids after the frameshift.
As the genomic alteration associated with AE5 is not known and AE5 may in fact
be due to an alternative splicing effect the area removed from the full-length
constructs was removed in frame. Additionally previous experiments in budding
yeast had studied the effects ofN terminal portions of Bublp and Mad3p on spindle
checkpoint function (Warren et al., 2002). N terminal protein fragments of Bublp
containing amino acids 1-210 and 1-367 were shown to exhibit similar spindle
checkpoint defects to null mutants. Similar results were obtained for truncation
mutants of Mad3p containing only the first 60, 87 or 236 amino acids (Hardwick et
al., 2000). Thus truncation mutants containing 120 amino acids of Bublp or 152
amino acids ofMad3p, including some new amino acids would be predicted to have
similar detrimental effects on checkpoint function. Thus an in frame 198 base pair
section containing amino acids 140-205 of Mad3p was targeted for removal and
amino acids 121-186 were removed from Bublp. This was a circumspect strategy as
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any effect seen upon removing the section in frame is likely to be amplified in the
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Figure 3.1 Alignment of BUB1 and BUBR1 homologues and
position of AE5 in yeast constructs
Alignments of homology region 1 by Cahill et al and Hardwick et al were
used to identify the equivalent region to AE5 in yeast (Hardwick et al., 2000;
Cahill et al., 1998). A) shows the position of BUBR1AE5 and its equivalent
in BUB1, V400. It also indicates the predicted AE5 start site in S. cerevisiae
according to Cahill et al.
B) The AE5 start sites identified using different alignments are indicated by
the coloured boxes. Purple indicates the position of AE5 in human BUB1 and
BUBR1 and the position of the equivalent start site in yeast identified using
the Hardwick alignment. Using the Cahill alignment to identify the
equivalent start site in S. cerevisiae Bublp corresponds to the position
indicated in blue in the other homologues. The area deleted in the yeast
cassettes constructed is shown in red and represents a compromise between
the two alignments.
C) Since the construction of the AE5 plasmids a further alignment has been
published by Millband and Hardwick comparing homologues from additional
species. This alignments varies slightly from the previous Hardwick
alignment and demonstrates that the exact site of AE5 may alter as sequence
data from further BUB1 and BUBR1 orthologues becomes available for
alignment (Millband and Hardwick 2002).
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3.3.2 Primer Design
PCR mutagenesis methods were used to construct the mutant form of the BUB1
and MAD3 genes. Primers with specific restriction endonuclease recognition sites
were designed to flank AE5. The primers used to produce the flanking sections of
MAD3 and BUB1 were lfor and lrev, and 2for and 2rev, producing section one and
section two. The details of these primers are summarised in table 3.1.
Table 3.1 Sections Generated for AE5 Construction
Section Forward Reverse 5' restriction 3' restriction Size Base
primer primer site site pairs
MAD3 seel MAD3 MAD3 Sacl BsmBl 226
sec lfor seclrev
MAD3 sec2 MAD3 MAD3 Xbal BsmBl 569
sec2for sec2rev
BUB1 seel BUB1 BUB1 EcoRl Btsl 642
sec 1 for seclrev
BUB1 sec2 BUB1 BUB1 Kpnl Btsl 1140
sec2for sec2rev
The endonuclease sites on the external primers matched the internal sites in the
full-length gene constructs towards the 5' and 3' ends to allow the deletion to be
ligated into the vector cassette once constructed. The internal primers contained sites
recognised by restriction enzymes which cut downstream of their recognition sites
allowing the area of the deletion to be removed exactly. This primer design and the
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Figure 3.2 Primer design and construction of the AE5 deletion
section
This figure summarises the procedure used for the MAD3 construct. The
section primers were designed to contain recognition sites for the restriction
enzyme BsmBI which cuts upstream of the site. PCR was used to generate
two sections flanking the deletion with these recognition sites at the 3' end of
section 1 and the 5' end of section 2. Digestion with these enzymes produced
two sections with compatible overhangs. The primers were designed such
that the overhangs formed the 4 bases immediately after the AE5 section.
Thus when the sections were ligated, the exact area of AE5 was removed in
the resulting fragment. A similar procedure was used for BUB1 although the
Btsl restriction site was used for this as the BUB1 coding sequence includes a
BsmBI restriction site.
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3.3.3 Cloning Strategy for the generation of BUB1AE5 and MAD3AE5
constructs
The Expand Hi fidelity PCR method was used to amplify the two sections either
side of the deletion as described in chapter 2. The section PCRs were visualised
using agarose gel electrophoresis, sequenced and gel purified using the Qiagen
method described. The sections were then digested with appropriate internal
enzymes, BsmBl for MAD3 and Btsl for BUB1 and sections one and two were
ligated together producing products of 773 and 1750 base pairs respectively. The
ligation products were digested with the enzymes recognising the external restriction
sites. The full-length constructs were also digested with these enzymes and the
vector backbones were gel purified. The ligated insert sections were then ligated into
the vector backbone and the new ligation reaction was transformed into bacterial




Figure 3.3 Cloning Strategy for Sc pMAD3 AE5
The newly constructed deletion section and the full-length construct were
digested with the same enzymes and the vector backbone was gel purified.
These were then ligated together to produce the AE5 construct. A similar
strategy was used for pBUBl-AE5 using restriction enzymes EcoRl and
Kpnl. The enzymes chosen were specific single cutters within the coding
sequence flanking the area of AE5.
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Positive transformants were isolated and analysed by colony PCR and initially
visualised on agarose gels before sequencing. Positive transformants indicated by
sequencing of the colony PCR reactions were grown on a small scale, DNA was
isolated by miniprep and the recombinant gene was fully sequenced to ensure the
deletion site formed correctly and the DNA sequence was error free. A comparison
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Figure 3.4 Sequencing of the Recombinant AE5 plasmids
A Sequencing of the S. cerevisiae BUB1 full-length and AE5 plasmids
showing the start site of the deletion, indicated by the black arrow. The red
asterisk indicates a silent variant acquired in the BUB1 full-length coding
sequence during culture and preparation. This variation was not present in the
original plasmid stock and hence is not seen in the deletion. However as it is
a silent variant it would be unlikely to affect protein function.
B Sequencing of the equivalent MAD3 full-length and AE5 constructs for
comparison of the sequence following the deletion.
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3.3.4 Generation of MAD3 AE5 Over-expression Construct
The recombinant YCPLac22 AE5 plasmids were used to generate over-expression
constructs containing the MAD3 and BUB1 AE5 genes. The recombinantMAD3 AE5
gene was excised from the pMAD3-AE5 vector by digestion with restriction enzymes
BamHl and EcoRl to produce a 1363 base pair deletion fragment. The fragment
was ligated into over-expression vector p423MET digested with the same enzymes,
the ligation mix was transformed into E.coli and positive transformants were isolated
and checked by fully sequencing as before. This cloning strategy is summarised in
figure 3.5.
pMET:BUBl-AE5 was generated with the help of Dr Kevin Hardwick from
pBUBl-AES.
Diagrams of all the constructs generated are shown in figure 3.6.
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Figure 3.5 Cloning Strategy for the MAD3 AE5 over-expression
construct
The MAD3-AE5 over-expression construct was generated using restriction
digestion and ligation techniques as shown.
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The deletion AE5 identified in aneuploid colorectal tumours removed a domain of
BUB 1 related proteins conserved from yeast to man. Hardwick et al and Cahill et al
have both published alignments of BUBR1 with homologues in other species. Cahill
et al initially identified BUBR1 as a BUB1 related protein and aligned homologous
regions of the protein with human BUB1 and S.cerevisiae Bublp (Cahill et al.,
1998). Later Hardwick et al repeated the alignment to include S.cerevisiae Mad3p
and S.pombe Bublp (Hardwick et al., 2000). These alignments are slightly different.
To establish the area homologous to that removed by AE5 in yeast Mad3p and
Bublp, I used each alignment in turn to identify the start point ofBUBR1AE5 and the
BUB1 equivalent V400 as indicated in Figure 3.1. I examined those residues whose
inclusion differed between the two alignments and decided to remove only those
which were unconsented. This retained all the conserved amino acids whose
deletion was predicted in only one of the two alignments. Specifically, the Cahill
alignment states the deletion begins just after a Leucine residue in S.cerevisiae
Bublp. By marking the start of BUBR1AE5 after a WLKL motif on the Hardwick
alignment we can see there is a discrepancy between these two predicted areas. Of
the 5 residues between the two predicted start sites (IELFT in S.cerevisiae Mad3p),
the Glutamic Acid (E) and the Leucine (L) are conserved between several species.
Additionally the Phenylalanine (F) is conserved between S.cerevisiae Bublp and
Mad3p. Thus these residues were not deleted in the constructs. However, the
Threonine (T) residue is not conserved in any of the other species and thus was
removed in the deleted portion. Thus the starts of the AE5 deletions are one amino
acid upstream of that predicted by Cahill et al.
Most recently Millband and Hardwick have aligned Mad3p and Bublp
homologues from many species including S.pombe, S.cerevisiae, mouse, human,
Xenopus and Aspergillus (Millband and Hardwick, 2002). This alignment is more
extensive and is largely similar to the previous Hardwick alignment. The threonine
upstream of the AE5 start site predicted by the Cahill alignment is unconsented in all
these additional species. However, the positions of some of the homologues are
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slightly different. It seems that the presence of a gap in the homologues of higher
eukaryotes leads to increasing variation in alignments as orthologues from more
species are included. Thus the exact position of the AE5 region may be altered as
homologues of BUB1 and BUBR1 are identified in other organisms and as more
alignments become available.
The deletions were constructed in frame, as described earlier. As the genomic
change associated with the deletion has not been identified and the size of the protein
produced is also unknown we have been unable to ascertain whether the protein is
truncated due to a frameshift effect after the deletion. Additionally, AE5 removes an
entire exon and therefore may be due to an alternative splicing effect and this may be
predicted to retain the sequence in frame. Thus 198 base pairs were removed in AE5
corresponding to 66 amino acids and preserving the frame of the coding sequence.
These measures represent prudence in the construction of the AE5 constructs, as
truncation mutants have been shown to abrogate spindle checkpoint function and
those removing large numbers of conserved amino acids would be predicted to have
a similar detrimental effect (Hardwick et ah, 2000; Warren et ah, 2002).
Although the full relevance of the deletion constructed in yeast would be clearer
with greater knowledge of the behaviour of AE5 in tumours these constructs can be
used to give a clearer understanding of the possible functional consequences of the
deletion. The nature of the AE5 mutation in tumours is being further investigated
using long range PCR of genomic DNA to search for the genomic change in the
tumours which cause the deletion of exon 5 in the messenger RNA and this work has
so far been inconclusive. Sequencing of the entire 13 kilobases of intronic sequence
surrounding exon 5 is also in progress to address our understanding of the deletion at
the genomic level. In addition we have recently generated antibodies to the first 25
amino acids of the N terminal of BUB1 and BUBR1 and these could be used to
establish the size of the mutant BUBR1 protein and any truncation effect.
Two cloning strategies were used to generate constructs described in this chapter;
one using PCR based techniques and the other using restriction digestion and ligation
techniques. The cloning strategies used were both fairly successful, although
isolation of positive clones typically took several attempts. The PCR based method
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used to construct pMAD3-AE5 and pBUB1-AE5 was more troublesome than that
used for the over-expression constructs and at least 5 attempts were required to yield
positive clones. I briefly attempted other PCR based techniques such as overlapping
PCR but this was unsuccessful despite 3 attempts and the recombinant AE5
constructs were eventually created using the method described.
Once generated, the clones were fully sequenced to verify the deletion and to
ensure the remainder of the coding sequence was error free. This identified several
variants in the sequences. The pMAD3-AE5 plasmid was found to contain 3 single
base changes including one nonsense mutation predicted to cause truncation of
Mad3p to just 60 amino acids. These errors were also present in the full-length clone
stock. The errors were removed using restriction digestion of fragments of the AE5
plasmid and a new error free full-length plasmid and ligation of appropriate sections.
The pMAD3-AE5 plasmid used in the subsequent functional assays was error free.
Two variations were identified in the pBUB1-AE5 sequencing out with the
deletion site which did not appear to be present in the wild type construct.
Unfortunately numerous attempts to separate the AE5 deletion from these variants,
using similar digestion and ligation techniques as those used for pMAD3-AE5, were
unsuccessful. Elowever, after discussions with Dr Hardwick it was concluded that
the nature of these alterations suggested they were unlikely to significantly affect
checkpoint function and thus would not interfere with functional assays on AE5. The
first of these was AAC—>AGC converting an asparagine to a serine at amino acid
334 in CD2. According to homology alignments this residue is actually a conserved
serine in Mad3p, S. pombe Bublp and in human BUB1 and BUBR1 suggesting it
will have no effect on protein function. An ATA—>ATG converted an isoleucine to a
methionine at amino acid 293, which is a conservative change, and an ACA—»ACG
had no effect on the threonine residue 268. These are unlikely to have a significant
effect on protein function as they both occur in unconsented regions of the protein.
Sequencing of the full-length BUB1 clone after pBUBl-AE5 had been generated
revealed a single base alteration which had not been present in either the original
stock nor in the AE5 construct made. This was a silent change at nucleotide 349
converting a TTT codon to a TCT, still encoding Phenylalanine. The high number of
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variants seen in the sequencing results was surprising as high fidelity Expand Taq
enzyme was used for all the PCRs. We hypothesised it may be a result of the type
of electrocompetent E.coli cells which were used, TOP 10 cells. These are very
efficient cells for transformations but do not have any measures in place to prevent
rearrangements of carrier plasmids. This may have been a factor in the incorporation
of incorrect nucleotides in the numerous cell division cycles during preparation of
E.coli cultures for isolation of plasmid DNA and for glycerol stocks. Subsequent
cloning experiments utilised SURE® cells, which are engineered to carry inactivating
mutations in the pathways catalysing gene rearrangements in an attempt to reduce the
number of variants created.
The constructs generated by the work in this chapter were vital in functional
assays to determine the effect of AE5 on spindle checkpoint function. The constructs
in which MAD3 and BUB1 AE5 were under the control of their wild type promoters
were used in strains null for either BUB1 orMAD3 in assays investigating their affect
on checkpoint function, chromosomal instability and the generation of aneuploidy.
The over-expression constructs were used to investigate the effect of AE5 on
checkpoint protein interactions and spindle checkpoint complexes.
The results of these functional analyses are described in chapters 4 and 5.
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Chapter 4: AE5 Abrogates Spindle Checkpoint Function
and Confers a Chromosome Loss Phenotype in S.cerevisiae
4.1 Introduction
The overall aim of this chapter was to determine the effect of AE5 on spindle
checkpoint function using the constructs described in chapter 3, pMAD3-AE5 and
pBUBl-AE5.
4.1.1 Spindle Checkpoint Mutants Exhibit a Marked Sensitivity to
Microtubule Poisons
Benomyl (Methyl l-(butylcarbamoyl)-2-benzimidazolecarbamate) is an inhibitor
of microtubule polymerization. Treatment with microtubule poisons at
concentrations of 10-15pg/ml considerably lengthens the cell cycle in wild type cells
in which the spindle checkpoint is functional, due to a slowed assembly of the
mitotic microtubule spindle and activation of the spindle checkpoint. Spindle
checkpoint mutants do not exhibit this delay and exit mitosis with incomplete
spindles leading to aberrant chromosome segregation, the accumulation of lethal
chromosome defects and cell death. Thus yeast spindle checkpoint mutants show a
decreased growth ability on media containing benomyl and the mad and bub null
mutants were initially identified through this marked sensitivity (Li and Murray,
1991; Hoyt et al., 1991).
Recently the benomyl sensitivity of bub and mad null mutants have been directly
compared. Cells containing mutations in BUB1 and BUB3 showed an order of
magnitude greater benomyl sensitivity than madl, mad2 or mad3 mutants. This
indicates that the checkpoint proteins contribute different roles to the maintenance of
cell viability via the spindle checkpoint and may also reflect other mitosis-related
functions, in kinetochore structure or cell cycle progression for example (Warren et
al., 2002).
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Complementation of the null bub and mad strains with exogenously expressed
full-length Bublp or Mad3p rescues this sensitivity phenotype by restoring
checkpoint function. The empty YCPLac22 vector does not achieve this rescue,
acting as a negative control (Warren et ah, 2002). These full-length constructs and
the empty vector can therefore be used as positive and negative controls in this
characteristic spindle checkpoint assay to assess spindle checkpoint function in the
AE5 mutants.
This assay has previously been used to clarify function and important regions of
spindle checkpoint proteins by mutating conserved residues and domains and testing
their benomyl sensitivity. Specifically MAD3 mutants replacing the conserved
GIGS domain with four alanine residues or the conserved Glutamic acid residue 382
to a lysine, both show marked benomyl sensitivity. In the GIGS mutants this is
equivalent to that seen in a null mutant and in the E382K mutant it is slightly less
severe. This indicates the relative contributions of these conserved amino acids to
Mad3p checkpoint function (Hardwick et ah, 2000).
Thus this assay was essential to primarily determine whether the AE5 deletion
conveys a spindle checkpoint defect and disrupts the function of Mad3p and Bublp
in the checkpoint.
However, benomyl sensitivity may also represent defects in tubulin and other
microtubule spindle related components, perturbed microtubule dynamics and
inappropriate cell cycle progression (Stearns et ah, 1990; Stearns and Botstein, 1988;
Hoyt et ah, 1990).
Thus further assays were required to confirm that the defects observed were
related to abrogation of the checkpoint and not a result of disruption of additional
protein functions of Bublp and Mad3p.
4.1.2 Null mad3 Mutants Initially Divide Faster in Microcolony Assays
Li and Murray initially identified the Madp proteins through the isolation of
benomyl sensitive mutant cell populations. However, as stated above, this would
143
include structural microtubule mutants as well as those involved in feedback control
(Li and Murray, 1991). To distinguish between these structural mutants and mutants
with defective spindle checkpoints, microcolony assays were used. These assays
involve the isolation of individual cells and monitoring their growth on benomyl
containing solid media over a 12 hour period. Wild type cells divide slowly initially
before undergoing adaptation to the microtubule poison allowing an increased rate of
growth. The mutants harboring defects in spindle checkpoint control initially divide
more rapidly due to a bypass of checkpoint arrest but later accumulate lethal defects
slowing their growth rate and resulting in the limited viability seen in the benomyl
sensitivity assay. Cells harboring mutations in structural microtubule components
such as tub and cin mutants behave very differently in microtubule assays, budding
only once and arresting as a single large bud. This is of particular importance as
some of the spindle checkpoint proteins are believed to have additional microtubule
related functions which may contribute to the benomyl sensitivity phenotypes of
mutants. Again the characteristic null mad3 phenotype can be rescued by plasmid
expression of full-length Mad3p but not by expression of the equivalent empty
vector.
Thus by exogenously expressing the Mad3AE5 protein in the mad3 null strain I
have assessed the functional effect of AE5 on Mad3p spindle checkpoint function. In
addition the microcolony assay will distinguish those mutations effecting checkpoint
function from those effecting microtubule structure and clarify the effect of AE5.
This assay was important to distinguish spindle checkpoint disruption by AE5 from
an effect on microtubule structure.
This microcolony assay is not suitable for examining the effect of AE5 on spindle
checkpoint function in bubl mutants as they are hypersensitive to benomyl compared
to mad3 mutants. This results in a high level of cell death in bubl mutants after only
a few hours even at low concentrations of benomyl ( see figure 4.11 and appendix 5).
Thus an alternative liquid culture assay was used to investigate the spindle
checkpoint affect of AE5 on Bublp function.
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4.1.3 Null bubl Mutants Show a Characteristic Budding Phenotype in
Liquid Culture Assays
This liquid culture assay has been used as an alternative to the microcolony assays
described above to examine the effect of BUB1 mutations on spindle checkpoint
function (Warren et al., 2002). In this assay, synchronized cultures are grown in
liquid media containing nocodazole, a benomyl related compound used as an
alternative in liquid media due to technical considerations. The resulting cell
populations are vigorously sonicated to separate cell clusters and examined
microscopically. Almost 100% of wild type cells arrest at mitosis as large budded
cells whereas up to 60-70% of bubl mutants progress through mitosis unperturbed to
produce at least one further bud showing a characteristic multi-budded phenotype
(Hoyt et al., 1991).
Warren et al effectively used this assay to show that truncating mutants containing
only the first 367 amino acids of Bublp displayed a similar multi-budded phenotype
to a bubl null mutant. Mutants containing the N terminal 608 amino acids, amino
acids 211-1021, a K733R substitution and an E333K substitution also exhibited
multi-budded phenotypes of varying severity, indicating the important residues of
Bublp involved in spindle checkpoint function.
To summarise, these experiments suggest amino acids 1-608 are sufficient to
maintain Bublp spindle checkpoint function, the kinase domain of Bublp is not
required and amino acids 211-367 may be particularly crucial. The phosphorylation
of E333 is also thought to be important to checkpoint function whereas the K733R
substitution is likely to disrupt function due to a destabilizing effect on the Bublp
protein (Warren et al., 2002).
Thus null bubl mutant strains can be used in rescue experiments as the multi-
budded phenotype can be rescued by addition of the full-length BUB1 plasmid but
not by the empty vector. The liquid assay will be used to test the ability of the
BUB1AE5 to rescue the null multi-budded phenotype, indicating its influence on
spindle checkpoint function and identifying if any defects associated with benomyl
sensitivity are also associated with multi-budded phenotypes indicative of aberrant
spindle checkpoint function in BUB1AE5.
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4.1.4 Spindle Checkpoint Mutants Exhibit Increased Rates of
Chromosome Loss
The association of the AE5 mutations with aneuploid tumours raises questions
about the effect of the mutation on chromsome stability. Chromosome loss
phenotypes have previously been associated with madl, mad.2 and mad3 spindle
checkpoint mutants in budding yeast when challenged with microtubule poisons (Li
and Murray, 1991). bubl and mad2 mutants also exhibit chromosome loss in the
absence of spindle damage (Pangilinan and Spencer, 1996) as do S. pombe bubl
mutants (Bernard et al., 1998), Drosophila bubl mutants (Basu et al., 1999) and C.
elegans mdf-1 and mdf-2 mutants (Kitagawa and Rose, 1999).
Specific chromosome loss assays have been devised to efficiently test this
phenotype. The S.cerevisiae chromosome loss assay utilizes the Ade20Chre strain
which harbors a mutation in the 5AIR carboxylase enzyme involved in the purine
biosynthesis pathway. Cells thus accumulate a red pigmented intermediate, resulting
in colonies which are red in colour. Addition of a SUP11 minichromosome encoding
the ochre-suppressing tRNA allele ade2-101 restores the enzyme and leads to white
colonies. Chromosome segregation defects resulting in mis-segregation of the
minichromosome are observed as reversion of the cells to red. Thus rates of
chromosome loss can be calculated by examining the red-white sectoring phenotype
exhibited. The rate of chromosome loss is standardized against the number of cell
divisions by scoring the number of colonies which are at least half sectored,
representing loss of the minichromosome at the first division, as a proportion of the
total number of colonies counted. Red colonies are not included in the total count, as
they have undergone a chromosome loss event prior to the start of the assay at
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Figure 4.1 Colour colony chromosome loss assay
The chromosome loss assay uses the ADE2-101 strain which harbours an
ochre mutation in ADE2 gene producing pigmented red colonies.
Transformation of this strain with the CFIII ochre suppressing
minichromosome restores the purine biosynthesis pathway producing white
colonies.
This strain is transformed with test plasmids and plated onto indicator plates
lacking adenine to activate the purine biosynthesis pathway. Any cell in
which the mini-chromosome has been lost due to mis-segregation appear red.
For each test strain, the number of half sectored colonies which are at least
half red and the total number of colonies which are not entirely red are scored.
Rates of chromosome loss in units of losses per thousand divisions are
calculated as shown.
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In this assay null bubl and mad3 mutants exhibit increased rates of chromosome
loss compared to wild type strains. Supplementation of the null strains with the
appropriate full-length gene construct restores checkpoint function and reduces
chromosome loss rates to wild type levels. Addition of the empty vector does not
achieve this rescue. Thus using the empty YCPLac22 cassette as a negative control
and the full-length pMAD3 and pBUB1 vectors as positive controls, I have
investigated the ability of pMAD3-AE5 and pBUB 1-AE5 to restore checkpoint
function to null strains and rescue this phenotype. This addresses the ability of the
AE5 proteins to function in the spindle checkpoint and whether the mutations can be
responsible for mis-segregation of chromosomes.
Warren et al have shown that chromosome loss rates vary between different
spindle checkpoint mutants and that this correlates with the benomyl sensitivity
phenotype. Thus the rates of chromosome loss are indicative of mis-segregation due
to aberrant spindle checkpoint function. Additionally, they examined the effects of
deletions and mutations in BUB1 on the chromosome loss phenotype. They report
increased rates of chromosome loss for all the mutants analysed although the degree
of increase varied between the mutants and suggested functional domains at both the
N and C termini of Bublp are important in chromosome segregation (Warren et al.,
2002).
This assay is of particular interest for BUBR1AE5 and the equivalent mutation
found by Cahill et al, BUB1 V400 due to their involvement in colon cancers. Current
hypotheses suggest aneuploidy in tumours is generated by errors in chromosome
segregation so an assay measuring the frequency of such mis-segregation events in
cells harbouring tumour associated mutations will help to clarify both the
contribution of these mutations to tumourigenesis and ultimately the mechanism by
which such an effect may be mediated. This may also provide an assay system for
evaluating the contribution of tumour associated variants identified in the future.
These are all well established assays in yeast which have been used to assess the
effect of mutations and truncations on the spindle checkpoint function of the Madp
and Bubp proteins. Although most of these studies have been involved in isolating
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important domains of spindle checkpoint proteins and deciphering their specific
functions, the principals can be easily applied to cancer associated mutations.
Thus the results described in this chapter describe the use of the AE5 constructs in
these assays to investigate their effect on spindle checkpoint function and
chromosome segregation, and to ascertain whether the AE5 mutant phenotypes are
consistent with a role in the generation of aneuploidy and ultimately, tumourigenesis.
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4.2 Methodological Overview
4.2.1 Transformation into Null Strains
The YCPLac22 empty vector, full-length pMAD3 and pMAD3-AE5 constructs
were each transformed into the mad3 null mutant strain YRJ111 via the lithium
acetate procedure as described in 2.7.6. Similarly YCPLac22, pBUB1 and pBUB1-
AE5 were transformed into the bubl null mutant strain YRJ112. Positive
transformants were selected on media lacking tryptophan and mixed colonies were
streaked onto new selective plates before use in the described assays. Each assay
was performed on at least 3 independent occasions, using a new transformation for
each repetition.
The YCPLac22 and full-length constructs were used as negative and positive
controls respectively. Additionally the wild type strain (KH34) and untransformed
null strains (YRJ111 and YRJ 112) were included in at least one of the repetitions to
validate the controls.
4.2.2 Benomyl Sensitivity Assays
Benomyl sensitivity assays were carried out as described in 2.7.12. The assays
were generally performed in duplicate with two mixed populations assayed per
transformation. The sensitivity of the transformants were tested at several
concentrations of benomyl, typically 10, 12.5 and 15pg/ml and also on benomyl free
media to ascertain their growth under unchallenged conditions. Two plates were
prepared for each benomyl concentration.
4.2.3 Microcolony Assays
Microcolony assays were performed on the mad3 + pMAD3, pMAD3-AE5 and
YCPLac22 transformants as described in 2.7.13 (Li and Murray, 1991).
4.2.4 Liquid Culture Assays
Liquid culture assays were performed on the bubl + pBUB1, pBUBl-AE5 and
YCPLac22 transformants as described in 2.7.14 (Hoyt et al., 1991).
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4.2.5 Chromosome Loss Assays
Chromosome loss assays were performed using both the MAD3 and BUB1
transformants as described in 2.7.15 (Hieter et al., 1985; Spencer et al., 1990).
Overnight cultures were grown in selective media lacking tryptophan to select for the
YCPLac22 plasmids and uracil to select for the minichromosome. The cultures were
then diluted to an OD of 0.3 and grown in non-selective media for 4 hours before
further dilution, typically 1 in 2500 and plating on indicator plates lacking adenine.
4.2.6 Calculations and Statistics
For each of the assays described, three experimental repetitions were performed.
Due to the large volume of data acquired, the data presented in this chapter is
representative of that observed in each of the repetitions. Further details of
individual experiments are presented in the appendix.
In the microcolony assays, the mean number of cells and buds per microcolony
was calculated for 25 cells for each experiment. The mean of the three repetitions
has been calculated and this data is displayed graphically.
In the liquid culture assays the proportion of multi-budded cells with more than 2
buds was calculated as a percentage of the total number of a 200-cell population.
Again the mean of the three repetitions is presented here graphically with variation
indicated as error bars showing the standard deviation between the individual
repetitions. The 200 cell counts (not percentages) for each repetition were pooled
and the total numbers of multi-budded cells observed in the 600-cell populations
were compared in pairs as shown in the table below.
In the chromosome loss assays, the sample size (total number of colonies) for
each transformant population and each experimental repetition varies. Thus the
original counts of half sectored/non-red colonies are shown to indicate the sample
size. The chromosome loss rate per thousand divisions was calculated using:
Chromosome loss rate = number half sectored colonies * 1000
total number non-red colonies
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These figures were calculated for each of the individual experiments and for the
total of the three repetitions as an alternative to the standard method of calculating
the mean to allow for the differences in sample size between repetitions. This total
chromosome loss rate is presented in the figures.
Both the liquid culture assays and the chromosome loss assays were analysed
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The expected value for a was calculated by the product of the relevant row and
column totals divided by the total sample size. For example the expected number of
half-sectored colonies for the Vector population would be
Expected = ci * nt
N
Each of the three experimental repetitions for the pair were analysed and totalled
according to the Mantel-Haenszel analysis
Mantel-Haenszel statistic t = ^Observed -£ Expected
Ve Variance




This test is similar to a chi-squared analysis but is more powerful as it also
considers the variation between the three experimental repetitions and the direction
of the differences observed between populations. If all the experimental repetitions
show differences in the same direction (e.g. the proportion of half-sectored colonies
in the vector is always higher than in the deletion) the t2 value should equal the value
obtained by adding the chi-squared values from the three individual experiments
together. The probabilities associated with the t values obtained were calculated
using Minitab.
Chi-squared was used to analyse the data within individual experimental
repetitions for chromosome loss assays and liquid culture assays and this is presented
in the appendices.
Chi-squared analysis was performed at 1 degree of freedom using the formula
below:
2 2
X = E (Observed - Expected)
Expected
For Chi-squared statistical analyses the probability of statistical significance (p
values) was calculated using Microsoft Excel. P values of less than 0.05 were
considered statistically significant (5% confidence interval) unless otherwise stated.
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4.3 Results
The results presented here are representative of at least three duplicate
experiments using fresh transformants. The statistical analysis have generally been
carried out on the three experimental repetitions or occasionally the mean of the three
data sets where stated. The data presented generally shows the cumulative data from
the three repetitions or the mean where stated. Further data from individual
experiments and statistical analysis of these is presented in the appendix at the end of
this thesis.
4.3.1 MAD3AE5 Mutants are as Benomyl Sensitive as Null mad3
Mutants
To address the hypothesis that AE5 abrogated the function of Mad3p in the
spindle checkpoint, the ability of pMAD3-AE5 to rescue the benomyl sensitivity
phenotype associated with the null mad3 mutant was investigated. Figure 4.2A
shows the benomyl sensitivity shown by the null mad3 mutant strain, YRJ111, as
indicated by the reduction in yeast colony size and abundance compared with the
wild type KH34 strain. This is due to the accumulation of lethal chromosome defects
in a proportion of the null cells. The mutants are more sensitive to higher
concentrations of benomyl. The YPD plates without benomyl act as a control to
ensure any reduced viability on the benomyl plates is not due to an intrinsic growth
defect.
Figure 4.2B shows the phenotypes of the null mad3 strain separately transformed
with either the empty YCPLac22 vector, yMAD3-AE5 or the full-length construct
pMAD3. A sensitivity equivalent to that in the null mutant is seen in the YCPLac22
transformant, acting as a negative control. The addition of the control full-length
pMAD3 construct rescues this sensitivity phenotype and restores viability to a level
equivalent to the wild type strain.
The pMAD3-AE5 transformant does not achieve this rescue and exhibits a similar
limited viability on benomyl to that seen in the YCPLac22 transformant. The
benomyl sensitivity of this mutant indicates the Mad3AE5p protein does not perform
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its spindle checkpoint function as well as the full-length protein. Additionally there
seems to be little difference in the sensitivity phenotype of the AE5 mutant and the
empty vector suggesting the AE5 mutation removes all the checkpoint function of
Mad3p, rendering it null. The experiment was repeated in triplicate with fresh
transformants. The results shown in figure 4.2 show results from one experiment but
are representative of all the results obtained and photographs of individual
experimental repetitions are presented in Appendix 1 at the back of this thesis.
Thus the benomyl sensitivity assay suggests that the Mad3 AE5 mutation would
abrogate the spindle checkpoint in cells which harbour it. This is consistent with the
hypothesis that the AE5 variant could induce the chromosome mis-segregation and
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Figure 4.2: MAD3 benomyl sensitivity assay results
A The null mad3 mutant YRJ111 shows a benomyl sensitivity phenotype which is
not present in the wild type strain.
B This phenotype can be rescued by expression of the full-length protein from the
pMAD3 construct. The empty YCPLac22 vector does not achieve this rescue.
The pMAD3-AE5 construct cannot achieve this rescue either suggesting the
Mad3AE5p protein cannot maintain checkpoint function.
The sensitivity is shown at 3 dilutions 100, 10 and 1 times.
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4.3.2 BUB1AE5 Confers an Intermediate Benomyl Sensitivity
Phenotype
The null bubl mutant shows a benomyl sensitivity phenotype much greater than
that seen in the null mad3 mutant. This is indicative of a greater role for Bublp in
the spindle checkpoint. Bublp is also thought to be involved in additional mitotic
functions such as in kinetochore assembly whose disruption may contribute to the
benomyl sensitivity phenotype.
Figure 4.3A shows the extent of the benomyl sensitivity phenotype seen in the
bubl mutant and 4.3B shows that this phenotype can be rescued by the full-length
protein by exogenously expressing the pBUB1 construct. The ScBUBlAE5 does not
fully achieve this rescue although the benomyl sensitivity phenotype it confers is not
as severe as that seen in the null mutant when transformed with the empty vector.
This suggests the BUB1AE5 mutation does compromise the checkpoint although
partial function is retained. This retained function of Bublp could be mediated
through the C terminal kinase domain which is absent in Mad3p, consistent with the
differing phenotype conferred by MAD3AE5 and perhaps with additional functions
of Bublp in mitosis via its C terminus. This is particularly interesting as previous
analysis of BUB 1 mutants indicate the C-terminal domain is required for full protein
function (Warren et al., 2002).
This may have relevance to the relatively small number of mutations in spindle
checkpoint genes observed in tumours. Severe spindle checkpoint mutations that
remove checkpoint function entirely may induce a similar lethality to that seen in
BUB3 and MAD2 knockout mice. Thus only those mutations which compromise
checkpoint function may avoid this lethality, while inducing the chromosome
instability phenotype which drives tumourigenesis.
The set of results shown in these figures are representative of all the experimental
repetitions and photographs of individual experiments are presented in appendix 2 at
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Figure 4.3: BUB1 benomyl sensitivity assay results
A The null bubl mutant YRJ112 shows a severe benomyl sensitivity phenotype
which is not present in the wild type strain.
B This phenotype can be rescued by expression of the full-length protein from the
pBUB1 construct. The empty YCPLac22 vector does not achieve this rescue.
The pBUBl-AE5 construct cannot fully achieve this rescue but is less sensitive than
the null strain suggesting the BUB1AE5 protein can support partial checkpoint
function.
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4.3.3 MAD3 AE5 Abolishes Spindle Checkpoint Function
As benomyl sensitivity phenotypes can be attributed to other mitosis related
defects, such as in structural microtubule components, microcolony assays were used
to determine whether the benomyl sensitivity of MAD3AE5 was due to a spindle
checkpoint defect or to interference in other mitotic functions.
Microcolony assays were initially carried out on wild type, madS null strain and a
cinl microtubule structural mutant to verify the assay. The individual and mean
numerical results of the three experimental repetitions are shown in table 4.1 and the
mean of these experiments is displayed in figure 4.4. Further details of individual
repetitions are shown in appendix 3.
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Table 4.1 Microcolony assay optimisation
The data below shows the results from each of three experimental repetitions, A, B
and C. Each repetition analysed the growth of 25 microcolonies of each strain over
12 hours and the mean number of cells per microcolony was calculated. The mean
of these three experiments was calculated and is presented in figure 4.4.
Time Mean cell number per microcolony
(Hrs) Wild Type cinl mad3
A B C Mean A B C Mean A B C Mean
0 1 1 1 1 1 1 1 1 1 1 1
2 1.72 1.35 1.72 1.60 1.84 1.31 - 1.58 2.08 1.84 1.88 1.93
4 2.56 2.18 2.16 2.3 2 1.64 - 1.82 3.08 2.6 2.84 2.84
6 3.6 3.12 2.8 3.17 2 1.95 - 1.98 4.44 3.68 4 4.04
8 4.92 5.06 4.12 4.7 2 2 2 5.72 5.08 5.52 5.44
10 5.96 8.12 6.04 6.71 2.08 2 2.04 6.46 7.96 6.76 7.06




























Figure 4.4: MAD3 microcolony assay optimisation
In microcolony assays, wild type strains initially arrest at the checkpoint showing a slow rate
of growth. After prolonged treatment with microtubule poisons, the cells adapt showing an
increased growth rate. Spindle checkpoint mutants such as mad3 exhibit no initial arrest,
dividing faster than wild type cells but accumulate lethal defects, resulting in reduced growth
rate upon prolonged exposure. Structural mutants such as cinl arrest as a double bud due to
defects in cytokinesis.
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The mad3 null strain initially shows an increased rate of growth compared to wild
type due to defective growth arrest at the spindle checkpoint. This increased growth
rate is not sustainable in the mutant however as a proportion of the cells accumulate
chromosomal abnormalities leading to cell lethality. Thus the rate of growth in the
null mutant begins to fall. However, the wild type strain grows slowly initially due
to the mitotic block at the spindle checkpoint but after several hours the cells adapt to
the presence of the microtubule poison, perhaps through metabolism of the poison
and thus are able to adapt to the block and continue to grow and divide. This results
in an increased growth rate compared to the null strain upon prolonged exposure and
also explains the greater viability of the wild type strain in the benomyl sensitivity
assays.
The results of the three repetitions of the microcolony assay are shown in table 4.2
for the mad3 null mutants transformed with the MAD3 constructs and the mean of
these are presented in figure 4.5.
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Table 4.2 Microcolony assay results
The data below shows the results from each of three experimental repetitions, A, B
and C. Each repetition analysed the growth of 25 microcolonies of each transformant
over 12 hours and the mean number of cells per microcolony was calculated. The
mean of these three experiments was calculated and is presented in figure 4.5.
Time Mean cell number per microcolony
(Hrs) mad3 + YCPLac22 mad3+ pMAD3 mad3+pMAD3-AE5
A B C Mean A B C Mean A B C Mean
0 1 1 1 1 1 1 1 1 1 1 1 1
2 1.92 1 1.75 1.56 2.04 1.41 1.74 1.73 1.91 1.14 1.70 1.58
4 3.16 1.73 2.25 2.38 2.88 2 2.13 2.34 3 1.59 2.65 2.41
6 5.16 2.46 3.292 3.64 3.88 2.12 2.83 2.94 4.5 2.38 3.26 3.38
8 7.52 3.45 4.542 5.17 4.88 2.94 3.78 3.87 6.18 3.57 4.91 4.89
10 11.36 4.18 5.208 6.92 7.36 3.29 5.65 5.43 8.86 4.81 6.63 6.77


































Figure 4.5: MAD3 microcolony assay results
The vector and full-length transformants show similar phenotypes to the null mad3 and wild
type strains respectively as shown in figure 4.4.The AE5 transformant shows a similar
phenotype to the null strain indicative of a spindle checkpoint defect.
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A comparable growth rate pattern to the null mutant is seen in the mad3
YCPLac22 transformant. The full-length mad3 transformant shows a similar pattern
to the wild type strain, verifying these as controls. MAD3AE5 shows a growth
pattern similar to the null strain consistent with a reduced spindle checkpoint
function. MAD3AE5 shows an increased growth rate at the early time point of
treatment in a similar way to the null strain but maintains this increased growth rate
longer than the null mutants suggesting spindle checkpoint function may not be fully
abolished and thus the cells may not accumulate lethal defects at such an increased
rate. Alternatively this may reflect a general effect on cell growth.
The quantitative behaviour of the transformants is variable between experiments
although the MAD3AE5 transformants behave similarly relative to the vector and
full-length in each of the repetitions (see appendix 4). Therefore this assay is
analysed qualitatively to compare the behaviour of the AE5 mutant with the
behaviour of the control full-length, vector and structural mutant controls but
statistical analysis has not been performed.
These variations in behaviour make it difficult to draw any firm conclusions about
the proportion of MAD3 function which is abolished by AE5 but they consistently
show a deleterious effect of AE5 on spindle checkpoint function. Significantly, the
pattern of growth in the MAD3AE5 mutants does not resemble that of the structural
microtubule mutant cinl. This suggests the benomyl sensitivity phenotype of the
MAD3AE5 mutant is attributable to a defect in spindle checkpoint function and not
any structural component of the spindle.
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4.3.4 BUB1 AE5 Shows a Multi-budding Phenotype in Liquid Culture
Assays, Consistent with Spindle Checkpoint Abrogation
The extreme benomyl sensitivity phenotype seen in the bubl null mutants makes
them unsuitable for analysis by microcolony assay. Many attempts were made to
optimise this assay for use with the bubl null mutants at various concentrations of
benomyl (see appendix 5) but the behaviour of the mutants was inconsistent and
eventually I decided an alternative assay was required to specifically analyse spindle
checkpoint function in BUB1AE5.
Liquid culture assays were used as an alternative to analyse the budding behaviour
of the bubl mutants after spindle checkpoint activation with nocodazole. Under
normal growth conditions (zero hour time point) spindle checkpoint mutants will
behave similarly to checkpoint functional cells, cycling from a single cell to a double
bud and rarely showing a multi-budded phenotype as shown in figure 4.6. However,
when challenged with microtubule poison for 6 hours or more wild type cells arrest
at the spindle checkpoint as a single large budded cell. The null mutants transformed
with full-length BUB1 acted comparably to wild type cells. However, spindle
checkpoint mutants are unable to arrest at the metaphase to anaphase transition and
thus continue through the checkpoint to produce at least one further bud exhibiting a
multi budded phenotype. On analysis, the AE5 transformants also exhibit this multi-
budded phenotype indicative of spindle checkpoint failure. Photographic examples
of the characteristic phenotypes shown by the three transformed populations after 6
hours of nocodazole treatment are shown in figure 4.7. A similar phenotype is seen
after 8 hours of nocodazole treatment (see figure 4.8).
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bubl + pBUB 1 0 hours
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bubl + pBUBl-AE5 0 hours





bub l + pBUBl 6 hours
bubl + pBUBl-AE5 6 hours
Figure 4.7 BUB1 Liquid culture assay results after 6 hours
treatment with nocodazole
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bubl + pBUBl 8 hours
bubl + \)BUB1-AE5 8 hours
Figure 4.8 BUB1 liquid culture assay results after 8
hours treatment with nocodazole
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The efficiency of spindle checkpoint function was quantified by scoring the
number of cells showing a multi-budded phenotype as a proportion of a 200 cell
population for each of the bubl transformants, YCPLac22, BUB1AE5 and full-length
BUBI. These experiments were repeated three times and the individual and total
results are presented in table 4.3A with the individual and mean percentages of
multi-budded cells shown in table 4.3B. Statistical analysis of the three repetitions is
shown in figure 4.9 where the mean percentages of multi-budded cells are also
presented graphically. The results of the individual repetitions are presented
graphically in appendix 6 later in this thesis with statistical analysis in appendix 7.
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Table 4.3 Liquid culture assay results
A The table below shows the number ofmulti-budded cells in a 200 cell
population of each transformant in three repetitions of the liquid culture assay and
in the total 600 cell population of these three repetitions. The means of these three
assays are shown graphically with Mantel haenszel statistical analysis in figure
4.9. Chi squared statistical analysis of the individual experimental counts are
shown in Appendix 7.
Time (Hrs) Number ofmulti-budded cells
bubl + YCPLac22 bubl + pBUBl-AE5 bubl + pBUBl
A B C Total A B C Total A B C Total
0 3 6 5 14 10 5 8 23 4 1 5 10
6 64 53 52 169 66 37 43 146 9 3 9 21
8 57 46 65 168 47 34 45 126 2 5 9 16
B The table below shows the percentage ofmulti-budded cells in each transformant
population in three repetitions of the liquid culture assay and the mean of these values
The mean values are presented graphically in figure 4.9 with Mantel Haenszel
statistical analysis of the total counts. Graphical representations of the percentage of
multibudded cells for the individual experiments are shown in Appendix 6.
Time Percentage of multi-budded cells
(Hrs)
bubl + YCPLac22 bubl + pBUBl-AE5 bubl + pBUB1
A B C Mean A B C Mean A B C Mean
0 1.5 3 2.5 2.33 5 2.5 4 3.83 2 0.5 2.5 1.67
6 32 26.5 26 28.17 33 18.5 21.5 24.33 4.5 1.5 4.5 3.5
8 28.5 23 32.5 28 23.5 17 22.5 21 1 2.5 4.5 2.67
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I I I I I I
p values 0.404 0.034 0.0424
Mantel ' ' ' ' ' '
0.606 0.752 0.5708
I I I I I IHaenszel
Analysis 0.729 0.0224 0.0166
(3 d.f.)
Figure 4.9 BUB1AE5 liquid culture assay results
The mean percentage ofmulti-budded cells for each transformed population
(over 3 experimental repetitions) are presented in the graph above. Error bars
indicate ± 1 standard deviation ( 0.763, 3.329 and 4.770 for vector at 0,6 and 8
hours; 1.258, 7.654 and 3.5 for deletion at 0, 6 and 8 hours and 1.041, 1.732 and
1.756 for full-length at 0, 6 and 8 hours).
The p values for Mantel Haenszel analyses ofpaired data sets are indicated
below the graph with statistically significant values in red. This statistical test
analyses the data from all three repetitions.
Both the vector and AE5 transformed bubl strains show an increased multi-
budded phenotype after nocodazole treatment indicative of aberrant spindle
checkpoint function.
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Prior to nocodazole treatment both the vector and full-length transformant
populations produce low proportions of multi-budded cells which do not
significantly differ (t = 0.346, p=0.729). After treatment with nocodazole the
proportion ofmulti-budded cells remains low in the full-length population indicative
of spindle checkpoint arrest. A significantly higher percentage of vector
transformants show a multi-budded phenotype after prolonged 6 or 8 hour arrest in
nocodazole than full-length transformants (t = 2.2819 p=0.0224, t =2.397 p=0.0166,
after 6 and 8 hours respectively). Thus the full-length and vector transformants act
as suitable controls behaving in a manner consistent with previous reports for wild
type and null strains.
The AE5 transformant shows a similar phenotype to the vector and full-length
prior to nocodazole treatment. However, the proportion of multi-budded cells is
significantly increased compared to the full-length transformant after 6 or 8 hours
treatment with nocodazole consistent with the hypothesis that AE5 confers a spindle
checkpoint defect (t =2.120 p= 0.034, t =2.030 p=0.0424 after 6 and 8 hours
respectively). The severity of the multi-budded phenotype does not significantly
diverge from that of the vector transformant (t =0.316 p=0.752, t =0.567 p=0.571).
Thus these data do not provide any evidence to support the partial function of
BublAE5p in the spindle checkpoint as suggested by the benomyl sensitivity data but
they are consistent in that they demonstrate that BUB1AE5 harbours a spindle
checkpoint defect.
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4.3.5 MAD3AE5 is Associated with a Defect in Chromosome
Segregation and an Increased Level of Chromosome Loss
The benomyl sensitivity phenotypes of the AE5 mutants and the results of the
microcolony and liquid culture assays suggest they are able to escape checkpoint
arrest despite defects in chromosome capture caused by the depolymerisation of
microtubules. This lead to the hypothesis that the AE5 mutations allow cells to
undergo aberrant mitoses which may lead to errors in chromosome segregation and
the chromosome instability associated with aneuploid tumours.
In yeast, spindle checkpoint mutants have previously been shown to have elevated
rates of chromosome loss due to mis-segregation events through colour colony
chromosome loss assays. This assay allows quantification of the frequency of
chromosome loss in different spindle checkpoint mutants thus clarifying the effect of
the mutations on chromosome segregation defects.
Thus the constructs YCPLac22, AE5 and full-length were used in the ADE101
indicator strain to assess chromosome number. Raw data of the relative chromosome
loss rates seen in the wild type and null mad3 strains and the vector, AE5 and full-
length transformants are shown in tables 4.4 and 4.5. The total results of three
experimental repetitions are presented graphically with statistical analysis of the
three data sets in figure 4.10. Similar graphs and analysis of individual experiments
appear in appendix 9 and 10. Additionally, photographic representations of the
sectoring phenotypes shown by the transformant populations from one repetition are
shown in figure 4.11 and further photographs are shown in appendix 8.
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Table 4.4 MAD3 chromosome loss colony counts
The number of half sectored colonies as a proportion of non-red colonies for
each experiment is shown below. This also indicates the sample size for
each transformant.
These counts are combined to produce a total ratio of half sectored colonies
to total non-red colonies for each strain and transformant. The loss rates of
these total counts are presented in figure 4.10 with Mantel Haenszel
statistical analysis of the three data sets.
Experiment Proportion of half sectored colonies
mad3 Wild Type mad3 + mad3 + mad3 +
YCPLac22 pMAD3-AE5 pMAD3
A 13/9934 22/11854 3/6668
B 15/3751 10/19159 69/18492 65/17775 18/11937
C 25/6008 16/6224 3/8266
Total 15/3751 10/19159 107/34434 103/35853 24/26871
Table 4.5 MAD3 chromosome loss rates
Chromosome loss rates were calculated using the proportions listed in table 4.4 for
each experiment. The loss rates for each mutant using the total data is shown in
figure 4.10. The loss rates and Chi-squared statistical analyses of individual
experiments are presented in Appendix 9 and 10.
Experiment Chromosome loss rate per thousand divisions
mad3 Wild Type mad3 + mad3 + mad3 +
YCPLac22 pMAD3-AE5 pMAD3
A 1.309 1.856 0.450
B 3.999 0.522 3.731 3.657 1.508
C 4.161 2.571 0.36
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Figure 4.10 MAD3 chromosome loss assay results
The graph illustrates the rate of chromosome loss in losses per thousand divisions.
The values shown are an accumulation of three individual experiments, results of
individual repetitions and their individual chi-squared statistical analyses are
shown in the appendix.
The p values of the Mantel Haenszel analysis comparing pairs ofmutants across
all three repetitions are shown below the graph with statistically significant values
in red.
The vector and full-length loss rates are comparable to the mad3 null mutant and
wild type control strains respectively as shown by chi-squared analysis. AE5
shows an increased chromosome loss rate similar to the vector alone indicative of
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Figure 4.11 MAD3 chromosome loss assay results
A high rate of chromosome loss is seen in the vector transformant which is rescued in the full-
length transformant. The deletion does not achieve this rescue indicating it harbours a spindle
checkpoint defect.
This increased chromosome loss rate is indicated by the half red sectored colonies.
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The mcid3 null mutants have been reported to exhibit an increased rate of
chromosome loss compared to wild type strains. My analysis of these strains
revealed differences in rates of chromosome loss in the wild type and mad3 null
strains, consistent with previous chromosome loss experiments (Warren et ah, 2002;
K. Hardwick, unpublished). These were compared to the loss rates of the control
full-length and vector transformants and Chi-squared analysis revealed no significant
difference between the loss rates of mad3 and vector (yj = 0.844 p=0.358) or
between wild type and full-length (x2 =2.088 p=0.148) indicating the vector and full-
length behave comparably to the null and wild type strains as controls. However,
the rate of chromosome loss between the vector and full-length transformants are
highly statistically significantly different indicating the power of the assay (t = 5.854
p<0.0001). Chi squared analysis was used here as the loss rates of the null mad3
mutant and wild type strain were tested only once.
The rate of chromosome loss in AE5 is significantly different to the full-length
transformant (t = 5.303 p<0.0001) indicative of a defect in chromosome segregation.
This is consistent with the hypothesis that AE5 initiates a chromosomal instability
phenotype and that this may be associated with the aneuploid phenotype observed in
colorectal tumourigenesis.
The loss rate seen in AE5 is not significantly different to that seen in the vector
alone (t = 0.357 p = 0.721), which is consistent with the similar benomyl sensitivities
of these two transformant populations. These data suggest MAD3AE5 is unable to
function in the spindle checkpoint, providing no rescue of the null mad3 phenotype.
Thus removal of the AE5 region seems to have rendered the Mad3p protein non¬
functional. This could be a result of removal of important functional domains of
Mad3p or may indicate the tertiary structure ofMad3p has been disrupted. The exact
effect of AE5 at the protein level was investigated further as described in chapter 5.
Overall these data indicate MAD3AE5 induces a benomyl sensitivity phenotype,
abrogates spindle checkpoint function and is associated with defective chromosome
segregation. These phenotypes are consistent with the hypothesis that AE5 induces
chromosomal instability and aneuploidy, phenotypes associated with colorectal
cancer. Thus these yeast functional assays support the role ofBUBR1AE5 in
colorectal tumourigenesis.
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4.3.6 BUB1AE5 is Associated with an Intermediate Chromosome Loss
Phenotype
Null bubl mutants are also associated with a very severe chromosome loss
phenotype in S.cerevisiae. The phenotype is much greater than that seen in mad3
mutants suggesting that bubl has a greater role in chromosome segregation. This
may be mediated through its role in the spindle checkpoint and/or through additional
mitotic roles.
The rates of chromosome loss in the bubl null mutants transformed with vector
alone and the full-length construct are comparable to those previously reported for
bubl null mutants and wild type strains (Warren et al., 2002). The numerical results
of the chromosome loss assays are shown in table 4.6 and 4.7. Photographic
representations of the sectoring phenotypes are shown in figure 4.12. The total loss
rates are displayed graphically in figure 4.13 with statistical analysis. The equivalent
results and analyses of individual repetitions are presented in appendix 11-13 at the
back of this thesis. As was found for the MAD3 assay, the loss rates of the vector
and full-length transformant populations significantly differ, indicating the power of
the assay (t = 23.181 p<0.0001). The loss rate of the BUB1AE5 transformant is
significantly increased compared to the full-length transformant indicative of a
spindle checkpoint defect (t = 17.692 p<0.0001). Additionally, this AE5 loss rate
significantly differs from that of vector alone (t =2.332 p=0.0198). This intermediate
phenotype of BUB1AE5 suggests it retains some function in chromosome
segregation, perhaps through the C terminal kinase domain of the protein. This is in
agreement with the initial benomyl sensitivity data described earlier. However, as no
convincing intermediate phenotype is seen in the liquid culture assay analysing
spindle checkpoint function, this intermediate loss rate may be achieved through
retention of a protein domain involved in chromosome segregation which is separate
from the spindle checkpoint functions ofBubl p.
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Table 4.6 BUB1 chromosome loss colony counts
The number of half sectored colonies as a proportion of non-red colonies for
each experiment is shown below. This also indicates the sample size for
each transformant.
These counts are combined to produce a total ratio ofhalf sectored colonies
to total non-red colonies for each strain and transformant. These loss rate
was calculated for these total counts and is presented in figure 4.13.
Experiment Proportion of half sectored colonies
bub 1 + bubl + bubl +
YCPLac22 VBUB1-AE5 pBL/Bl
A 64/2184 59/1346 10/4331
B 83/1660 90/4109 21/8208
C 62/2270 1 15/4465 2/7008
Total 209/6114 264/9920 33/19547
Table 4.7 BUB1 chromosome loss rates
Chromosome loss rates were calculated using the proportions listed in table 4.6 for
each experiment. The loss rates for each mutant using the total data is shown in
figure 4.13. The individual loss rates and statistical analyses of individual
experiments are presented in Appendix 12 and 13.
Experiment Chromosome loss rate per thousand divisions
bubl + bubl + bubl +
YCPLac22 pBUB1-AE5 pBUB1
A 29.304 43.834 2.309
B 50.00 21.903 2.558
C 27.313 25.756 0.285











Figure 4.12 BUB1 chromosome loss assay results
A high rate of chromosome loss is seen in the vector transformant which is rescued in the
full-length transformant. The deletion does not achieve this rescue indicating it harbours a
spindle checkpoint defect.






































Figure 4.13 BUB1 chromosome loss assay results
The graph illustrates the rate of chromosome loss in losses per thousand divisions.
The values shown represent an accumulation of three individual experiments,
results of individual repetitions and their statistical analyses are shown in the
appendix. The p values of the Mantel Haenszel analysis comparing pairs of
mutants (at 1 degree of freedom) are shown below the graph with statistically
significant values in red. This statistical test analyses data from all three
experiments.
AE5 shows an increased chromosome loss rate but this is less severe than the
vector alone, indicative of a partial defect in spindle checkpoint function.
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4.4 Discussion
The results presented in this chapter show that MAD3AE5 confers a benomyl
sensitivity phenotype associated with a spindle checkpoint defect in S.cerevisiae and
results in an increased rate of chromosome loss, indicative of a defect in
chromosome segregation. These phenotypes are equivalent in severity to those seen
in a null mad3 strain signifying a complete loss ofMad3p function by removal of the
AE5 region.
The MAD3AE5 mutation has thus been shown to produce a spindle checkpoint
defect and chromosomal instability in S.cerevisiae which has relevance to the
understanding of aneuploidy in colorectal tumours harbouring this mutation in BUB1
and BUBR1. It is hypothesised that these mutations abrogate the spindle checkpoint
in colorectal cells and invoke a chromosomal instability phenotype, accelerating the
accumulation of mutations required for tumourigenesis. This is supported by the
increased rate of chromosome loss seen in the MAD3AE5 S.cerevisiae mutants.
In addition, the benomyl sensitivity and checkpoint deficient phenotypes of the
AE5 mutants suggest they are able to bypass the spindle checkpoint despite errors in
chromosome attachment due to destruction of the microtubule spindle. This may
impart a growth advantage on the cells which may act as an accelerator of
tumourigenesis. This is supported by the increased growth rate exhibited by the
MAD3AE5 mutants in the microcolony assay. In yeast cells this checkpoint bypass
eventually leads to a reduced viability when challenged with microtubule poisons.
However, it is envisaged that in human cells a small population of cells may acquire
mutations in those genes which allow them to avoid this lethality such as those
involved in apoptosis for example. These could then be preferentially selected and
may continue to accumulate mutations at an accelerated rate to promote
carcinogenesis. Interestingly, the initial microcolony assay indicated that after 24-26
hours on benomyl containing media, the MAD3AE5 mutants exhibit 2-fold increased
mean numbers of cells per microcolony compared to the equivalent vector alone
transformants. Thus our hypothesis that the AE5 mutation fulfils both the mutation
and selection for growth advantage criteria important for tumourigenesis is supported
by these experiments in S.cerevisiae.
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These experiments also provide a useful insight into the role of Mad3p in the
yeast spindle checkpoint. The loss of function phenotype exhibited by MAD3AE5
can be attributed in part to the removal of the 66 amino acids by AE5, however the
remaining C terminal amino acids of Mad3p would be predicted to retain partial
protein function. Previous reports show there are two major functional protein
domains in Mad3p (CD1 and CD2) and mutation of either domain causes a benomyl
sensitivity phenotype (Elardwick et al., 2000). Removal of CD2 in a truncation
mutant also confers a spindle checkpoint defect as shown by microcolony assays,
indicating both domains are required for full checkpoint function (Hardwick et al.,
2000). CD2 function would not be expected to be affected by AE5 as it is situated
out with the area. However the results presented in this chapter disprove this
hypothesis, showing that spindle checkpoint function is abolished by removal of the
AE5 domain alone. Thus CD2 function seems to be dependent on CD1. This is
consistent with previous reports in which mutation of the GIGS domain in Mad3p to
four alanine residues (AAAA) produced a benomyl sensitivity phenotype equivalent
to that seen in a null strain (Hardwick et al., 2000). However, a CD2 mutant, E382K,
in which a conserved residue of CD2 is altered, shows a less severe benomyl
sensitivity phenotype than the null strain. Thus mutation of CD1 is sufficient to
nullify the protein function of Mad3p whereas mutation of CD2 is not. One
explanation for this phenomenon is that CD1 mediates the major spindle checkpoint
function of Mad3p and disruption of this domain abolishes checkpoint function,
whereas CD2 may be associated with a secondary Mad3p function and thus
checkpoint proficiency is only reduced when CD2 is mutated. Alternatively, the
structure of the Mad3p protein may be affected by the mutation of CD1 both in the
AAAA and the AE5 mutant. This may reduce protein stability and ultimately protein
concentration or may affect the tertiary structure of Mad3p, either of which could
manifest itself as protein dysfunction and spindle checkpoint abrogation. The nature
of AE5 on protein stability and the formation of protein-protein interactions has been
further investigated and will be described in Chapter 5.
Overall, these results suggest the area removed by AE5 is essential for spindle
checkpoint function and its removal is sufficient to destroy checkpoint function.
This destruction ofMad3p function produces a benomyl sensitivity phenotype and an
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elevated frequency of chromosome segregation defects, consistent with the
established role ofMad3p in the checkpoint. Thus the deletion of AE5 in Mad3p has
provided us with important insight into the role of this region and ultimately ofMad3
in the spindle checkpoint.
The BUB1AE5 mutant shows a similar phenotype to MAD3AE5 in S.cerevisiae.
BUB1AE5 shows severe benomyl sensitivity and chromosome loss phenotypes
associated with a spindle checkpoint defect. This is again consistent with the
hypothesis that the BUBR1AE5 and BUB1V400 mutations found in colorectal
cancers induce a chromosomal instability phenotype and accelerate tumourigenesis.
There is substantial evidence that aneuploidy is important in tumourigenesis
(Fischbach et al., 1991). The characterisation of S.cerevisiae BUB1AE5 has
relevance to the equivalent mutation in both human BUB1 and BUBR1, as BUBR1
shows homology to both yeast BUB1 and MAD3 and includes a C-terminal kinase
domain, similar to BUB1, which is absent in MAD3.
Previous studies with human cell lines containing the BUB1V400 mutation show
they have a compromised ability to arrest at mitosis, although the severity of this
defect is uncertain (Cahill et al., 1998; Tighe et al., 2001). This arrest is specifically
associated with aneuploid tumour cell lines and absent from diploid lines.
Exogenous over-expression of the wild type BUB1 protein restores this checkpoint
arrest indicative of a causative role of the BUB1V400 mutation in the generation of
aneuploidy (Cahill et al., 1998a). That the BUB1V400 mutation is important in
aneuploid tumourigenesis is supported by the functional analysis of BUB1AE5 in
S.cerevisiae reported here. These studies of BUB1V400 in the human cell system
and the similar mitotic checkpoint deficient and chromosomal instability phenotypes
seen in the equivalent yeast BUB1 and MAD3 mutants, further support the
pathogenic nature ofBUBR1AE5.
In addition to the obvious relevance of these results to tumourigenesis, they
provide important information about the yeast Bublp protein and its role in mitosis.
Like the MAD3AE5 mutant, BUB1AE5 shows similar phenotypes to the
corresponding null mutant indicative of abrogated checkpoint function and mitotic
defects. However, consistent with previous experiments, the phenotype in the BUB1
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mutant is more severe. This is thought to be due to additional functions for BUB1 in
the spindle checkpoint and mitosis.
Interestingly, the BUB1AE5 benomyl sensitivity and chromosome loss
phenotypes are intermediate in severity between the null and wild type strains,
suggesting AE5 does not destroy all of Bublp's function. However, there is no
evidence that the spindle checkpoint defect is anything less than a total abolishment.
This could be due to a limitation of the liquid culture assay or may suggest the
mitotic functions retained by BublAE5p are not spindle checkpoint associated. The
reduced severity of the benomyl sensitivity and defective chromosome segregation
phenotypes in AE5 compared to the null mutant may represent some function of
Bublp in kinetochore assembly or structure, which would contribute to these
phenotypes but would not be apparent in the liquid culture assay. This additional
function of Bublp may be mediated by the C-terminal kinase domain of the protein
which has previously been shown to be uninvolved in checkpoint function (Warren
et ah, 2002). This hypothesis is also supported by the null spindle checkpoint
phenotype seen in the MAD3AE5 mutant which lacks the C terminal kinase domain.
Additionally, previous studies of kinase domain truncation mutants show they exhibit
elevated chromosome loss rates but achieve spindle checkpoint arrest as efficiently
as wild type strains, consistent with a chromosome segregation role of Bublp's
kinase domain which is separable from its checkpoint function (Warren et ah, 2002).
Studies in fission yeast show some Bublp is retained at kinetochores until
cytokinesis, again indicating an additional role for Bublp after the metaphase to
anaphase transition (Bernard et ah, 1998).
However, the spindle checkpoint defect exhibited by bubl null and AE5 mutants
is far more severe than that seen in the respective mad3 mutants. Thus the greater
severity of the benomyl sensitivity and chromosome loss phenotypes of bubl
mutants are partly attributable to defects in Bublp's spindle checkpoint function.
This supports the greater role for Bublp in the spindle checkpoint than Mad3p, also
supported by previous studies of chromosome loss rates and spindle checkpoint
function in BUB and MAD mutants (Warren et ah, 2002).
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The differing severity of phenotype between MAD3AE5 and BUB1AE5 suggests
AE5 is having a different effect at the protein level in the two proteins. Thus the
ability of the mutant AE5 proteins to form spindle checkpoint protein complexes was
examined in order to clarify the mechanism through which AE5 affects spindle
checkpoint function. The results are discussed in the next chapter.
The AE5 and V400 mutations identified in colon cancer cells are heterozygous in
nature and may exert a dominant negative effect on the wild type protein. The
experiments so far have investigated the effect of the yeast mutation in strains
otherwise null for the protein. Thus in an attempt to clarify the dominant negative
nature of the AE5 proteins, the effect of pMTD5-AE5 and pBUB1-AE5 on
chromosome segregation and benomyl sensitivity was examined by transforming the
plasmids into wild type strains. This is also addressed in Chapter 5.
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Chapter 5: The AE5 Proteins are Defective in the Formation
of Spindle Checkpoint Protein Complexes
5.1 Introduction
The results presented in chapter 4 describe the affect of the AE5 mutations on
spindle checkpoint function. AE5 appears to abrogate the spindle checkpoint and
induce a chromosome mis-segregation phenotype. The severity of these defects
varies between the MAD3AE5 and BUB1AE5 mutants. In subsequent experiments I
wanted to investigate the underlying defect leading to this phenotype. One
hypothesis is that removal of the AE5 domain destabilises the Mad3p and Bublp
proteins and that the resulting reduced protein concentration impairs checkpoint
function. Alternatively, the removal of the AE5 domain may have disrupted specific
interactions between Mad3p and Bublp and other spindle checkpoint proteins which
are important for correct checkpoint function. The differing severity of the
BUB1AE5 and MAD3AE5 mutants suggest the underlying mechanism of checkpoint
disruption may be different in the two mutants.
Thus the experiments described in this chapter set out to investigate the effect of
the AE5 mutation on the formation of spindle checkpoint protein complexes.
Specifically, the affinity of the interactions of the AE5 proteins for Bub3p, Cdc20p,
Madlp and Mad2p were investigated. The effect of AE5 on protein phosphorylation
was also studied. Both BUB1 and BUBR1 proteins are known to be phosphorylated
upon spindle checkpoint activation (Chan et al., 1999; Chen, 2002; Taylor et al.,
1998) and Bublp is also shown to be phosphorylated in a budding yeast mitosis
(Brady and Hardwick, 2000). Inhibition of the phosphorylation ofBUBR1 by aurora
B kinase abrogates spindle checkpoint function and localisation of the spindle
checkpoint proteins (Ditchfield et al., 2003). The role of phosphorylation in the
checkpoint is discussed further in chapter 1. Thus we hypothesised that the AE5
proteins may be aberrantly phosphorylated and this may be responsible for the
defects in spindle checkpoint function exhibited by the AE5 mutants.
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The effect of AE5 at the protein level was investigated in three ways. Firstly the
mutant proteins expressed at wild type levels were visualised in yeast total cellular
extracts using standard polyacrylamide gel electrophoresis (PAGE) and western
blotting techniques. This aimed to verify that the mutant proteins were of the
predicted size and to examine the stability of the mutant proteins relative to their full-
length counterparts. The phosphorylation status of the mutant proteins was also
investigated using total cellular extracts.
To investigate the ability of the mutant proteins to form interactions with specific
checkpoint proteins; Bub3p, Cdc20p, Madlp and Mad2p additional co-
immunoprecipitation experiments were combined with PAGE and western blotting.
The affinity of these interactions relative to their full-length counterparts were
quantitated by a combination of densitometry and comparison of serially diluted
fractions. Over-expression constructs were used in these co-immunoprecipitation
experiments to investigate the formation of checkpoint complexes, as the expression
levels from the wild type promoters were difficult to visualise with the antibodies
available. For these experiments the methionine promoters were not induced but the
leaky nature of the system increased the concentration of the exogenously expressed
protein approximately 2-3 fold. Similar over-expression plasmids in which spindle
checkpoint proteins are expressed from a methionine repressible promoter have
previously been used to analyse the interactions of wild type spindle checkpoint
proteins (Warren et al., 2002). Strains in which checkpoint proteins were myc-
tagged were also used to assist in co-immunoprecipitation of Bub3p and Cdc20p for
which antibodies to the native proteins were unavailable.
Mad3p is known to form interactions with Bub3p and Cdc20p and these are
thought to be important for spindle checkpoint function (Hardwick et ah, 2000). The
interaction with Cdc20p is mediated by conserved domain 1 (CD1), part of which is
removed by AE5. Elowever, the second conserved domain, CD2 is thought to
mediate the interaction of Mad3p with Bub3p and the primary structure of this
domain is not altered in the AE5 mutant. Thus the hypothesis was that the ability to
interact with Cdc20p would be reduced in the Mad3AE5p protein but the interaction
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with Bub3p may be unaffected. In checkpoint arrested wild type strains, the Mad3p-
Cdc20p complex is also associated with Mad2p and thus the effect of the AE5
mutation on the formation of this Mad3p-Cdc20p-Mad2p complex which is thought
to be important for checkpoint function, was also investigated (Hardwick et al.,
2000). Mad2p has also been found to associate with a Mad3p and Bub3p complex
(Fraschini et al., 2001) and this was also investigated in the mutant.
The effect of AE5 on the interactions ofBublp was also analysed. The formation
of a Madlp-Bublp-Bub3p complex is important in spindle checkpoint function
(Brady and Hardwick, 2000) so the ability of BublAE5p to form these interactions
has been investigated. Other data has indicated that a truncating mutant containing
amino acids 1-210 does not co-immunoprecipitate with Bub3p whereas those
containing amino acids 1-367 and 1-608 do, suggesting amino acids 211-367 of
Bublp are important in the interaction with Bub3p (Warren et al., 2002).
Additionally the 1-608 truncation mutant is the only one to retain interaction with
Madlp suggesting amino acids 368-608 are involved in Madlp binding. The area
removed by AE5 includes neither of these domains suggesting these interactions
should be unperturbed. However, the results in chapter 4 demonstrate that
BUB1AE5 does induce a spindle checkpoint defect and, as disruption of the Madlp-
Bublp-Bub3p complex also abolishes spindle checkpoint function (Brady and
Hardwick, 2000), this suggests that this may be the underlying mechanism behind
BUB1AE5 spindle checkpoint inactivation. Bublp has also been shown to interact
with Cdc20p in a yeast 2-hybrid assay and in Mad3p the interaction with Cdc20p is
thought to be mediated by CD1 (Hardwick et al., 2000), a domain conserved in
Bublp and removed by AE5. Thus it was hypothesised that the ability of BublAE5p
to interact with Cdc20p would be compromised in the AE5 mutant protein and this
has also been investigated.
Finally, the methionine repressible over-expression constructs were induced in
chromosome loss assays to investigate the ability of the mutant proteins to interact
with Bub3p. Over-expression of Bublp and Mad3p by MET423 promoters have
previously been reported by Warren et al to induce chromosome loss phenotypes in
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wild type strains, due to sequestering of Bub3p from functional spindle checkpoint
complexes (Warren et al., 2002). This effect is seen with full-length constructs but is
absent when using the p423MET vector alone. Thus to investigate the efficiency of
Bub3p interaction with the AE5 proteins, the AE5 over-expression plasmids were
used in chromosome loss assays with full-length MET and p423MET vectors as
positive controls. The aim was to clarify the ability of the AE5 proteins to interact
with Bub3p and also to understand how the predicted dominant negative effect of the
equivalent human mutations may be mediated.
Previous investigation into over-expression phenotypes have aided identification
of specific amino acid domains which mediate interactions with Bub3p. Specifically,
N-terminal truncation mutants of Bublp (containing amino acids 1-211) do not
display an elevated chromosome loss rate, indicating this area does not interact with
Bub3p. The main area for Bub3p interaction was identified as amino acids 211-367
of Bublp consistent with the parallel co-immunoprecipitation studies (Warren et al.,
2002). The area removed by AE5 is amino acids 121-186 of Bublp and thus is
unlikely to be involved in Bub3p interaction. Hence over-expression of the AE5
protein from the p423MET plasmid would be predicted to induce a similar elevated
chromosome loss phenotype to that seen in the full-length plasmid, through
sequestering of Bub3p and spindle checkpoint disruption. However as described in
chapter 4 deletion of AE5 in Bublp both abolishes spindle checkpoint function and
induces a chromosome loss phenotype which may be mediated in part by abrogation
of the Bublp-Bub3p interaction.
The full-length Mad3p protein also induces a chromosome loss phenotype when
over-expressed due to sequestering of Bub3p. Two hybrid experiments indicate
amino acids 308-409 mediate the interaction between Mad3p and Bub3p. In
Mad3AE5p the area removed, amino acids 140-205, is again out with the area
predicted to interact with Bub3p (Hardwick et al., 2000). However, spindle
checkpoint function has been shown to be abolished in the S.cerevisiae MAD3AE5
mutant suggesting the Bub3 interaction may be affected. Thus the ability of over-
expressed Mad3AE5p and BublAE5p to interact with and sequester Bub3p were also
investigated in wild type strains. Again this is important in clarifying the effect of
the heterozygous BUBR1AE5 and BUB1V400 mutations in colorectal tumours.
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These over-expression experiments are particularly interesting as over-expression
of spindle checkpoint proteins is associated with certain cancers, and may act by
sequestering other spindle checkpoint proteins, preventing their usual spindle
checkpoint interactions important for function. Indeed over-expression of spindle
checkpoint proteins in S.cerevisiae induces a chromosome loss phenotype (Warren et
al., 2002). The expression level of the mutant AE5 protein in human tumours has not
yet been investigated but if over-expressed, sequestering of Bub3p by mutant Bublp
may be a factor in checkpoint deficiency. These experiments also have specific
relevance to the human mutations, BUB1V400 and BUBR1AE5, as both are
heterozygous and sequestering of Bub3p, preventing interaction with wild type
proteins may allow them to exert a dominant negative effect.
To further investigate the ability of the AE5 mutations to exert a dominant
negative effect wild type strains were transformed with the plasmids in which MAD3
and BUB1 were under the control of their wild type promoters. Chromosome loss
assays were again utilised to analyse the ability of the mutant protein to sequester the
wild type pool of Bub3p when expressed at twice the wild type concentration.
The combination of these experiments were essential to elucidate the mechanism
of checkpoint disruption by AE5 at the protein level and to clarify the dominant
negative manner of checkpoint disruption in human cells.
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5.2 Methodological Overview
5.2.1 Production of New Strains YLB1, 2 and 3
A number of new strains were essential for co-immunoprecipitation analyses to
analyse the interactions between Mad3p and Cdc20p and Bublp and Cdc20p. This
required strains containing myc-tagged Cdc20p as no anti-Cdc20p antibodies were
available and strains which were also deleted for Mad3p and Bublp, to ensure all the
protein detected was interacting with the exogenously expressed protein, allowing
the extracts from the full-length and AE5 transformants to be accurately compared.
New strains YLB1, YLB2 and YLB3 were created by mating of appropriate existing
strains as described in 2.7.9. YLB1 and YLB2 were both created from crosses
between KH304 and YRJ112. YLB3 was isolated from a cross between KH304 and
YRJ10. Zygotes were isolated from these crosses as described in 2.710 and tetrads
were dissected and selected from these as described in 2.7.11.
5.2.2 Lithium Acetate Transformations
Lithium acetate transformations were carried out as described in 2.7.6. A
summary of the transformations relevant to the work in this chapter are shown in
table 5.1 below.
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Table 5.1: Transformations for Analysis of Protein Interactions
Strain Strain Transformed Selective Experimental Use
properties plasmids media
YRJ111 mad3A pMAD3, URA, Preparation of total cellular extracts to
pMAD3-AE5 TRP examine protein expression, stability
YCPLac22 and modification by phosphorylation of
YRJ112 bublA pBUBl, URA, AE5 compared to the full-length
pBUBl-AE5 TRP protein.
YCPLac22
YKH231 Wild Type pMAD3, URA, In chromosome loss assays to assess




proteins when expressed at same level
as wild type protein.
YPH278 Wild Type pMET:MAD3, URA, In chromosome loss assays to analyse










HIS In co-immunoprecipitation experiments
to analyse interaction between Bublp
and Cdc20p
YLB2 Cdc20-myc, p423MET HIS In co-immunoprecipitation experiments
bublA pMET.BUBl,
pMET:BUBl-AE5
to analyse interaction between Bublp
and Cdc20p
KH238 Bub3-myc, p423MET HIS In co-immunoprecipitation experiments
bublA pMET.BUBl,
pMET-.BUBl-AE5
to analyse interaction between Bublp
and Bub3p
YLB3 Cdc20-myc, pMET:MAD3, HIS In co-immunoprecipitation experiments
mad3A pMET:MAD3-AE5
p423MET
to analyse interaction between Mad3p
and Cdc20p
YRJ10 Bub3-myc, pMET:MAD3, HIS In co-immunoprecipitation experiments
mad3A pMET:MAD3-AE5
p423MET
to analyse interaction between Mad3p,
Bub3p and Mad2p.
MB003 bub3A pBUBl HIS In phosphorylation analysis
Positive transformants were streaked onto fresh selective plates before use in the
following assays.
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5.2.3 Preparation of Total Cell Extracts
Total cellular extracts were prepared as described in 2.8.1 and analysed by PAGE
as described below.
5.2.4 SDS Polyacrylamide Gel Electrophoresis (PAGE)
The total cellular extracts and protein fractions from the co-immunoprecipitation
experiments were loaded onto polyacrylamide gels and the proteins were separated
by electrophoresis as described in 2.8.3. Large 10% gels were used to analyse Bublp
fractions as the full-length protein is approximately 120kDa and smaller 12.5% or
15% gels were used for Mad3p analysis as Mad3p is approximately 60kDa in size.
5.2.5 Western Blotting
The proteins were transferred to nitrocellulose membrane as described in 2.8.4
and probed with the appropriate antibodies as listed in table 2.9. 0.5M NaCl was
added to blots probed with anti-Bublp and anti-Madlp antibodies to reduce the
amount ofnon-specific background binding.
5.2.6 Enhanced Chemiluminescence (Delhommeau et al., 2002)
Protein bands were visualised by ECL as described in 2.8.5. The protein bands
were quantitated by densitometry using Biorad quantity one software and by
comparison of diluted fractions.
5.2.7 Lambda protein Phosphatase Treatment
Protein samples showing modification in western blot analyses were treated with
lambda protein phosphatase and analysed by western blot analysis to confirm that
any additional bands were due to protein phosphorylation, as described in 2.8.7.
5.2.8 Co-immunoprecipitation
Protein interactions were analysed by co-immunoprecipitation experiments as
described in 2.8.2. For analysis of Bublp interactions, extracts from strains
containing myc tagged Bub3p or Cdc20p (YLB1, YLB2, KH238) transformed with
the BUB1 over-expression constructs were incubated with protein A Sepharose
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beads and anti-Bublp 12/99 antibody. Bublp (~118kDa) was then detected by
western blotting and probing with anti-Bublp G antibody, myc-Bub3p (~78 kDa)
using anti-myc 9E10 antibody and Madlp (~90kDa) using either anti-Madlp R or S
as described in 2.8.3-2.8.5. Mad3p interactions were similarly analysed by
incubating cell lysates from myc-tagged Bub3p or Cdc20p strains (YLB3 and
YRJ10) transformed with the MAD3 over-expression constructs with c-myc 9E10
antibody coupled beads. Western blots were then probed with anti-Mad3p GG to
detect Mad3p (~58kDa), anti-Mad2p to detect Mad2p (~36kDa) or anti-MYC A14
antibody to detect myc-Bub3p or myc-Cdc20p (~180kDa).
The relative amounts of protein co-immunoprecipitated from the AE5 and full-
length cellular extracts were quantitated using a combination of densitometry
methods and comparing serial dilutions of fractions.
5.2.9 Chromosome Loss Assays
Chromosome loss assays were performed on KH231 transformants and KH278
over-expression transformants as described in 2.7.15. Overnight cultures were
prepared in minimal media lacking appropriate selection as listed in table 5.1.
Cultures were diluted and grown in YPD and plated onto indicator plates. The
indicator plates used for the over-expression experiments lacked methionine to
induce expression from the met423 promoter.
5.2.10 Benomyl Sensitivity Assays
Benomyl sensitivity experiments were carried out in parallel with the
chromosome loss experiments as described in 2.7.12.
5.2.11 Preparation of Cultures for Protein Analysis
Transformants were grown overnight in selective media as described in 2.7.4.
These cultures were either used directly for preparation of total cellular extracts or
were diluted in YPDA and used in preparation of G2/M nocodazole arrested cultures
as described in 2.7.7 or S-phase arrested cultures as described in 2.7.8. These




5.3.1 pMAD3-AE5 and pBUB1-AE5 Produce Proteins of Appropriate
Size which are as Stable as their Full-length Counterparts
The vectors in which MAD3 and BUB1 were under control of their wild type
promoters were transformed into mad3 and bubl null strains respectively. The
transformants were cultured to mid-log phase and total cellular extracts were
prepared from the cultures. These were analysed for the presence of the Mad3p and
Bublp proteins by western blot analysis. Figure 5.1 shows proteins are produced
from the MAD3 and BUB1 containing vectors and that the proteins produced by the
AE5 constructs are approximately 7.3kDa smaller than those produced by the full-
length constructs. The stability of the AE5 and full-length proteins is approximately
equal suggesting the spindle checkpoint and segregation defects reported are not
attributable to a reduction in the stability of the AE5 proteins.
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Figure 5.1 AE5 proteins are as stable as the full-length proteins
The proteins expressed by vectors YCPLac22, pMAD3 and pMAD3-AE5 in a null mad3 strain and
the YCPLac22, pBUBl and pBUBlAE5 transformants in a null bubl strain. The proteins expressed
by the AE5 constructs are approximately 7.3kilo daltons smaller than the full-length proteins due to
the deletion of the 66amino acids. The additional bands shown in the vector lanes are additional
non-specific antibody bands. The figure also shows that the stability of the AE5 and full-length
proteins are approximately equal and therefore a reduction in stability is unlikely to be responsible
for the checkpoint defective phenotypes described in chapter 4.
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5.3.2 The Mad3AE5p Protein has a Reduced Affinity for Other Spindle
Checkpoint Proteins Compared to the Full-length Protein
Co-immunoprecipitation experiments were used to determine the effects of the
AE5 deletion on the interaction of Mad3p with Bub3p and Mad2p and also on the
interaction between Mad3p and Cdc20p.
Strains null for mad3 containing myc-tagged Bub3p were transformed with the
over-expression constructs pMAD3, pMAD3-AE5 and p423MET. The resulting
transformants were cultured to mid-log phase. These cultures were
immunoprecipitated with anti-myc conjugated beads and resulting extracts were
analysed for Mad3p, myc-tagged Bub3p and Mad2p. Three controls were used; the
p423MET transformant and a mad2 deletion strain acted as controls against non¬
specific bands in the western blot analysis, and a wild type strain in which Bub3p
was not myc-tagged transformed with pMAD3 ensured no non-specific complexes
were immunoprecipitated.
Representative results of these co-immunoprecipitation experiments are shown in
figure 5.2. The co-immunoprecipitation was repeated three times on fresh cultures
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Figure 5.2 Mad3AE5p forms reduced interactions with Bub3p
and the amount of Mad2p in this complex is also reduced
An equivalent amount of protein is expressed from pMET:MAD3 and pMET:MAD3-AE5,
supporting the previous evidence of their similar stability. However, the amount ofMad3p which
immunoprecipitates with myc-tagged Bub3p, as indicated by the bead fraction, is slightly reduced
in the AE5 mutant suggesting a reduction in the Bub3p binding activity ofMad3AE5p. Consistent
with this, the amount ofMad3AE5p in the supernatant fraction is slightly raised compared to the
amount of full-length Mad3p.
The amount ofMad2p immunoprecipitated by myc-tagged Bub3p is also reduced in the AE5
mutant. Similarly Mad2p does not immunoprecipitate with Bub3p in the mad3 null strain
transformed with vector alone, suggesting a trimer complex of Bub3p, Mad3p and Mad2p is formed
in yeast and Mad3p is essential for the interaction between Bub3p and Mad2p in this complex. The
AE5 deletion appears to reduce formation of this checkpoint complex.
The mad2 null strain and non-myc wild type strain transformed with full-length pMAD3 act as
controls.
200
The results show the interaction between Mad3AE5p and Bub3p is reduced by
approximately 35% compared to the full-length protein as determined by
densitometry and serial dilution of three repetitions.
The amount ofMad2p associated with this Mad3p-Bub3p complex is also reduced
in the AE5 mutant by approximately 75%. This may be a direct result of the
reduction in the amount ofMad3p associated with Bub3p or may be due to deletion
of the AE5 region disrupting a direct interaction between Mad3p and Mad2p. Bub3p
does not immunoprecipitate Mad2p in the mad3 null strain transformed with vector
alone suggesting Mad3p is required for the interaction between Bub3p and Mad2p.
This may be due to a direct interaction between Mad3p and Mad2p which recruits
Mad2p to the Mad3p-Bub3p complex. Alternatively, the interaction between Mad3p
and Bub3p may induce a conformational change in the complex inducing its
interaction with Mad2p. The removal of the AE5 region disrupts this interaction
between Mad2p and the Mad3p-Bub3p complex, this could be achieved through a
reduced ability of Mad3p to bind Mad2p or may be a down stream effect of the
reduced interaction between Mad3p and Bub3p.
In addition the ability of Mad3p to interact with Cdc20p was investigated by co-
immunoprecipitation experiments. This required production of a mad3 deletion myc-
tagged Cdc20p strain into which the three over-expression constructs were
transformed. Nocodazole arrested cultures of the transformants were prepared and
these were again immunoprecipitated using anti-myc conjugated beads. The
resulting fractions were analysed for the presence of Mad3p and Cdc20p by western
blotting. Again a wild type strain in which Cdc20p was not myc-tagged ensured the
proteins pulled down were the result of specific interactions, and the mad3 null strain
transformed with the p423MET vector alone ensured anti-Mad3p antibody
specificity. The results of this analysis are shown in figure 5.3. The mean
densitometry of the three repetitions show the interaction between Mad3AE5p and
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Figure 5.3 Mad3AE5p forms reduced interactions with Cdc20p
Similar amounts of the AE5 and full-length Mad3p proteins are isolated from total cellular extracts.
However, the amount ofMad3p which immunoprecipitates with myc-tagged Cdc20p is slightly
reduced (in bead fraction) in the AE5 mutant indicative of a reduction in the Cdc20p binding
activity ofMad3AE5p.
The amount ofMad2p immunoprecipitated by myc-tagged Cdc20p is not reduced in the vector
transformant suggesting Mad3p does not directly interact with Mad2p and that it is not required for
an interaction between Mad2p and Cdc20p. Consistent with this hypothesis, the amount ofMad2p
interacting with Cdc20p is unaffected by Mad3AE5p.
The non-myc wild type strain transformed with full-length pMET:MAD3 is included as a control.
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Mad2p is also associated with the Mad3p-Cdc20p complex and Mad2p is
immunoprecipitated with Cdc20p in the mad3 null mutant transformed with vector
alone suggesting the Cdc20p-Mad2p complex is not dependent on Mad3p. The
amount of Mad2p associated with Cdc20p is unaffected by Mad3AE5p, consistent
with the independence of the Mad2p-Cdc20p interaction and suggests Mad2p does
not interact with Mad3p directly in this complex.
This has relevance to the nature of the Mad3p-Mad2p interaction in the Mad3p-
Bub3p-Mad2p complex. The hypothesis that the interaction between Mad3p and
Bub3p recruits Mad2p to the complex, perhaps through a conformational change is
supported by studies of the interaction between Mad3p, Cdc20p and Mad2p. Mad2p
is immunoprecipitated with Cdc20p even in a mad.3 null strain transformed with
vector alone, suggesting the interaction between Mad3p and Mad2p is not a direct
one. However, if the reduced interaction between Mad2p and Bub3p is a result of
the reduced interaction between Bub3p and Mad3p in the AE5 mutant, we might
expect these interactions to be reduced by similar amounts. This phenomenon is not
observed as the 35% reduced interaction between Bub3p and Mad3p corresponds to
a 75% reduced interaction between Bub3p and Mad2p. However, this may be due to
in part to a dimeric form ofMad2p associated with the complex. Thus perhaps both
a reduced interaction between Mad3p and Bub3p and disruption of a direct
interaction between Mad3p and Mad2p contribute to the loss ofMad2p in the Bub3p-
Mad3p-Mad2p complex in the AE5 mutant.
In addition this suggests the reduced association between Bub3p and Mad2p seen
in the Mad3AE5 mutant (figure 5.2) is not due to an effect on a direct interaction
between Mad2p and Mad3p by AE5. It may in fact be a result of the reduced
interaction between Bub3p and Mad3p in the AE5 mutant.
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5.3.3 The Interaction Between Bublp and Bub3p is Reduced in the
BUB1AE5 Mutant
A null bubl strain containing myc-tagged Bub3p was used to compare the
interaction between the AE5 and full-length Bublp proteins with Bub3p using co-
immunoprecipitation experiments. This strain was transformed with the over-
expression vectors pMET:BUBl and pMET:BUBl-AE5, and p423MET as a control
to ensure detection by the anti-Bublp antibody is specific. Again a wild type strain
transformed with pMET:BUBl ensured the co-immunoprecipitation specifically
pulled down myc-tagged complexes. The results of these co-immunoprecipitation
experiments are shown in figure 5.4 and indicate that the interaction between
BublAE5p and Bub3p is reduced by approximately 60% when compared with the
full-length protein and Bub3p. This was observed in three independent experiments,
the quantitation includes densitometry results from the three repetitions and
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Figure 5.4 Bub1AE5p forms reduced interactions with Bub3p
An equivalent amount of protein is observed in the total cellular extracts isolated from both the AE5
and full-length transformants supporting the equivalent stability of the wild type and mutant
proteins. However, the amount ofmyc-tagged Bub3p which immunoprecipitates with Bublp in the
bead fraction is reduced by 60% in the AE5 mutant indicative of a reduction in the Bub3p binding
activity of Bubl AE5p compared to the full-length protein. Consistent with this, the amount ofmyc-
Bub3p in the AE5 supernatant fraction is slightly raised compared to the full-length fraction.
The vector transformant and non-myc wild type strain transformed with full-length pMET:BUB1
and pMET:BUBl-AE5 act as controls.
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The interaction between Bublp and Madlp was also investigated in the AE5
mutant. However, despite numerous attempts, co-immunoprecipitation of Madlp
with anti-Bub lp antibodies and vice versa was unsuccessful and so the effect of AE5
on this interaction is uncertain. However, previous studies indicate Bub3p-Bublp
and Madlp form a trimer complex and so abrogation of the interaction between
Bublp and Bub3p by AE5 is likely to affect the function of the Bub3p-Bublp-Madlp
signalling complex and hence spindle checkpoint function.
A null bubl strain containing myc-tagged Cdc20p was constructed in order to
investigate the interaction between Bublp and Cdc20p in the AE5 mutant but
unfortunately technical difficulties and time constraints prevented completion of this
analysis. Some initial immunoprecipitations from nocodazole arrested cultures
showed the interaction between Bublp and Cdc20p to be reduced in AE5 using a
wild type strain with myc-tagged Cdc20p as shown in figure 5.5. However, the
absence of non-myc controls for this experiment made it difficult to draw firm
conclusions from the data. The relevance of such a Bublp-Cdc20p complex in a
normal cell cycle is unclear as it has only been detected when Bublp is over-

















































































bubl/Cdc20-myc+ p423MET pMET:BUB1-AE5 pMET:BUBl
Figure 5.5 Initial data suggest Bub1AE5p may form reduced
interactions with Cdc20p
A roughly equivalent amount of protein is observed in the total cellular extracts isolated from both
the AE5 and full-length transformants. However, the amount ofBublp which immunoprecipitates
with myc-tagged Cdc20p is reduced in the AE5 mutant indicative of a reduction in the Cdc20p
binding activity ofBubl AE5p compared to the full-length protein. Consistent with this, the amount
ofBublp in the AE5 supernatant fraction is raised compared to the full-length fraction.
These are very preliminary results with limitations as they were not performed in a bubl null strain,
nor were non-myc controls included to check for the stickiness of the beads nor the amount ofmyc-
Cdc20 analysed by western blotting to standardise amount of beads added.
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5.3.4 Bub1AE5p is Aberrantly Phosphorylated
Western blot analysis of total cellular extracts from pBUB1 and pBUBl-AE5
transformants showed they are extensively modified, producing at least 5 protein
bands, one of which may be a doublet. This is shown in figure 5.6A and can also be
seen in many of the other figures. Treatment of the extracts with lambda protein
phosphatase removes these bands indicating the modification is due to the
phosphorylation of Bublp. The phosphorylation of BublAE5p is also altered
compared to the full-length protein. While each of the individual bands appear to be
present in BublAE5p, the relative intensities of the bands are altered. Thus it is
unlikely that the phosphorylated residues are situated within the region deleted by
AE5 as this would be predicted to result in fewer modified forms and less bands on
the protein gel. Thus I hypothesised that the reduced interaction between Bublp and
Bub3p in the AE5 mutant may be responsible for the aberrant phosphorylation.
To address this hypothesis the full-length BUB1 construct, pBUB1, was
transformed into a null bub3 strain and the phosphorylation was analysed by western
blotting analysis. The results shown in figure 5.6B indicate Bublp was heavily
phosphorylated in the bub3A strain and did not show the alternate pattern seen in the
BublAE5p mutant. Thus we concluded that the aberrant phosphorylation of
BublAE5p does not seem to be a result of it's reduced affinity for Bub3p and that
Bublp phosphorylation is not Bub3p dependent. The altered phosphorylation pattern
appears to be an independent effect of AE5, perhaps due to disruption of other




























Figure 5.6 Bub1AE5p is aberrantly phosphorylated
A) Bublp is heavily modified and this modification is reduced and altered in the AE5 mutant.
The most heavily modified and slowly migrating bands are reduced in intensity relative to
the other bands in Bubl AE5p compared to the full-length protein. This modification is
removed upon treatment with phosphatase confirming it is a phosphorylation effect.
B) The phosphorylation of the full-length Bublp protein is not altered in a bub3 mutant strain.
Thus the aberrant phosphorylation effect seen in BublAE5p is not a result of it's reduced
interaction with Bub3p.
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5.3.5 Mad3AE5 Confers a Mild Chromosome Loss Phenotype when
Over-expressed
To further investigate the ability of BublAE5p to interact with Bub3p and to
observe whether it acts in a dominant negative fashion Wild type strains were
transformed with the over-expression constructs pMET:MAD3, pMET:MAD3-AE5
and p423MET. The transformants were analysed using benomyl sensitivity and
chromosome loss assays for checkpoint dysfunction and chromosome mis-
segregation.
Benomyl sensitivity assays were unsuccessful, with the full-length control
transformants showing no noticeable increased sensitivity to microtubule poisons
than the wild type strain transformed with vector alone. This is thought to be due to
technical difficulties in producing low methionine media to induce protein over-
expression from the plasmids, which also contains benomyl.
The total results of the chromosome loss experiments are presented in tables 5.2
and 5.3 and presented graphically in figure 5.7. As previously reported an increased
rate of chromosome loss was observed when full-length Mad3p was over-expressed
compared to that seen in the vector transformant. This has previously been attributed
to the ability of Mad3p to interact with and sequester Bub3p exerting a dominant
negative effect (Warren et al., 2002). This increased loss was seen in two
experimental repetitions and analysis showed this increased loss to be statistically
significant (t = 4.806 p<0.0001). A similar increased chromosome loss phenotype
was seen in the pMET:MAD3-AE5 transformant suggesting Mad3AE5p is both able
to bind Bub3p and to exert a dominant negative phenotype through retention of this
binding. This loss phenotype is significantly elevated over the vector transformant (t
= 3.831 p = 0.0002) but does not significantly differ from that seen in the full-length
transformant (t = 1.160 p = 0.246). Thus there is no evidence from these assays that
loss ofBub3p binding by Mad3AE5p is responsible for the spindle checkpoint defect
and chromosome mis-segregation phenotype exhibited by MAD3AE5 mutants.
In addition, the ability ofMad3AE5p to interact with Bub3p may allow it to exert
dominant negative effects when heterozygous in colorectal tumour cells. Such a
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dominant negative phenotype has been observed in the colorectal tumour cell lines
harbouring the equivalent BUB1 mutation V400 (Cahill et al., 1998).
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Table 5.2 MAD3 over-expression chromosome loss assay
The number of half-sectored colonies observed in the MAD3 over-expression chromosome
loss assay are listed below as a proportion of total non-red colonies. The results of two
experimental repetitions are listed as well as the total of the two experiments
Experiment Proportion of half sectored colonies
WT+ WT+ WT+
p423MET pMET.MAD3-AE5 pMET.MAD3
A 3/7144 34/14603 19/6393
B 1/9562 5/5967 10/7567
Total 4/16706 39/20570 29/13960
Table 5.3 MAD3 over-expression chromosome loss assay
The rates of chromosome loss observed when mutant and full-length Mad3p are over-
expressed in a wild type strain are shown below. The table shows results from two
experimental repetitions and the total loss rate for these two experiments which is presented
graphically in figure 5.7.
Experiment Chromosome loss rate per thousand divisions
WT+ WT+ WT+
p423MET pMET.MAD3-AE5 MET:\1A1)3
A 0.420 2.328 2.972
B 0.105 0.838 1.322
Total 0.239 1.896 2.077
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Figure 5.7 Over-expression of Mad3AE5p causes a
chromosome loss phenotype
The graph above shows the chromosome loss rates observed when the over-
expression constructs were expressed in a wild type strain. The p values resulting
from Mantel Haenszel statistical analysis of the data from three experimental
repetitions are shown below the graph with statistically significant values in red.
Results of individual experimental repetitions and their individual analysis using chi-
squared are presented in appendix 14.
The Mad3AE5p protein causes a chromosome loss phenotype similar to the full-
length protein when over-expressed suggesting it is able to interact with Bub3p and
exert dominant negative effects.
213
5.3.6 Over-expression of Bub1AE5 is Associated with an Intermediate
Chromosome Loss Phenotype
The equivalent experiments were also used to analyse the ability of BublAE5p to
interact with Bub3p and cause a dominant negative phenotype. The over-expression
plasmids pMET:BUB1, pMET:BUBl-AE5 and p423MET were transformed into wild
type chromosome loss strains and transformants were used in benomyl sensitivity
and chromosome loss assays. As in the MAD3 experiments, the benomyl sensitivity
assays were unsuccessful with full-length and vector controls showing no difference
in benomyl sensitivity. The total results of two repetitions of the chromosome loss
experiments are shown in tables 5.4 and 5.5 and presented graphically in figure 5.8.
Again over-expression of the full-length Bublp protein produced an elevated rate of
chromosome loss compared to the vector transformant (t = 4.750 p < 0.0001).
However, a great deal of variation was observed in the loss rate of the full-length
transformant. The results of the individual repetitions are shown in Appendix 15 and
indicate the rate of loss in the full-length transformant is increased relative to the
vector in both repetitions. The rate of chromosome loss observed in the BUB1AE5
mutant is also elevated compared to the vector alone (t = 3.083, p = 0.0024) but is
intermediate between that and the full-length transformant from which it also
significantly differs (t = 2.907 p = 0.0018). This is indicative of a reduced
BublAE5p interaction with Bub3p. Thus, consistent with the previous data,
BublAE5p seems to retain partial function but its interaction with Bub3p is
compromised and may be causing a spindle checkpoint defect and chromosome
segregation phenotype.
In addition there is substantial evidence from both the co-immunoprecipitation
studies and the over-expression chromosome loss studies that while the interaction
between BublAE5p and Bub3p is compromised, it is not entirely abolished. This is
consistent with the dominant negative effect of BUB1AE5 as previously reported for
the human V400 mutation in colorectal tumour cells (Cahill et al., 1996).
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Table 5.4 BUB1 over-expression chromosome loss assay
The number of half-sectored colonies observed in the BUB1 over-expression chromosome
loss assay are listed below as a proportion of total non-red colonies. The results of two
experimental repetitions are listed as well as the total of the two experiments.
Experiment Proportion of half sectored colonies
WT+ WT+ WT+
p423MET pMET:BUB1-AE5 pMET.BUBl
A 3/7144 11/13238 32/9815
B 1/9562 8/4760 12/13064
Total 4/16706 19/17998 44/22879
Table 5.5 BUB1 over-expression chromosome loss assay
The rates of chromosome loss observed when mutant and full-length Bublp are over-
expressed in a wild type strain are shown below. The table shows results from two
experimental repetitions and the total of these two experiments. The total data are presented
graphically in figure 5.7.
Loss rates from individual experiments and their chi-squared statistical analysis are
presented in Appendix 15.
Experiment Chromosome loss rate per thousand divisions
WT+ WT+ WT+
p423MET pMET:BUBl-AE5 pMET.BUBl
A 0.420 0.831 3.260
B 0.105 1.681 0.919
Total 0.239 1.056 1.923
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Figure 5.8 Over-expression of Bub1AE5p causes a
chromosome loss phenotype
The graph above shows the total chromosome loss rates observed in two experiments
when the over-expression constructs were expressed in a wild type strain. The data
from the two individual data sets was analysed using Mantel Haenszel statistical
analysis and the p values resulting from this are shown below the graph with
statistically significant values in red.
The Bubl AE5p protein causes a chromosome loss phenotype similar to the full-
length protein when over-expressed suggesting it is able to interact with Bub3p and
exert dominant negative effects.
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5.3.7 Mad3AE5 and Bub1AE5 Exert Mild Dominant Negative Effects
Next I wished to further investigate any dominant negative effects of the AE5
proteins. For this purpose the constructs in which BUB1 and MAD3 were under the
control of their wild type promoters were transformed into a wild type strain and
tested for benomyl sensitivity and chromosome loss phenotypes. These experiments
were designed to partially mimic the heterozygous nature of the human mutations, as
both full-length and mutant protein were present in the cell.
Unfortunately the results of the benomyl sensitivity assays were inconclusive and
the sensitivities of the three populations could not be distinguished qualitatively.
This could be due to the subtle nature of the phenotypes observed even in the full-
length transformants and also previously discussed technical difficulties in observing
these phenotypes. However, some conclusions can be drawn from the results of the
chromosome loss studies, although it should be noted that due to time constraints
these experiments were performed only once. Statistical analyses of these
experiments used Chi-squared analysis due to the single repetition.
The results of the MAD3 studies are shown in figure 5.9 and indicate that a mild
dominant negative phenotype is seen in the full-length transformant which
significantly differs from that seen in the vector transformant (x2 = 9.770,p =
0.00177). This phenotype is thought to be due to a similar, but less severe,
sequestering of Bub3p by Mad3p to that seen in the over-expression studies and
indicates that dominant negative phenotypes can occur even when Mad3p is
expressed only 2-fold. The AE5 transformant also shows an elevated chromosome
loss phenotype compared to the vector transformant (x2 = 5.590, p = 0.0181,
significant at the 2% confidence interval) and indistinguishable from the full-length
phenotype (x2 = 0.915, p = 0.339) suggesting it can also exert a dominant negative
effect. These results are consistent with the conclusions drawn from the over-
expression experiments that Mad3AE5p retains a large proportion of Bub3p binding.
The results of similar expression of the BUB1 constructs are shown in figure 5.10.
The full-length transformant produces a significant chromosome loss phenotype (x2
= 5.908, p = 0.0151) indicative of a dominant negative effect. The AE5 transformant
shows a much milder chromosome loss phenotype which does not significantly differ
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from the vector transformant (%2 = 0.661, p = 0.416) but is different to the full-length
transformant (%2 = 3.649, p = 0.0561 significant only at 6% confidence interval),
consistent with its greater reduced ability to interact with Bub3p. Thus it appears
that if BublAE5p does exert a dominant negative effect, it is a very mild one and
cannot be detected at 2-fold over-expression in S.cerevisiae.
This assay does however have limitations as it is actually performed in a haploid
environment which is not truly representative of diploid tumour cells. The strains
contain only haploid amounts of the spindle checkpoint proteins other than those
transformed in on the extrinsic plasmids, which may affect the protein interactions
and dominant negative effects displayed.
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Figure 5.9 Expression of Mad3AE5p in a wild type strain causes a
chromosome loss phenotype
The graph above shows the chromosome loss rates observed when the MAD3 constructs under
the control of their wild type promoters were expressed in a wild type strain. The number of
half sectored colonies as a proportion of total colony number are shown for each transformant
population and p values resulting from statistical analysis of the counts are shown below the
graph. The Mad3AE5p protein causes a chromosome loss phenotype similar to the full-length
protein consistent with over-expression studies and suggesting it is able to exert a dominant
negative effect.
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Figure 5.10 Expression of Bub1AE5p in a wild type strain does not
cause a chromosome loss phenotype
The graph above shows the chromosome loss rates observed when the BUB1 constructs under
the control of their wild type promoters were expressed in a wild type strain. The number of
half sectored colonies as a proportion of total colony number are shown for each transformant
population and p values resulting from statistical analysis of the counts are shown below the
graph. The BublAE5p protein causes an intermediate chromosome loss phenotype suggesting
it does not exert a dominant negative effect.
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5.4 Discussion
The aim of this work was to assess the underlying cause of the checkpoint and
mis-segregation defects associated with the AE5 mutations at the protein level. The
results presented demonstrate that Mad3AE5p and BublAE5p proteins are as stable
as the full-length proteins both at wild type and over-expression levels. Thus the
defects in the AE5 mutants do not appear to be due to altered concentration of the
deleted Mad3p or Bublp proteins. Further investigation showed that Mad3AE5p has
a reduced affinity for Cdc20p and Bub3p and the amount of Mad2p in a Mad3p-
Bub3p-Mad2p complex is also reduced in the AE5 mutant. The BublAE5p protein
forms interactions with Bub3p with a reduced affinity and is aberrantly
phosphorylated compared to the full-length protein. Thus it appears that a reduction
in specific protein complexes, known to be important in spindle checkpoint function,
and altered protein modifications are responsible for the phenotypes observed in the
MAD3AE5 and BUB1AE5 mutants.
The area removed by AE5 is predicted to mediate interactions with Cdc20p. This
interaction between Mad3p and Cdc20p is disrupted in the AE5 mutant and there is
initial evidence of its disruption in the BublAE5p protein but this requires further
clarification using a bublA CDC20-myc strain. The Bublp-Cdc20p interaction has
previously only been observed when Bublp is over-expressed in a 2-hybrid system
in vitro or in the absence ofMad3p, so the significance of this observed interaction in
vivo is not clear (Elardwick et al., 2000).
The ability of the Bublp and Mad3p proteins to interact with Bub3p is also altered
in the AE5 mutants. This would not be expected from the amino acid sequence
removed by AE5, as the domain predicted to interact with Bub3p remains intact.
This suggests that there may be additional Bub3p interaction domains towards the N-
terminals of the proteins. Alternatively, the removal of the E5 region may alter the
tertiary structure of the Mad3p and Bublp proteins and affect their ability to interact
with Bub3p, although in both cases there is a reduction rather than an abolishment of
interaction.
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With respect to defective formation of the Bublp-Bub3p complex, this is
predicted to prevent formation of the Madlp-Bublp-Bub3p signalling complex,
thought to be essential for effector complex formation and inhibition of the APC/C
and chromosome segregation. This in turn could cause defects in chromosome
segregation and loss effects if defective chromosome attachment is not detected and
metaphase to anaphase transition continues. Defects in Cdc20p, Mad2p and Bub3p
binding by Mad3p would be predicted to affect formation of the APC/C inhibitor
complex causing spindle checkpoint and chromosome segregation defects through a
similar mechanism.
The phosphorylation of Bublp is reduced and altered in the AE5 mutant but
Mad3p is normally phosphorylated. The significance of phosphorylation in the
spindle checkpoint is not clear but both Mad3p and Bublp are phosphorylated during
mitosis. The aberrant phosphorylation of Bublp is unlikely to be due to deletion of
specific phosphorylated amino acids, as modified bands of equivalent sizes are
observed in both the AE5 and full-length proteins. This effect is not related to the
reduced interaction with Bub3p. The Bub3p protein kinase is thought to be involved
in phosphorylation of Bublp, however, over-expressed full-length Bublp in a null
bub3 strain does not show the aberrant phosphorylation effect shown in the AE5
protein, suggesting the reduced Bublp-Bub3p interaction is not causative of the
aberrant phosphorylation effect. However, the reduced interaction between Bublp
and Bub3p may be a function of the reduced Bublp phosphorylation. This could be
further investigated using known bubl mutants which form defective interactions
with Bub3p, such as bubl-1. I attempted to investigate the phosphorylation of
Bublp in these bubl-1 mutants but the endogenous Bublp protein in total cell
extracts from the bubl-1 strain could not be detected with current antibodies. Thus
in order to confirm whether other Bublp mutant proteins, with reduced Bub3p
interactions, are also associated with aberrant phosphorylation, cloning of the
mutants such as bubl-1 into over-expression constructs would be required, or the
development of more sensitive antibodies. These experiments were not within the
scope of this thesis. A further possibility is that the aberrant phosphorylation of
Bublp is actually a result of its inability to arrest at the spindle checkpoint and the
proportion of cells in each of the stages of the cell cycle and thus the extent of cell
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cycle stage specific Bublp phosphorylation may be altered in BublAE5. This is not
consistent with our results which exhibit extensive phosphorylation of full-length
Bublp observed in extracts both in the presence of and the absence of nocodazole
arrest.
Therefore it is likely that reduction in the protein interactions and/or in Bublp
phosphorylation contribute to the spindle checkpoint and chromosome segregation
defects exhibited by the AE5 mutants. These protein alterations may be directly due
to the AE5 deletion or may all be a result of aberrant kinetochore localisation of the
proteins, induced by AE5. However, we would then expect all the interactions to be
reduced to the same extent which is not consistent with the results obtained.
However, the contribution of mislocalisation of the AE5 proteins to the spindle
checkpoint deficient phenotype may be a topic for future investigation.
Bublp and Mad3p are homologous and most of the area removed by AE5 falls
into a functional domain conserved between Bublp and Mad3p. Thus the effect of
deletion of E5 on the protein function ofBublp and Mad3p would be expected to be
similar. The Bublp and Mad3p mutants do both show a reduced ability to interact
with Bub3p, although the reduction is greater in the BUB1 mutant. There are some
further differences between the protein functions of BublAE5p and Mad3AE5p, in
that Cdc20p interaction is reduced in Mad3AE5p but the effect on this interaction is
not clear in BublAE5p. In addition the Bublp mutant protein is aberrantly
phosphorylated unlike Mad3AE5p.
The differences in protein function may be due to differences in the normal
function of Mad3p and Bublp in the checkpoint or may relate to differences in the
primary structure of the proteins. Bublp and Mad3p are homologous showing most
similarity in the conserved domains, CD1 and CD2 however they do show sequence
variations which may relate to their differing functions and phenotypes. The tertiary
structures of Mad3p and Bublp may also differ and these disparities may in part
explain the diversities in the phenotypes of the AE5 mutants. Alternatively, the less
severe phenotype exhibited in MAD3AE5 compared to BUB1AE5 may be due to the
greater proportion of the Bub3p binding activity retained by the Mad3AE5p protein
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(approximately 65%) as shown by both co-immunoprecipitation analysis and in the
over-expression chromosome loss experiments.
The defects in BublAE5p function and the spindle checkpoint defects are unlikely
to be attributable to the additional variations in the sequence of the AE5 plasmid out
with the area of the deletion. As previously discussed in chapter 3, these alterations
affect unconserved amino acids or result in conservative changes. An amino acid
alteration in conserved domain 2 of Bublp is altered from a Serine to a threonine.
This may potentially affect the phosphorylation of Bublp but as serine kinases also
phosphorylate threonine residues, and this residue is actually a conserved threonine
in several other species, this is unlikely to have a significant effect either on protein
phosphorylation or checkpoint function. Thus the phenotypes exhibited by the
BUB1AE5 mutant can be attributed to the AE5 mutation.
To investigate protein interactions, some of the experiments used over-expression
of the full-length and AE5 proteins. These methods have previously been used to
examine such protein interactions (Warren et ah, 2002). The over-expression nature
of the system may not directly reflect the interactions seen at wild type expression
levels, but they do clarify the ability of the mutant proteins to form these interactions.
In addition the use of the full-length proteins as controls with which to compare the
intensity of the interactions increases the validity of the results.
In addition to clarifying the Bub3p binding defects in the AE5 mutants, the over-
expression chromosome loss experiments provide information about the ability of the
AE5 mutants to convey dominant negative phenotypes through interaction with and
sequestering of Bub3p. Mad3AE5p retains much of its ability to interact with Bub3p
in the chromosome loss assays, exhibiting a similar dominant negative phenotype to
the full-length protein. The expression ofMad3AE5p from its wild type promoter to
mimic heterozygosity of the human mutations, results in a similar increased
chromosome loss phenotype to the full-length transformant. This indicates that the
Mad3AE5p protein could potentially exert a dominant negative effect on the spindle
checkpoint in heterozygous cells, abrogating the spindle checkpoint and leading to
chromosomal instability.
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Over-expression of the BublAE5p protein also leads to a chromosome loss
phenotype consistent with its ability to bind some Bub3p. This phenotype is
intermediate between the vector and full-length transformants and is less severe than
in the Mad3AE5p mutant, presumably due to the greater reduction in Bub3p binding
of BublAE5p as shown in co-immunoprecipitation experiments. This intermediate
phenotype was also observed in the second set of experiments, where the
heterozygous nature of the mutations are investigated. However, analysis of the
vector and BUB1AE5 transformants results showed no statistically significantly
differences. This suggests that BublAE5p does not exert dominant negative effects,
which is not consistent with the over-expression assays or Cahill analysis of the
human V400 mutation. However, the wild type level assays assessing the Bublp
proteins were repeated only once and do not fully reflect the diploid nature of the
heterozygous cells in a human system and therefore have their limitations. The mild
nature of the chromosome loss phenotypes exhibited in the over-expression and
dominant negative experiments indicate that very large sample sizes would be
required to clarify the data. Further repetition of these assays may be undertaken in
the future to confirm these effects.
Thus to summarise the yeast functional work indicates the AE5 mutations are
associated with a benomyl sensitivity phenotype indicative of a mitotic defect.
Further analysis shows this to be due to aberrant spindle checkpoint function and that
the mutations also confer a chromosome segregation defect. These phenotypes are
attributable to the disruption of specific protein interactions and aberrant
phosphorylation in the case of Bublp. Mad3AE5p forms reduced interactions with
Cdc20p and with a Bub3p-Mad2p complex. The interaction between Bub3p and
Bublp is also compromised in the AE5 mutants. There is some evidence that the
mutant proteins are able to exert mild dominant negative effects.
Future directions for this yeast functional analysis could investigate the
interactions of the AE5 mutants using yeast 2-hybrid analyses, particularly those
interactions which have proved difficult to observe with co-immunoprecipitation
experiments, for example, interactions between Bublp and Madlp and Bublp and
Cdc20p. A 1-hybrid assay has previously been used to investigate the ability of
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mutants to localise to the kinetochore in budding yeast. Localisation to the
kinetochore may be important for formation of important interactions and for correct
phosphorylation and therefore may have relevance to the effects and phenotypes
shown by the AE5 mutants. Further analysis of protein localisation and interactions
using fluorescently tagged proteins could be investigated in S.pombe which are larger
in size and have larger chromosomes, centromeres and kinetochores. Additionally,
in silico or in vitro work such as X-ray crystallography could investigate the effects
of the AE5 mutations on the structure of the Mad3p and Bublp proteins and whether
this relates to the defective interactions shown.
The ability of the AE5 proteins to retain some Bub3p binding and the mild
phenotype seen in the over-expression and dominant negative experiments may
suggest that the checkpoint defects conferred by the AE5 mutations in humans are
minor and would lead to a slightly increased chromosomal instability rate. This may
well explain the high frequency of detection of the BUBR1AE5 mutations in
tumours, whereas other studies aiming to identify mutations in spindle checkpoint
genes in tumours have revealed few variants. The AE5 mutants may alter the
chromosomal stability of the cell to a level which is tolerated, whereas other
mutations may produce such severe defects that they induce apoptosis and lethality.
To further our knowledge of the AE5 mutations in the human system we wished to
further investigate the effect of BUBR1AE5 in human cell lines. The aim was to
determine whether BUBR1AE5 causes a mitotic checkpoint defect and chromosome
instability in diploid colon cancer cell lines. In addition we wished to investigate the
effect of BUBR1AE5 and BUB1V400 on the formation of spindle checkpoint
complexes using immunofluorescence and co-immunoprecipitation experiments.
These experiments are discussed in further detail in chapter 6.
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Chapter 6: The Functional Analysis of BUBR1AE5 in Human
Cell Lines
6.1 Introduction
The findings from the functional analysis in budding yeast indicated that AE5
affected chromosome segregation and the spindle checkpoint. Thus it was important
to investigate the consequences of the AE5 mutations in a human system as this has a
wider relevance to colorectal cancer. The effect of the BUB1 V400 mutation was
previously analysed in human diploid tumour cell lines and shown to induce
phenotypes similar to those observed in aneuploid cell lines (Cahill et al., 1998).
Specifically, Cahill et al showed that aneuploid cell lines exhibit an abnormal cell
phenotype upon nocodazole induced mitotic arrest compared to diploid cell lines.
The diploid cells were shown to arrest at the G2/M transition, with large numbers of
cells showing condensed chromosomes, indicative of a sustained mitotic block.
Fewer aneuploid cell lines maintained this block and in general they showed a
reduced mitotic index with a less defined peak, indicative of defective mitotic arrest.
In addition, the aneuploid cell lines show a similar defective response to treatment
with colcemid and a large proportion of the aneuploid cells continued to synthesise
DNA after treatment with either drug, unlike the diploid cell lines. Two of these
aneuploid cell lines were shown to harbour mutations in the spindle checkpoint gene
BUB1. V429 contained a missense mutation resulting in the substitution of a
tyrosine for a conserved serine and V400 showed an alteration of a splice donor site
leading to a 197 base pair deletion homologous to BUBR1AE5. Both mutations were
heterozygous with the other allele being wild type and occurred only in somatic
tumour tissue (Cahill et al., 1998).
Subsequent expression of these mutant proteins was achieved by Cahill et al via
an inducible expression system using the Tet-On strategy (Clontech). A stable Tet-
On cell line is generated by transfection of the pTet-On plasmid, based on the E.coli
tetracycline-resistance operon, encoding the reverse tetracycline repressor, rTetR and
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integrants are selected using the neomycin resistance marker on the plasmid. These
stable cell lines can then express the reverse tetracycline-controlled transactivator,
rtTA. This consists of the N-terminal of the Tetracycline repressor, providing the
control by tetracycline and doxycycline, fused to the C-terminal of the Herpes
simplex virus VP16 activation domain, converting the repressor to an activator. In
addition, the pTet-On plasmid contains 4 amino acid changes in the tetracycline
repressor domain resulting in expression of the rtTA in the presence of doxycycline
rather than in its absence. The response plasmids, pBI-GFP in these experiments, are
transfected into the pTet-On stable cell lines, which can be induced to produce rtTA
by addition of the antibiotic, doxycycline, to the culture media. The target plasmids
contain the gene of interest (in this case BUB1) under the control of a promoter
containing a Tetracycline Responsive Element (TRE) and, within it, seven copies of
the tetracycline operator sequence. Thus expression from this promoter is induced in
the presence of the rtTA and hence in the presence of doxycycline. The promoter
region in the pBI-GFP plasmids, Pbi-i, is bi-directional allowing co-expression of
BUB1 and GFP and easy recognition and selection ofBUB 1 expressing cells through
their fluorescence. Overall, this provides a system in which expression of the BUB1
and GFP proteins from the Pbi-i promoter can be induced by addition of antibiotics.
In addition, expression from this promoter can be altered in a dose dependent manner
producing over-expression of the target protein up to 10,000 fold. This system is
summarised in figure 6.1.
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Figure 6.1: An inducible over-expression system used to analyse the
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In Cahill et al., the system was used to express the mutant BUB1 proteins in
diploid cell lines using the wild type BUB1 plasmid as a control. Cells successfully
transfected with mutant plasmids were isolated by Fluorescence Activated Cell
Sorting (FACS) on the basis of GFP expression. The phenotypes of the cells were
analysed after nocodazole treatment and the cells transformed with the mutant
plasmids exhibited similar phenotypes to the aneuploid cell lines previously analysed
including a reduced mitotic index and increased S-phase re-entry compared to those
transfected with the wild type plasmid. Thus these mutant BUB1 proteins do appear
to confer checkpoint defects when introduced into diploid cell lines. In addition, co-
transfection of the mutant plasmid with the wild type plasmid produces a similar
phenotype, suggesting the mutant BUB1 proteins exert dominant negative effects.
These phenotypes are similar to the checkpoint defects exhibited by the yeast
BUB1AE5 and MAD3AE5 mutants and we wished to further establish the effects of
the BUBR1AE5 mutant in the human system using similar experiments. This
required the construction of pTet-On stable cell lines in a diploid colon cancer cell
line background and also construction of the wild type and mutant AE5 BUBR1
coding sequences in the pBI-GFP plasmids. The wild type and mutant BUB1
constructs described above form suitable controls for experimental verification.
Thus the BUB1 mutant plasmids were also required to be transformed into pTet-On
inducible diploid cell lines and the effect of the mutants proteins on mitotic arrest,
mitotic index and bromodeoxyuridine (BrdU) incorporation, indicative of DNA
synthesis, were to be examined following mitotic arrest with microtubule poisons.
The aim was to demonstrate checkpoint deficiency of the mutant proteins and to
assess the formation of spindle checkpoint complexes using immunofluorescence and
co-immunoprecipitation experiments. Previously published antibodies were raised to
the C-terminal or a large part of the N terminal of BUB1 and BUBR1. It was
necessary to construct antibodies to the very N terminal sequences of BUB1 and
BUBR1 as the tertiary structure of this area of the proteins was unlikely to be
disrupted by the deletion of E5 and thus N terminal antibodies should be able to
recognise both the wild type and mutant proteins. We also aimed to construct GFP
fusion BUB1 and BUBR1 constructs to use in immunofluorescence experiments to
investigate the localisation and interactions of the mutant and wild type proteins.
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This provides advantages over the budding yeast system in that the localisation of the
mutant proteins to kinetochores can be visualised. Finally, some proteins thought to
interact with BUB1 and BUBR1 have no known homologues in yeast such as CENP-
E and CENP-F and the effect of these interactions could be investigated using
immunofluorescence in human cell lines.
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6.2 Methodological Overview
6.2.1 Chemical Transformation into E.coli
A full-length construct of BUBR1 was obtained from Dr Stephen Taylor (Taylor
et al., 2001). The full-length and mutant BUB1 plasmids previously analysed were
obtained from Professor Bert Vogelstein (Cahill et al., 1998). These were
transformed into E.coli TOP 10 cells as described in 2.5.2 and plated on selective
media containing ampicillin.
6.2.2 Colony Selection and Plasmid Identification
Positive transformants were selected as described in 2.5.3 and analysed by colony
PCR (2.4.3). Positive transformants were cultured (2.5.5), their DNA isolated by
miniprep analysis as described in 2.33 and sequenced to confirm the identity of the
insert as described in 2.6.
6.2.3 Polymerase Chain Reaction
Expand Hi fidelity PCR as described in 2.4.2 was used to amplify the two sections
of coding sequence flanking the area of AE5 seel and sec2 using the human BUBR1
section primers. The pcDNA-3 Myc hMad3 plasmid (2.2.2) was used as a template.
Correct amplification of the sections was confirmed by agarose gel electrophoresis,
as described in 2.4.4 and sequencing of the PCR reactions, as described in 2.6, to
determine accuracy of the PCR.
In addition Expand Hi fidelity PCR was used to amplify the full coding sequence
ofwild type BUB1 and BUBR1 for construction of the GFP fusion plasmids.
6.2.4 Restriction Digestion
Restriction sites for cloning inserts were carefully designed to be compatible with
the plasmids while retaining the reading frame of any tags or promoters and to ensure
they were single cutters and the fragments were inserted in the correct orientation.
Restriction digestions were performed on the amplified sections to construct the
AE5 sequence and on the ligated sections to prepare them for ligation with the vector
backbone. They were also used to switch the full-length coding sequences between
different plasmids and to digest full-length PCR products for insertion into new
232
vectors. Various enzymes were used and these are discussed with cloning strategies
in the results section. Digestion reactions were carried out as described in 2.5.4 and
resulting fragments were purified using gel purification as described in 2.5.5.
Digests with two enzymes were performed sequentially with an ethanol
precipitation step in between, to remove incompatible buffers.
6.2.5 Ligation
The digested fragments of seel and sec2 for BUBR1 were ligated together as
described in 2.5.6 to produce the insert for the cassette. The insert of seel and sec2
and the appropriate vector were then appropriately digested with restriction enzymes
at external sites. The gel purified insert was then ligated into the gel purified vector
as described in 2.5.6. Restriction and then ligation reactions were used to switch
inserts between different vectors ensuring the vectors were in frame for correct
translation.
6.2.6 Generation of pTet-On Stable Cell Lines
Stable pTet-On cell lines were generated with DLD1 and HCT116 and LoVo
diploid colorectal carcinoma cell lines. The cell lines were maintained as described
in 2.11.2. They were transfected with the pTet-On plasmid using FuGene reagent as
described in 2.11.3 and stable integration of the plasmid was selected using
Geneticin. The populations of transfected cells underwent serial dilutions to allow
isolation of single cell clones as described in 2.11.3.
The single cell clones were tested for pTet-On activity using luciferase assays as
described in 2.11.4. P-galactosidase assays were used to normalise for cell number
and these two assays were used to identify the clones with greatest inducibility. This
was necessary as the pTet-On plasmid may have integrated into a silent site and thus
would not be expressed or induce the test plasmids. Clones with at least 2-fold
inducibility were grown on a large scale and frozen down for use in subsequent
assays to test the effect of the BUBR1AE5 mutant.
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6.2.7 Generation of Double Stable Cell Lines
The inducible cell lines were transfected with the test and control BUBR1 and
BUB1 pBI constructs using FuGene reagent as described in 2.11.3 and double stable
cell lines were selected with Geneticin and Hygromycin.
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6.3 Results
6.3.1 Construction of BUB1 and BUBR1 Plasmids
The BUB1 wild type and mutant vectors obtained from Professor Vogelstein and
the BUBR1 vector obtained from Dr Taylor were manipulated to form various BUB1
and BUBR1 constructs for analysis. To provide a renewable source of the coding
sequences in a more extensive multiple cloning site (MCS) than that present in the
functional vectors the inserts were placed into pBluescript. This provided increased
options for construction of the required vectors. Initial sequencing indicated that
some of the cloning sites in the pBI vectors were altered which limited the cloning
possibilities. The coding sequence of BUBR1 was also transferred to a pBI-GFP
vector. This construct was important for investigation of the effect of BUBR1AE5
on mitotic checkpoint function. It allows us to differentiate the specific effects
attributable to the BUBR1AE5 mutant protein from any effects produced due to the
over-expression of the BUBR1 protein in general. The mutant and coding sequences
were also transferred into Enhanced Green Fluorescent Protein vectors (EGFP) in
order to produce GFP-fusion proteins for use in immunofluorescence experiments.
Restriction maps of each of the coding sequences and restriction maps/diagrams
of the vectors were obtained and created. These were used to identify appropriate
single cutter restriction enzymes whose recognition sites were present in the MCS of
the vectors and which cleaved at the termini of the insert but not within the coding
sequence. The selected enzymes were also checked for compatibility with the all
new vector to ensure a single suitable site was present. The orientation of the insert
considerably narrowed the scope of suitable restriction sites. Once suitable
restriction enzymes had been identified, these were used to excise the insert and
digest the vector before both were purified and ligated together.
The coding sequences of BUB1, BUB1V400, BUB1V429 and BUBR1 were
removed from their original vector background and transferred into pBluescript to
allow for easy manipulation of the coding sequences and to provide maximum
compatible restriction sites for future cloning. The wild type and mutant BUB1
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coding sequences were excised from the pBI-GFP vectors by digestion with Notl
and Sail unique restriction sites and purified using gel purification. The pBluescript
vector was digested with the same enzymes and purified using a PCR purification
method. These were ligated together and transformed into chemically competent
E.coli strain. A map of one of the BUB1 pBluescript constructs generated is shown
in figure 6.2.
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BUBR1 was similarly cloned into pBluescript using Notl and Sail restriction
sites. These sites were also used to excise the full-length BUBR1 for cloning into
pBI-GFP. A BUBR1 pBI-GFP construct was required as a control for investigating
the effect of BUBR1AE5 on mitotic checkpoints. The pBI-GFP vector was gel
purified from the digested BUB1 pBI-GFP construct and the Notl/Sail BUBR1
fragment was ligated with it. Colony PCR and sequencing analysis of 94 clones
identified 6 containing BUBR1, a recovery of 6.4%. A map of one of the constructs
generated is shown in figure 6.3.
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Figure 6.3 BUBR1 coding sequences were transferred into pBI-GFP
vectors for use in an inducible expression system
Sail NotI
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The wild type and mutant BUB1 and BUBR1 coding sequences were cloned into
EGFP constructs in order to generate GFP-fusion proteins for use in localisation and
interaction studies. We decided to construct these so that the GFP tag was situated at
the N-terminal of the BUB1 and BUBR1 proteins as any effect on the primary
structure translation or folding of the protein would be less likely to affect an N-
terminal tag.
Unfortunately, due to the absence of compatible unique restriction sites between
the vector MCS and the gene sequences this has proved difficult. Initially the
method involved the PCR amplification of the entire coding sequence from the
pBluescript construct using primers with restriction sites complimentary to those in
the MCS of EGFP-C1; BspEI and BamHI for BUB1 and SacII and Smal for BUBR1.
These primers did not amplify very successfully and optimisation of the PCR was
difficult and time consuming. However, eventually products were obtained and these
were digested and ligated into the similarly digested EGFP vector. Analysis of 93
potential BUB1 wild type clones identified 2 containing the wild type sequence and a
map of this construct is shown in figure 6.4, but analyses of 186 BUB1V429 clones
and 186 deletion clones for BUB1V400 and 93 clones for BUBR1 were all negative.
Thus a new strategy was employed for cloning these.
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The new method involved using Sacl and Sail restriction enzymes to digest the
pBluescript constructs. This produced a vector fragment and two insert fragments
that were ligated together before the total insert was ligated into digested EGFP-C1
and the ligation site within the coding sequence and orientation were confirmed by
sequencing. Analysis of approximately 300 colonies for each of BUB1V400 and
BUB1V429 and BUBR1 revealed none containing appropriate sequence.
The constructs which were successfully isolated were sequenced fully and stored
at -70°C as glycerol stocks for future use in functional assays.
These cloning strategies are summarised in figure 6.5.
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Figure 6.5 Cloning strategies for the BUB1 and BUBR1 constructs
243
6.3.2 A Strategy for Construction of the BUBR1AE5 Coding Sequence
Unfortunately the BUBR1AE5 mutant coding sequence could not be isolated from
the tumour samples in which it was initially identified as the RNA was of poor
quality and thus the initial analysis PCR amplified the tumour RNA in sections.
Thus we attempted to construct the BUBR1AE5 coding sequence using PCR based
methods.
The initial attempts to construct the BUBR1 deletion used the same restriction
strategy as that used for the yeast deletion clones. The two sections flanking the AE5
deletion were PCR amplified using the pBluescript and original BUBR1 constructs as
templates. The internal primers used contained Btsl recognition sequences and
external primers contained sites for Notl and Sail enzymes. Attempts to digest these
and ligate them together did not produce a product of appropriate size even after a
further round of PCR amplification. Nor did transformation experiments and
analysis of 281 colonies, from 4 separate experiments, yield any positive deletion
clones.
A new strategy was employed in which overlapping PCR methods were used.
This involved PCR amplification of the same flanking sections with internal primers
containing no restriction enzyme recognition sequences. The products from these
PCRs are then utilised as a template in a secondary PCR using the external primers
with unique Notl and Sail restriction sites. This cloning strategy is summarised in
figure 6.6. Analysis of 93 clones revealed only full-length BUBR1 constructs. This
strategy was then altered to include a gel purification of the primary PCR products
before use as a template. Unfortunately, analysis of 186 clones revealed no
sequences containing BUBR1AE5.
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Figure 6.6 Cloning strategy for BUBR1AE5
AEI pcDNA-3 Myc hMad3
* EXPAND PCR amplify Sail
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6.3.3 Production of pTet-On stable cell lines
The pBI-GFP constructs will be used to analyse the effect of the mutations on
the spindle checkpoint response of mammalian cell lines when over-expressed. The
principal for this experiment is shown in figure 6.1 and requires the generation of
pTet-On stable cell lines. This produces a system in which expression of the BUBR1
protein can be controlled by the addition of antibiotics to the cell culture media. The
mammalian cell lines to be used, DLD1, HCT116 and LoVo, were transfected with
the pTet-On plasmid using Fu-Gene reagent. The transfectants were treated with
Geneticin to select for incorporation of the plasmid and the surviving cells were
diluted to obtain single cell clones. These were tested for expression of pTet-On by
co-transfection using lipofectin with pCMVp, a control vector which allows
standardisation through (3-galactosidase assays, and pTRELuc, which contains a
luciferase gene under the control of Tet-responsive promoter. The cells were
induced with doxycycline for 48hours before luciferase and P-galactosidase assays
were carried out to determine the inducibility of the cell populations.
A great deal of variation was observed in the induction levels of the luciferase
plasmid between clones. Transfection of a large flask of cultured cells yielded only
1-2 clones with inducible luciferase activity. In fact, many transfections produced no
clones with inducible activity at all. From these three cell line populations, at least
35 geneticin resistant single cell clones were identified from at least 2 transfection
procedures. From these only one clone of each of LoVo, HCT116 and DLD1 were
identified with inducibility at levels ranging from 6 to 11.7 fold when corrected for
cell number. Further investigation of these most responsive clones revealed the
inducibility to be highly variable and unreliable. The LoVo and DLD1 clones were
both found to have little inducibility in experimental repetitions and the HCT116
clone showed inconsistent levels of inducibility varying from 0.97 to 5.5 fold. These
results are summarised in figure 6.7 and table 6.1.
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Table 6.1: Variability in Induction Levels of pTet-On Stable Cell Lines
Cell Number of Single
Line Cell Clones
Analysed
Maximum Inducibility of individual
Induction experimental repetitions
(fold)
HCT116 48 6 fold 2.40, 5.50, 0.97
DLD1 36 11.7 fold 1.96, 0.07, 0.48,3.20
LoVo 41 6.8 fold 1.54, 1.13,0.95,0.19










Figure 6.7 Inducibility of pTet-On Stable Cell Lines
Identical repetitions of luciferase assays on single cell clone populations show a
dramatic variability in the induction of the pTet-On stable cell lines.
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The pTet-On HCT116 cell line was used in further pilot experiments to generate
pTet-On / BUB1 stable cell lines by co-transfection with the BUB1 pBI-GFP vector
and a pTK-Hyg plasmid to confer hygromycin resistance. Positive transformants
were then selected by adding hygromycin to the cell culture media at concentrations
shown to cause death in over 90% of untransfected HCT116 control populations.
Unfortunately, the transfected populations were unaffected by the hygromycin and
positive transfectants could not be isolated. Further experiments showed the
untransfected HCT116 pTet-On stable cell line was resistant to hygromycin even at
extremely high levels suggesting integration of the pTet-On plasmid had somehow
conferred a hygromycin resistant phenotype to the HCT116 cells. An alternative
drug resistance plasmid would be required for future experiments.
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6.3.4 Generation of BUB1 and BUBR1 N Terminal Antibodies
In combination with the localisation studies of the GFP-fusion proteins, I wished
to use immunofluorescence techniques and co-immunoprecipitation experiments to
explore the biochemistry of spindle checkpoint proteins. No N-terminal antibodies
were available for BUB1 or BUBR1 at the time of these experiments and N-terminal
antibodies were specifically required as the deletions being studied are likely to
cause truncations or alterations in tertiary structure which may remove any C-
terminal or central antibody epitopes. To this end we identified a string of 25 amino
acids at the N terminus of BUB1 and 21 amino acids at the N terminus of BUBR1
which, according to the UK HGMP resource centre and the BLAST facility,
http://www.ncbi.nlm.nih.gov/blast, shares little homology with other proteins. In
addition these motifs are not conserved between BUB1 and BUBR1 reducing the
possibility of cross reactivity. Initially I tried to PCR amplify these regions from
wild type constructs but the small product produced was difficult to isolate and clone
so an alternative technique was used. The oligomers encoding the entire peptide
sequence were obtained (MWG Biotech) and annealed together before inserting into
a Glutathione-S Transferase (GST)-fusion vector, pGEX4Tl. The peptide sequences
to which the antibodies were raised and a map of the GST construct generated is
shown in figure 6.8. This plasmid was transformed into TOPIO E.coli cells and
stored as a glycerol stock. Sequencing analysis of 24 clones of each identified 3
positive BUB1 clones and 5 positive BUBR1 clones, an efficiency of 12.5% and
20.8% respectively. These were transformed into E.coli M15 (pRep4) for expression
of the fusion proteins and pilot induction experiments were successful. Two clones
were selected for mass induction experiments and affinity purification of the GST-
fusion proteins were performed using glutathione coupled sepharose beads. The
protein eluted mostly in the 2nd and 3rd fractions and fractions 2-4 were concentrated
by dialysis to finally yield 4mg of BUB1-GST and 8mg of BUBR1-GST (figure 6.9).
This protein was to be used to generate polyclonal antibodies for use in biochemical
studies. However, shortly after production of the GST-fusion protein, the initial
plasmids were found to be altered in sequence. This is thought to be due to the cells
used for cloning and storage of the recombinant plasmids. Thus we could not be sure
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that the sequences of the GST fused peptides generated were correct. To avoid any
potential error in the antibodies generated, peptides of the N-terminal sequences were
commissioned from an external manufacturer and these were used for antibody
generation.
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Figure 6.9: Expression and Purification of BUB1 and BUBR1 GST-
fusion Proteins
A) Pilot Study of Inducibility
Total protein extracts with and without induction by IPTG.











B) Large-Scale Expression and Protein Purification
8mg ofBUB 1-GST and 4mg ofBUBR1-GST was isolated from fractions 2,3 and 4 and concentrated





























































N-BUB1-GST (B2) N-BUBR1-GST (A6)
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6.4 Discussion
The functional analysis in S.cerevisiae clarifies the effect of the V400 and AE5
mutations on specific functions including checkpoint arrest, chromosome segregation
and protein complex formation. However, it is important to verify these effects in
the human system. The BUBIX400 mutation has been shown to abrogate the spindle
checkpoint in diploid cell lines using an inducible expression system. The work
described in this chapter aimed to construct tools to be used in similar functional
analyses in human cell lines. Time constraints indicated these experiments were
beyond the scope of this thesis but these tools will be vital in future investigations
into the role of BUBR1AE5 and BUB1V400 on the spindle checkpoint and protein
function. In addition, the antibodies and GFP-fusion constructs can be used in
immunofluorescence experiments to further investigate the roles of BUB1 and
BUBR1 in the spindle checkpoint.
The primary aim of the functional analysis was to determine whether BUBR1AE5
induced an abnormal mitotic checkpoint arrest, similar to that seen in CIN cell lines,
when over-expressed. Such an effect has previously been shown for the BUB1V400
mutant protein. This required construction of BUBR1 full-length and AE5 coding
sequences in pBI-GFP inducible plasmids. Several attempts at cloning have isolated
a BUBR1 pBI-GFP construct which can be used in future checkpoint assays. This
construct can be used as a positive control to ensure over-expression of the wild type
protein in diploid cell lines does not abrogate the mitotic checkpoint. Unfortunately,
multiple attempts to construct BUBR1AE5 in a pBluescript plasmid have been
unsuccessful. These techniques could be adapted in future attempts perhaps by
further optimisation of the PGR techniques. In addition the PGR products of the
sections could be PCR cloned with a TOPO PCR cloning kit for example which has
the added advantage of using topoisomerase and does not require the TA overhang
and would thus be suitable for use with a Hi Fidelity Taq polymerase such as that
from an Expand kit. This would provide a renewable source of the section PCRs and
may allow the DNA to be concentrated, aiding future digestion and cloning attempts.
A similar PCR amplification and cloning technique can be used to concentrate the
recombinant PCR before cloning into the functional vectors.
253
This functional work also requires pTet-On stable cell lines in which expression
from the pBI promoter is induced in the presence of doxycycline. This inducible
system allows the specific effects of the mutant proteins to be investigated at a
certain time point. By generating double pTet-On, BUBR1 pBI-GFP stable cell lines,
a renewable source for future analyses can be produced, minimising the number of
future transfection procedures. For these experiments pTet-On stable cell lines were
generated from several diploid tumour cell lines. These were found to have a great
deal of variability in their levels of induction even between individual repetitions
using aliquots of cells derived from the same single cell clone transfectant. Ideally
the induction levels would require some optimisation and confirmation before these
cells could be used in checkpoint assays. This could be done by varying the
conditions of the luciferase assays to obtain consistent luminescence in experimental
repeats. Although the experimental repetitions carried out here maintained external
conditions they may have been subtly affected by other factors such as cell number.
Alternatively, a sub-population of these cells may have undergone additional
alterations, which have caused a reduction in the induction levels and further dilution
cloning may help to identify and isolate a more consistent population. In addition,
preliminary experiments suggest that some of the HCT116 pTet-On cells are resistant
to hygromycin and thus an alternative resistance plasmid would be required for co-
transfection with and selection for stable integration of the pBI-GFP plasmids, for
example puromycin. Neither geneticin nor doxycycline can be used for this selection
as they are used in the selection for pTet-On stables and induction of target gene
expression respectively. Alternatively, positive transfectants could be isolated by
FACS.
Additionally, the range of Tet-On cell lines available commercially are increasing
and although they do not include any colorectal carcinoma cell lines, these may be
available in the future (http://www.clontech.eom/products/cat/HTML/l 193.shtml).
In order to assess the effect of the mutant BUB1 and BUBR1 proteins on spindle
checkpoint function, the checkpoint function in the untreated diploid CRC cell lines
must be established. The HCT116 cell line has previously been shown to be
checkpoint proficient by Dr Farrington but insertion of the pTet-On plasmid may
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have potentially disrupted the checkpoint. This involves blocking the cells in mitosis
by treatment with nocodazole and harvesting them at several time points before
scoring the proportion of metaphase cells to determine the efficiency of the mitotic
block. If the cells have a functional mitotic checkpoint, a high proportion of the cells
will arrest at the metaphase transition. The cell lines from which the stable BUBR1
cell lines are to be generated must have functional checkpoints in order to ascertain
the effect of AE5 on these checkpoints.
The BUB1 pBI-GFP plasmids act as controls for the experimental strategy as the
effects of these mutant and wild type proteins on checkpoint function has already
been reported. Thus the assay can be optimised using these constructs before testing
the effect oiBUBRl full-length and BUBR1AE5.
The effect of the BUBR1AE5 and BUB1 V400 mutations on protein function can
ultimately be investigated using GFP-fusion constructs and the N-terminal
antibodies. Immunofluorescence analyses will be used to clarify the localisation of
the mutant proteins and to investigate their interactions under different conditions
and during different stages of the cell cycle. This will aid our understanding of the
relevance of the yeast functional analyses and also provide information about
conservation between the human and yeast spindle checkpoints.
The full-length GFP-fusion plasmids can be used in these assays both as controls
for determining the specific influences of the mutant proteins and to further
investigate wild type protein function in the mitotic processes such as checkpoint
arrest, chromosome segregation and kinetochore assembly. In addition the
antibodies generated can be used in co-immunoprecipitation experiments to see if the
AE5 and V400 mutations have a similar effect on spindle checkpoint complex
formation in human cells to that seen in yeast.
These antibodies will also be useful in extending our knowledge of the impact of
the AE5 mutations on colorectal tumours. Unfortunately, the tumours in which the
mutation was originally identified are of poor quality and cannot be used for further
RNA and protein expression anlaysis. We are currently collecting a panel of
tumours for further mutation analysis in order to identify tumours containing the
BUBR1 variant. The protein and genomic tumour DNA from this sample can then be
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further analysed to determine the genomic change associated with the deletion and
the effect of this at the protein level. It will be particularly interesting to determine
the expression levels, stability and truncation status of the mutant protein compared
to that expressed from the wild type allele. This could be compared with the yeast
functional work which investigated an in frame form of the deletion.
These antibodies could also be used for immunohistochemistry on tumour sample
cohorts to identify any changes in expression levels in tumour tissue. Altered
expression levels of spindle checkpoint proteins have previously been observed in a
variety of tumours and associated with checkpoint defects (Wang et al., 2000a; Wang
et al., 2002) and are probably an important aspect by which loss of checkpoint
control may be implemented.
In summary, the yeast functional analyses have shown the AE5 and V400
mutations have a detrimental effect on the spindle checkpoint and chromosome
segregation. The full effect of the mutations on tumourigenesis will ultimately
require analysis in human cell lines. This initial work has achieved the construction
of important plasmids, cell lines and antibodies which are an important resource and
vital for use in the functional analysis ofBUBR1AE5 and BUB1V400. These results
can be compared with the yeast results to expand our knowledge of the conservation
between the yeast and human spindle checkpoints and further our insight of the
influence of the BUBR1AE5 mutation on colorectal tumourigenesis.
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Chapter 7: Summary and Discussion
The work presented in this thesis aimed to clarify the importance of spindle
checkpoint mutations in colorectal tumours. This was approached in two ways.
Firstly, a yeast model system was used to investigate the effects of cancer associated
deletions in MAD3 and BUB1, the yeast homologues of BUBR1 and BUB1, on
spindle checkpoint function, chromosome segregation and checkpoint protein
complex formation. Secondly, molecular biological tools were developed to address
the effect of the mutations on checkpoint activity in human cell lines.
The mutations investigated in these analyses were the BUBR1AE5 mutation
observed in 20% of a panel of aneuploid colorectal tumours during previous work by
this laboratory and the BUB1 V400 mutation, previously identified in CIN colorectal
tumour cell lines (Cahill et al., 1998). Alignments of the sequences of these two
related proteins revealed the area removed in these two deletions was identical and
also showed that this area is highly conserved between species (Hardwick et al.,
2000). The mutations remove part of a functional domain thought to interact with
Cdc20p (Hardwick et al., 2000) an interaction important for checkpoint function.
The functional analysis in the yeast system involved the construction of plasmid
forms of the AE5 and V400 mutations in the MAD3 and BUB1 coding sequences,
the yeast homologues of BUBR1 and BUB1 respectively. These were transformed
into strains null for either BUB1 or MAD3 and the ability of the mutant plasmids to
rescue phenotypes associated with the null mutants was examined. These
experiments effectively examined the effect of the AE5 mutations on spindle
checkpoint function and chromosome segregation. The mad3 and bubl null mutants
exhibit a sensitivity to the microtubule poison benomyl indicative of a mitotic defect
(Warren et al., 2002). Further phenotypic analyses demonstrated that the mad3 null
mutant is associated with an altered pattern of growth in microcolony assays and
bubl mutants exhibit a multi-budded phenotype when arrested with nocodazole.
These additional studies aimed to dissect the mitotic defect producing the benomyl
sensitivity phenotypes, and identified that the defect is a result of abrogation of
spindle checkpoint arrest. Additionally both the mad3 and bubl null mutants exhibit
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an elevated chromosome mis-segregation rate. These assays also demonstrated that
the MAD3 and BUB1 AE5 mutants exhibit increased benomyl sensitivity, spindle
checkpoint abrogation and chromosome loss phenotypes, indicating that the function
of the protein is compromised by the AE5 mutation. In the MAD3 mutant these
phenotypes are as severe as the null mutant suggesting the protein is fully
compromised. However, the BUB1AE5 mutant shows an intermediate phenotype
between that of the null mutant and wild type strains suggesting the BublAE5p
protein, while defective in its checkpoint and segregation roles, does retain some of
its function. The null and AE5 BUB1 mutants exhibit more severe phenotypes than
the MAD3 mutants consistent with previous reports that in yeast Bublp has a greater
function in the spindle checkpoint and additional roles in mitosis compared to
Mad3p.
These defects were further investigated at the protein level using co-
immunoprecipitation experiments and over-expression studies. The AE5 mutant
proteins were found to be expressed at equivalent levels to their full-length
counterparts both when expressed from wild type promoters and from methionine-
inducible over-expression promoters. Thus a reduced stability or expression of the
mutant protein does not seem to be responsible for the phenotypes exhibited by the
AE5 mutants. Further investigations showed specific interactions important in
checkpoint function are disrupted in the AE5 proteins. Mad3AE5p forms interactions
with both Cdc20p and Bub3p with a reduced affinity compared to the full-length
proteins (reduced by 50% and 35% respectively) and the interaction between Bub3p
and Mad2p is also reduced by 75% in the presence of the AE5 mutant protein,
probably through an indirect effect of the reduced Mad3p-Bub3p complex formation.
Over-expression of the full-length Mad3p protein causes an elevated chromosome
loss phenotype due to sequestering of Bub3p which is also exhibited by the AE5
mutant although at a slightly reduced level. This is consistent with the co-
immunoprecipitation experiments which indicate Mad3AE5p retains a large
proportion of Bub3p binding. The reduced formation of these complexes is
hypothesised to interfere with the formation of the constitutive Mad3p-Bub3p
complex, important for Mad3p localisation to the kinetochore; the Mad3p-Cdc20p
complex, involved in APC/C inhibition and thus the Mad3p-Bub3p-Mad2p complex
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which may also be involved in APC/C inhibition through sequestering of Cdc20p.
Preliminary experiments suggest Mad3AE5p is normally phosphorylated. Thus the
phenotypes exhibited by the MAD3AE5 mutants can be attributed to the disruption
of these three checkpoint complexes.
The BUB1AE5 mutant also shows a reduced affinity for Bub3p (by 60%), which
is a complex which is important for Bublp localisation to the kinetochore and also in
the formation of a Bublp-Bub3p-Madlp signalling complex from which Mad2p is
released in an activated form to inhibit the APC/C. This is supported in experiments
analysing the chromosome loss phenotype, when the full-length and mutant proteins
are over-expressed. Over-expression of the full-length protein induces a
chromosome loss phenotype due to sequestering of Bub3p. This phenotype is far
less severe in the AE5 mutant due to a much reduced ability to interact with Bub3p.
In addition, BublAE5p shows aberrant phosphorylation, the importance of which is
not yet clear. The effect of the AE5 deletion on the interactions between Bublp and
Madlp and Bublp and Cdc20p is also not clear, although preliminary evidence
suggests AE5 may compromise an interaction between Bublp and Cdc20p. Thus the
spindle checkpoint and mis-segregation defects exhibited by the BUB1AE5 mutant
can be attributed, at least in part to this reduced protein function, possibly via
phosphorylation effects and reduced protein complex formation.
The interactions are compromised in the MAD3 and BUB1AE5 mutants by
between 35 and 75% suggesting the checkpoint and segregation defects in the
mutants should be compromised but not equivalent to the null mutant. Although this
is consistent with the phenotype observed in the BUB1AE5 mutant, this is not the
case for the MAD3AE5 mutant which in fact exhibits phenotypes as severe as those
seen in the null mad3 strain. This may be due to an additive effect of the disruption
of multiple interactions or may be due to the reduction of the concentration of
important complexes below a threshold level required for correct spindle checkpoint
function. However, the BUB1AE5 mutant exhibits a compromised checkpoint
complex formation with a more extreme disruption of the interaction with Bub3p, but
a phenotype intermediate between the null and wild type strains is observed in the
AE5 mutant. Perhaps this total loss of Mad3p protein function is an additive effect of
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compromisation of several of Mad3p's protein interactions, whereas in Bublp only
the interaction with Bub3p is known to be specifically disrupted, producing an
intermediate phenotype between the full-length and vector transformants.
Alternatively this may be due to the limitations of the assays used, which require
large sample sizes to accurately and statistically distinguish between the null mad3
mutant and wild type strain in the chromosome loss assay in particular. Thus to
distinguish between these and an intermediate mutant may be difficult. The more
severe mis-segregation phenotype observed in the bubl mutants would allow
intermediate phenotypes to be distinguished statistically even with smaller sample
numbers.
The area removed by AE5 removes a functional domain conserved between
Bublp and Mad3p (Hardwick et ah, 2000) and thus the effect of the AE5 mutation
would be expected to be similar in both BUB1 and MAD3. However, BUB1AE5
produces a far more severe phenotype than MAD3 and also shows a partial defect in
chromosome segregation and mitosis, whereas these functions ofMad3p are entirely
abrogated in MAD3AE5. This variation in the phenotypes of the BUB1 and MAD3
mutants probably partially reflects the greater role of Bublp in the spindle
checkpoint and in other functions in mitosis, consistent with the similar multi-budded
phenotype of the bubl null and AE5 mutants. Variations in the primary sequence
and tertiary structure may also be reflected in the differing phenotypes of the MAD3
and BUB1 mutants. In addition, the mild nature of the MAD3 mutant phenotype
may reflect redundancy in the inhibitory complex. Both Mad3p (and it's homologue
BUBR1) and Mad2p have been shown to be involved in complexes able to inhibit
the APC/C (Sudakin et ah, 2001; Fraschini et ah, 2001; Fang et ah, 1998) and some
studies especially in vertebrates, indicate these form two separate inhibitory
complexes (Tang et ah, 2001). The severity of the phenotype in the BUB1 mutants
may partly reflect the greatly reduced interaction between Bublp and Bub3p. This is
supported by the high levels of chromosome loss exhibited by bub3 null mutants and
upon over-expression of Bublp, resulting in the sequestering of Bub3p. The defect
in Bub3p binding in the MAD3AE5 mutant is less severe as demonstrated by co-
immunoprecipitation and over-expression experiments, consistent with the milder
phenotype of the MAD3AE5 mutant. However, the difference in the severity of the
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defect in the interaction with Bub3p is not entirely responsible for the milder
phenotypes of the MAD3AE5 mutant, as abolishment of the interaction between
Mad3p and Bub3p in the mad3 null mutant is still associated with a milder
phenotype than the BUB1 mutants. The interaction of Bublp and Mad3p with
Bub3p is thought to be important for the kinetochore localisation of (Roberts et al.,
1994; Hardwick et al., 2000) both proteins and thus the AE5 proteins may be
mislocalised. The milder phenotype of the MAD3 mutant may be due to the
involvement of Mad3p in APC/C inhibitory complexes away from the kinetochore.
The Mad2p-Mad3p-Cdc20p complex is thought to be involved in APC/C inhibition
in a soluble pool as well as at the kinetochore (Fang, 2002) and the association with
this complex may occur despite minor defects in Bub3p binding and therefore
kinetochore localisation. However, the localisation of Bublp to the kinetochore
through interaction with Bub3p is important for the formation of the Madlp-Bublp-
Bub3p signalling complex at the kinetochore (Brady and Hardwick, 2000) and
disruption and mislocalisation of this is hypothesised to produce the severe
checkpoint defects observed here. Thus the reduced interaction between Mad3p and
Cdc20p in the AE5 mutant may be a greater contributor to the phenotype of the
MAD3 mutant, whereas the defect in Bub3p binding is the major cause of the severe
BUB1 mutant phenotype. This hypothesis would be consistent with the different
phenotypes seen in the two mutants as the importance of an interaction between
Bublp and Cdc20p is not clear and the effect of AE5 on this interaction has not been
fully elucidated.
The effect of the AE5 mutation on the Bublp- Madlp complex has not been fully
investigated. Co-immunoprecipitation experiments to investigate this have been
inconclusive and this is an area for future investigation by optimisation of the assays
or using yeast 2-hybrid assays. This interaction is important in the formation of a
Bublp-Bub3p-Madlp signalling complex (Brady and Hardwick, 2000), although it is
likely to be defective in the AE5 mutant due to a reduced interaction between Bublp
and Bub3p but this could be confirmed in further analyses.
Other future work could investigate the different phenotypes observed, with a
view to separating the individual interactions and the residues which affect them.
Previous mutation analysis of Bublp has identified two main functional domains
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CD1 and CD2 which are involved in Cdc20p and Bub3p interactions respectively
(Hardwick et al., 2000). Similar analysis ofMad3p involving mutation of conserved
amino acids and domains could aid the understanding of the interactions of Mad3p
and clarify the phenotypes associated with the defects in complex formation seen
here. The areas deleted by AE5 in both the MAD3 and the BUB 1 mutants remove a
large proportion of CD1 and thus would be expected to effect the protein interaction
with Cdc20p. However, CD2 is not directly altered by the deletion AE5 and thus the
effect on Bub3p binding is probably due to an alteration of the tertiary structure of
the protein through removal of a large section. This is difficult to confirm in
functional assays but could be further investigated using an in silico approach or
using structural analyses such as X-ray crystallography. There is also the possibility
that Bub3p binding sites are present in CD1.
In addition the defects in individual protein interactions could be further
investigated to relate them to the specific phenotypes shown by the mutants. This
again could involve mutating individual amino acids and domains and analysing their
effect on spindle checkpoint function and chromosome segregation using the
benomyl sensitivity, checkpoint and chromosome loss assays. Further information
would also be provided by mutational analysis of the Mad3p and Bublp proteins
with regard to individual protein interactions, using co-immunoprecipitation
experiments and two hybrid assays. Mutational analysis of the interaction partners
Cdc20p, Bub3p and Madlp to identify residues involved in the interactions with
Bublp and Bub3p is of importance and some analysis has already identified
important amino acids involved in protein interactions (Hardwick et al., 2000;
Warren et al., 2002). Comparison of any mutant phenotypes produced may aid in
identifying the specific defective interactions involved in the checkpoint defect and
chromosome mis-segregation phenotypes of the MAD3 and BUB1AE5 mutants.
The relationship between the individual phenotypes and the defective interactions
can also be investigated by complementation of the mutant strains with a plasmid
over-expressing that protein. For example, by addition of a plasmid over-expressing
Bub3p to the BUB1AE5 mutant, the increased concentration of Bub3p should restore
the interaction between Bublp and Bub3p to normal levels. If the disruption of this
interaction was the major contributing defect to the phenotypes observed in the
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mutants, then this complementation should restore the chromosome loss rates and
spindle checkpoint function to wild type levels. This has previously been used to
confirm the importance of interactions (Warren et ah, 2002) and the same theory
could be used for each of the interactions with Cdc20p, Bub3p and Mad2p. In
addition the phosphorylation of BublAE5p in this complemented mutant, could be
investigated to determine whether the aberrant phosphorylation is a result of the
reduced Bub3p-Bublp interaction. Preliminary experiments of this nature were
undertaken involving transformation of a Bub3p overexpression plasmid into the
BUB1 and MAD3AE5 transformants in order to restore the interaction with Bub3p.
The relative contribution of the Bub3p binding defect to the mutant phenotypes could
then be investigated using chromosome loss and benomyl sensitivity assays.
Unfortunately time constraints prevented the optimisation and completion of these
experiments.
The aberrant phosphorylation of BublAE5p has been further investigated to
clarify whether it is a result of the reduced interaction between Bublp and Bub3p.
Full-length Bublp is normally phosphorylated in a bub3 null strain suggesting Bublp
phosphorylation is not Bub3p dependent. This could be further investigated using
other mutants which are defective in Bub3p binding such as bubl-1. The bubl-1
mutant strain harbours the mutation in E333K and has been shown to be suppressible
by an increased dosage of Bub3p and thus is thought to form a defective interaction
with Bub3p (Hoyt et ah, 1991; Roberts et ah, 1994). This bubl-1 strain could also be
used in co-immunoprecipitation experiments with anti-Bub3p or anti-myc (in a
Bub3p-myc strain) beads to investigate the relationship between the phosphorylation
of Bublp and its interaction with Bub3p. Alternatively, co-immunoprecipitation
experiments with phosphatase treated extracts could be used to determine whether
the interaction with Bub3p is dependent on the phosphorylation ofBublp.
The aberrant phosphorylation of BublAE5p may in fact be unrelated to the
reduced interaction with Bub3p. It may be a specific effect of removal of the E5
domain, perhaps due to alterations in tertiary structure masking the amino acids to be
phosphorylated, or may reflect a mis-localisation of the protein. The localisation of
the Bublp and Mad3p proteins are difficult to assess in budding yeast due to their
small size but their localisation to the kinetochore can be investigated using a one
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hybrid assay (Warren et al., 2002). In this assay the ability of the mutant protein
fused to a Gal4 activation domain to activate transcription of a centromere reporter
gene, HIS3 indicative of centromere localisation, is assessed by analysing cell
growth on media lacking histidine (Warren et al., 2002).
The chromosome loss phenotypes associated with over-expression of Mad3p
and Bublp provide information about the interaction with Bub3p and have additional
relevance to colorectal cancer in two ways. Firstly, variations in the expression
levels of spindle checkpoint proteins have been observed in various cancers (see
table 1.4) and these phenotypes suggest a mechanism by which the over-expression
of these proteins may contribute to tumourigenesis. Secondly, the over-expression of
the mutant proteins in a wild type background produces a mis-segregation
phenotype, suggesting they may exert dominant negative effects. This is thought to
be mediated by the interaction with and sequestering of spindle checkpoint proteins
such as Bub3p by the mutant proteins, preventing the formation of important spindle
checkpoint protein complexes. This dominant negative effect is consistent with a
mitotic defect observed upon over-expression of BUB1V400 in human colorectal
cancer cell lines (Cahill et al., 1998a). The dominant negative effect observed in
these over-expression experiments was further investigated by expression of the
mutant proteins from their wild type promoters in a wild type strain, mimicking the
heterozygous nature of the mutations. Preliminary data from my experiments
indicated Mad3AE5p can exert dominant negative effects whereas the effect of
BublAE5p appears to be milder. The difficulties discussed above in interpreting
milder phenotypes in chromosome loss assays are also evident here and are
confounded by the small sample sizes and single repetition in these pilot
experiments. In addition, these experiments are not truly indicative of the human
system as the other checkpoint proteins are expressed only at haploid levels and thus
there must be a degree of caution in these interpretations.
In summary, this functional analysis in yeast has been extremely important in our
understanding of the phenotypic effects of the AE5 mutations of spindle checkpoint
function and chromosome segregation. They have revealed that the mutations are
associated with a spindle checkpoint defect and chromosome mis-segregation
phenotype consistent with the CIN frequently observed in colorectal tumours. These
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defects are more severe in the BUB1AE5 mutant than in MAD3AE5 consistent with a
greater role for BUB1 in mitosis. The AE5 mutation also appears to abolish Mad3p
checkpoint function whereas Bublp function is only compromised. Furthermore,
defects in specific protein interactions appear to mediate these mitotic defects and
may allow the mutant proteins to exert dominant negative effects. These
experiments have contributed significantly to our knowledge of both the control of
the spindle checkpoint in S.cerevisiae and the AE5 mutations and how they may be
influencing tumourigenesis.
The functional assays used in these experiments are important to examine the
effect of the mutation on checkpoint and mitotic function in S.cerevisiae. However,
they do have limitations. The benomyl sensitivity assays are most useful in
qualitative analysis which is less informative than a quantitative assay due to the
error margin introduced through human interpretation, although this is reduced
through repetition of the experiments and the analysis of several separate
transformants. The benomyl media used does not select for the transformed plasmids
due to technical constraints in plate preparation. However, the rate of spontaneous
plasmid loss should be consistent for both the mutant and full-length transformants.
In addition this assay does not directly analyse spindle checkpoint function but
represents defects in a sum of mitotic processes. For this reason further checkpoint
assays were carried out; the microcolony assay and the liquid culture assay. These
assays have similar technical limitations in that they are carried out in a benomyl (or
nocodazole) containing media which does not contain nutrient selection for the
exogenous plasmids, the use of the full-length transformants acts as controls. In
performing the microcolony assay, a proportion of cells die during the experimental
set up and this can result in different sample sizes for each transformant which is not
ideal for comparison. However, in each repetition at least 20 cells remained viable
during the early divisions and the use of appropriate controls compensates for this
error. The chromosome loss experiments also incorporate a lack of selection during
the actual assay (although the overnight cultures are prepared in selective media)
however the use of full-length controls standardises for this. Some of these technical
difficulties could be removed through integration of the mutant sequences into the
yeast genome. This would also ensure equal expression of the mutant proteins as the
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plasmid nature of the system may allow alterations in plasmid copy number and
expression levels. However, protein analysis has not revealed any such problems in
our experiments and indeed integration of mutant sequences has its own technical
problems, can be more time consuming and has been associated with reduced protein
stability. Additionally the use of plasmids allows the easy transfer of the mutant
sequences to new strains without the need for crosses which can also be both
problematic and time consuming. As discussed previously, the chromosome loss
assays are limiting in the analysis of mild phenotypes such as those exhibited by the
over-expression transformants, the mad3 mutants and in the dominant negative
assays. The sample size for the MAD3 mutants was much greater than for the BUB1
mutants and this was important to obtain consistent phenotypes for statistical
analysis. The assay is fairly time consuming, particularly the scoring of colonies
(with nearly 280,000 colonies counted during the course of this thesis!) and thus may
not be the most suitable for routinely investigating the effect of mutations on
chromosome segregation. Certainly the checkpoint assays are practically easier for
analysing checkpoint function and alternative assays analysing chromosome
segregation may prove more suitable in future mutational analyses.
The co-immunoprecipitation experiments provided important information on
interactions but were limited due to the robust nature of the antibodies. The
antibodies used here did not easily recognise proteins expressed at wild type levels
and hence the over-expression plasmids were used for this analysis. The production
of new antibodies could improve these results or an alternative could involve the use
of yeast 2-hybrid systems to investigate the protein interactions. This assay still
relies on over-expression of the proteins and is an in vitro assay, but could be used
for those interactions where the antibodies were too poor for co-immunoprecipitation
assays, for example the Madlp-Bublp interaction.
However, S.cerevisiae has its limitations as a model system. The cells are small
in size and thus cannot easily be used to analyse the localisation of the proteins or
view their interactions microscopically using immunofluorescence. This could be
done in the fission yeast S.pombe on construction of the homologous S.pombe mutant
plasmids. However, the organism with most relevance to the colorectal tumours is
the human system itself. Human cell lines can be used to confirm whether the effects
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of the BUBR1AE5 mutation are consistent with the phenotypes observed in the
BUB1AE5 and MAX)3AE5 mutants in S.cerevisiae. Both the MAD3 and BUB1 AE5
mutants are likely to have relevance to the BUBR1AE5 mutation in humans.
BUBR1 was initially identified as a BUB1 related protein (Cahill et ah, 1998a) but is
now generally considered to be the MAD3 homologue. The protein sequence of
BUBR1 is more homologous to MAD3 (Millband and Hardwick, 2002) and the
functions described for BUBR1, in the inhibition of the APC/C by direct binding of
CDC20 are similar to those described for MAD3 (Sudakin et ah, 2001; Fraschini et
ah, 2001). Thus the phenotype of the MAD3 mutant may be the most relevant to
BUBR1AE5. However, BUBR1 does contain a BUB 1-like C-terminal kinase
domain, absent from MAD3, which is thought to have additional functions in mitosis
(Warren et ah, 2002) suggesting the more severe phenotype and intermediate
phenotype between that of a null mutant and the wild type protein exhibited by
BUB1AE5 in S.cerevisiae may be relevant. Thus it appears both the BUB1 and
MAD3 mutants may be pertinent to the phenotype of BUBR1AE5. To clarify this,
investigation of BUBR1 in higher organisms is required. For this reason, the aim of
further investigations was to analyse BUBR1AE5 function using human cell lines.
The functional analysis in human cell lines is based upon previous investigations
of the BUB1 V400 mutation (Cahill et ah, 1998a). Over-expression of this mutant
protein in MIN colorectal tumour cell lines induced a mitotic checkpoint phenotype
similar to that seen in CIN colorectal tumour cell lines. This included a reduced
mitotic index peak and incomplete arrest at mitosis in the presence of nocodazole
with a high proportion of cells re-entering S-phase. These experiments utilised an
inducible expression system involving pTet-On cell lines and tetracycline responsive
vectors expressing the mutant or wild type BUB1 coding sequence and GFP. Thus
similar experiments to investigate the effect ofBUBR1AE5 required the construction
of stable pTet-On colorectal tumour cell lines and full-length and mutant BUBR1
inducible pBI-GFP plasmids. These would then be used to generate double stable
cell lines in which both the pTet-On inducer, rTetR and the appropriate BUBR1
coding sequence under the control of a tetracycline responsive promoter, were
integrated into the genome. Then by addition of the tetracycline derivative
doxycycline to the culture media, the expression of the target BUBR1 gene is turned
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on, with expression being switched off in the absence of the antibiotic. Thus the
double transformants can be induced using doxycycline and the effect of the mutant
protein on mitotic checkpoints analysed by examining the mitotic index and BrdU
incorporation of the mutant and full-length transfected populations. This would
indicate whether BUBR1AE5 induces a mitotic defect in human cell lines and thus
whether it is likely to be a major contributor to CIN in colorectal cancer. The work
described in this thesis attempted to construct the cell line and plasmid tools required
for this analysis. I successfully managed to isolate clones of diploid colorectal
tumour cell lines with the pTet-On plasmid stably integrated into the genome.
However, luciferase assays revealed this cell line showed variable levels of induction
of target genes and this would require optimisation before use in further assays. In
addition, construction of plasmid forms of the mutant and wild type BUBR1
sequences was undertaken. The wild type pBI-GFP BUBR1 plasmid was
successfully constructed but unfortunately, numerous attempts at constructing
BUBR1AE5 did not yield any plasmids containing the mutant sequence and the
cloning strategy may require further development or optimisation for isolation of the
deleted plasmid. These will however be useful resources for future analysis of the
function ofBUBR1AE5 in colorectal tumourigenesis.
The effect of the mutations on the localisation and interactions of BUBR1 and
BUB1 would also be a good direction for future investigation. Chen et ah, have
previously reported that BUBR1 is required for the kinetochore localisation of
BUB1, MAD1, MAD2 and CENP-E (Chen et ah, 2002) and also that BUB1 may be
required as a scaffold to recruit BUB3, MAD1, MAD2 and CENP-E (Sharp-Baker
and Chen, 2001) and the effect of the AE5 mutation on these functions could be
investigated in human cell lines. For this analysis, antibodies to the N-terminal of
BUB1 and BUBR1 were developed as currently available antibodies were raised to
sequences predicted to be removed or altered by the AE5 and V400 deletions. In
addition molecular biology techniques were utilised to construct EGFP fusion
vectors of the BUB1 and BUBR1 mutant and wild type proteins. These are to be
utilised in future immunofluorescence and co-immunoprecipitation experiments to
investigate the effects of AE5 and V400 on the localisation and interactions of
BUBR1 and BUB1.
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These antibodies could also be used to investigate the effect and occurrence of the
BUBR1AE5 mutation in tumours through western blot analysis of tumour protein
samples. The mutation was initially identified through a mutant RNA transcript in
colorectal tumours and is predicted to cause a frameshift and truncation of the
BUBR1 protein, but the effect at the protein level is unknown and it would be useful
to clarify this. The antibodies may aid further investigation of the size and nature of
the protein expressed by the BUBR1AE5 allele. This may also help to solve
hypotheses that AE5 may represent an alternative splicing affect as it deletes the
entire exon 5 ofBUBRl.
The genomic change associated with the AE5 deletion has been investigated using
long-range genomic PCR techniques and sequencing of the surrounding introns, but
as yet no genomic change has been identified and other deletion mapping strategies
are being employed. Much of these difficulties are believed to be due to poor quality
DNA and protein material from the original tumours and thus we are also currently
attempting to identify the change in a new panel of tumours from which higher
quality DNA and protein material can be isolated and used in further analysis.
This will be important for clarifying the relevance of the results from the yeast
studies. The yeast assays investigated the effect of the AE5 mutations on the
assumption that they did not cause truncation of the BUB1 or BUBR1 proteins. If
this is not valid and the AE5 and V400 proteins are truncated, the phenotypes
associated with them might be expected to be more severe.
One of the interesting outcomes of the yeast functional analyses was the
suggestion that the phenotypes exhibited by tumours with spindle checkpoint
mutations may vary in their severity according to the gene which is mutated and the
type of mutation. In human tumour studies, mutations in spindle checkpoint genes
are fairly rare but combinations of polymorphisms and variations in levels of spindle
checkpoint protein expression may contribute to the CIN observed frequently in
tumours(see table 1.4) (Sato et al., 2000; Seike et al., 2002). Polymorphic variants of
MAD1 which are associated with cancer cell lines have been demonstrated to disrupt
its interactions with MAD2 and are thus thought to compromise spindle checkpoint
function. In addition a polymorphic variant of STK15 (an auroraB homologue) is
associated with increased levels of aneuploidy in colorectal tumours and confers an
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increased cancer risk in mice (Ewart-Toland, 2003). It appears the contribution of
spindle checkpoint defects to tumours is widespread and very variable, with a great
deal of variation between tumour types. Several spindle checkpoint mutations have
been identified in colorectal tumours but extensive analysis of other tumour types,
including those specifically associated with aneuploidy have not identified many
spindle checkpoint mutations, but some polymorphisms and variations in protein
expression (Saeki et ah, 2002). Thus it appears the contribution of mutations in
spindle checkpoint genes to aneuploidy may be a colorectal tumour specific effect.
The explanation for this is not clear but perhaps the high turnover rate of colorectal
cells or the driving influence of faecal carcinogens may be contributory factors,
perhaps by accelerating the rate of mutations in apoptotic genes to allow checkpoint
mutant cells to avoid lethality. Studies ofmultiple tumour types suggest mild spindle
checkpoint mutations, polymorphisms and variations in expression levels may be
responsible for a proportion of all aneuploid cancers and these may act in
combination with similar minor defects in other mitotic genes to produce CIN and
accelerate tumourigenesis. It is likely that a broad range of mitotic genes, some of
which are listed in table 1.2, each contribute to a subset of tumours by producing
CIN and allowing aneuploidy to develop.
The two conflicting theories regarding the driving force behind tumourigenesis
are selection versus growth advantage. Early mutation of genes involved in
protecting the stability of the genome would invoke a mutator phenotype necessary
for tumour progression (Loeb, 2001) but Tomlinson and Bodmer argue that selection
for growth advantage is the initiator and accelerator of tumourigenesis (Tomlinson
and Bodmer, 1999) Defects in mitotic genes and proteins may provide a solution to
the selection for mutation versus growth advantage paradox. They are envisaged to
induce a mutator phenotype by the development of CIN and thus accelerate
tumourigenesis. Cells with mutations in checkpoint genes, which prevent mitotic
arrest at mitosis in the presence of defects, may also impart a growth advantage on
the cell and thus the cell cycle would be shorter, further accelerating tumourigenesis.
The p53 protein is involved in both the maintenance of genomic stability through cell
cycle checkpoints and also in apoptosis and would thus confer a growth advantage
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when mutated. Mutations in p53 are common in tumours, occurring in at least 50%,
and in colorectal tumours p53 mutations are generally late events (Molinari, 2000).
So where do spindle checkpoint defects fit into the established order ofmutations
in colorectal tumours? Current evidence suggests CIN and aneuploidy are early
events in tumourigenesis (Fischbach et al., 1991). Assuming that this is true we
would expect spindle checkpoint defects to also be early events in colorectal
tumourigenesis providing a chromosomal instability and growth advantage to drive
later stages of tumour progression. For the CIN to allow the accumulation of
multiple gene alterations, through mutation, gene rearrangements and the loss and
gain of chromosomes, it is likely there must also be at least one mutation in the
apoptosis pathway to allow survival of the mutant cells and their subsequent
selection to tumourigenesis. This apoptotic mutation may be an earlier event than
the development of the mitotic defect, thus allowing the survival of a sub-population
of cells with defects in chromosome segregation. Alternatively, it may develop as a
result of the accelerated mutator phenotype produced by CIN and occur downstream
of it. The population of cells with a mitotic defect would be expected to accumulate
a wide range of different mutations through chromosome segregation. By chance, a
proportion of these cells may develop mutations in apoptotic genes, allowing them to
survive the accumulation of numerous genetic alterations and accelerating their
tumourigenic potential. This hypothesis could be further addressed by examining
colorectal tumours with mitotic defects for mutations and variable expression of
apoptotic genes and other key contributors to colorectal tumourigenesis such as K-
Ras, p53 and APC. The examination of tumours at different stages of
tumourigenesis would also provide important information when determining the
order of mutations in tumour progression. The BUB1 and BUBR1 antibodies
developed during the work described in this thesis could be used for example to
examine the expression of these spindle checkpoint proteins in tumours and
adenomas at different stages. Understanding the order of mutations in
carcinogenesis, can aid diagnosis and treatment of patient tumours.
The relatively rare identification of spindle checkpoint mutations in tumours may
reflect the wide range ofmitotic genes potentially involved in generating aneuploidy.
However, studies in mice suggest mutations in spindle checkpoint genes may be
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lethal (Dobles et al., 2001) and thus mutations which abolish checkpoint function
may be selected against in tumourigenesis. This is interesting in the context of the
checkpoint mutations described here, where the yeast functional analysis shows that
the identified mutations induce compromisation but not full abolition of checkpoint
function and checkpoint protein complex formation, at least in the case of BUB1.
This would impart the advantageous mutator and growth advantage phenotypes on
the cell but may allow them to escape the lethality associated with full abolishment
of protein function. Thus only those mutations which compromise checkpoint
function without fully abolishing it may be observed in tumours, with full 'knock¬
out' mutations being lethal to the cell, reducing the frequency of such mutations.
This is supported by evidence from microcolony and benomyl sensitivity assays
which demonstrate that the AE5 mutants are more viable than the null bubl and
mad3 mutants. In summary, it is likely that there is a small range of spindle
checkpoint mutations which impart growth advantages and mutator phenotypes while
avoiding the lethality associated with null mutants.
This is further supported by the hypothesis that the known checkpoint mutations,
which are heterozygous in nature, exert dominant negative effects, preventing the
protein expressed from the wild type allele from functioning correctly. If the mutant
allele produced a protein whose function was abolished this would produce a near
null phenotype, which may be lethal to the cell. In addition, only one germline
defect in spindle checkpoint proteins has been identified in BUB1 (Cahill et al.,
1998) and the effect of this has not been studied, supporting the hypothesis that they
may be lethal during development, even in heterozygous form. Thus spindle
checkpoint mutations may contribute to sporadic colorectal tumours but not to an
inherited susceptibility to aneuploid colorectal tumours. However, spindle
checkpoint polymorphisms may confer a familial susceptibility to aneuploid
colorectal tumours through more subtle defects in mitotic processes.
Future directions for this work could focus on further analysis of the effects of the
AE5 mutations using S.pombe and human systems. This would allow more intricate
investigation of the effects of the mutations on the localisation and interactions of the
proteins. Analysis in the human system also has increased relevance to the BUBR1
AE5 mutation, as the protein does differ in sequence from the yeast Mad3p and
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Bublp proteins and BUBR1 is suggested to have a prominent role in mitosis
(Ditchfield et el., 2003) and thus the relevance of the BUB1 and MAD3AE5
phenotypes is not clear.
In addition, the genomic change associated with the mutant transcript and nature
of the protein defect will be examined in future work. The development of the
antibodies generated during this work will aid these investigations into the effect of
the AE5 change at the protein level and may also be utilised in
immunohistochemistry experiments to examine expression levels of BUB1 and
BUBR1 at different stages of tumourigenesis.
Ultimately, the effect of the BUBR1AE5 mutation could be further determined by
development of a mutant mouse. The conservation between human and mouse
proteins is greater than that between yeast and human and thus the relevance to
tumourigenesis is greater than that of the yeast functional analysis. In addition, the
physiological effect and impact on tumourigenesis can be examined in mice, while
the mouse embryonic stem cells provide a renewable source for similar functional
analysis to that planned in the human cell lines, including the effect of protein
complex formation, mitotic checkpoint function and protein localisation. The
interaction with other important spindle checkpoint and chromosome segregation
genes could easily be investigated with appropriate strain crosses.
In conclusion, spindle checkpoint mutations such as BUBR1AE5 and BUB1V400
make a significant contribution to spindle checkpoint dysfunction and mis-
segregation of chromosomes. The work presented in this thesis, using a yeast model
system, demonstrated that these mutations abrogate spindle checkpoint function and
induce a chromosome mis-segregation phenotype which is associated with the CIN
observed in the majority of colorectal tumours. These phenotypes are attributable to
specific defects in spindle checkpoint protein complex formation and tools have been
developed to further investigate these effects in a human system. These
investigations will aid our understanding of the significant contribution of spindle
checkpoint mutations to aneuploid tumour formation.
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Appendix 2: BUB1 benomyl sensitivity assay
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Microcolony assay optimisation A
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Appendix 3 Microcolony assay optimisation
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Microcolony assay results A
Appendix 4 MAD3 microcolony assay results
304
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Appendix 5 BUB1 microcolony assay trial
The buhl null strain shows an extreme sensitivity to benomyl, even at low concentrations.
Thus it was decided that the microcolony assay is unable to differentiate between spindle
checkpoint defects and other defects causing a benomyl sensitivity phenotype in BUB1
mutants making it unsuitable for assessing Bublp spindle checkpoint function.
305
Appendix 6: BUB1 liquid culture assay results
306
Experiment Time (Hrs) Comparison x2/1 Probability
Liquid Culture A 0 Vector/Full length 0.148 0.700
0 Vector/AE5 4.031 0.0447
0 AE5/ Full length 2.765 0.0963
6 Vector/Full length 65.257 6.573*10"16
6 Vector/AE5 0.0879 0.767
6 AE5/ Full length 69.312 8.406*10"17
8 Vector/Full length 72.725 1.490*10"17
8 Vector/AE5 2.003 0.157
8 AE5/ Full length 54.737 1.378*10"13
Liquid Culture B 0 Vector/Full length 3.701 0.0544
0 Vector/AE5 0.0962 0.756
0 AE5/ Full length 2.749 0.0973
6 Vector/Full length 62.004 3.428*10"15
6 Vector/AE5 5.172 0.0230
6 AE5/ Full length 36.125 1.851*10"9
8 Vector/Full length 44.243 2.901*10~u
8 Vector/AE5 3 0.0833
8 AE5/ Full length 26.788 2.271 *10"7
Liquid Culture C 0 Vector/Full length 0 1
0 Vector/AE5 0.740 0.390
0 AE5/ Full length 0.740 0.390
6 Vector/Full length 43.614 4.000* 10~n
6 Vector/AE5 1.624 0.203
6 AE5/ Full length 30.042 4.229* 10"8
8 Vector/Full length 67.267 2.371*10"16
8 Vector/AE5 8.081 0.00447
8 AE5/ Full length 32.877 9.819*10"9
Mantel Haenszel 0 Vector/Full length 0.346 0.729
analysis ofA, B and 0 Vector/AE5 0.5161 0.606
C 0 AE5/ Full length 0.8347 0.404
6 Vector/Full length 2.2819 0.0224
6 Vector/AE5 0.3159 0.752
6 AE5/ Full length 2.120 0.034
8 Vector/Full length 2.397 0.0166
8 Vector/AE5 0.567 0.571
8 AE5/ Full length 2.030 0.0424
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Appendix 9: MAD3 Chromosome loss assay results
309
Experiment Comparison y2 /1 Probability
Chromosome loss A Vector/Full length 3.056 0.0804
Vector/AE5 1.009 0.315
AE5/ Full length 6.259 0.0124
Chromosome loss B Vector/Full length 12.579 0.000390
Vector/AE5 0.0137 0.907





Chromosome loss C Vector/Full length 25.637 4.120*10"7
Vector/AE5 2.315 0.128
AE5/ Full length 13.216 0.000278
Mantel Haenszel analysis of A, B and C Vector/Full length 5.854 <0.0001
Vector/AE5 0.357 0.721
AE5/ Full length 5.303 <0.0001
Appendix 10: MAD3 chromosome loss assay Chi-squared analysis
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bubl + YCPLac22 bubl + pBUBl-AE5 bubl + pBUB1
bubl + YCPLac22 bubl + pBUBl-AE5 bubl + pBUBl
bubl + YCPLac22 bubl + pBUB1-AE5 bubl + pBUB1
Appendix 11: BUB1 chromosome loss assays
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Appendix 12: BUB1 Chromosome loss assay results
312
Experiment Comparison y2 /1 Probability
Chromosome loss A Vector/Full length 94.219 2.824*10"22
Vector/AE5 5.228 0.0222
AE5/Full length 147.471 6.191*10 34
Chromosome loss B Vector/Full length 298.010 8.940*10"67
Vector/AE5 32.088 1.474*10"08
AE5/Full length 114.737 8.985*10 27
Chromosome loss C Vector/Full length 182.833 1.167*10"41
Vector/AE5 0.143 0.7058
AE5/Full length 175.290 5.176*10~40
Mantel Haenszel analysis ofA, B and C Vector/Full length 23.181 <0.0001
Vector/AE5 2.332 0.0198
AE5/Full length 17.692 <0.0001










Appendix 14: MAD3 overexpression chromosome loss assays
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Appendix 15: BUB1 overexpression chromosome loss assays
315
